0001306830-23-000129.txt : 20230808 0001306830-23-000129.hdr.sgml : 20230808 20230808162523 ACCESSION NUMBER: 0001306830-23-000129 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 107 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230808 DATE AS OF CHANGE: 20230808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Celanese Corp CENTRAL INDEX KEY: 0001306830 STANDARD INDUSTRIAL CLASSIFICATION: PLASTIC MATERIAL, SYNTH RESIN/RUBBER, CELLULOS (NO GLASS) [2820] IRS NUMBER: 980420726 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-32410 FILM NUMBER: 231151789 BUSINESS ADDRESS: STREET 1: 222 W. LAS COLINAS BLVD., SUITE 900N CITY: IRVING STATE: TX ZIP: 75039-5421 BUSINESS PHONE: 972-443-4000 MAIL ADDRESS: STREET 1: 222 W. LAS COLINAS BLVD., SUITE 900N CITY: IRVING STATE: TX ZIP: 75039-5421 FORMER COMPANY: FORMER CONFORMED NAME: Celanese CORP DATE OF NAME CHANGE: 20041102 FORMER COMPANY: FORMER CONFORMED NAME: Blackstone Crystal Holdings Capital Partners (Cayman) IV Ltd. DATE OF NAME CHANGE: 20041022 10-Q 1 ce-20230630.htm 10-Q ce-20230630
000130683012/312023Q2falsehttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#InterestExpensehttp://fasb.org/us-gaap/2023#InterestExpensehttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2023#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#InterestExpensehttp://fasb.org/us-gaap/2023#InterestExpensehttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2023#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsCurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsCurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent61100013068302023-01-012023-06-300001306830us-gaap:CommonStockMember2023-01-012023-06-300001306830ce:EURSeniorUnsecuredNotesDue2023Member2023-01-012023-06-300001306830ce:EURSeniorUnsecuredNotesDue2025Member2023-01-012023-06-300001306830ce:EURSeniorUnsecuredNotesDue2026Member2023-01-012023-06-300001306830ce:EURSeniorUnsecuredNotesDue2027Member2023-01-012023-06-300001306830ce:EURSeniorUnsecuredNotesDue2028Member2023-01-012023-06-300001306830ce:EURSeniorUnsecuredNotesDue2029Member2023-01-012023-06-3000013068302023-08-04xbrli:shares00013068302023-04-012023-06-30iso4217:USD00013068302022-04-012022-06-3000013068302022-01-012022-06-30iso4217:USDxbrli:shares00013068302023-06-3000013068302022-12-310001306830us-gaap:CommonStockMember2023-03-310001306830us-gaap:CommonStockMember2022-03-310001306830us-gaap:CommonStockMember2023-04-012023-06-300001306830us-gaap:CommonStockMember2022-04-012022-06-300001306830us-gaap:CommonStockMember2023-06-300001306830us-gaap:CommonStockMember2022-06-300001306830us-gaap:TreasuryStockCommonMember2023-03-310001306830us-gaap:TreasuryStockCommonMember2022-03-310001306830us-gaap:TreasuryStockCommonMember2023-04-012023-06-300001306830us-gaap:TreasuryStockCommonMember2022-04-012022-06-300001306830us-gaap:TreasuryStockCommonMember2023-06-300001306830us-gaap:TreasuryStockCommonMember2022-06-300001306830us-gaap:AdditionalPaidInCapitalMember2023-03-310001306830us-gaap:AdditionalPaidInCapitalMember2022-03-310001306830us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001306830us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001306830us-gaap:AdditionalPaidInCapitalMember2023-06-300001306830us-gaap:AdditionalPaidInCapitalMember2022-06-300001306830us-gaap:RetainedEarningsMember2023-03-310001306830us-gaap:RetainedEarningsMember2022-03-310001306830us-gaap:RetainedEarningsMember2023-04-012023-06-300001306830us-gaap:RetainedEarningsMember2022-04-012022-06-300001306830us-gaap:RetainedEarningsMember2023-06-300001306830us-gaap:RetainedEarningsMember2022-06-300001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-3000013068302022-06-300001306830us-gaap:NoncontrollingInterestMember2023-03-310001306830us-gaap:NoncontrollingInterestMember2022-03-310001306830us-gaap:NoncontrollingInterestMember2023-04-012023-06-300001306830us-gaap:NoncontrollingInterestMember2022-04-012022-06-300001306830us-gaap:NoncontrollingInterestMember2023-06-300001306830us-gaap:NoncontrollingInterestMember2022-06-300001306830us-gaap:CommonStockMember2022-12-310001306830us-gaap:CommonStockMember2021-12-310001306830us-gaap:CommonStockMember2023-01-012023-06-300001306830us-gaap:CommonStockMember2022-01-012022-06-300001306830us-gaap:TreasuryStockCommonMember2022-12-310001306830us-gaap:TreasuryStockCommonMember2021-12-310001306830us-gaap:TreasuryStockCommonMember2023-01-012023-06-300001306830us-gaap:TreasuryStockCommonMember2022-01-012022-06-300001306830us-gaap:AdditionalPaidInCapitalMember2022-12-310001306830us-gaap:AdditionalPaidInCapitalMember2021-12-310001306830us-gaap:AdditionalPaidInCapitalMember2023-01-012023-06-300001306830us-gaap:AdditionalPaidInCapitalMember2022-01-012022-06-300001306830us-gaap:RetainedEarningsMember2022-12-310001306830us-gaap:RetainedEarningsMember2021-12-310001306830us-gaap:RetainedEarningsMember2023-01-012023-06-300001306830us-gaap:RetainedEarningsMember2022-01-012022-06-300001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-300001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-300001306830us-gaap:NoncontrollingInterestMember2022-12-310001306830us-gaap:NoncontrollingInterestMember2021-12-310001306830us-gaap:NoncontrollingInterestMember2023-01-012023-06-300001306830us-gaap:NoncontrollingInterestMember2022-01-012022-06-3000013068302021-12-310001306830ce:ConsolidatedVenturesMember2023-06-30xbrli:pure0001306830ce:MobilityMaterialsMember2022-11-010001306830ce:MobilityMaterialsMember2022-11-012022-11-01ce:facilityce:patentce:employees0001306830ce:MobilityMaterialsMember2022-04-012022-06-300001306830ce:MobilityMaterialsMember2022-01-012022-06-300001306830ce:CelaneseCorporationMemberce:NutrinovaJointVentureMember2023-06-220001306830ce:MitsuiCoLtdMemberce:NutrinovaJointVentureMember2023-06-220001306830ce:MitsuiCoLtdMemberce:NutrinovaJointVentureMember2023-06-222023-06-220001306830us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberce:FoodIngredientsMember2023-06-300001306830ce:KoreaEngineeringPlasticsCoLtdMemberce:CelaneseCorporationMember2022-04-010001306830ce:KoreaEngineeringPlasticsCoLtdMemberce:MitsubishiGasChemicalCompanyMember2022-04-010001306830ce:KoreaEngineeringPlasticsCoLtdMember2022-04-012022-04-010001306830ce:KoreaEngineeringPlasticsCoLtdMember2022-04-01ce:annualInstallmentiso4217:EUR0001306830ce:EngineeredMaterialsMember2022-12-310001306830ce:AcetylChainMember2022-12-310001306830ce:EngineeredMaterialsMember2023-01-012023-06-300001306830ce:AcetylChainMember2023-01-012023-06-300001306830ce:EngineeredMaterialsMember2023-06-300001306830ce:AcetylChainMember2023-06-300001306830us-gaap:LicensingAgreementsMember2022-12-310001306830us-gaap:CustomerRelationshipsMember2022-12-310001306830us-gaap:DevelopedTechnologyRightsMember2022-12-310001306830us-gaap:OtherIntangibleAssetsMember2022-12-310001306830us-gaap:LicensingAgreementsMember2023-01-012023-06-300001306830us-gaap:CustomerRelationshipsMember2023-01-012023-06-300001306830us-gaap:DevelopedTechnologyRightsMember2023-01-012023-06-300001306830us-gaap:OtherIntangibleAssetsMember2023-01-012023-06-300001306830us-gaap:LicensingAgreementsMember2023-06-300001306830us-gaap:CustomerRelationshipsMember2023-06-300001306830us-gaap:DevelopedTechnologyRightsMember2023-06-300001306830us-gaap:OtherIntangibleAssetsMember2023-06-300001306830us-gaap:TrademarksAndTradeNamesMember2022-12-310001306830us-gaap:TrademarksAndTradeNamesMember2023-01-012023-06-300001306830us-gaap:TrademarksAndTradeNamesMember2023-06-300001306830ce:MobilityMaterialsMember2023-06-300001306830ce:MobilityMaterialsMember2022-12-310001306830us-gaap:RevolvingCreditFacilityMember2023-06-300001306830us-gaap:RevolvingCreditFacilityMember2022-12-310001306830us-gaap:ShortTermDebtMember2023-06-300001306830us-gaap:ShortTermDebtMember2022-12-310001306830us-gaap:RevolvingCreditFacilityMember2023-06-300001306830us-gaap:RevolvingCreditFacilityMember2022-12-310001306830ce:EURSeniorUnsecuredNotesDue2023Member2023-06-300001306830ce:EURSeniorUnsecuredNotesDue2023Member2022-12-310001306830ce:SeniorUnsecuredNotesDue2024Member2023-06-300001306830ce:SeniorUnsecuredNotesDue2024Member2022-12-310001306830ce:USDSeniorUnsecuredNotesDue2024Member2023-06-300001306830ce:USDSeniorUnsecuredNotesDue2024Member2022-12-310001306830ce:EURSeniorUnsecuredNotesDue2025Member2023-06-300001306830ce:EURSeniorUnsecuredNotesDue2025Member2022-12-310001306830ce:USDSeniorUnsecuredNotesDue2025Member2023-06-300001306830ce:USDSeniorUnsecuredNotesDue2025Member2022-12-310001306830ce:SeniorUnsecuredTermLoanDue2025Member2023-06-300001306830ce:SeniorUnsecuredTermLoanDue2025Member2022-12-310001306830ce:USDSeniorUnsecuredNotesDue2026Member2023-06-300001306830ce:USDSeniorUnsecuredNotesDue2026Member2022-12-310001306830ce:EURSeniorUnsecuredNotesDue2026Member2023-06-300001306830ce:EURSeniorUnsecuredNotesDue2026Member2022-12-310001306830ce:EURSeniorUnsecuredNotesDue2027Member2023-06-300001306830ce:EURSeniorUnsecuredNotesDue2027Member2022-12-310001306830ce:USDSeniorUnsecuredNotesDue2027Member2023-06-300001306830ce:USDSeniorUnsecuredNotesDue2027Member2022-12-310001306830ce:SeniorUnsecuredTermLoanDue2027Member2023-06-300001306830ce:SeniorUnsecuredTermLoanDue2027Member2022-12-310001306830ce:EURSeniorUnsecuredNotesDue2028Member2023-06-300001306830ce:EURSeniorUnsecuredNotesDue2028Member2022-12-310001306830ce:EURSeniorUnsecuredNotesDue2029Member2023-06-300001306830ce:EURSeniorUnsecuredNotesDue2029Member2022-12-310001306830ce:USDSeniorUnsecuredNotesDue2029Member2023-06-300001306830ce:USDSeniorUnsecuredNotesDue2029Member2022-12-310001306830ce:USDSeniorUnsecuredNotesDue2032Member2023-06-300001306830ce:USDSeniorUnsecuredNotesDue2032Member2022-12-310001306830srt:MinimumMemberce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember2023-06-300001306830srt:MaximumMemberce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember2023-06-300001306830ce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember2023-06-300001306830ce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember2022-12-310001306830us-gaap:LoansPayableMember2023-06-300001306830us-gaap:LoansPayableMember2022-12-310001306830ce:TermLoanFacilityMemberce:A364DayDelayedDrawTermLoanMember2022-03-312022-03-310001306830ce:TermLoanFacilityMemberce:A364DayDelayedDrawTermLoanMember2022-03-310001306830ce:TermLoanFacilityMemberce:A5YearDelayedDrawTermLoanMember2022-03-312022-03-310001306830ce:TermLoanFacilityMemberce:A5YearDelayedDrawTermLoanMember2022-03-310001306830ce:TermLoanFacilityMemberce:A3YearDelayedDrawTermLoanMember2022-09-302022-09-300001306830ce:TermLoanFacilityMemberce:A3YearDelayedDrawTermLoanMember2022-09-300001306830us-gaap:RevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2022-03-310001306830ce:ChinaRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2023-01-04iso4217:CNY0001306830ce:ChinaWorkingCapitalTermLoanMemberce:ChinaWorkingCapitalTermLoanMember2023-01-060001306830ce:ChinaWorkingCapitalTermLoanMemberce:ChinaWorkingCapitalTermLoanMember2023-01-062023-01-060001306830ce:VariableInterbankInterestRateMemberce:ChinaWorkingCapitalTermLoanMemberce:ChinaWorkingCapitalTermLoanMember2023-01-062023-01-060001306830us-gaap:RevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2023-06-300001306830ce:ChinaRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2023-06-300001306830ce:AcquisitionNotesMember2022-07-310001306830ce:AcquisitionNotesMember2022-07-312022-07-310001306830ce:AmendedRestatedReceivableSecuritizationFacilityMemberus-gaap:SecuredDebtMember2023-01-012023-06-300001306830ce:AmendedRestatedReceivableSecuritizationFacilityMemberus-gaap:SecuredDebtMember2023-06-300001306830ce:AmendedRestatedReceivableSecuritizationFacilityMemberus-gaap:SecuredDebtMember2022-12-310001306830ce:AmendedRestatedReceivableSecuritizationFacilityMemberus-gaap:SecuredDebtMember2023-01-012023-06-300001306830ce:AmendedRestatedReceivableSecuritizationFacilityMemberus-gaap:SecuredDebtMember2022-01-012022-12-310001306830ce:EuropeFactoringAgreementsMember2023-06-300001306830ce:SingaporeFactoringAgreementsMember2023-06-300001306830ce:EuropeAndSingaporeFactoringAgreementsMember2023-06-300001306830ce:EuropeAndSingaporeFactoringAgreementsMember2022-12-310001306830ce:EuropeAndSingaporeFactoringAgreementsMember2023-01-012023-06-300001306830ce:EuropeAndSingaporeFactoringAgreementsMember2022-01-012022-12-310001306830us-gaap:PensionPlansDefinedBenefitMember2023-04-012023-06-300001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-04-012023-06-300001306830us-gaap:PensionPlansDefinedBenefitMember2022-04-012022-06-300001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-04-012022-06-300001306830us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-06-300001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-012023-06-300001306830us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-06-300001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-06-300001306830us-gaap:PensionPlansDefinedBenefitMember2023-06-300001306830us-gaap:OtherPensionPlansDefinedBenefitMember2023-01-012023-06-300001306830us-gaap:OtherPensionPlansDefinedBenefitMember2023-06-300001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-06-300001306830us-gaap:PensionPlansDefinedBenefitMember2022-12-310001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-12-310001306830ce:PassaicRiverNewJerseyMember2023-01-012023-06-300001306830ce:PassaicRiverNewJerseyMember2016-03-312016-03-310001306830ce:PassaicRiverNewJerseyMember2021-09-302021-09-300001306830ce:PassaicRiverNewJerseyMember2022-12-162022-12-160001306830ce:PassaicRiverNewJerseyMember2023-03-242023-03-240001306830ce:PassaicRiverNewJerseyMember2023-06-300001306830us-gaap:SubsequentEventMember2023-07-192023-07-1900013068302008-02-012023-06-300001306830us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001306830us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310001306830us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310001306830us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-06-300001306830us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-06-300001306830us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-06-300001306830us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300001306830us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-06-300001306830us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-06-300001306830us-gaap:NetInvestmentHedgingMember2023-01-012023-06-300001306830ce:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2023-06-302023-06-300001306830ce:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2022-12-312022-12-310001306830us-gaap:CurrencySwapMemberce:USDSeniorUnsecuredNotesDue2027Member2022-07-310001306830ce:USDSeniorUnsecuredNotesDue2032Memberus-gaap:CurrencySwapMember2022-07-310001306830ce:AcquisitionNotesMemberus-gaap:NetInvestmentHedgingMember2022-07-312022-07-310001306830us-gaap:NondesignatedMember2023-01-012023-06-300001306830us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-06-300001306830us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2022-12-310001306830us-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMember2023-04-012023-06-300001306830us-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMember2022-04-012022-06-300001306830us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2023-04-012023-06-300001306830us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2022-04-012022-06-300001306830us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2023-04-012023-06-300001306830us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-04-012022-06-300001306830us-gaap:CashFlowHedgingMember2023-04-012023-06-300001306830us-gaap:CashFlowHedgingMember2022-04-012022-06-300001306830ce:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2023-04-012023-06-300001306830ce:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2022-04-012022-06-300001306830us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2023-04-012023-06-300001306830us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2022-04-012022-06-300001306830us-gaap:NetInvestmentHedgingMember2023-04-012023-06-300001306830us-gaap:NetInvestmentHedgingMember2022-04-012022-06-300001306830us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-04-012023-06-300001306830us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2022-04-012022-06-300001306830us-gaap:NondesignatedMember2023-04-012023-06-300001306830us-gaap:NondesignatedMember2022-04-012022-06-300001306830us-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMember2023-01-012023-06-300001306830us-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMember2022-01-012022-06-300001306830us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2023-01-012023-06-300001306830us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2022-01-012022-06-300001306830us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2023-01-012023-06-300001306830us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-01-012022-06-300001306830us-gaap:CashFlowHedgingMember2023-01-012023-06-300001306830us-gaap:CashFlowHedgingMember2022-01-012022-06-300001306830ce:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2023-01-012023-06-300001306830ce:ForeignCurrencyDenominatedDebtMemberus-gaap:NetInvestmentHedgingMember2022-01-012022-06-300001306830us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2023-01-012023-06-300001306830us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMember2022-01-012022-06-300001306830us-gaap:NetInvestmentHedgingMember2022-01-012022-06-300001306830us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-01-012023-06-300001306830us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2022-01-012022-06-300001306830us-gaap:NondesignatedMember2022-01-012022-06-300001306830us-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:CommodityContractMember2023-06-300001306830us-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:CommodityContractMember2023-06-300001306830us-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2023-06-300001306830us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:CurrencySwapMember2023-06-300001306830us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMember2023-06-300001306830us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001306830us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMember2023-06-300001306830us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:OtherNoncurrentLiabilitiesMember2023-06-300001306830us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:NondesignatedMember2023-06-300001306830us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMember2023-06-300001306830us-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:CommodityContractMember2022-12-310001306830us-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:CommodityContractMember2022-12-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:CurrencySwapMember2022-12-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:OtherNoncurrentAssetsMember2022-12-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMember2022-12-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001306830us-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2022-12-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMember2022-12-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:OtherNoncurrentLiabilitiesMember2022-12-310001306830us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:NondesignatedMember2022-12-310001306830us-gaap:FairValueInputsLevel2Member2023-06-300001306830us-gaap:FairValueInputsLevel3Member2023-06-300001306830us-gaap:FairValueInputsLevel2Member2022-12-310001306830us-gaap:FairValueInputsLevel3Member2022-12-310001306830ce:IndemnificationAgreementsHoechstMember2023-06-300001306830ce:IndemnificationAgreementsHoechstMember1999-11-012023-06-300001306830ce:DivestitureAgreementsMember2023-06-300001306830ce:EngineeredMaterialsMemberus-gaap:OperatingSegmentsMember2023-04-012023-06-300001306830ce:AcetylChainMemberus-gaap:OperatingSegmentsMember2023-04-012023-06-300001306830us-gaap:CorporateNonSegmentMemberus-gaap:CorporateAndOtherMember2023-04-012023-06-300001306830us-gaap:IntersegmentEliminationMember2023-04-012023-06-300001306830ce:EngineeredMaterialsMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300001306830ce:AcetylChainMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300001306830us-gaap:CorporateNonSegmentMemberus-gaap:CorporateAndOtherMember2022-04-012022-06-300001306830us-gaap:IntersegmentEliminationMember2022-04-012022-06-300001306830ce:EngineeredMaterialsMemberus-gaap:OperatingSegmentsMember2023-01-012023-06-300001306830ce:AcetylChainMemberus-gaap:OperatingSegmentsMember2023-01-012023-06-300001306830us-gaap:CorporateNonSegmentMemberus-gaap:CorporateAndOtherMember2023-01-012023-06-300001306830us-gaap:IntersegmentEliminationMember2023-01-012023-06-300001306830ce:EngineeredMaterialsMemberus-gaap:OperatingSegmentsMember2023-06-300001306830ce:AcetylChainMemberus-gaap:OperatingSegmentsMember2023-06-300001306830us-gaap:CorporateNonSegmentMemberus-gaap:CorporateAndOtherMember2023-06-300001306830us-gaap:IntersegmentEliminationMember2023-06-300001306830ce:EngineeredMaterialsMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300001306830ce:AcetylChainMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300001306830us-gaap:CorporateNonSegmentMemberus-gaap:CorporateAndOtherMember2022-01-012022-06-300001306830us-gaap:IntersegmentEliminationMember2022-01-012022-06-300001306830ce:EngineeredMaterialsMemberus-gaap:OperatingSegmentsMember2022-12-310001306830ce:AcetylChainMemberus-gaap:OperatingSegmentsMember2022-12-310001306830us-gaap:CorporateNonSegmentMemberus-gaap:CorporateAndOtherMember2022-12-310001306830us-gaap:IntersegmentEliminationMember2022-12-3100013068302023-07-012023-06-3000013068302024-01-012023-06-3000013068302025-01-012023-06-300001306830ce:EngineeredMaterialsMembersrt:NorthAmericaMember2023-04-012023-06-300001306830ce:EngineeredMaterialsMembersrt:NorthAmericaMember2022-04-012022-06-300001306830ce:EngineeredMaterialsMembersrt:NorthAmericaMember2023-01-012023-06-300001306830ce:EngineeredMaterialsMembersrt:NorthAmericaMember2022-01-012022-06-300001306830ce:EngineeredMaterialsMemberus-gaap:EMEAMember2023-04-012023-06-300001306830ce:EngineeredMaterialsMemberus-gaap:EMEAMember2022-04-012022-06-300001306830ce:EngineeredMaterialsMemberus-gaap:EMEAMember2023-01-012023-06-300001306830ce:EngineeredMaterialsMemberus-gaap:EMEAMember2022-01-012022-06-300001306830ce:EngineeredMaterialsMembersrt:AsiaPacificMember2023-04-012023-06-300001306830ce:EngineeredMaterialsMembersrt:AsiaPacificMember2022-04-012022-06-300001306830ce:EngineeredMaterialsMembersrt:AsiaPacificMember2023-01-012023-06-300001306830ce:EngineeredMaterialsMembersrt:AsiaPacificMember2022-01-012022-06-300001306830ce:EngineeredMaterialsMembersrt:SouthAmericaMember2023-04-012023-06-300001306830ce:EngineeredMaterialsMembersrt:SouthAmericaMember2022-04-012022-06-300001306830ce:EngineeredMaterialsMembersrt:SouthAmericaMember2023-01-012023-06-300001306830ce:EngineeredMaterialsMembersrt:SouthAmericaMember2022-01-012022-06-300001306830ce:EngineeredMaterialsMember2023-04-012023-06-300001306830ce:EngineeredMaterialsMember2022-04-012022-06-300001306830ce:EngineeredMaterialsMember2022-01-012022-06-300001306830ce:AcetylChainMembersrt:NorthAmericaMember2023-04-012023-06-300001306830ce:AcetylChainMembersrt:NorthAmericaMember2022-04-012022-06-300001306830ce:AcetylChainMembersrt:NorthAmericaMember2023-01-012023-06-300001306830ce:AcetylChainMembersrt:NorthAmericaMember2022-01-012022-06-300001306830ce:AcetylChainMemberus-gaap:EMEAMember2023-04-012023-06-300001306830ce:AcetylChainMemberus-gaap:EMEAMember2022-04-012022-06-300001306830ce:AcetylChainMemberus-gaap:EMEAMember2023-01-012023-06-300001306830ce:AcetylChainMemberus-gaap:EMEAMember2022-01-012022-06-300001306830ce:AcetylChainMembersrt:AsiaPacificMember2023-04-012023-06-300001306830ce:AcetylChainMembersrt:AsiaPacificMember2022-04-012022-06-300001306830ce:AcetylChainMembersrt:AsiaPacificMember2023-01-012023-06-300001306830ce:AcetylChainMembersrt:AsiaPacificMember2022-01-012022-06-300001306830srt:SouthAmericaMemberce:AcetylChainMember2023-04-012023-06-300001306830srt:SouthAmericaMemberce:AcetylChainMember2022-04-012022-06-300001306830srt:SouthAmericaMemberce:AcetylChainMember2023-01-012023-06-300001306830srt:SouthAmericaMemberce:AcetylChainMember2022-01-012022-06-300001306830ce:AcetylChainMember2023-04-012023-06-300001306830ce:AcetylChainMember2022-04-012022-06-300001306830ce:AcetylChainMember2022-01-012022-06-300001306830ce:AcetylChainMemberus-gaap:IntersegmentEliminationMember2023-04-012023-06-300001306830ce:AcetylChainMemberus-gaap:IntersegmentEliminationMember2022-04-012022-06-300001306830ce:AcetylChainMemberus-gaap:IntersegmentEliminationMember2023-01-012023-06-300001306830ce:AcetylChainMemberus-gaap:IntersegmentEliminationMember2022-01-012022-06-300001306830us-gaap:EmployeeStockOptionMember2023-04-012023-06-300001306830us-gaap:EmployeeStockOptionMember2022-04-012022-06-300001306830us-gaap:EmployeeStockOptionMember2023-01-012023-06-300001306830us-gaap:EmployeeStockOptionMember2022-01-012022-06-300001306830us-gaap:RestrictedStockUnitsRSUMember2023-04-012023-06-300001306830us-gaap:RestrictedStockUnitsRSUMember2022-04-012022-06-300001306830us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-06-300001306830us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-06-300001306830ce:EngineeredMaterialsMemberus-gaap:EmployeeSeveranceMember2022-12-310001306830ce:AcetylChainMemberus-gaap:EmployeeSeveranceMember2022-12-310001306830us-gaap:CorporateAndOtherMemberus-gaap:EmployeeSeveranceMember2022-12-310001306830us-gaap:EmployeeSeveranceMember2022-12-310001306830ce:EngineeredMaterialsMemberus-gaap:EmployeeSeveranceMember2023-01-012023-06-300001306830ce:AcetylChainMemberus-gaap:EmployeeSeveranceMember2023-01-012023-06-300001306830us-gaap:CorporateAndOtherMemberus-gaap:EmployeeSeveranceMember2023-01-012023-06-300001306830us-gaap:EmployeeSeveranceMember2023-01-012023-06-300001306830ce:EngineeredMaterialsMemberus-gaap:EmployeeSeveranceMember2023-06-300001306830ce:AcetylChainMemberus-gaap:EmployeeSeveranceMember2023-06-300001306830us-gaap:CorporateAndOtherMemberus-gaap:EmployeeSeveranceMember2023-06-300001306830us-gaap:EmployeeSeveranceMember2023-06-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________________________________
Form 10-Q
☑QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
June 30, 2023
Or
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 001-32410
CElogo.jpg
CELANESE CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Delaware98-0420726
(State or Other Jurisdiction of Incorporation or Organization)(I.R.S. Employer Identification No.)

222 W. Las Colinas Blvd., Suite 900N
Irving, TX 75039-5421
(Address of Principal Executive Offices and zip code)

(972) 443-4000
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s) Name of Each Exchange on Which Registered
Common Stock, par value $0.0001 per shareCEThe New York Stock Exchange
1.125% Senior Notes due 2023CE /23The New York Stock Exchange
1.250% Senior Notes due 2025CE /25The New York Stock Exchange
4.777% Senior Notes due 2026CE /26AThe New York Stock Exchange
2.125% Senior Notes due 2027CE /27The New York Stock Exchange
0.625% Senior Notes due 2028CE /28The New York Stock Exchange
5.337% Senior Notes due 2029CE /29AThe New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑  No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑  No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer  þ Accelerated filer  ☐ Non-accelerated filer  ☐ Smaller reporting company  ☐ Emerging growth company  ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No ☑
The number of outstanding shares of the registrant's Common Stock, $0.0001 par value, as of August 4, 2023 was 108,852,226.

CELANESE CORPORATION AND SUBSIDIARIES
Form 10-Q
For the Quarterly Period Ended June 30, 2023
TABLE OF CONTENTS
Page
2

Item 1. Financial Statements
CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended
June 30, 		Six Months Ended
June 30,
2023202220232022
(In $ millions, except share and per share data)
Net sales2,795 2,486 5,648 5,024 
Cost of sales(2,109)(1,781)(4,331)(3,574)
Gross profit686 705 1,317 1,450 
Selling, general and administrative expenses(274)(197)(559)(371)
Amortization of intangible assets(42)(11)(83)(22)
Research and development expenses(40)(26)(82)(50)
Other (charges) gains, net(10)1 (33)— 
Foreign exchange gain (loss), net15 (1)21 (2)
Gain (loss) on disposition of businesses and assets, net— 12 5 9 
Operating profit (loss)335 483 586 1,014 
Equity in net earnings (loss) of affiliates23 60 38 116 
Non-operating pension and other postretirement employee benefit (expense) income(2)25 (1)49 
Interest expense(182)(48)(364)(83)
Interest income7 1 15 2 
Dividend income - equity investments31 36 65 73 
Other income (expense), net4 (3)(2)(1)
Earnings (loss) from continuing operations before tax216 554 337 1,170 
Income tax (provision) benefit4 (112)(21)(224)
Earnings (loss) from continuing operations220 442 316 946 
Earnings (loss) from operation of discontinued operations— (8)(3)(8)
Income tax (provision) benefit from discontinued operations1 2 1 2 
Earnings (loss) from discontinued operations1 (6)(2)(6)
Net earnings (loss)221 436 314 940 
Net (earnings) loss attributable to noncontrolling interests(1)(2)(3)(4)
Net earnings (loss) attributable to Celanese Corporation220 434 311 936 
Amounts attributable to Celanese Corporation    
Earnings (loss) from continuing operations219 440 313 942 
Earnings (loss) from discontinued operations1 (6)(2)(6)
Net earnings (loss)220 434 311 936 
Earnings (loss) per common share - basic    
Continuing operations2.01 4.06 2.88 8.70 
Discontinued operations0.01 (0.06)(0.02)(0.06)
Net earnings (loss) - basic2.02 4.00 2.86 8.64 
Earnings (loss) per common share - diluted    
Continuing operations2.00 4.03 2.86 8.63 
Discontinued operations0.01 (0.05)(0.01)(0.06)
Net earnings (loss) - diluted2.01 3.98 2.85 8.57 
Weighted average shares - basic108,886,678 108,392,155 108,761,071 108,289,603 
Weighted average shares - diluted109,306,331 109,123,349 109,281,364 109,158,055 

See the accompanying notes to the unaudited interim consolidated financial statements.
3
CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF
COMPREHENSIVE INCOME (LOSS)
Three Months Ended
June 30, 		Six Months Ended
June 30,
2023202220232022
(In $ millions)
Net earnings (loss)221 436 314 940 
Other comprehensive income (loss), net of tax
Foreign currency translation gain (loss)(201)(131)(188)(152)
Gain (loss) on cash flow hedges— 26 4 41 
Pension and postretirement benefits1 — — 2 
Total other comprehensive income (loss), net of tax(200)(105)(184)(109)
Total comprehensive income (loss), net of tax21 331 130 831 
Comprehensive (income) loss attributable to noncontrolling interests
(1)(2)(3)(4)
Comprehensive income (loss) attributable to Celanese Corporation
20 329 127 827 

See the accompanying notes to the unaudited interim consolidated financial statements.
4
CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED CONSOLIDATED BALANCE SHEETS
As of
June 30,
2023		As of
December 31,
2022
(In $ millions, except share data)
ASSETS
Current Assets  
Cash and cash equivalents1,296 1,508 
Trade receivables - third party and affiliates1,338 1,379 
Non-trade receivables, net625 675 
Inventories2,514 2,808 
Assets held for sale211 — 
Other assets268 241 
Total current assets6,252 6,611 
Investments in affiliates1,028 1,062 
Property, plant and equipment (net of accumulated depreciation - 2023: $3,830; 2022: $3,687)
5,541 5,584 
Operating lease right-of-use assets403 413 
Deferred income taxes832 808 
Other assets523 547 
Goodwill7,063 7,142 
Intangible assets, net4,007 4,105 
Total assets25,649 26,272 
LIABILITIES AND EQUITY
Current Liabilities  
Short-term borrowings and current installments of long-term debt - third party and affiliates
1,507 1,306 
Trade payables - third party and affiliates1,243 1,518 
Liabilities held for sale19 — 
Other liabilities1,146 1,201 
Income taxes payable7 43 
Total current liabilities3,922 4,068 
Long-term debt, net of unamortized deferred financing costs12,889 13,373 
Deferred income taxes1,220 1,242 
Uncertain tax positions285 322 
Benefit obligations406 411 
Operating lease liabilities347 364 
Other liabilities492 387 
Commitments and Contingencies
Shareholders' Equity  
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2023 and 2022: 0 issued and outstanding)
— — 
Common stock, $0.0001 par value, 400,000,000 shares authorized (2023: 170,458,836 issued and 108,847,435 outstanding; 2022: 170,135,425 issued and 108,473,932 outstanding)
— — 
Treasury stock, at cost (2023: 61,611,401 shares; 2022: 61,661,493 shares)
(5,490)(5,491)
Additional paid-in capital383 372 
Retained earnings11,433 11,274 
Accumulated other comprehensive income (loss), net(702)(518)
Total Celanese Corporation shareholders' equity5,624 5,637 
Noncontrolling interests464 468 
Total equity6,088 6,105 
Total liabilities and equity25,649 26,272 
See the accompanying notes to the unaudited interim consolidated financial statements.
5
CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF EQUITY
Three Months Ended June 30,
20232022
SharesAmountSharesAmount
(In $ millions, except share data)
Common Stock
Balance as of the beginning of the period108,786,738 — 108,307,341 — 
Stock awards60,697 — 38,694 — 
Balance as of the end of the period108,847,435 — 108,346,035 — 
Treasury Stock
Balance as of the beginning of the period61,661,493 (5,491)61,736,289 (5,492)
Issuance of treasury stock under stock plans(50,092)1 (32,243)— 
Balance as of the end of the period61,611,401 (5,490)61,704,046 (5,492)
Additional Paid-In Capital
Balance as of the beginning of the period365 326 
Stock-based compensation, net of tax18 18 
Balance as of the end of the period383 344 
Retained Earnings
Balance as of the beginning of the period11,289 10,106 
Net earnings (loss) attributable to Celanese Corporation220 434 
Common stock dividends(76)(74)
Balance as of the end of the period11,433 10,466 
Accumulated Other Comprehensive Income (Loss), Net
Balance as of the beginning of the period(502)(333)
Other comprehensive income (loss), net of tax(200)(105)
Balance as of the end of the period(702)(438)
Total Celanese Corporation shareholders' equity5,624 4,880 
Noncontrolling Interests
Balance as of the beginning of the period469 346 
Net earnings (loss) attributable to noncontrolling interests1 2 
Distributions/dividends to noncontrolling interests(6)(3)
Balance as of the end of the period464 345 
Total equity6,088 5,225 

See the accompanying notes to the unaudited interim consolidated financial statements.
6
CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF EQUITY
Six Months Ended June 30,
20232022
SharesAmountSharesAmount
(In $ millions, except share data)
Common Stock
Balance as of the beginning of the period108,473,932 — 108,023,735 — 
Stock awards373,503 — 322,300 — 
Balance as of the end of the period108,847,435 — 108,346,035 — 
Treasury Stock
Balance as of the beginning of the period61,661,493 (5,491)61,736,289 (5,492)
Issuance of treasury stock under stock plans(50,092)1 (32,243)— 
Balance as of the end of the period61,611,401 (5,490)61,704,046 (5,492)
Additional Paid-In Capital
Balance as of the beginning of the period372 333 
Stock-based compensation, net of tax11 11 
Balance as of the end of the period383 344 
Retained Earnings
Balance as of the beginning of the period11,274 9,677 
Net earnings (loss) attributable to Celanese Corporation311 936 
Common stock dividends(152)(147)
Balance as of the end of the period11,433 10,466 
Accumulated Other Comprehensive Income (Loss), Net
Balance as of the beginning of the period(518)(329)
Other comprehensive income (loss), net of tax(184)(109)
Balance as of the end of the period(702)(438)
Total Celanese Corporation shareholders' equity5,624 4,880 
Noncontrolling Interests
Balance as of the beginning of the period468 348 
Net earnings (loss) attributable to noncontrolling interests3 4 
Distributions/dividends to noncontrolling interests(7)(7)
Balance as of the end of the period464 345 
Total equity6,088 5,225 

See the accompanying notes to the unaudited interim consolidated financial statements.
7
CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS
Six Months Ended
June 30,
20232022
(In $ millions)
Operating Activities
Net earnings (loss)314 940 
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities
Depreciation, amortization and accretion359 213 
Pension and postretirement net periodic benefit cost7 (42)
Pension and postretirement contributions(24)(23)
Deferred income taxes, net(3)15 
(Gain) loss on disposition of businesses and assets, net(4)(8)
Stock-based compensation32 31 
Undistributed earnings in unconsolidated affiliates(15)(10)
Other, net(4)5 
Operating cash provided by (used in) discontinued operations(4)(19)
Changes in operating assets and liabilities
Trade receivables - third party and affiliates, net(10)(216)
Inventories220 (251)
Other assets187 22 
Trade payables - third party and affiliates(211)169 
Other liabilities(178)(15)
Net cash provided by (used in) operating activities666 811 
Investing Activities
Capital expenditures on property, plant and equipment(309)(261)
Acquisitions, net of cash acquired— (14)
Proceeds from sale of businesses and assets, net9 16 
Other, net(41)(26)
Net cash provided by (used in) investing activities(341)(285)
Financing Activities
Net change in short-term borrowings with maturities of 3 months or less(300)19 
Proceeds from short-term borrowings349 — 
Repayments of short-term borrowings(370)— 
Repayments of long-term debt(13)(14)
Purchases of treasury stock, including related fees— (17)
Common stock dividends(152)(147)
Distributions to noncontrolling interests(7)(7)
Issuance cost of bridge facility— (63)
Other, net(23)(25)
Net cash provided by (used in) financing activities(516)(254)
Exchange rate effects on cash and cash equivalents(21)(25)
Net increase (decrease) in cash and cash equivalents(212)247 
Cash and cash equivalents as of beginning of period1,508 536 
Cash and cash equivalents as of end of period1,296 783 

See the accompanying notes to the unaudited interim consolidated financial statements.
8
CELANESE CORPORATION AND SUBSIDIARIES
NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
1. Description of the Company and Basis of Presentation
Description of the Company
Celanese Corporation and its subsidiaries (collectively, the "Company") is a global chemical and specialty materials company. The Company produces high performance engineered polymers that are used in a variety of high-value applications, as well as acetyl products, which are intermediate chemicals, for nearly all major industries. The Company also engineers and manufactures a wide variety of products essential to everyday living. The Company's broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, consumer and medical, energy storage, filtration, food and beverage, paints and coatings, paper and packaging, performance industrial and textiles.
Definitions
In this Quarterly Report on Form 10-Q ("Quarterly Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The term "Celanese U.S." refers to the Company's subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries.
Basis of Presentation
The unaudited interim consolidated financial statements for the three and six months ended June 30, 2023 and 2022 contained in this Quarterly Report were prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for all periods presented and include the accounts of the Company, its majority owned subsidiaries over which the Company exercises control and, when applicable, variable interest entities in which the Company is the primary beneficiary. The unaudited interim consolidated financial statements and other financial information included in this Quarterly Report, unless otherwise specified, have been presented to separately show the effects of discontinued operations.
In the opinion of management, the accompanying unaudited consolidated balance sheets and related unaudited interim consolidated statements of operations, comprehensive income (loss), cash flows and equity include all adjustments, consisting only of normal recurring items necessary for their fair presentation in conformity with U.S. GAAP. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with rules and regulations of the Securities and Exchange Commission ("SEC"). These unaudited interim consolidated financial statements should be read in conjunction with the Company's consolidated financial statements as of and for the year ended December 31, 2022, filed on February 24, 2023 with the SEC as part of the Company's Annual Report on Form 10-K.
Operating results for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the entire year.
In the ordinary course of business, the Company enters into contracts and agreements relative to a number of topics, including acquisitions, dispositions, joint ventures, supply agreements, product sales and other arrangements. The Company endeavors to describe those contracts or agreements that are material to its business, results of operations or financial position. The Company may also describe some arrangements that are not material but in which the Company believes investors may have an interest or which may have been included in a Form 8-K filing. Investors should not assume the Company has described all contracts and agreements relative to the Company's business in this Quarterly Report.
For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside shareholders' interests are shown as noncontrolling interests.
Estimates and Assumptions
The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of Net sales, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension
9
and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates.
2. Recent Accounting Pronouncements
There are no recent Accounting Standard Updates issued by the Financial Accounting Standards Board which are expected to materially impact the Company's financial position, operating results or financial disclosures.
3. Acquisitions, Dispositions and Plant Closures
Acquisitions
In November 2022, the Company acquired 100% ownership of entities and assets consisting of a majority of the Mobility & Materials business ("M&M") of DuPont de Nemours, Inc. ("DuPont") (the "M&M Acquisition") for a purchase price of $11.0 billion, subject to transaction adjustments, in an all-cash transaction. The Company acquired a global production network of 29 facilities, including compounding and polymerization, customer and supplier contracts and agreements, an intellectual property portfolio, including approximately 850 patents with associated technical and R&D assets, and approximately 5,000 employees across the manufacturing, technical, and commercial organizations. This acquisition of M&M enhances the engineered materials product portfolio by adding new polymers, brands, product technology, and backward integration in critical polymers, allowing the Company to accelerate growth in high-value applications including future mobility, connectivity and medical. The acquisition was accounted for as a business combination and the acquired operations are included in the Engineered Materials segment.
The Company preliminarily allocated the purchase price of the acquisition to identifiable assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date. The purchase price allocation was based upon preliminary information and is subject to change if additional information about the facts and circumstances that existed at the acquisition date becomes available. The Company is in the ongoing process of conducting a valuation of the assets acquired and liabilities assumed related to the acquisition, including trade names and customer relationships, personal and real property, investment in equity affiliates and deferred taxes. The final fair value of the net assets acquired may result in adjustments to these assets and liabilities, including goodwill. During the measurement period to date, there were no adjustments that materially impacted the Company's goodwill initially recorded.
The following unaudited pro forma financial information presents the consolidated results of operations as if the M&M Acquisition had occurred at the beginning of 2022. M&M's pre-acquisition results have been added to the Company's historical results. The pro forma results contained in the table below include adjustments for (i) increased depreciation expense as a result of acquisition date fair value adjustments, (ii) amortization of acquired intangibles, (iii) interest expense and amortization of debt issuance costs of $171 million and $343 million related to borrowings under the U.S. Term Loan Facility (defined below) and the issuance of Acquisition Notes (defined below) as if these had taken place at the beginning of 2022 for the three and six months ended June 30, 2022, respectively and (iv) net total inventory step up of inventory amortized to Cost of sales of $33 million and $131 million for the three and six months ended June 30, 2022, respectively.
These pro forma results have been prepared for comparative purposes only and are not necessarily indicative of the results of operations as they would have been had the acquisitions occurred on the assumed dates, nor are they necessarily an indication of future operating results.
Three Months Ended
June 30, 2022		Six Months Ended
June 30, 2022
(In $ millions)
Unaudited Consolidated Pro Forma Results
Proforma Net sales
3,397 6,824 
Proforma Earnings (loss) from continuing operations before tax
285 597 
Nutrinova Joint Venture
On June 22, 2023, the Company announced the signing of a definitive agreement with Mitsui & Co., Ltd. ("Mitsui") to form a food ingredients joint venture under the name Nutrinova. The Company will contribute receivables, inventory, property, plant and equipment, certain intangible assets, other assets, other liabilities, technology and employees of its food ingredients business while retaining a 30% stake in the joint venture. Mitsui will acquire the remaining 70% stake at a purchase price of
10
$473 million. The parties expect to close the transaction in the second half of 2023, pending regulatory approvals. The Company will account for its remaining investment in the food ingredients business as an equity method investment.
As of June 30, 2023, the food ingredients business, currently included in the Engineered Materials segment, was classified as held for sale and measured and reported at the lower of its carrying amount or fair value less costs to sell. The assets and liabilities classified as held for sale in the unaudited consolidated balance sheet are as follows:
As of
June 30,
2023
(In $ millions)
Current assets83 
Goodwill80 
Other long-term assets48 
Assets held for sale211 
Other liabilities19 
Liabilities held for sale19 
Korea Engineering Plastics Co. Restructuring
In April 2022, the Company completed the restructuring of Korea Engineering Plastics Co. ("KEPCO"), a joint venture owned 50% by the Company and 50% by Mitsubishi Gas Chemical Company, Inc. KEPCO was first formed in 1987 to manufacture and market polyoxymethylene ("POM") in Asia, with a particular focus on serving domestic demand in South Korea. KEPCO will now focus solely on manufacturing and supplying high quality products to its shareholders, who will independently market them globally. As part of the restructuring of KEPCO, the Company paid KEPCO $5 million and will pay 5 equal annual installments of €24 million on October 1 of each year beginning in 2022. This resulted in an increase to the Company's investment in KEPCO of $134 million. The Company's joint venture partner will make similar payments to KEPCO. The restructuring did not result in a change in ownership percentage of KEPCO, nor a change in control, and KEPCO will continue to be accounted for as an equity method investment.
4. Inventories
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Finished goods1,632 1,820 
Work-in-process202 202 
Raw materials and supplies680 786 
Total2,514 2,808 
11
5. Goodwill and Intangible Assets, Net
Goodwill
Engineered
Materials		Acetyl ChainTotal
(In $ millions)
As of December 31, 20226,775 367 7,142 
Acquisitions (Note 3)
8 — 8 
Transfer(1)
(80)— (80)
Exchange rate changes(11)4 (7)
As of June 30, 2023(2)
6,692 371 7,063 
______________________________
(1)Related to goodwill reclassified to assets held for sale (Note 3).
(2)There were no accumulated impairment losses as of June 30, 2023.
Intangible Assets, Net
Finite-lived intangible assets are as follows:
LicensesCustomer-
Related
Intangible
Assets		Developed
Technology		Covenants
Not to
Compete
and Other		Total
(In $ millions)
Gross Asset Value
As of December 31, 202242 2,455 601 55 3,153 
Transfer(1)
— (58)(1)— (59)
Exchange rate changes(2)9 (6)— 1 
As of June 30, 202340 2,406 594 55 3,095 
Accumulated Amortization
As of December 31, 2022(39)(567)(50)(40)(696)
Amortization— (63)(20)— (83)
Transfer(1)
— 58 1 — 59 
Exchange rate changes2 (7)(1)— (6)
As of June 30, 2023(37)(579)(70)(40)(726)
Net book value3 1,827 524 15 2,369 
______________________________
(1)Related to finite-lived intangible assets reclassified to assets held for sale (Note 3).
Indefinite-lived intangible assets are as follows:
Trademarks
and Trade Names
(In $ millions)
As of December 31, 20221,648 
Transfer(1)
(14)
Exchange rate changes4 
As of June 30, 20231,638 
______________________________
(1)Related to indefinite-lived intangible assets reclassified to assets held for sale (Note 3).
During the six months ended June 30, 2023, the Company did not renew or extend any intangible assets.
12
Estimated amortization expense for the succeeding five fiscal years is as follows:
(In $ millions)
2024160 
2025160 
2026160 
2027160 
2028160 
6. Current Other Liabilities
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Benefit obligations (Note 8)
25 25 
Customer rebates88 101 
Derivatives (Note 12)
64 63 
Interest (Note 7)
290 265 
Legal (Note 14)
25 21 
Operating leases89 83 
Restructuring (Note 18)
21 6 
Salaries and benefits132 151 
Sales and use tax/foreign withholding tax payable99 108 
Investment in affiliates87 79 
Other(1)
226 299 
Total1,146 1,201 
____________________________
(1)Includes $115 million and $166 million payable to DuPont related to the M&M Acquisition and transition activities as of June 30, 2023 and December 31, 2022, respectively.
7. Debt
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates
Current installments of long-term debt1,050 506 
Short-term borrowings, including amounts due to affiliates(1)
250 500 
Revolving credit facilities(2)
207 300 
Total1,507 1,306 
______________________________
(1)The weighted average interest rate was 4.9% and 5.8% as of June 30, 2023 and December 31, 2022, respectively.
(2)The weighted average interest rate was 3.4% and 5.8% as of June 30, 2023 and December 31, 2022, respectively.
13
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Long-Term Debt
Senior unsecured notes due 2023, interest rate of 1.125%
489 480 
Senior unsecured notes due 2024, interest rate of 3.500%
500 499 
Senior unsecured notes due 2024, interest rate of 5.900%
2,000 2,000 
Senior unsecured notes due 2025, interest rate of 1.250%
326 320 
Senior unsecured notes due 2025, interest rate of 6.050%
1,750 1,750 
Senior unsecured term loan due 2025, interest rate of 6.760%
750 750 
Senior unsecured notes due 2026, interest rate of 1.400%
400 400 
Senior unsecured notes due 2026, interest rate of 4.777%
1,087 1,067 
Senior unsecured notes due 2027, interest rate of 2.125%
541 531 
Senior unsecured notes due 2027, interest rate of 6.165%
2,000 2,000 
Senior unsecured term loan due 2027, interest rate of 6.760%
1,000 1,000 
Senior unsecured notes due 2028, interest rate of 0.625%
543 533 
Senior unsecured notes due 2029, interest rate of 5.337%
543 533 
Senior unsecured notes due 2029, interest rate of 6.330%
750 750 
Senior unsecured notes due 2032, interest rate of 6.379%
1,000 1,000 
Pollution control and industrial revenue bonds due at various dates through 2030, interest rates ranging from 4.05% to 5.00%
163 164 
Bank loans due at various dates through 2026(1)
4 4 
Obligations under finance leases due at various dates through 2054
157 172 
Subtotal14,003 13,953 
Unamortized debt issuance costs(2)
(64)(74)
Current installments of long-term debt(1,050)(506)
Total12,889 13,373 
______________________________
(1)The weighted average interest rate was 1.3% and 1.3% as of June 30, 2023 and December 31, 2022, respectively.
(2)Related to the Company's long-term debt, excluding obligations under finance leases.
Senior Credit Facilities
In March 2022, Celanese, Celanese U.S. and certain subsidiaries entered into a term loan credit agreement (the "March 2022 U.S. Term Loan Credit Agreement"), pursuant to which lenders provided a tranche of delayed-draw term loans due 364 days from issuance in an amount equal to $500 million and a tranche of delayed-draw term loans due 5 years from issuance in an amount equal to $1.0 billion. In September 2022, Celanese, Celanese U.S. and certain subsidiaries entered into an additional term loan credit agreement (the "September 2022 U.S. Term Loan Credit Agreement" and, together with the March 2022 U.S. Term Loan Credit Agreement, the "U.S. Term Loan Credit Agreements"), pursuant to which lenders have provided delayed-draw term loans due 3 years from issuance in an amount equal to $750 million (the term loans represented by the U.S. Term Loan Credit Agreements collectively, the "U.S. Term Loan Facility"). The U.S. Term Loan Facility was fully drawn during the three months ended December 31, 2022.
Also in March 2022, Celanese, Celanese U.S. and certain subsidiaries entered into a new revolving credit agreement (the "U.S. Revolving Credit Agreement" and, together with the U.S. Term Loan Credit Agreements, the "U.S. Credit Agreements") consisting of a $1.75 billion senior unsecured revolving credit facility (with a letter of credit sublimit), maturing in 2027 (the "U.S. Revolving Credit Facility").
On February 21, 2023, the Company amended certain covenants in the U.S. Credit Agreements, including financial ratio maintenance covenants. The U.S. Credit Agreements are guaranteed by Celanese, Celanese U.S. and domestic subsidiaries together representing substantially all of the Company's U.S. assets and business operations (the "Subsidiary Guarantors"). The Subsidiary Guarantors are listed in Exhibit 22.1 to this Quarterly Report.
14
On January 4, 2023, Celanese (Shanghai) International Trading Co., Ltd ("CSIT"), a fully consolidated subsidiary, entered into a restatement of an existing credit facility agreement (the "China Revolving Credit Agreement") to upsize and modify the facility thereunder to consist of an aggregate CNY1.75 billion uncommitted senior unsecured revolving credit facility available under two tranches (with overdraft, bank guarantee and documentary credit sublimits) (the "China Revolving Credit Facility"). Obligations bear interest at certain fixed and floating rates. The China Revolving Credit Agreement is guaranteed by Celanese U.S.
On January 6, 2023, CSIT entered into a senior unsecured working capital loan contract for CNY800 million (the "China Working Capital Term Loan Agreement," together with the China Revolving Credit Agreement, the "China Credit Agreements," and the China Credit Agreements together with the U.S. Credit Agreements, the "Global Credit Agreements"), payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates. The loan under the China Working Capital Term Loan Agreement was fully drawn on January 10, 2023 and is supported by a letter of comfort from the Company. The Company expects that the China Credit Agreements will facilitate its efficient repatriation of cash to the U.S. to repay debt and effectively redomicile a portion of its U.S. debt to China at a lower average interest rate.
The Company's debt balances and amounts available for borrowing under its senior unsecured revolving credit facilities are as follows:
As of
June 30,
2023
(In $ millions)
U.S. Revolving Credit Facility
Borrowings outstanding— 
Available for borrowing1,750 
China Revolving Credit Facility
Borrowings outstanding207 
Available for borrowing34 
Senior Notes
The Company has outstanding senior unsecured notes, issued in public offerings registered under the Securities Act of 1933 ("Securities Act"), as amended (collectively, the "Senior Notes"). The Senior Notes were issued by Celanese U.S. and are guaranteed on a senior unsecured basis by Celanese and the Subsidiary Guarantors. Celanese U.S. may redeem some or all of each of the Senior Notes, prior to their respective maturity dates, at a redemption price of 100% of the principal amount, plus a "make-whole" premium as specified in the applicable indenture, plus accrued and unpaid interest, if any, to the redemption date.
In July 2022, Celanese U.S. completed an offering of $7.5 billion aggregate principal amount of notes of various maturities in a public offering registered under the Securities Act (the "Acquisition USD Notes"). In July 2022, Celanese U.S. completed an offering of €1.5 billion in aggregate principal amount of euro-denominated senior unsecured notes due in 2026 and 2029 in a public offering registered under the Securities Act (collectively, the "Acquisition Euro Notes" and together with the Acquisition USD Notes, the "Acquisition Notes"). Certain of the Acquisition Notes were issued at a discount to par, which will be amortized to Interest expense in the consolidated statements of operations over the terms of the applicable Acquisition Notes. Fees and expenses of the offering of the Acquisition Notes, inclusive of underwriting discounts, were $65 million.
15
Accounts Receivable Purchasing Facility
On June 1, 2023, the Company entered into an amendment to the amended and restated receivables purchase agreement (the "Amended Receivables Purchase Agreement") under its U.S. accounts receivable purchasing facility among certain of the Company's subsidiaries, its wholly-owned, "bankruptcy remote" special purpose subsidiary ("SPE") and certain global financial institutions ("Purchasers"). The Amended Receivables Purchase Agreement extends the term of the accounts receivable purchasing facility such that the SPE may sell certain receivables until June 18, 2025. Under the Amended Receivables Purchase Agreement, transfers of U.S. accounts receivable from the SPE are treated as sales and are accounted for as a reduction in accounts receivable because the agreement transfers effective control over and risk related to the U.S. accounts receivable to the SPE. The Company and related subsidiaries have no continuing involvement in the transferred U.S. accounts receivable, other than collection and administrative responsibilities and, once sold, the U.S. accounts receivable are no longer available to satisfy creditors of the Company or the related subsidiaries. These sales are transacted at 100% of the face value of the relevant U.S. accounts receivable, resulting in derecognition of the U.S. accounts receivables from the Company's unaudited consolidated balance sheet. The Company de-recognized $663 million and $1.1 billion of accounts receivable under this agreement for the six months ended June 30, 2023 and year ended December 31, 2022, respectively, and collected $565 million and $1.1 billion of accounts receivable sold under this agreement during the same periods. Unsold U.S. accounts receivable of $86 million were pledged by the SPE as collateral to the Purchasers as of June 30, 2023.
Factoring and Discounting Agreements
The Company has factoring agreements in Europe and Singapore with financial institutions to sell 100% and 90% of certain accounts receivable, respectively, on a non-recourse basis. These transactions are treated as sales and are accounted for as reductions in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyer. The Company has no continuing involvement in the transferred receivables, other than collection and administrative responsibilities and, once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. The Company de-recognized $196 million and $320 million of accounts receivable under these factoring agreements for the six months ended June 30, 2023 and year ended December 31, 2022, respectively, and collected $189 million and $325 million of accounts receivable sold under these factoring agreements during the same periods.
Covenants
The Company's material financing arrangements contain customary covenants, such as events of default and change of control provisions, and in the case of the U.S. Credit Agreements the maintenance of certain financial ratios (subject to adjustment following certain qualifying acquisitions and dispositions, as set forth in the U.S. Credit Agreements, as amended). Failure to comply with these covenants, or the occurrence of any other event of default, could result in acceleration of the borrowings and other financial obligations. The Company is in compliance with the covenants in its material financing arrangements as of June 30, 2023.
8. Benefit Obligations
The components of net periodic benefit cost are as follows:
Three Months Ended June 30, Six Months Ended June 30,
2023202220232022
Pension
Benefits		Post-retirement
Benefits		Pension
Benefits		Post-retirement
Benefits		Pension
Benefits		Post-retirement
Benefits		Pension
Benefits		Post-retirement
Benefits
(In $ millions)
Service cost2 — 4 — 6 — 7 — 
Interest cost34 1 16 1 66 1 33 1 
Expected return on plan assets
(33)— (42)— (66)— (83)— 
Total3 1 (22)1 6 1 (43)1 
16
Benefit obligation funding is as follows:
As of
June 30,
2023
Total
Expected
2023
(In $ millions)
Cash contributions to defined benefit pension plans13 27 
Benefit payments to nonqualified pension plans9 18 
Benefit payments to other postretirement benefit plans2 4 
The Company's estimates of its U.S. defined benefit pension plan contributions reflect the provisions of the Pension Protection Act of 2006.
Pension and postretirement benefit plan balances recognized in the unaudited consolidated balance sheets consist of the following:
As of June 30, 2023As of December 31, 2022
Pension
Benefits		Post-retirement
Benefits		Pension
Benefits		Post-retirement
Benefits
(In $ millions)
Noncurrent Other assets164 — 160 — 
Current Other liabilities(21)(3)(21)(3)
Benefit obligations(366)(35)(372)(35)
Net amount recognized(223)(38)(233)(38)
9. Environmental
The Company is subject to environmental laws and regulations worldwide that impose limitations on the discharge of pollutants into the air and water, establish standards for the treatment, storage and disposal of solid and hazardous wastes, and impose record keeping and notification requirements. Failure to timely comply with these laws and regulations may expose the Company to penalties. The Company believes that it is in substantial compliance with all applicable environmental laws and regulations and engages in an ongoing process of updating its controls to mitigate compliance risks. The Company is also subject to retained environmental obligations specified in various contractual agreements arising from the divestiture of certain businesses by the Company or one of its predecessor companies.
The components of environmental remediation liabilities are as follows:
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Demerger obligations (Note 14)
18 20 
Divestiture obligations (Note 14)
13 14 
Active sites20 21 
U.S. Superfund sites8 10 
Other environmental remediation liabilities2 2 
Total61 67 
17
Remediation
Due to its industrial history and through retained contractual and legal obligations, the Company has the obligation to remediate specific areas on its own sites as well as on divested, demerger, orphan or U.S. Superfund sites (defined below). In addition, as part of the demerger agreement between the Company and Hoechst AG ("Hoechst"), a specified portion of the responsibility for environmental liabilities from a number of Hoechst divestitures was transferred to the Company (Note 14). Certain of these sites, at which the Company maintains continuing involvement, were and continue to be designated as discontinued operations when closed. The Company provides for such obligations when the event of loss is probable and reasonably estimable. The Company believes that environmental remediation costs will not have a material adverse effect on the financial position of the Company, but may have a material adverse effect on the results of operations or cash flows in any given period.
U.S. Superfund Sites
In the U.S., the Company may be subject to substantial claims brought by U.S. federal or state regulatory agencies or private individuals pursuant to statutory authority or common law. In particular, the Company has a potential liability under the U.S. Federal Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, and related state laws (collectively referred to as "Superfund") for investigation and cleanup costs at certain sites. At most of these sites, numerous companies, including the Company, or one of its predecessor companies, have been notified that the U.S. Environmental Protection Agency ("EPA"), state governing bodies or private individuals consider such companies to be potentially responsible parties ("PRP") under Superfund or related laws. The proceedings relating to these sites are in various stages. The cleanup process has not been completed at most sites, and the status of the insurance coverage for some of these proceedings is uncertain. Consequently, the Company cannot accurately determine its ultimate liability for investigation or cleanup costs at these sites.
As events progress at each site for which it has been named a PRP, the Company accrues any probable and reasonably estimable liabilities. In establishing these liabilities, the Company considers the contaminants of concern, the potential impact thereof, the relationship of the contaminants of concern to its current and historic operations, its shipment of waste to a site, its percentage of total waste shipped to the site, the types of wastes involved, the conclusions of any studies, the magnitude of any remedial actions that may be necessary and the number and viability of other PRPs. Often the Company joins with other PRPs to sign joint defense agreements that settle, among PRPs, each party's percentage allocation of costs at the site. Although the ultimate liability may differ from the estimate, the Company routinely reviews the liabilities and revises the estimate, as appropriate, based on the most current information available.
One such site is the Diamond Alkali Superfund Site, which is comprised of a number of sub-sites, including the Lower Passaic River Study Area ("LPRSA"), which is the lower 17-mile stretch of the Passaic River ("Lower Passaic River Site"), and the Newark Bay Study Area. The Company and 70 other companies are parties to a May 2007 Administrative Order on Consent with the EPA to perform a Remedial Investigation/Feasibility Study ("RI/FS") at the Lower Passaic River Site in order to identify the levels of contaminants and potential cleanup actions, including the potential migration of contaminants between the LPRSA and the Newark Bay Area.
In March 2016, the EPA issued its final Record of Decision concerning the remediation of the lower 8.3 miles of the Lower Passaic River Site ("Lower 8.3 Miles"). Pursuant to the EPA's Record of Decision, the Lower 8.3 Miles must be dredged bank to bank and an engineered cap must be installed at an EPA estimated cost of approximately $1.4 billion. In September 2021, the EPA issued a Record of Decision selecting an interim remedial plan for the upper 9 miles of the Lower Passaic River ("Upper 9 Miles"). Pursuant to the EPA's Record of Decision, targeted dredging will be conducted in the Upper 9 Miles to address surface sediments with elevated contamination followed by the installation of an engineered cap at an EPA estimated cost of $441 million.
The Company owned and/or operated facilities in the vicinity of the Lower 8.3 Miles, but has found no evidence that it contributed any of the contaminants of concern to the Passaic River. In June 2018, Occidental Chemical Corporation ("OCC"), the successor to the Diamond Alkali Company, sued a subsidiary of the Company and 119 other parties alleging claims for joint and several damages, contribution and declaratory relief under Section 107 and 113 of Superfund for costs to clean up the LPRSA portion of the Diamond Alkali Superfund Site, Occidental Chemical Corporation v. 21st Century Fox America, Inc., et al, No. 2:18-CV-11273 (MCA) (LDW) (U.S. District Court New Jersey) (the "2018 OCC Lawsuit"), alleging that each of the defendants owned or operated a facility that contributed contamination to the LPRSA. With respect to the Company, the 2018 OCC lawsuit is limited to the former Celanese facility that Essex County, New Jersey has agreed to indemnify the Company for and does not change the Company's estimated liability for LPRSA cleanup costs.
18
Separately, the United States lodged a Consent Decree in U.S. District Court for the District of New Jersey on December 16, 2022 that will resolve the Company's liability (and that of more than 80 other settling defendants) to the EPA for costs to clean up both the Lower 8.3 Miles and Upper 9 Miles of the Lower Passaic River Site in exchange for a collective payment of $150 million, United States v. Alden Leeds, Inc., No. 2:22-7326 (MCA) (LDW) (U.S. District Court New Jersey) ("Consent Decree Action"). The Consent Decree also will provide the Company protection from contribution claims by others for costs incurred to clean up both the Lower 8.3 Miles and Upper 9 Miles of the Lower Passaic River Site. The Company's proposed payment toward the $150 million collective settlement payment is not material to the Company's results of operations, cash flows or financial position. The Consent Decree is still subject to public comment and court approval.
On March 7, 2023, the U.S. District Court for the District of New Jersey entered an order staying and administratively terminating the 2018 OCC Lawsuit, pending resolution of the request for judicial approval of the Consent Decree in the Consent Decree Action. On March 24, 2023, OCC filed a new lawsuit against 40 parties, including a subsidiary of the Company, seeking to recover costs for remedial design work the EPA has ordered OCC to undertake for a portion of the LPRSA at an estimated cost of $71 million, Occidental Chemical Corporation v. Givaudan Fragrances Corporation, No. 2:23-cv-1699 (U.S. District Court New Jersey) (the "2023 OCC Lawsuit"). Like the earlier lawsuit, the 2023 OCC Lawsuit concerns the facility Essex County, New Jersey purchased and for which Essex County, New Jersey has agreed to defend and indemnify the Company. This new lawsuit does not change the Company's estimated liability for LPRSA cleanup costs.
The Company will continue to vigorously defend these matters and continues to believe that its ultimate allocable share of the cleanup costs with respect to the Lower Passaic River Site, previously estimated at less than 1%, will not be material.
Other Environmental Matters
In April 2022, a methanol leak on a pipeline to our Bishop, Texas facility was discovered. The release has been contained, the leak has been repaired and the pipeline has resumed operation. The Company promptly disclosed the incident to state and federal authorities, including the Texas Commission on Environmental Quality and the EPA, and remediation activities are now completed. While the Company has not received a notice of violation nor been assessed any fines or penalties to date, the Company recorded a reserve in Other current liabilities based on anticipated clean-up costs and possible penalties to state or federal authorities. The Company does not believe that resolution of this matter will have a material impact on our financial condition or results of operations.
10. Shareholders' Equity
Common Stock
The Company's Board of Directors follows a policy of declaring, subject to legally available funds, a quarterly cash dividend on each share of the Company's Common Stock, par value $0.0001 per share ("Common Stock"), unless the Company's Board of Directors, in its sole discretion, determines otherwise. The amount available to the Company to pay cash dividends is not currently restricted by its existing Global Credit Agreements and its indentures governing its senior unsecured notes. Any decision to declare and pay dividends in the future will be made at the discretion of the Company's Board of Directors and will depend on, among other things, the results of operations, cash requirements, financial condition, contractual restrictions and other factors that the Company's Board of Directors may deem relevant.
The Company declared a quarterly cash dividend of $0.70 per share on its Common Stock on July 19, 2023, amounting to $76 million. The cash dividend will be paid on August 14, 2023 to holders of record as of July 31, 2023.
Treasury Stock
The Company's Board of Directors authorizes repurchases of Common Stock from time to time. These authorizations give management discretion in determining the timing and conditions under which shares may be repurchased. This repurchase program does not have an expiration date.
19
Total From
February 2008
Through
June 30, 2023
Shares repurchased69,324,429 
Average purchase price per share$83.71 
Shares repurchased (in $ millions)$5,803 
Aggregate Board of Directors repurchase authorizations during the period (in $ millions)
$6,866 
The purchase of treasury stock reduces the number of shares outstanding. The repurchased shares may be used by the Company for compensation programs utilizing the Company's stock and other corporate purposes. The Company accounts for treasury stock using the cost method and includes treasury stock as a component of shareholders' equity.
The Company did not repurchase any Common Stock during the six months ended June 30, 2023 or 2022.
Other Comprehensive Income (Loss), Net
Three Months Ended June 30,
20232022
Gross
Amount		Income
Tax
(Provision)
Benefit		Net
Amount		Gross
Amount		Income
Tax
(Provision)
Benefit		Net
Amount
(In $ millions)
Foreign currency translation gain (loss)(214)13 (201)(107)(24)(131)
Gain (loss) on cash flow hedges(1)1 — 33 (7)26 
Pension and postretirement benefits gain (loss)— 1 1 — — — 
Total(215)15 (200)(74)(31)(105)
Six Months Ended June 30,
20232022
Gross
Amount		Income
Tax
(Provision)
Benefit		Net
Amount		Gross
Amount		Income
Tax
(Provision)
Benefit		Net
Amount
(In $ millions)
Foreign currency translation gain (loss)(218)30 (188)(122)(30)(152)
Gain (loss) on cash flow hedges3 1 4 52 (11)41 
Pension and postretirement benefits gain (loss)(1)1 — 2 — 2 
Total(216)32 (184)(68)(41)(109)
Adjustments to Accumulated other comprehensive income (loss), net, are as follows:
Foreign
Currency
Translation Gain (Loss)
Gain (Loss)
on Cash
Flow
Hedges
Pension and
Postretirement
Benefits Gain (Loss)
Accumulated
Other
Comprehensive
Income
(Loss), Net
(In $ millions)
As of December 31, 2022(488)(22)(8)(518)
Other comprehensive income (loss) before reclassifications(218)(2)(1)(221)
Amounts reclassified from accumulated other comprehensive income (loss)
— 5 — 5 
Income tax (provision) benefit30 1 1 32 
As of June 30, 2023(676)(18)(8)(702)
20
11. Income Taxes
Three Months Ended
June 30, 		Six Months Ended
June 30,
2023202220232022
(In percentages)
Effective income tax rate(2)20 6 19 
The effective income tax rate for the three months ended June 30, 2023 was lower compared to the same period in 2022, primarily due to decreased earnings in high taxed jurisdictions related to current demand conditions and a decrease in valuation allowances on U.S. foreign tax credit carryforwards due to revised forecasts of foreign sourced income and expenses during the carryforward period. The effective income tax rate for the six months ended June 30, 2023 was lower compared to the same period in 2022, primarily due to decreased earnings in high taxed jurisdictions related to current demand conditions.
In December 2017, the Tax Cuts and Jobs Act (the "TCJA") was enacted and was effective January 1, 2018. The U.S. Treasury has issued various final and proposed regulatory packages supplementing the TCJA provisions since 2018. There have been no material proposed or final regulatory packages during the three months ended June 30, 2023.
In August 2022, the Inflation Reduction Act (the "IRA") was enacted and included a 1% excise tax on share repurchases in excess of $1 million, and a corporate minimum tax of 15% on adjusted book earnings. The corporate minimum tax paid is creditable in future years to the extent that regular tax liability exceeds the minimum tax in any given year. The Company does not expect these provisions and any newly issued administrative guidance to have a material impact to future income tax expense. The IRA also provides various beneficial credits for energy efficient related manufacturing, transportation and fuels, hydrogen/carbon recapture and renewable energy, which the Company is evaluating in regards to planned projects.
The Company will continue to monitor the expected impacts of any new guidance on the Company's filing positions and will record the impacts as discrete income tax expense or benefit in the period the guidance is finalized or becomes effective.
Due to the TCJA and uncertainty as to future foreign source income, the Company previously recorded a valuation allowance on a substantial portion of its foreign tax credit carryforwards. The Company is currently evaluating tax planning strategies to enable the use of the Company's foreign tax credit carryforwards that may decrease the Company's effective tax rate in future periods as the valuation allowance is reversed.
The Company's tax returns have been under joint audit for the years 2013 through 2015 by the United States, Netherlands and Germany (the "Authorities"). In September 2021, the Company received a draft joint audit report proposing adjustments to transfer pricing and the reallocation of income between the related jurisdictions. The Authorities also proposed to apply these adjustments to open tax years through 2019. The Company and the Authorities were unable to reach an agreement jointly and therefore the audits continued on a separate jurisdictional basis. In the fourth quarter of 2022, the Company concluded settlement discussions with the Dutch tax authorities. The Company is engaged in discussions with the other authorities regarding the ongoing examinations and will evaluate all additional potential remedies as the discussions progress.
In addition, the Company's income tax returns in Mexico are under audit for the year 2018, and in Canada for the years 2016 through 2018. In January 2022, the Mexico tax authorities issued preliminary findings for disallowance of operating expenses on several of the applicable tax returns. The Company has analyzed the preliminary findings, engaged in preliminary discussions with the Mexico tax authorities and has recorded the appropriate tax reserves as of June 30, 2023. The Company will continue discussions with the Mexico authorities in 2023. Related to Canada, the Company is in ongoing discussions regarding the audit findings with the Canadian authorities and does not expect a material impact to income tax expense.
As of June 30, 2023, the Company believes that an adequate provision for income taxes has been made for all open tax years related to the examinations by government authorities. However, the outcome of tax audits cannot be predicted with certainty. If any issues raised in the audits described above are resolved in a manner inconsistent with the Company's expectations or the Company is unsuccessful in defending its positions, the Company could be required to adjust its provision for income taxes in the period such resolution occurs. If required, any such adjustments could be material to the statements of operations and cash flows in the period(s) recorded.
21
12. Derivative Financial Instruments
Derivatives Designated As Hedges
Net Investment Hedges
The total notional amount of foreign currency denominated debt and cross-currency swaps designated as net investment hedges are as follows:
As of
June 30,
2023		As of
December 31,
2022
(In € millions)
Total5,591 5,639 
Concurrently with the offering of the Acquisition USD Notes in July 2022 (Note 7), the Company entered into cross-currency swaps to effectively convert $2.0 billion and $500 million of the Acquisition USD Notes into a euro-denominated borrowing at prevailing euro interest rates, maturing on July 15, 2027 and July 15, 2032, respectively. The swaps and €1.5 billion of the Acquisition Euro Notes qualify and have been designated as net investment hedges of the Company's foreign currency exchange rate exposure on the net investments of certain of its euro-denominated subsidiaries.
Derivatives Not Designated As Hedges
Foreign Currency Forwards and Swaps
Gross notional values of the foreign currency forwards and swaps not designated as hedges are as follows:
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Total1,715 1,314 
22
Information regarding changes in the fair value of the Company's derivative and non-derivative instruments is as follows:
Gain (Loss) Recognized in Other Comprehensive Income (Loss)Gain (Loss) Recognized in Earnings (Loss)
Three Months Ended June 30, Statement of Operations Classification
2023202220232022
(In $ millions)
Designated as Cash Flow Hedges
Commodity swaps(7)42 — 11 Cost of sales
Interest rate swaps— — (2)(2)Interest expense
Foreign currency forwards2 — (1)— Cost of sales
Total(5)42 (3)9 
Designated as Net Investment Hedges
Foreign currency denominated debt (Note 7)
(5)93 — — N/A
Cross-currency swaps(74)25 — — N/A
Total(79)118 — — 
Not Designated as Hedges
Foreign currency forwards and swaps
— — (1)(3)Foreign exchange gain (loss), net; Other income (expense), net
Total— — (1)(3)
Gain (Loss) Recognized in Other Comprehensive Income (Loss)Gain (Loss) Recognized in Earnings (Loss)
Six Months Ended June 30, Statement of Operations Classification
2023202220232022
(In $ millions)
Designated as Cash Flow Hedges
Commodity swaps(7)59 1 11 Cost of sales
Interest rate swaps— — (4)(4)Interest expense
Foreign currency forwards4 — (2)— Cost of sales
Total(3)59 (5)7 
Designated as Net Investment Hedges
Foreign currency denominated debt (Note 7)
(61)121 — — N/A
Cross-currency swaps(93)27 — — N/A
Total(154)148 — — 
Not Designated as Hedges
Foreign currency forwards and swaps— — 1 (4)Foreign exchange gain (loss), net; Other income (expense), net
Total— — 1 (4)
See Note 13 for additional information regarding the fair value of the Company's derivative instruments.
Certain of the Company's commodity swaps, interest rate swaps, cross-currency swaps and foreign currency forwards and swaps permit the Company to net settle all contracts with the counterparty through a single payment in an agreed upon currency in the event of default or early termination of the contract, similar to a master netting arrangement.
23
Information regarding the gross amounts of the Company's derivative instruments and the amounts offset in the unaudited consolidated balance sheets is as follows:
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Derivative Assets
Gross amount recognized156 169 
Gross amount offset in the consolidated balance sheets— — 
Net amount presented in the consolidated balance sheets156 169 
Gross amount not offset in the consolidated balance sheets17 16 
Net amount139 153 
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Derivative Liabilities
Gross amount recognized279 189 
Gross amount offset in the consolidated balance sheets— — 
Net amount presented in the consolidated balance sheets279 189 
Gross amount not offset in the consolidated balance sheets17 16 
Net amount262 173 
13. Fair Value Measurements
The Company's financial assets and liabilities are measured at fair value on a recurring basis as follows:
Derivative financial instruments include interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps and are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 fair value measurement inputs such as interest rates and foreign currency exchange rates. These market inputs are utilized in the discounted cash flow calculation considering the instrument's term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation for interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps are observable in the active markets and are classified as Level 2 in the fair value measurement hierarchy.

24
Fair Value Measurement
Significant Other Observable Inputs
(Level 2)		Balance Sheet Classification
(In $ millions)
As of June 30, 2023
Derivatives Designated as Cash Flow Hedges
Commodity swaps6 Current Other assets
Commodity swaps34 Noncurrent Other assets
Foreign currency forwards and swaps4 Current Other assets
Derivatives Designated as Net Investment Hedges
Cross-currency swaps101 Current Other assets
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps11 Current Other assets
Total assets156 
Derivatives Designated as Net Investment Hedges
Cross-currency swaps(60)Current Other liabilities
Cross-currency swaps(207)Noncurrent Other liabilities
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps(4)Current Other liabilities
Foreign currency forwards and swaps(8)Noncurrent Other liabilities
Total liabilities(279)
Fair Value Measurement
Significant Other Observable Inputs
(Level 2)		Balance Sheet Classification
(In $ millions)
As of December 31, 2022
Derivatives Designated as Cash Flow Hedges
Commodity swaps9 Current Other assets
Commodity swaps39 Noncurrent Other assets
Derivatives Designated as Net Investment Hedges
Cross-currency swaps99 Current Other assets
Cross-currency swaps13 Noncurrent Other assets
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps9 Current Other assets
Total assets169 
Derivatives Designated as Cash Flow Hedges
Commodity swaps(2)Current Other liabilities
Derivatives Designated as Net Investment Hedges
Cross-currency swaps(58)Current Other liabilities
Cross-currency swaps(126)Noncurrent Other liabilities
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps(3)Current Other liabilities
Total liabilities(189)
25
Carrying values and fair values of financial instruments that are not carried at fair value are as follows:
Fair Value Measurement
Carrying
Amount		Significant Other
Observable
Inputs
(Level 2)		Unobservable
Inputs
(Level 3)		Total
(In $ millions)
As of June 30, 2023
Equity investments without readily determinable fair values
170 — — — 
Insurance contracts in nonqualified trusts21 21 — 21 
Long-term debt, including current installments of long-term debt
14,003 13,650 157 13,807 
As of December 31, 2022
Equity investments without readily determinable fair values
170 — — — 
Insurance contracts in nonqualified trusts22 23 — 23 
Long-term debt, including current installments of long-term debt
13,953 13,247 172 13,419 
In general, the equity investments included in the table above are not publicly traded and their fair values are not readily determinable. The Company believes the carrying values approximate fair value. Insurance contracts in nonqualified trusts consist of long-term fixed income securities, which are valued using independent vendor pricing models with observable inputs in the active market and therefore represent a Level 2 fair value measurement. The fair value of long-term debt is based on valuations from third-party banks and market quotations and is classified as Level 2 in the fair value measurement hierarchy. The fair value of obligations under finance leases, which are included in long-term debt, is based on lease payments and discount rates, which are not observable in the market and therefore represents a Level 3 fair value measurement.
As of June 30, 2023, and December 31, 2022, the fair values of cash and cash equivalents, receivables, marketable securities, trade payables, short-term borrowings and the current installments of long-term debt approximate carrying values due to the short-term nature of these instruments. These items have been excluded from the table with the exception of the current installments of long-term debt.
14. Commitments and Contingencies
Commitments
Guarantees
The Company has agreed to guarantee or indemnify third parties for environmental and other liabilities pursuant to a variety of agreements, including asset and business divestiture agreements, leases, settlement agreements and various agreements with affiliated companies. Although many of these obligations contain monetary and/or time limitations, others do not provide such limitations.
The Company has accrued for all probable and reasonably estimable losses associated with all known matters or claims. These known obligations include the following:
•Demerger Obligations
In connection with the Hoechst demerger, the Company agreed to indemnify Hoechst, and its legal successors, for various liabilities under the demerger agreement, including for environmental liabilities associated with contamination arising either from environmental damage in general ("Category A") or under 19 divestiture agreements entered into by Hoechst prior to the demerger ("Category B") (Note 9).
The Company's obligation to indemnify Hoechst, and its legal successors, is capped under Category B at €250 million. If and to the extent the environmental damage should exceed €750 million in aggregate, the Company's obligation to indemnify Hoechst and its legal successors applies, but is then limited to 33.33% of the remediation cost without further limitations. Cumulative
26
payments under the divestiture agreements as of June 30, 2023 are $110 million. Though the Company is significantly under its obligation cap under Category B, most of the divestiture agreements have become time barred and/or any notified environmental damage claims have been partially settled.
The Company has also undertaken in the demerger agreement to indemnify Hoechst and its legal successors for (i) 33.33% of any and all Category A liabilities that result from Hoechst being held as the responsible party pursuant to public law or current or future environmental law or by third parties pursuant to private or public law related to contamination and (ii) liabilities that Hoechst is required to discharge, including tax liabilities, which are associated with businesses that were included in the demerger but were not demerged due to legal restrictions on the transfers of such items. These indemnities do not provide for any monetary or time limitations. The Company has not been requested by Hoechst to make any payments in connection with this indemnification. Accordingly, the Company has not made any payments to Hoechst and its legal successors.
Based on the Company's evaluation of currently available information, including the lack of requests for indemnification, the Company cannot estimate the remaining demerger obligations, if any, in excess of amounts accrued.
•Divestiture Obligations
The Company and its predecessor companies agreed to indemnify third-party purchasers of former businesses and assets for various pre-closing conditions, as well as for breaches of representations, warranties and covenants. Such liabilities also include environmental liability, product liability, antitrust and other liabilities. These indemnifications and guarantees represent standard contractual terms associated with typical divestiture agreements and, other than environmental liabilities, the Company does not believe that they expose the Company to significant risk (Note 9).
The Company has divested numerous businesses, investments and facilities through agreements containing indemnifications or guarantees to the purchasers. Many of the obligations contain monetary and/or time limitations, which extend through 2037. The aggregate amount of outstanding indemnifications and guarantees provided for under these agreements is $116 million as of June 30, 2023. Other agreements do not provide for any monetary or time limitations.
Based on the Company's evaluation of currently available information, including the number of requests for indemnification or other payment received by the Company, the Company cannot estimate the remaining divestiture obligations, if any, in excess of amounts accrued.
Purchase Obligations
In the normal course of business, the Company enters into various purchase commitments for goods and services. The Company maintains a number of "take-or-pay" contracts for purchases of raw materials, utilities and other services. Certain of the contracts contain a contract termination buy-out provision that allows for the Company to exit the contracts for amounts less than the remaining take-or-pay obligations. Additionally, the Company has other outstanding commitments representing maintenance and service agreements, energy and utility agreements, consulting contracts and software agreements. As of June 30, 2023, the Company had unconditional purchase obligations of $4.1 billion, of which $355 million will be paid in 2023, $665 million in 2024, $558 million in 2025, $436 million in 2026, $355 million in 2027 and the balance thereafter through 2042.
Contingencies
The Company is involved in legal and regulatory proceedings, lawsuits, claims and investigations incidental to the normal conduct of business, relating to such matters as product liability, land disputes, insurance coverage disputes, contracts, employment, antitrust or competition, intellectual property, personal injury and other actions in tort, workers' compensation, chemical exposure, asbestos exposure, taxes, trade compliance, acquisitions and divestitures, claims of current and legacy shareholders, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where the Company is named as a defendant and, based on the current facts, does not believe the outcomes from these matters would be material to the Company's results of operations, cash flows or financial position.
27
15. Segment Information
Engineered
Materials		Acetyl
Chain		Other
Activities		EliminationsConsolidated
(In $ millions)
Three Months Ended June 30, 2023
Net sales1,585 1,233 — (23)(1)2,795 
Other (charges) gains, net (Note 18)
(8)— (2)— (10)
Operating profit (loss)158 295 (118)— 335 
Equity in net earnings (loss) of affiliates
18 2 3 — 23 
Depreciation and amortization112 54 6 — 172 
Capital expenditures58 67 27 — 152 (2)
Three Months Ended June 30, 2022
Net sales
948 1,559 — (21)(1)2,486 
Other (charges) gains, net (Note 18)
1 — — — 1 
Operating profit (loss)
166 428 (111)— 483 
Equity in net earnings (loss) of affiliates
53 3 4 — 60 
Depreciation and amortization
45 52 6 — 103 
Capital expenditures
35 87 10 — 132 (2)
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes an increase in accrued capital expenditures of $7 million and $8 million for the three months ended June 30, 2023 and 2022, respectively.
Engineered
Materials		Acetyl
Chain		Other
Activities		EliminationsConsolidated
(In $ millions)
Six Months Ended June 30, 2023
Net sales3,215 2,483 — (50)(1)5,648 
Other (charges) gains, net (Note 18)
(29)(1)(3)— (33)
Operating profit (loss)270 573 (257)— 586 
Equity in net earnings (loss) of affiliates
29 3 6 — 38 
Depreciation and amortization224 108 12 — 344 
Capital expenditures103 118 39 — 260 (2)
As of June 30, 2023
Goodwill and intangible assets, net
10,646 424 — — 11,070 
Total assets
18,146 5,589 1,914 — 25,649 
Six Months Ended June 30, 2022
Net sales
1,858 

3,211 

— (45)(1)5,024 
Operating profit (loss)
290 931 (207)— 1,014 
Equity in net earnings (loss) of affiliates
102 7 7 — 116 
Depreciation and amortization
91 108 10 — 209 
Capital expenditures
65 157 24 — 246 (2)
As of December 31, 2022
Goodwill and intangible assets, net
10,826 421 — — 11,247 
Total assets
20,611 5,471 190 — 26,272 
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes a decrease in accrued capital expenditures of $49 million and $15 million for the six months ended June 30, 2023 and 2022, respectively.
28
16. Revenue Recognition
The Company has certain contracts that represent take-or-pay revenue arrangements in which the Company's performance obligations extend over multiple years. As of June 30, 2023, the Company had $1.3 billion of remaining performance obligations related to take-or-pay contracts. The Company expects to recognize approximately $272 million of its remaining performance obligations as Net sales in 2023, $481 million in 2024, $324 million in 2025 and the balance thereafter.
Contract Balances
Contract liabilities primarily relate to advances or deposits received from the Company's customers before revenue is recognized. These amounts are recorded as deferred revenue and are included in Current and Noncurrent Other liabilities in the unaudited consolidated balance sheets.
The Company does not have any material contract assets as of June 30, 2023.
Disaggregated Revenue
In general, the Company's business segmentation is aligned according to the nature and economic characteristics of its products and customer relationships and provides meaningful disaggregation of each business segment's results of operations.
The Company manages its Engineered Materials business segment through its project management pipeline, which is comprised of a broad range of projects which are solutions-based and are tailored to each customer's unique needs. Projects are identified and selected based on success rate and may involve a number of different polymers per project for use in multiple end-use applications. Therefore, the Company is agnostic toward products and end-use markets for the Engineered Materials business segment.
The Company manages its Acetyl Chain business segment by leveraging its ability to sell chemicals externally to end-use markets or downstream to its acetate tow, intermediate chemistry, emulsion polymers, redispersible powders and ethylene vinyl acetate polymers businesses. Decisions to sell externally and geographically or downstream and along the Acetyl Chain are based on market demand, trade flows and maximizing the value of its chemicals. Therefore, the Company's strategic focus is on executing within this integrated chain model and less on driving product-specific revenue.
Further disaggregation of Net sales by business segment and geographic destination is as follows:
Three Months Ended
June 30, 		Six Months Ended
June 30,
2023202220232022
(In $ millions)
Engineered Materials
North America471 284 950 573 
Europe and Africa519 380 1,079 757 
Asia-Pacific554 256 1,102 477 
South America41 28 84 51 
Total1,585 948 3,215 1,858 
Acetyl Chain
North America361 451 726 876 
Europe and Africa437 545 897 1,137 
Asia-Pacific379 510 746 1,071 
South America33 32 64 82 
Total(1)
1,210 1,538 2,433 3,166 
______________________________
(1)Excludes intersegment sales of $23 million and $21 million for the three months ended June 30, 2023 and 2022, respectively. Excludes intersegment sales of $50 million and $45 million for the six months ended June 30, 2023 and 2022, respectively.
29
17. Earnings (Loss) Per Share
Three Months Ended
June 30, 		Six Months Ended
June 30,
2023202220232022
(In $ millions, except share data)
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations219 440 313 942 
Earnings (loss) from discontinued operations1 (6)(2)(6)
Net earnings (loss)220 434 311 936 
Weighted average shares - basic108,886,678 108,392,155 108,761,071 108,289,603 
Incremental shares attributable to equity awards(1)
419,653 731,194 520,293 868,452 
Weighted average shares - diluted109,306,331 109,123,349 109,281,364 109,158,055 
______________________________
(1)Excludes options to purchase 242,421 and 0 shares of Common Stock for the three months ended June 30, 2023 and 2022, respectively, and 164,739 and 0 shares of Common Stock for the six months ended June 30, 2023 and 2022, respectively, as their effect would have been antidilutive. Excludes 102,773 and 107,287 equity award shares for the three months ended June 30, 2023 and 2022, respectively, and 46,008 and 82,887 equity award shares for the six months ended June 30, 2023 and 2022, respectively, as their effect would have been antidilutive.
18. Other (Charges) Gains, Net
Three Months Ended
June 30, 		Six Months Ended
June 30,
2023202220232022
(In $ millions)
Restructuring(1)
(10)1 (33)— 
Total(10)1 (33)— 
______________________________
(1)Includes employee termination benefits primarily related to Company-wide business optimization projects during the three and six months ended June 30, 2023.
The changes in the restructuring liabilities by business segment are as follows:
Engineered
Materials		Acetyl
Chain		OtherTotal
(In $ millions)
Employee Termination Benefits
As of December 31, 20224 1 1 6 
Additions29 1 3 33 
Cash payments(14)(1)(3)(18)
As of June 30, 202319 1 1 21 
30
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
In this Quarterly Report on Form 10-Q ("Quarterly Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The terms the "Company," "we," "our" and "us," refer to Celanese and its subsidiaries on a consolidated basis. The term "Celanese U.S." refers to the Company's subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries.
The following discussion should be read in conjunction with the Celanese Corporation and Subsidiaries consolidated financial statements as of and for the year ended December 31, 2022 filed on February 24, 2023 with the Securities and Exchange Commission ("SEC") as part of the Company's Annual Report on Form 10-K ("2022 Form 10-K") and the unaudited interim consolidated financial statements and notes to the unaudited interim consolidated financial statements herein, which are prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP").
Investors are cautioned that the forward-looking statements contained in this section and other parts of this Quarterly Report involve both risk and uncertainty. Several important factors could cause actual results to differ materially from those anticipated by these statements. Many of these statements are macroeconomic in nature and are, therefore, beyond the control of management. See "Forward-Looking Statements" below and at the beginning of our 2022 Form 10-K.
Forward-Looking Statements
Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") and other parts of this Quarterly Report contain certain forward-looking statements and information relating to us that are based on the beliefs of our management as well as assumptions made by, and information currently available to, us. Generally, words such as "believe," "expect," "intend," "estimate," "anticipate," "project," "plan," "may," "can," "could," "might," and "will," and similar expressions, as they relate to us are intended to identify forward-looking statements. These statements reflect our current views and beliefs with respect to future events at the time that the statements are made, are not historical facts or guarantees of future performance and involve risks and uncertainties that are difficult to predict and many of which are outside of our control. Further, certain forward-looking statements are based upon assumptions as to future events that may not prove to be accurate. All forward-looking statements made in this Quarterly Report are made as of the date hereof, and the risk that actual results will differ materially from expectations expressed in this Quarterly Report will increase with the passage of time. We undertake no obligation, and disclaim any duty, to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in our expectations or otherwise.
Risk Factors
See Part I - Item 1A. Risk Factors of our 2022 Form 10-K for a description of certain risk factors that you should consider which could significantly affect our financial results. In addition, the following factors, among others, could cause our actual results to differ materially from those results, performance or achievements that may be expressed or implied by such forward-looking statements:
•changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate;
•volatility or changes in the price and availability of raw materials and energy, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources;
•the length and depth of product and industry business cycles particularly in the automotive, electrical, textiles, electronics and construction industries;
•the ability to pass increases in raw material prices, logistics costs and other costs on to customers or otherwise improve margins through price increases;
•the accuracy or inaccuracy of our beliefs or assumptions regarding anticipated benefits of the acquisition (the "M&M Acquisition") by us of the majority of the Mobility & Materials business (the "M&M Business") of DuPont de Nemours, Inc. ("DuPont");
•the possibility that we will not be able to realize all of the anticipated improvements in the M&M Business's financial performance – including optimizing pricing, currency mix and inventory – or realize all of the anticipated benefits of the M&M Acquisition, including synergies and growth opportunities, within the anticipated timeframe or at all, whether as a
31
result of difficulties arising from the operation or integration of the M&M Business or other unanticipated delays, costs, inefficiencies or liabilities;
•increased commercial, legal or regulatory complexity of entering into, or expanding our exposure to, certain end markets and geographies;
•risks in the global economy and equity and credit markets and their potential impact on our ability to pay down debt in the future and/or refinance at suitable rates, in a timely manner, or at all;
•diversion of management's attention from ongoing business operations and opportunities and other disruption caused by the M&M Acquisition and the integration processes and their impact on our existing business and relationships;
•risks and costs associated with increased leverage from the M&M Acquisition, including increased interest expense and potential reduction of business and strategic flexibility;
•the ability to maintain plant utilization rates and to implement planned capacity additions, expansions and maintenance;
•the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants;
•increased price competition and the introduction of competing products by other companies;
•the ability to identify desirable potential acquisition or divestiture opportunities and to complete such transactions, including obtaining regulatory approvals, consistent with our strategy;
•market acceptance of our products and technology;
•compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, transportation, logistics or supply chain disruptions, cybersecurity incidents, terrorism or political unrest, public health crises (including, but not limited to, the COVID-19 pandemic), or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the occurrence of acts of war (such as the Russia-Ukraine conflict) or terrorist incidents or as a result of weather, natural disasters, or other crises;
•the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to us;
•changes in applicable tariffs, duties and trade agreements, tax rates or legislation throughout the world including, but not limited to, adjustments, changes in estimates or interpretations or the resolution of tax examinations or audits that may impact recorded or future tax impacts and potential regulatory and legislative tax developments in the United States and other jurisdictions;
•changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property;
•potential liability for remedial actions and increased costs under existing or future environmental, health and safety regulations, including those relating to climate change or other sustainability matters;
•potential liability resulting from pending or future claims or litigation, including investigations or enforcement actions, or from changes in the laws, regulations or policies of governments or other governmental activities, in the countries in which we operate;
•changes in currency exchange rates and interest rates; and
•various other factors, both referenced and not referenced in this Quarterly Report.
Many of these factors are macroeconomic in nature and are, therefore, beyond our control. Should one or more of these risks or uncertainties materialize, affect us in ways or to an extent that we currently do not expect or consider to be significant, or should underlying assumptions prove incorrect, our actual results, performance or achievements may vary materially from those described in this Quarterly Report as anticipated, believed, estimated, expected, intended, planned or projected. We neither intend nor assume any obligation to update these forward-looking statements, which speak only as of their dates.
32
Overview
We are a global chemical and specialty materials company. We are a leading global producer of high performance engineered polymers that are used in a variety of high-value applications, as well as one of the world's largest producers of acetyl products, which are intermediate chemicals, for nearly all major industries. As a recognized innovator in the chemicals industry, we engineer and manufacture a wide variety of products essential to everyday living. Our broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, medical, consumer electronics, energy storage, filtration, food and beverage, paints and coatings, paper and packaging, performance industrial and textiles. Our products enjoy leading global positions due to our differentiated business models, large global production capacity, operating efficiencies, proprietary technology and competitive cost structures.
Our large and diverse global customer base primarily consists of major companies across a broad array of industries. We hold geographically balanced global positions and participate in diversified end-use applications. We combine a demonstrated track record of execution, strong performance built on differentiated business models and a clear focus on growth and value creation. Known for operational excellence, reliability and execution of our business strategies, we partner with our customers around the globe to deliver best-in-class technologies and solutions.
Results of Operations
Financial Highlights
Three Months Ended June 30, Six Months Ended June 30,
20232022Change20232022Change
(unaudited)
(In $ millions, except percentages)
Statement of Operations Data
Net sales2,795 2,486 309 5,648 5,024 624 
Gross profit686 705 (19)1,317 1,450 (133)
Selling, general and administrative ("SG&A") expenses(274)(197)(77)(559)(371)(188)
Other (charges) gains, net(10)1 (11)(33)— (33)
Operating profit (loss)335 483 (148)586 1,014 (428)
Equity in net earnings (loss) of affiliates23 60 (37)38 116 (78)
Non-operating pension and other postretirement employee benefit (expense) income(2)25 (27)(1)49 (50)
Interest expense(182)(48)(134)(364)(83)(281)
Interest income7 1 6 15 2 13 
Dividend income - equity investments31 36 (5)65 73 (8)
Earnings (loss) from continuing operations before tax216 554 (338)337 1,170 (833)
Earnings (loss) from continuing operations220 442 (222)316 946 (630)
Earnings (loss) from discontinued operations1 (6)7 (2)(6)4 
Net earnings (loss)221 436 (215)314 940 (626)
Net earnings (loss) attributable to Celanese Corporation220 434 (214)311 936 (625)
Other Data
Depreciation and amortization172 103 69 344 209 135 
SG&A expenses as a percentage of Net sales9.8 %7.9 %9.9 %7.4 %
Operating margin(1)
12.0 %19.4 %10.4 %20.2 %
Other (charges) gains, net
Restructuring
(10)1 (11)(33)— (33)
Total Other (charges) gains, net
(10)1 (11)(33)— (33)
______________________________
(1)Defined as Operating profit (loss) divided by Net sales.
33
As of
June 30,
2023		As of
December 31,
2022
(unaudited)
(In $ millions)
Balance Sheet Data
Cash and cash equivalents1,296 1,508 
Short-term borrowings and current installments of long-term debt - third party and affiliates1,507 1,306 
Long-term debt, net of unamortized deferred financing costs12,889 13,373 
Total debt14,396 14,679 
Factors Affecting Business Segment Net Sales
The percentage increase (decrease) in Net sales attributable to each of the factors indicated for each of our business segments is as follows:
Three Months Ended June 30, 2023 Compared to Three Months Ended June 30, 2022
VolumePriceCurrencyTotal
(unaudited)
(In percentages)
Engineered Materials75 (8)— 67 
Acetyl Chain(2)(19)— (21)
Total Company27 (15)— 12 
Six Months Ended June 30, 2023 Compared to Six Months Ended June 30, 2022
VolumePriceCurrencyTotal
(unaudited)
(In percentages)
Engineered Materials77 (2)(2)73 
Acetyl Chain(5)(17)(1)(23)
Total Company26 (12)(2)12 
34
Consolidated Results
Three Months Ended June 30, 2023 Compared to Three Months Ended June 30, 2022
Net sales increased $309 million, or 12%, for the three months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•higher volume in our Engineered Materials segment, primarily related to the M&M Acquisition and the KEPCO restructuring (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information);
partially offset by:
•lower pricing, primarily driven by our Acetyl Chain segment due to weaker economic conditions particularly in Asia, as well our Engineered Materials segment due to decreased energy surcharges, an unfavorable product mix, primarily in Asia and reduced pricing due to market considerations; and
•lower volume in our Acetyl Chain segment, primarily due to decreased demand in Europe.
Operating profit decreased $148 million, or 31%, for the three months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•higher raw material costs and spending in our Engineered Materials segment as a result of the M&M Acquisition;
•lower Net sales in our Acetyl Chain segment; and
•an unfavorable impact of $11 million to Other (charges) gains, net related to Company-wide business optimization projects in the current year (see Note 18 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information);
partially offset by:
•higher Net sales in our Engineered Materials segment; and
•lower raw material and sourcing costs in our Acetyl Chain segment, primarily for ethylene, methanol and acid.
Non-operating pension and other postretirement employee benefit (expense) income decreased $27 million, or 108%, for the three months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•higher interest cost and lower expected return on plan assets.
Equity in net earnings (loss) of affiliates decreased $37 million for the three months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•losses from our DuPont Teijin Films strategic affiliates due to restructuring; and
•a decrease in equity investment in earnings of $4 million as a result of our KEPCO strategic affiliate restructuring.
Our effective income tax rate for the three months ended June 30, 2023 was (2)% compared to 20% for the same period in 2022. The lower effective income tax rate was primarily due to decreased earnings in high taxed jurisdictions related to current demand conditions and a decrease in valuation allowances on U.S. foreign tax credit carryforwards due to revised forecasts of foreign sourced income and expenses during the carryforward period (see Note 11 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information).
35
Six Months Ended June 30, 2023 Compared to Six Months Ended June 30, 2022
Net sales increased $624 million, or 12%, for the six months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•higher volume in our Engineered Materials segment, primarily related to the M&M Acquisition and the KEPCO restructuring (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information);
partially offset by:
•lower pricing, primarily in our Engineered Materials segment due to decreased energy surcharges and an unfavorable product mix in Asia and our Acetyl Chain segment due to weaker economic conditions particularly in Asia;
•lower volume in our Acetyl Chain segment, primarily due to decreased demand in Europe; and
•unfavorable currency impacts, primarily resulting from weaker CNY and euro relative to the U.S. dollar.
Operating profit decreased $428 million, or 42%, for the six months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•higher raw material costs and spending in our Engineered Materials segment as a result of the M&M Acquisition;
•lower Net sales in our Acetyl Chain segment; and
•an unfavorable impact of $33 million to Other (charges) gains, net related to Company-wide business optimization projects in the current year (see Note 18 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information);
partially offset by:
•higher Net sales in our Engineered Materials segment; and
•lower raw material and sourcing costs in our Acetyl Chain segment, primarily for ethylene, methanol and acid.
Non-operating pension and other postretirement employee benefit (expense) income decreased $50 million, or 102%, for the six months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•higher interest cost and lower expected return on plan assets.
Equity in net earnings (loss) of affiliates decreased $78 million for the six months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•losses from our DuPont Teijin Films strategic affiliates due to restructuring; and
•a decrease in equity investment in earnings of $19 million as a result of our KEPCO strategic affiliate restructuring.
Our effective income tax rate for the six months ended June 30, 2023 was 6% compared to 19% for the same period in 2022. The lower effective income tax rate was primarily due to decreased earnings in high taxed jurisdictions related to current demand conditions. See Note 11 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information.
36
Business Segments
Engineered Materials
Three Months Ended June 30, Change%
Change		Six Months Ended June 30, Change%
Change
2023202220232022
(unaudited)
(In $ millions, except percentages)
Net sales1,585 948 637 67.2 %3,215 1,858 1,357 73.0 %
Net Sales Variance
Volume75 %77 %
Price(8)%(2)%
Currency— %(2)%
Other— %— %
Other (charges) gains, net(8)1 (9)(900.0)%(29)— (29)(100.0)%
Operating profit (loss)158 166 (8)(4.8)%270 290 (20)(6.9)%
Operating margin10.0 %17.5 %8.4 %15.6 %
Equity in net earnings (loss) of affiliates
18 53 (35)(66.0)%29 102 (73)(71.6)%
Depreciation and amortization
112 45 67 148.9 %224 91 133 146.2 %
Our Engineered Materials segment includes our engineered materials business, our food ingredients business and certain strategic affiliates. Our engineered materials business develops, produces and supplies a broad portfolio of high performance specialty polymers for automotive and medical applications, as well as industrial products and consumer electronics. Together with our strategic affiliates, our engineered materials business is a leading participant in the global specialty polymers industry.
The pricing of products within the Engineered Materials segment is primarily based on the value of the material we produce and is generally independent of changes in the cost of raw materials, but may be impacted during periods of inflation and increased costs. Therefore, in general, margins may expand or contract in response to changes in raw material costs. We attempt to address increases in raw material costs through appropriate pricing actions.
Three Months Ended June 30, 2023 Compared to Three Months Ended June 30, 2022
Net sales increased for the three months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•higher volume, primarily related to the M&M Acquisition and the KEPCO restructuring (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information);
partially offset by:
•lower pricing for most of our products, primarily due to decreased energy surcharges, an unfavorable product mix, primarily in Asia, and reduced pricing due to market considerations.
Operating profit decreased for the three months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•higher raw material costs as a result of the M&M Acquisition;
•higher spending of $187 million as a result of the M&M Acquisition; and
•an unfavorable impact of $9 million to Other (charges) gains, net related to Company-wide business optimization projects in the current year (see Note 18 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information);
37
largely offset by:
•higher Net sales.
Equity in net earnings (loss) of affiliates decreased for the three months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•losses from our DuPont Teijin Films strategic affiliates due to restructuring; and
•a decrease in equity investment in earnings of $4 million as a result of our KEPCO strategic affiliate restructuring.
Six Months Ended June 30, 2023 Compared to Six Months Ended June 30, 2022
Net sales increased for the six months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•higher volume, primarily related to the M&M Acquisition and the KEPCO restructuring (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information);
partially offset by:
•lower pricing for most of our products, primarily due to decreased energy surcharges and an unfavorable product mix, primarily in Asia; and
•an unfavorable currency impact resulting from a weaker CNY and euro relative to the U.S. dollar.
Operating profit decreased for the six months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•higher raw material costs as a result of the M&M Acquisition;
•higher spending of $374 million as a result of the M&M Acquisition; and
•an unfavorable impact of $29 million to Other (charges) gains, net related to Company-wide business optimization projects in the current year (see Note 18 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information);
largely offset by:
•higher Net sales.
Equity in net earnings (loss) of affiliates decreased for the six months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•losses from our DuPont Teijin Films strategic affiliates due to restructuring; and
•a decrease in equity investment in earnings of $19 million as a result of our KEPCO strategic affiliate restructuring.
38
Acetyl Chain
Three Months Ended June 30, Change%
Change		Six Months Ended June 30, Change%
Change
2023202220232022
(unaudited)
(In $ millions, except percentages)
Net sales1,233 1,559 (326)(20.9)%2,483 3,211 (728)(22.7)%
Net Sales Variance
Volume(2)%(5)%
Price(19)%(17)%
Currency— %(1)%
Other— %— %
Operating profit (loss)295 428 (133)(31.1)%573 931 (358)(38.5)%
Operating margin23.9 %27.5 % 23.1 %29.0 %
Dividend income - equity investments
30 36 (6)(16.7)%63 72 (9)(12.5)%
Depreciation and amortization
54 52 2 3.8 %108 108 — — %
Our Acetyl Chain segment, which includes the integrated chain of our intermediate chemistry, emulsion polymers, ethylene vinyl acetate polymers, redispersible powders and acetate tow businesses, is active in every major global industrial sector and serves diverse consumer end-use applications. These include conventional uses, such as paints, coatings, adhesives, and filter products, as well as other unique, high-value end uses including flexible packaging, thermal laminations, pharmaceuticals, wire and cable, and compounds. Together with our strategic affiliates, our Acetyl Chain businesses are leading producers and suppliers in multiple global industrial sectors.
The pricing of products within the Acetyl Chain is influenced by industry utilization rates and changes in the cost of raw materials. Therefore, in general, there is a directional correlation between these factors and our Net sales for most Acetyl Chain products. This impact to pricing typically lags changes in raw material costs over months or quarters.
Three Months Ended June 30, 2023 Compared to Three Months Ended June 30, 2022
Net sales decreased for the three months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•lower pricing for most of our products, primarily vinyl acetate monomer ("VAM") and acid, due to weaker economic conditions particularly in Asia, partially offset by higher pricing for acetate tow; and
•lower volume for most of our products due to decreased demand, primarily in Europe.
Operating profit decreased for the three months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•lower Net sales;
partially offset by:
•lower raw material and sourcing costs, primarily for ethylene, methanol and acid.
Six Months Ended June 30, 2023 Compared to Six Months Ended June 30, 2022
Net sales decreased for the six months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•lower pricing for most of our products, primarily VAM and acid, due to weaker economic conditions particularly in Asia, partially offset by higher pricing for acetate tow;
•lower volume for most of our products due to decreased demand, primarily in Europe; and
•an unfavorable currency impact, primarily resulting from a weaker CNY relative to the U.S. dollar.
39
Operating profit decreased for the six months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•lower Net sales;
partially offset by:
•lower raw material and sourcing costs, primarily for ethylene, methanol and acid.
Other Activities
Three Months Ended June 30, Change%
Change		Six Months Ended June 30, Change%
Change
2023202220232022
(unaudited)
(In $ millions, except percentages)
Operating profit (loss)(118)(111)(7)(6.3)%(257)(207)(50)(24.2)%
Non-operating pension and other postretirement employee benefit (expense) income
(2)25 (27)(108.0)%(1)49 (50)(102.0)%
Other Activities primarily consists of corporate center costs, including administrative activities such as finance, information technology and human resource functions, interest income and expense associated with financing activities and results of our captive insurance companies. Other Activities also includes the components of net periodic benefit cost (interest cost, expected return on assets and net actuarial gains and losses) for our defined benefit pension plans and other postretirement plans not allocated to our business segments.
Three Months Ended June 30, 2023 Compared to Three Months Ended June 30, 2022
Operating loss increased for the three months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•higher project and functional spending of $21 million, primarily related to the M&M Acquisition;
partially offset by:
•a favorable currency impact of $16 million.
Non-operating pension and other postretirement employee benefit (expense) income decreased for the three months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•higher interest cost and lower expected return on plan assets.
Six Months Ended June 30, 2023 Compared to Six Months Ended June 30, 2022
Operating loss increased for the six months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•higher project and functional spending of $65 million, primarily related to the M&M Acquisition;
partially offset by:
•a favorable currency impact of $23 million.
Non-operating pension and other postretirement employee benefit (expense) income decreased for the six months ended June 30, 2023 compared to the same period in 2022, primarily due to:
•higher interest cost and lower expected return on plan assets.
40
Liquidity and Capital Resources
Our primary sources of liquidity are cash generated from operations, available cash and cash equivalents, dividends from our portfolio of strategic investments and available borrowings under our senior U.S. unsecured revolving credit facility and our China Revolving Credit Facility (defined below). As of June 30, 2023, we have $1.75 billion available for borrowing under our senior U.S. unsecured revolving credit facility, and $34 million available for borrowing under our separate China Revolving Credit Facility, if required, in meeting our working capital needs and other contractual obligations. In addition, we held cash and cash equivalents of $1.3 billion as of June 30, 2023. We are actively managing our business to maintain and improve cash flow, and we believe that liquidity from the above-referenced sources will be sufficient to meet our operational and capital investment needs and financial obligations for the foreseeable future.
On June 22, 2023, we announced the signing of a definitive agreement to form a food ingredients joint venture with Mitsui & Co., Ltd. ("Mitsui") under the name Nutrinova. Pursuant to the agreement, we will contribute receivables, inventory, property, plant and equipment, certain intangible assets, other assets, other liabilities, technology and employees of our food ingredients business while retaining a 30% stake in the joint venture. Mitsui will acquire the remaining 70% stake at a purchase price of $473 million. We expect to close the transaction in the second half of 2023, pending regulatory approvals. For further information regarding the food ingredients joint venture, see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements.
In November 2022, we acquired a majority of the M&M Business for a purchase price of $11.0 billion, subject to transaction adjustments, in an all-cash transaction. For further information regarding the acquisition, see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements.
Our incurrence of debt to finance the purchase price for the M&M Acquisition has increased our leverage and our ratio of indebtedness to consolidated EBITDA as set forth in our senior unsecured credit facilities. We believe that cash flows from our operations, together with cash generation, synergy opportunities from the M&M Acquisition and cost reduction initiatives, will support our deleveraging efforts over the next few years. In furtherance of these deleveraging efforts, we have paused our share repurchase program and are in the process of evaluating additional cash generation opportunities which may also include, in addition to the food ingredients joint venture described above, additional opportunistic dispositions or monetization of other product or business lines or other assets. We are committed to rapid deleveraging and to maintaining our investment grade debt rating.
While our contractual obligations, commitments and debt service requirements over the next several years are significant, we continue to believe we will have available resources to meet our liquidity requirements, including debt service, for the next twelve months. If our cash flow from operations is insufficient to fund our debt service and other obligations, we may be required to use other means available to us such as increasing our borrowings, reducing or delaying capital expenditures, seeking additional capital or seeking to restructure or refinance our indebtedness. There can be no assurance, however, that we will continue to generate cash flows at or above current levels.
We continue to prioritize those projects expected to drive productivity in the near term and expect capital expenditures to be approximately $500 million in 2023, primarily associated with certain investments in growth opportunities and productivity improvements. In Engineered Materials, at our Nanjing, China facility, our expansions of (1) the compounding plant is in construction and (2) the new liquid crystal polymer ("LCP") plant is in detailed engineering design. Our energy optimization productivity project at our polyoxymethylene ("POM") unit in Frankfurt, Germany is in detailed engineering design. In the Acetyl Chain, our planned expansion of our acetic acid unit at Clear Lake, Texas is on track to be commissioned in the fourth quarter of 2024. The other major projects that support the Acetyl Chain are in various stages of construction and on schedule, which include our planned expansions of (1) our vinyl acetate ethylene ("VAE") emulsions units in Nanjing, China, (2) our VAE emulsion plant in Frankfurt, Germany, and (3) the sustainable production of methanol ("MeOH") at our Fairway joint venture MeOH unit in Clear Lake, Texas using captured carbon dioxide as feedstock. The expansion of our vinyl acetate monomer ("VAM") plant in Bay City, Texas is on temporary hold. We continue to see the incremental capacity from investments made in recent years strengthen our manufacturing network reliability to best serve our customers.
On a stand-alone basis, Celanese and its immediate 100% owned subsidiary, Celanese U.S., have no independent external operations of their own. Accordingly, they generally depend on the cash flow of their subsidiaries and their ability to pay dividends and make other distributions to Celanese and Celanese U.S. in order to meet their obligations, including their obligations under senior credit facilities and senior notes, and to pay dividends on our Common Stock.
We are subject to capital controls and exchange restrictions imposed by the local governments in certain jurisdictions where we operate, such as China, South Korea, India and Indonesia. Capital controls impose limitations on our ability to exchange
41
currencies, repatriate earnings or capital, lend via intercompany loans or create cross-border cash pooling arrangements. Our largest exposure to a country with capital controls is in China. Pursuant to applicable regulations, foreign-invested enterprises in China may pay dividends only out of their accumulated profits, if any, determined in accordance with Chinese accounting standards and regulations. In addition, the Chinese government imposes certain currency exchange controls on cash transfers out of China, puts certain limitations on duration, purpose and amount of intercompany loans, and restricts cross-border cash pooling. While it is possible that future tightening of these restrictions or application of new similar restrictions could impact us, these limitations do not currently restrict our operations.
We remain in compliance with the covenants in the Global Credit Agreements (defined below, and as amended to date) and expect to remain in compliance based on our current expectation of future results of operations and planned cash generation activities. If the actual future results of our operations and cash generation activities differ materially from these expectations, we may be required to seek an amendment to or waiver of any impacted covenants, which may increase our borrowing costs under the Global Credit Agreements.
Cash Flows
Cash and cash equivalents decreased $212 million to $1.3 billion as of June 30, 2023 compared to December 31, 2022. As of June 30, 2023, $1.0 billion of the $1.3 billion of cash and cash equivalents was held by our foreign subsidiaries. Under the TCJA, we have incurred a prior year charge associated with the deemed repatriation of previously unremitted foreign earnings, including foreign held cash. These funds are largely accessible over a period of time without additional material tax consequences, if needed in the U.S., to fund operations.
•Net Cash Provided by (Used in) Operating Activities
Net cash provided by operating activities decreased $145 million to $666 million for the six months ended June 30, 2023 compared to net cash provided by operating activities of $811 million for the same period in 2022, primarily due to:
•lower earnings performance; and
•an increase in cash interest paid of $272 million;
partially offset by:
•favorable trade working capital of $297 million, primarily due to the timing of collections of trade receivables, inventory reduction due to lower volume, lower raw materials costs and cost of inventory, and settlement of trade payables during the six months ended June 30, 2023; and
•cash receipts of non-trade receivables of $91 million, primarily related to receivable balances arising from the M&M Acquisition and transition activities.
•Net Cash Provided by (Used in) Investing Activities
Net cash used in investing activities increased $56 million to $341 million for the six months ended June 30, 2023 compared to net cash used in investing activities of $285 million for the same period in 2022; primarily due to:
•an increase of $48 million in capital expenditures during the six months ended June 30, 2023.
•Net Cash Provided by (Used in) Financing Activities
Net cash used in financing activities increased $262 million to $516 million for the six months ended June 30, 2023 compared to net cash used in financing activities of $254 million for the same period in 2022, primarily due to:
•an increase in net payments on short-term debt of $340 million, primarily as a result of payment on our March 2022 U.S. Term Loan Credit Agreement (defined below) and revolving credit facilities partially offset by borrowings on our revolving credit facilities and China Working Capital Term Loan Agreement (defined below);
partially offset by:
•a payment of $63 million during the six months ended June 30, 2022 for fees related to a bridge facility commitment letter with Bank of America, N.A. ("Bank of America") pursuant to which Bank of America had committed to provide,
42
subject to the terms and conditions set forth therein, a 364-day $11.0 billion senior unsecured bridge term loan facility (the "Bridge Facility"), which did not recur in the current year; and
•a decrease in share repurchases of our Common Stock of $17 million during the six months ended June 30, 2023.
Debt and Other Obligations
In March 2022, we entered into a term loan credit agreement (the "March 2022 U.S. Term Loan Credit Agreement"), pursuant to which lenders have committed to provide a tranche of delayed-draw term loans due 364 days from issuance in an amount equal to $500 million and a tranche of delayed-draw term loans due 5 years from issuance in an amount equal to $1.0 billion. In September 2022, we entered into an additional term loan credit agreement (the "September 2022 U.S. Term Loan Credit Agreement" and, together with the March 2022 U.S. Term Loan Credit Agreement, the "U.S. Term Loan Credit Agreements"), pursuant to which lenders have committed to provide delayed-draw term loans due 3 years from issuance in an amount equal to $750 million (the term loans represented by the U.S. Term Loan Credit Agreements collectively, the "U.S. Term Loan Facility").
Also in March 2022, we entered into a new revolving credit agreement (the "U.S. Revolving Credit Agreement" and, together with the U.S. Term Loan Credit Agreements the "U.S. Credit Agreements") consisting of a $1.75 billion senior unsecured revolving credit facility (with a letter of credit sublimit), maturing in 2027. The proceeds of a $365 million borrowing under the new senior unsecured revolving credit facility were used to repay and terminate our then-existing revolving credit facility.
On February 21, 2023, we amended certain covenants in the U.S. Credit Agreements, including financial ratio maintenance covenants. The U.S. Credit Agreements are guaranteed by Celanese, Celanese U.S. and domestic subsidiaries together representing substantially all of the Company's U.S. assets and business operations.
On January 4, 2023, Celanese (Shanghai) International Trading Co., Ltd ("CSIT"), a fully consolidated subsidiary, entered into a restatement of an existing credit facility agreement (the "China Revolving Credit Agreement") to upsize and modify the facility thereunder to consist of an aggregate CNY1.75 billion uncommitted senior unsecured revolving credit facility available under two tranches (with overdraft, bank guarantee and documentary credit sublimits) (the "China Revolving Credit Facility"). Obligations bear interest at certain fixed and floating rates. The China Revolving Credit Agreement is guaranteed by Celanese U.S.
On January 6, 2023, CSIT entered into a senior unsecured working capital loan contract for CNY800 million (the "China Working Capital Term Loan Agreement", together with the China Revolving Credit Agreement, the "China Credit Agreements," and the China Credit Agreements together with the U.S. Credit Agreements, the "Global Credit Agreements"), payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates. The loan under the China Working Capital Term Loan Agreement was fully drawn on January 10, 2023 and is supported by a letter of comfort from us. We expect the China Credit Agreements will facilitate our efficient repatriation of cash to the U.S. to repay debt and effectively redomicile a portion of our U.S. debt to China at a lower average interest rate.
There have been no material changes to our debt or other obligations described in our 2022 Form 10-K other than those disclosed above and in Note 7 - Debt in the accompanying unaudited interim consolidated financial statements.
Accounts Receivable Purchasing Facility
On June 1, 2023, we entered into an amendment to the amended and restated receivables purchase agreement under our U.S. accounts receivable purchasing facility among certain of our subsidiaries, our wholly-owned, "bankruptcy remote" special purpose subsidiary ("SPE") and certain global financial institutions ("Purchasers"). We de-recognized $663 million and $1.1 billion of accounts receivable under this agreement for the six months ended June 30, 2023 and year ended December 31, 2022, respectively, and collected $565 million and $1.1 billion of accounts receivable sold under this agreement during the same periods. Unsold U.S. accounts receivable of $86 million were pledged by the SPE as collateral to the Purchasers as of June 30, 2023.
Factoring and Discounting Agreements
We have factoring agreements in Europe and Singapore with financial institutions to sell 100% and 90% of certain accounts receivable, respectively, on a non-recourse basis. We de-recognized $196 million and $320 million of accounts receivable under these factoring agreements for the six months ended June 30, 2023 and year ended December 31, 2022, respectively, and collected $189 million and $325 million of accounts receivable sold under these factoring agreements during the same periods.
43
Covenants
We are in compliance with the covenants in our material financing arrangements as of June 30, 2023.
See Note 7 - Debt in the accompanying unaudited interim consolidated financial statements for further information.
Guarantor Financial Information
We have outstanding senior unsecured notes, issued in public offerings registered under the Securities Act of 1933, as amended (collectively, the "Senior Notes"). The Senior Notes were issued by Celanese U.S. ("Issuer") and are guaranteed by Celanese Corporation ("Parent Guarantor") and the Subsidiary Guarantors (collectively the "Obligor Group"). See Note 7 - Debt in the accompanying unaudited interim consolidated financial statements for further information. The Issuer and Subsidiary Guarantors are 100% owned subsidiaries of the Parent Guarantor. The Subsidiary Guarantors are listed in Exhibit 22.1 to this Quarterly Report.
The Parent Guarantor and the Subsidiary Guarantors have guaranteed the Senior Notes on a full and unconditional, joint and several, senior unsecured basis. The guarantees are subject to certain customary release provisions, including that a Subsidiary Guarantor will be released from its respective guarantee in specified circumstances, including (i) the sale or transfer of all of its assets or capital stock; (ii) its merger or consolidation with, or transfer of all or substantially all of its assets to, another person; or (iii) its ceasing to be a majority-owned subsidiary of the Issuer in connection with any sale of its capital stock or other transaction. Additionally, a Subsidiary Guarantor will be released from its guarantee of the Senior Notes at such time that it ceases to guarantee the Issuer's obligations under the U.S. Credit Agreements (subject to the satisfaction of customary document delivery requirements). The obligations of the Subsidiary Guarantors under their guarantees are limited as necessary to prevent such guarantees from constituting a fraudulent conveyance or fraudulent transfer under applicable law.
The Parent Guarantor and the Issuer are holding companies that conduct substantially all of their operations through their subsidiaries, which own substantially all of our consolidated assets. The Parent Guarantor has no material assets other than the stock of its immediate 100% owned subsidiary, the Issuer. The principal source of cash to pay the Parent Guarantor's and the Issuer's obligations, including obligations under the Senior Notes and the guarantee of the Issuer's obligations under the U.S. Credit Agreements, is the cash that our subsidiaries generate from their operations. Each of the Subsidiary Guarantors and our non-guarantor subsidiaries is a distinct legal entity and, under certain circumstances, applicable country or state laws, regulatory limitations and terms of other debt instruments may limit our subsidiaries' ability to distribute cash to the Issuer and the Parent Guarantor.
For cash management purposes, we transfer cash among the Parent Guarantor, Issuer, Subsidiary Guarantors and non-guarantors through intercompany financing arrangements, contributions or declaration of dividends between the respective parent and its subsidiaries. While the non-guarantor subsidiaries do not guarantee the Issuer's obligations under our outstanding debt, the transfer of cash under these activities facilitates the ability of the recipient to make specified third-party payments for principal and interest on the Senior Notes, U.S. Credit Agreements, other outstanding debt, Common Stock dividends and Common Stock repurchases.
The summarized financial information of the Obligor Group is presented below on a combined basis after the elimination of: (i) intercompany transactions among such entities and (ii) equity in earnings from and investments in the non-guarantor subsidiaries. Transactions with, and amounts due to or from, non-guarantor subsidiaries and affiliates are separately disclosed.
Six Months Ended
June 30, 2023
(In $ millions)
(unaudited)
Net sales to third parties944 
Net sales to non-guarantor subsidiaries559 
Total net sales1,503 
Gross profit318 
Earnings (loss) from continuing operations1,187 
Net earnings (loss)1,185 
Net earnings (loss) attributable to the Obligor Group1,185 
44
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
(unaudited)
Receivables from non-guarantor subsidiaries643 754 
Other current assets1,675 1,588 
Total current assets2,318 2,342 
Goodwill528 567 
Other noncurrent assets2,745 2,718 
Total noncurrent assets3,273 3,285 
Current liabilities due to non-guarantor subsidiaries1,768 2,100 
Current liabilities due to affiliates1 2 
Other current liabilities2,030 2,201 
Total current liabilities3,799 4,303 
Noncurrent liabilities due to non-guarantor subsidiaries3,383 3,400 
Other noncurrent liabilities13,404 13,842 
Total noncurrent liabilities16,787 17,242 
Share Capital
We declared a quarterly cash dividend of $0.70 per share on our Common Stock on July 19, 2023, amounting to $76 million.
There have been no material changes to our share capital described in our 2022 Form 10-K other than those disclosed above and in Note 10 - Shareholders' Equity in the accompanying unaudited interim consolidated financial statements.
Contractual Obligations
We have not entered into any material off-balance sheet arrangements.
Except as otherwise described in this report, there have been no material revisions outside the ordinary course of business to our contractual obligations as described in our 2022 Form 10-K.
Tax Return Audits
Our tax returns are under joint audit for the years 2013 through 2015 by the United States, Netherlands and Germany (the "Authorities"). In addition, our income tax returns in Mexico are under audit for the year 2018, and in Canada for the years 2016 through 2018. As of June 30, 2023, we believe that an adequate provision for income taxes has been made for all open tax years related to the examinations by government authorities. We are in ongoing discussions regarding the audit findings with the Canadian authorities and do not expect a material impact to income tax expense. However, the outcome of tax audits cannot be predicted with certainty. If any issues raised by the government authorities are resolved in a manner inconsistent with our expectations or we are unsuccessful in defending its positions, we could be required to adjust our provision for income taxes in the period such resolution occurs. If required, any such adjustments could be material to the statements of operations and cash flows in the period(s) recorded. See Note 11 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information.
Business Environment
We continued to experience destocking in addition to volatile underlying demand conditions across several end-markets. We continue to closely monitor the impact of, and responses to, geopolitical effects on demand conditions and the supply chain. Demand conditions and moderating raw materials costs resulted in elevated industry competitive dynamics and pricing pressure across many end-markets. Average prices of raw materials and energy feedstocks, particularly natural gas, which is a significant input for our manufacturing operations, have continued to moderate. We expect demand and destocking challenges to persist, to put pressure on pricing partially offset by improvement in input costs across the year.
Following Russia's invasion of Ukraine, we suspended sales into Russia, Belarus and the sanctioned regions of Ukraine. Revenue from these countries and regions constituted less than 0.1% of our consolidated Net sales in fiscal year 2022 and we
45
have no manufacturing assets in these countries or regions. We do not currently expect the conflict to result in a material impact on our business or financial results, but the full impact of the conflict and international responses thereto remains uncertain and will depend on future geopolitical and economic developments that are impossible to predict. Potential risks we may face include increased volatility in capital and commodity markets, rapid changes to sanctions, supply chain and transportation disruptions, exacerbation of inflationary conditions, impacts to consumer or business sentiment and an increased risk of cyber security incidents.
Critical Accounting Policies and Estimates
Our unaudited interim consolidated financial statements are based on the selection and application of significant accounting policies. The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of Net sales, expenses and allocated charges during the reporting period. Actual results could differ from those estimates. However, we are not currently aware of any reasonably likely events or circumstances that would result in materially different results.
We describe our significant accounting policies in Note 2 - Summary of Accounting Policies, of the Notes to the Consolidated Financial Statements included in our 2022 Form 10-K. We discuss our critical accounting policies and estimates in MD&A in our 2022 Form 10-K.
Recent Accounting Pronouncements
See Note 2 - Recent Accounting Pronouncements in the accompanying unaudited interim consolidated financial statements included in this Quarterly Report for information regarding recent accounting pronouncements.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Market risk for the Company has not changed materially from the foreign exchange, interest rate and commodity risks disclosed in Item 7A. Quantitative and Qualitative Disclosures about Market Risk in our 2022 Form 10-K. See also Note 12 - Derivative Financial Instruments in the accompanying unaudited interim consolidated financial statements for further discussion of our market risk management and the related impact on the Company's financial position and results of operations.
Item 4. Controls and Procedures
Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this report. Based on that evaluation, as of June 30, 2023, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective.
Changes in Internal Control Over Financial Reporting
During the period covered by this report, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
46
PART II — OTHER INFORMATION
Item 1. Legal Proceedings
The Company is involved in legal and regulatory proceedings, lawsuits, claims and investigations incidental to the normal conduct of its business, relating to such matters as product liability, land disputes, insurance coverage disputes, contracts, employment, antitrust and competition, intellectual property, personal injury and other actions in tort, workers' compensation, chemical exposure, asbestos exposure, taxes, trade compliance, acquisitions and divestitures, claims of current and legacy shareholders, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where it is named as a defendant. Due to the inherent subjectivity of assessments and unpredictability of outcomes of legal proceedings, the Company's litigation accruals and estimates of possible loss or range of possible loss may not represent the ultimate loss to the Company from legal proceedings. See Note 9 - Environmental and Note 14 - Commitments and Contingencies in the accompanying unaudited interim consolidated financial statements for a discussion of material environmental matters and material commitments and contingencies related to legal and regulatory proceedings. There have been no significant developments in the "Legal Proceedings" described in our 2022 Form 10-K other than those disclosed in Note 9 - Environmental and Note 14 - Commitments and Contingencies in the accompanying unaudited interim consolidated financial statements. See Part I - Item 1A. Risk Factors of our 2022 Form 10-K for certain risk factors relating to these legal proceedings.
Item 1A. Risk Factors
In addition to the information in this Quarterly Report, readers should carefully consider the information in Part I, Item 1A. Risk Factors of our 2022 Form 10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
We did not repurchase any Common Stock during the three months ended June 30, 2023. As of June 30, 2023, our Board of Directors had authorized the repurchase of $6.9 billion of our Common Stock since February 2008, with approximately $1.1 billion value of shares remaining that may be purchased under the program. See Note 10 - Shareholders' Equity in the accompanying unaudited interim consolidated financial statements for further information.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
None.
Item 5. Other Information
(c) Trading Plans
During the quarter ended June 30, 2023, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading plans or "non-Rule 10b5-1 trading arrangements" as defined in Item 408 of Regulation S-K.
47
Item 6. Exhibits(1)
Exhibit
Number
Description
2.1†
3.1
3.1(a)
3.1(b)
3.1(c)
3.2
10.1‡
10.2*‡
10.3*‡
22.1
31.1*
31.2*
32.1*
32.2*
101.INS*Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*Inline XBRL Taxonomy Extension Schema Document.
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 has been formatted in Inline XBRL.
48
*    Filed herewith.
‡    Indicates a management contract or compensatory plan or arrangement.
†    The Company has omitted certain schedules and similar attachments to such agreements pursuant to Item 601(a)(5) of Regulation S-K. The Company will furnish a copy of such omitted documents to the SEC upon request.
(1)The Company and its subsidiaries have in the past issued, and may in the future issue from time to time, long-term debt. The Company may not file with the applicable report copies of the instruments defining the rights of holders of long-term debt to the extent that the aggregate principal amount of the debt instruments of any one series of such debt instruments for which the instruments have not been filed has not exceeded or will not exceed 10% of the assets of the Company at any pertinent time. The Company hereby agrees to furnish a copy of any such instrument(s) to the SEC upon request.
49
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
CELANESE CORPORATION
By: /s/ LORI J. RYERKERK
Lori J. Ryerkerk
Chair of the Board of Directors,
Chief Executive Officer and President
Date:August 8, 2023

By: /s/ SCOTT A. RICHARDSON
Scott A. Richardson
Executive Vice President and
Chief Financial Officer
Date:August 8, 2023
50
 EX-10.2 2 ex1026302310-q.htm EX-10.2 Document
Exhibit 10.2
[Form of 2023 Director Time-Based RSU Award Agreement]




celaneselogo.jpg









CELANESE CORPORATION
AMENDED AND RESTATED 2018 GLOBAL INCENTIVE PLAN

TIME-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT
DATED [Grant Date]


Pursuant to the terms and conditions of the Celanese Corporation Amended and Restated 2018 Global Incentive Plan, you have been awarded Time-Based Restricted Stock Units, subject to the restrictions described in this Agreement. In addition to the information included in this Award Agreement, the Participant's name and the number of Restricted Stock Units can be found in the Grant Summary located in the electronic stock plan award administration system maintained by the Company or its designee that contains a link to this Agreement (which summary information is set forth in the appropriate records of the Company authorizing such award).


2023 RSU Award

[Number of Shares Granted] Units

This grant is made pursuant to the Time-Based Restricted Stock Unit Award Agreement dated as of [Grant Date], between Celanese and [Participant Name], which Agreement is attached hereto and made a part hereof.



CELANESE CORPORATION
AMENDED AND RESTATED 2018 GLOBAL INCENTIVE PLAN

TIME-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT
(Non-Employee Director)

This Time-Based Restricted Stock Unit Award Agreement (the "Agreement"), is made and entered into effective as of [Grant Date] (the "Grant Date"), by and between Celanese Corporation, a Delaware corporation (the "Company"), and [Participant Name] (the "Participant"). Capitalized terms used, but not otherwise defined, herein shall have the meanings ascribed to such terms in the Celanese Corporation Amended and Restated 2018 Global Incentive Plan (as amended from time to time, the "2018 Plan").
1.Time-Based RSU Award: The Company hereby grants to the Participant, pursuant to the terms of the 2018 Plan and this Agreement, an award (the "Award") of [Number of Shares Granted] time-based Restricted Stock Units (the "RSUs") representing the right to receive an equal number of Common Shares upon vesting. The Participant hereby acknowledges and accepts such Award upon the terms and subject to the conditions, restrictions and limitations contained in this Agreement and the 2018 Plan.
2.Vesting of Restricted Stock Units:
(a)Normal Vesting. Subject to Sections 2(b) and 2(c) below, the RSUs shall vest on <<Vest Date>> (the "Vesting Date").
(b)Change in Control. Notwithstanding any other provision of this Agreement to the contrary, upon the occurrence of a Change in Control, the RSUs, to the extent not previously forfeited or canceled, shall immediately vest and a number of Common Shares equal to such RSUs shall be delivered to the Participant within thirty (30) days of the occurrence of such Change in Control.
(c)Termination of Service.
(i)Upon the termination of the Participant's service with the Company as a director due to the Participant's death or Disability, a prorated portion of RSUs will vest in an amount equal to (A) the number of unvested RSUs multiplied by (B) a fraction, the numerator of which is the number of complete and partial calendar months that have transpired from the Grant Date to the date of termination, and the denominator of which is twelve months, such product to be rounded up to the nearest whole number. The prorated number of RSUs shall vest on the applicable Vesting Date. The remaining portion of the Award shall be forfeited and cancelled without consideration.
(ii)Upon the termination of the Participant's service with the Company as a director due to voluntary resignation prior to the next regularly scheduled meeting of the Company's stockholders at which directors are elected, or removal for cause, the Award shall be forfeited and cancelled without consideration.
(iii)Upon the termination of the Participant's service with the Company as a director due to retirement by reason of the Company's Director Retirement Guideline, or for any other reason not listed in Section 2(c)(i) or (c)(ii), the Award shall vest on the Vesting Date.
1


3.Settlement of RSUs: Subject to Section 2 of this Agreement, and except to the extent the Participant has elected that delivery be deferred in accordance with the rules and procedures prescribed by the Board or the Compensation and Management Development Committee (which rules and procedures, among other things, shall be consistent with the requirements of Section 409A of the Code), the Company shall deliver to the Participant (or to a Company-designated brokerage firm or plan administrator) as soon as administratively practicable following the Vesting Date (but in no event later than 2 ½ months after the Vesting Date), in complete settlement of all vested RSUs, a number of Common Shares equal to the number of vested RSUs.
4.Rights as a Stockholder: The Participant shall have no voting, dividend or other rights as a stockholder with respect to the Award until the RSUs have vested and Common Shares have been delivered pursuant to this Agreement.
5.Non-Transferability of Award: The RSUs may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Participant other than by will or by the laws of descent and distribution, and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company; provided, that the Participant may designate a beneficiary, on a form provided by the Company, to receive any portion of the Award payable hereunder following the Participant's death.
6.Securities Laws: The Company may impose such restrictions, conditions or limitations as it determines appropriate as to the timing and manner of any resales by the Participant or other subsequent transfers by the Participant of any Common Shares issued as a result of the vesting or settlement of the RSUs, including without limitation (a) restrictions under an insider trading policy, and (b) restrictions as to the use of a specified brokerage firm for such resales or other transfers. Upon the acquisition of any Common Shares pursuant to the vesting or settlement of the RSUs, the Participant will make or enter into such written representations, warranties and agreements as the Company may reasonably request in order to comply with applicable securities laws or with this Agreement and the 2018 Plan. All accounts in which such Common Shares are held or any certificates for Common Shares shall be subject to such stop transfer orders and other restrictions as the Company may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any stock exchange or quotation system upon which the Common Shares are then listed or quoted, and any applicable federal or state securities law, and the Company may cause a legend or legends to be put on any such certificates (or other appropriate restrictions and/or notations to be associated with any accounts in which such Common Shares are held) to make appropriate reference to such restrictions.
7.Severability: In the event that any provision of this Agreement is declared to be illegal, invalid or otherwise unenforceable by a court of competent jurisdiction, such provision shall be reformed, if possible, to the extent necessary to render it legal, valid and enforceable, or otherwise deleted, and the remainder of this Agreement shall not be affected except to the extent necessary to reform or delete such illegal, invalid or unenforceable provision.
8.Further Assurances: Each party shall cooperate and take such action as may be reasonably requested by either party hereto in order to carry out the provisions and purposes of this Agreement.
9.Binding Effect: The Award and this Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective permitted heirs, beneficiaries, successors and assigns.
10.Electronic Delivery: By executing this Agreement, the Participant hereby consents to the delivery of any and all information (including, without limitation, information required to
2


be delivered to the Participant pursuant to applicable securities laws), in whole or in part, regarding the Company and its subsidiaries, the 2018 Plan, and the Award via electronic mail, the Company's or a plan administrator's web site, or other means of electronic delivery.
11.Governing Law. Notwithstanding the place where this Agreement may be executed by any of the parties hereto, the parties expressly agree that all the terms and provisions hereof shall be governed by, construed under and interpreted in accordance with the laws of the State of Delaware, without regard to its conflicts of laws rules.
12.Restricted Stock Units Subject to Plan: By entering into this Agreement the Participant agrees and acknowledges that the Participant has received and read a copy of the 2018 Plan and the 2018 Plan's prospectus. The RSUs and the Common Shares issued upon vesting of such RSUs are subject to the 2018 Plan, which is hereby incorporated by reference. In the event of any conflict between any term or provision of this Agreement and a term or provision of the 2018 Plan, the applicable terms and provisions of the 2018 Plan shall govern and prevail.
13.Validity of Agreement: This Agreement shall be valid, binding and effective upon the Company on the Grant Date. However, the Participant must accept this Agreement electronically pursuant to the online acceptance procedure established by the Company within ninety (90) days; otherwise the Company may, in its sole discretion, rescind the Award in its entirety.
14.Headings: The headings preceding the text of the sections hereof are inserted solely for convenience of reference, and shall not constitute a part of this Agreement, nor shall they affect its meaning, construction or effect.
15.Compliance with Section 409A of the Code: Notwithstanding any provision in this Agreement to the contrary, this Agreement will be interpreted and applied so that the Agreement does not fail to meet, and is operated in accordance with, the requirements of Section 409A of the Code. The Company reserves the right to change the terms of this Agreement and the 2018 Plan without the Participant's consent to the extent necessary or desirable to comply with the requirements of Section 409A of the Code, the Treasury regulations and other guidance thereunder. Further, in accordance with the restrictions provided by Treasury Regulation Section 1.409A-3(j)(2), any subsequent amendments to this Agreement or any other agreement, or the entering into or termination of any other agreement, affecting the RSUs provided by this Agreement shall not modify the time or form of issuance of the RSUs set forth in this Agreement.
16.Definitions: The following terms shall have the following meanings for purposes of this Agreement, notwithstanding any contrary definition in the 2018 Plan:
(a)"Change in Control" of the Company means:
(i) Any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) (a "Person") becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 30% or more of either (A) the then-outstanding shares of common stock of the Company (the "Outstanding Company Common Stock") or (B) the combined voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of directors (the "Outstanding Company Voting Securities"); provided, however, that, for purposes of this subparagraph, the following acquisitions shall not constitute a Change of Control: (i) any acquisition directly from the Company, (ii) any acquisition by the Company, (iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any Affiliate,
3


or (iv) any acquisition pursuant to a transaction that complies with clauses (A), (B) or (C) in paragraph (iii) of this definition; or
(ii) Individuals who, as of the effective date of this Agreement, constitute the Board (the "Incumbent Board") cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the effective date of this Agreement whose election, or nomination for election by the Company's stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual was a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or
(iii) Consummation of a reorganization, merger, statutory share exchange or consolidation or similar transaction involving the Company or any of its subsidiaries, a sale or other disposition of all or substantially all of the assets of the Company, or the acquisition of assets or stock of another entity by the Company or any of its subsidiaries (each, a "Business Combination"), in each case unless, following such Business Combination, (A) all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Company Common Stock and the Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock (or, for a non-corporate entity, equivalent securities) and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors (or, for a non-corporate entity, equivalent governing body), as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity that, as a result of such transaction, owns the Company or all or substantially all of the Company's assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership immediately prior to such Business Combination of the Outstanding Company Common Stock and the Outstanding Company Voting Securities, as the case may be, (B) no Person (excluding any corporation resulting from such Business Combination or any employee benefit plan (or related trust) of the Company or such corporation resulting from such Business Combination) beneficially owns, directly or indirectly, 30% or more of, respectively, the then-outstanding shares of common stock of the corporation resulting from such Business Combination or the combined voting power of the then-outstanding voting securities of such corporation, except to the extent that such ownership existed prior to the Business Combination, and (C) at least a majority of the members of the board of directors (or, for a non-corporate entity, equivalent governing body) of the entity resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement or of the action of the Board providing for such Business Combination; or
(iv) Approval by the stockholders of the Company of a complete liquidation or dissolution of the Company.
Notwithstanding the foregoing, if it is determined that an Award hereunder is subject to the requirements of Section 409A and the Change in Control is a "payment event" under Section 409A for such Award, the Company will not be deemed to have undergone a Change in Control unless the Company is deemed to have undergone a "change in control event" pursuant to the definition of such term in Section 409A.
4


(b)"Disability" has the same meaning as "Disability" in the Celanese Corporation 2008 Deferred Compensation Plan or such other meaning as determined by the Board in its sole discretion.
IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its duly authorized officer and the Participant has also executed this Agreement in duplicate.
CELANESE CORPORATION


                            
By: Lori J. Ryerkerk    
Chair, Chief Executive Officer and President
5

 EX-10.3 3 ex1036302310-q.htm EX-10.3 Document
Exhibit 10.3

Dated February 13, 2023
(1) CELANESE CORPORATION
– and –
(2) JOHN FOTHERINGHAM
Without Prejudice
Subject to Contract

SETTLEMENT AGREEMENT




GIBSON DUNN

Gibson, Dunn & Crutcher LLP
Telephone House 2-4 Temple Avenue
London EC4Y 0HB

CONTENTS

ClauseSubject MatterPage
1.DEFINITIONS1
2.TERMINATION OF EMPLOYMENT AND OFFICES3
3.GARDEN LEAVE3
4. PAYMENTS AND BENEFITS4
5.CONDITION PRECEDENT5
6.WAIVER OF CLAIMS5
7.WARRANTIES7
8.COMPANY PROPERTY8
9.CONFIDENTIAL INFORMATION8
10.INDEPENDENT LEGAL ADVICE9
11.COMPLIANCE WITH LEGISLATION9
12.REPAYMENT PROVISIONS9
13.DISPARAGING STATEMENTS10
14.RESTRICTIVE COVENANTS10
15.FUTURE COOPERATION13
16.WITHOUT PREJUDICE STATUS14
17.THIRD PARTIES RIGHTS14
18.ENTIRE AGREEMENT14
19.SEVERABILITY15
20.COUNTERPARTS15
21.ELECTRONIC SIGNATURE15
22.GOVERNING LAW AND JURISDICTION15
1.DEFINITIONS1
2.TERMINATION OF EMPLOYMENT2
4.WARRANTIES4
5.INDEPENDENT LEGAL ADVICE4
6.COMPLIANCE WITH LEGISLATION5
7.WITHOUT PREJUDICE STATUS5
8.THIRD PARTIES RIGHTS5
9.ENTIRE AGREEMENT5
10.SEVERABILITY6
11.COUNTERPARTS6
12.ELECTRONIC SIGNATURE6
13.GOVERNING LAW AND JURISDICTION6
i

SETTLEMENT AGREEMENT
THIS AGREEMENT is made on February 13, 2023
BETWEEN:
(1)    CELANESE CORPORATION, of 222 W. Las Colinas Blvd., Suite 900N, Irving, TX 75039 (the "Company"); and
(2)    JOHN FOTHERINGHAM, whose address is 5 Westminster Avenue, Chester, CH4 8JB ("You").
RECITALS
(A)    You have been employed by the Company under the terms of an letter dated 30 September 2020, incorporating the terms of employment for Staff of the Company (the "Employment Letter").
(B)    You have received independent legal advice from the Adviser a qualified lawyer as such term is defined in Section 203 of the Employment Rights Act 1996 as to the terms and effect of this Agreement and are aware that You have those potential claims against the Company which are listed and have been raised in clause 6.
THE PARTIES AGREE AS FOLLOWS:
1.    DEFINITIONS
1.1    In this Agreement the following terms shall have the meanings set out below:
"Adviser" means Kate Venables of Brabners LLP.
"Confidential Information" means any and all confidential information, whether or not recorded in documentary form, or stored on any magnetic or optical disk or memory, that shall include but not be limited to: (a) corporate and business strategies and plans; (b) details of actual or prospective clients or customers (together with their requirements or potential requirements and contact details); (c) details of actual or prospective employees and consultants and their remuneration arrangements, other than your own; (d) details and terms of any investment, partnership, joint venture or other form of commercial co-operation or agreement; (e) internal operating systems, trade arrangements, terms of business and price lists not generally known to the public, including sales information, pricing policies, credit policies and procedures, profit margins, discounts, rebates, marketing information or strategies; (f) financial information including budgets, management accounts, financial models, spreadsheets, costings, sales forecasts, projections, estimates, or results, information relating to internal funding requirements or allocation of resources; (g) confidential aspects of computer technology including systems, confidential algorithms, information relating to proprietary computer hardware or software (including updates and source and object codes) which are not generally known to the public; (h) disputes (whether existing, pending, potential or threatened), settlement terms and legally privileged materials; (i) personal or special categories of personal data; (j) trade secrets, confidential techniques, technology, know-how, systems and processes used for the production or development of products and services, including manufacturing processes, formulations, formulae, recipes, raw materials and technical data and including information that is a trade secret as defined in Regulation 2 of the Trade Secrets (Enforcement, etc.) Regulations 2018, as amended; (k) research and
1

development activities (including designs, applications, drawings or specifications of products and services contemplated or in the course of development, details of product or market testing), inventions, discoveries or improvements (whether patentable or not) and patent applications in the course of preparation; (l) details, designs, applications, drawings or specifications of products or services which are not generally known to the public; and (m) anything marked as confidential (or similar), which You are told is confidential, which You should realise is confidential, which is subject to an obligation of confidence owed to a third party, or which You should reasonably treat as being confidential.
"Connected Person" means any officer, employee, consultant, customer, client, supplier, business partner, shareholder or investor of the Company or any Group Company.
"Group Company" and "Group Companies" means the Company and any group undertaking (as defined in Section 1161(5) of the Companies Act 2006 and supplemented by Section 1162 of the Companies Act 2006) or any associated body corporate (as defined in Section 256 of the Companies Act 2006) for the time being of the Company and any of the Company's subsidiary undertakings (as defined in Section 1162 of the Companies Act 2006 which, for the avoidance of doubt shall include Celanese Services UK Limited.
"Leaving Date" means 1 September 2023, or an earlier date if agreed between the parties in advance and in writing.
"Post-Employment Notice Pay" has the meaning given in section 402D of the Income Tax (Earnings and Pensions) Act 2003 ("ITEPA").
"Post-Employment Notice Period" has the meaning given in section 402E(5) of ITEPA.
1.2    The headings in this Agreement are inserted for convenience only and shall not affect its construction.
1.3    A reference to a particular law is a reference to it as it is in force for the time being taking account of any amendment, extension, or re-enactment and includes any subordinate legislation for the time being in force made under it.
1.4    Unless the context otherwise requires, words in the singular include the plural and in the plural include the singular.
1.5    The schedules to this Agreement form part of (and are incorporated into) this Agreement.
2.    TERMINATION OF EMPLOYMENT AND OFFICES
2.1    You accept and confirm the termination of your employment with Celanese Services UK Limited and any Group Companies with effect from the Leaving Date and notice is hereby given to terminate your employment with Celanese Services UK Limited. You hereby agree and undertake, as a term of this Agreement, that you will continue to comply with your obligations under the Employment Letter and the various Long-Term Incentive Award Claw-Back Agreements between you and the Company entered into prior to the date of this Agreement which, obligations you agree, shall neither be superseded, terminated nor replaced by this Agreement save where expressly stated.
2

2.2    You shall be entitled to receive your salary and contractual benefits up to and including the Leaving Date in the normal way but, save as set out expressly herein, You shall not be entitled to receive any payments in respect of bonus or commissions.
2.3    As at the Leaving Date, You will have completed the period of notice to which You are entitled under the Employment Letter. The parties accordingly agree that your Post-Employment Notice Period and Post-Employment Notice Pay are nil. It is expressly recorded that You have the right to seek the agreement of the Company to an earlier Leaving Date (such agreement to be sought in advance and agreed in writing). If an earlier Leaving Date is agreed, You agree to waive any outstanding entitlement to notice or payment in lieu of unexpired notice pursuant to the Employment Letter.
2.4    You shall resign from any and all directorships or offices which You hold with any Group Companies or otherwise in connection with your employment with effect from 1 March 2023 and shall execute such documents and do such further things (at the cost of the Company) as may in the opinion of the Company be necessary in order to give full effect to this clause 2.4.
2.5    All of the sums referred to in this clause 2 will be subject to the normal PAYE deductions.
3.    GARDEN LEAVE
3.1    You shall, with effect from the date of this Agreement and until the Leaving Date, cease to carry out any duties for or attend any office of the Company and each Group Company. During such time You shall:
(a)    remain an employee of Celanese Services UK Limited and be bound by the terms of the Employment Letter;
(b)    may not be employed or engaged or otherwise interested in any business or company other than a Group Company;
(c)    not have any contact or communication with any client or customer employee, officer, director, agent or consultant of the Company or any Group Company except Lori J. Ryerkerk, Vanessa Dupuis and Lynne Puckett; and
(d)    take any period of accrued but unused holiday entitlement.
3.2    From the date this Agreement is executed by You and until the end of the 90th day following the Leaving Date (the "Covered Period"), you shall fully comply with all Company policies and procedures, including the Company's Insider Trading Policy and during the Covered Period you shall obtain clearance from the Company's General Counsel or the General Counsel's designee prior to acquiring or disposing of any sales of Company stock. Further, (i) you will be prohibited from selling any shares of Company Stock from the date this Agreement is executed by You until the end of the 90th day following the date of resignation set forth in clause 2.4, and (ii) in accordance with the Company's Insider Trading Policy you will be prohibited from buying or selling any Company securities from 17 March 2023 through the end of the second full trading day following the Company's widespread, public release of first quarter earnings. You warrant that you have not purchased nor sold any shares of
3

Company stock during the six months preceding the date this Agreement is executed by You.
4.    PAYMENTS AND BENEFITS
4.1    By way of compensation for the termination of your employment and without admission of liability (and provided You have previously returned to the Company a copy of this Agreement signed by You and the letter in schedule 1 signed by the Adviser and further provided You satisfy your obligations under this Agreement including, without limitation, entering into the Further Settlement Agreement as defined below), the Company shall:
(a)    pay to you an annual incentive in respect of the 2022 calendar year based the final Company performance modifier certified by the Compensation and Management Development Committee of the Board of Directors of the Company for 2022 as publicly disclosed in the Company's Proxy Statement for its 2023 Annual Meeting of Shareholders and an individual modifier of 1.0 against eligible 2022 earnings. Such 2022 annual incentive will be paid, less such deductions as are required by law, as soon as practicable following the later of (a) your execution and delivery of this Agreement and (b) the date 2022 annual incentives are paid to other Company executives. For the avoidance of doubt, you shall not be eligible to receive any 2023 annual incentive award,
(b)    treat your termination of employment as a termination "without Cause" solely for purposes of your outstanding equity awards under the Celanese Corporation 2018 Global Incentive Plan, such that each outstanding equity award shall vest on a pro-rata basis based on the number of complete and partial calendar months from the grant date of the award through 1 March 2023 over the number of complete and partial months in the applicable vesting period, and otherwise in accordance with the terms of the applicable award agreement. Outstanding equity awards that are subject to performance-based vesting conditions shall remain subject to attainment of applicable performance goals and shall be settled, to the extent earned, after completion of the applicable performance period. For the avoidance of doubt, it is acknowledged and agreed that: (i) your outstanding equity awards shall be settled at the same time as such equity awards are settled for other executive officers of the Company; (ii) performance goals applicable to your performance-based vesting conditions shall be assessed consistent with those applicable to other executive officers of the Company; and (iii) you shall not be eligible to receive any long-term incentive awards in 2023; and
(c)    contribute up to £5,000 (including any disbursements but excluding VAT) towards the legal fees You incur in reaching this Agreement. This payment shall be made directly to the legal advisers following receipt of appropriate invoices addressed to You in accordance with section 413A of the Income Tax (Earnings and Pensions) Act 2003.
5.    CONDITION PRECEDENT
The payment and benefits referred to in clause 4 above (the "Settlement") shall be subject to clauses 6 and 7 below.
4

6.    WAIVER OF CLAIMS
6.1    You agree that You have carefully considered facts and circumstances relating to your employment and its termination and accept the Settlement and other terms of this Agreement in full and final settlement of:
(a)    the following particular claims against the Company or any Group Company or any Connected Person (each of which is hereby intimated and waived):
(i)    for breach of contract or wrongful dismissal;
(ii)    for unfair dismissal, under section 111 of the Employment Rights Act 1996;
(iii)    for unfair dismissal under section 103A of the Employment Rights Act 1996;
(iv)    in relation to the right to a written statement of reasons for dismissal, under section 93 of the Employment Rights Act 1996;
(v)    for a statutory redundancy payment, under section 163 of the Employment Rights Act 1996;
(vi)    in relation to an unlawful deduction from wages or unlawful payment, under section 23 of the Employment Rights Act 1996;
(vii)    in relation to working time or holiday pay, under regulation 30 of the Working Time Regulations 1998; and
(viii)    in relation to personal injury of which You are aware or ought reasonably to be aware at the date of this Agreement,
(b)    the following additional claims against the Company or any Group Company or any Connected Person (each of which is hereby intimated and waived):
(i)    for unlawful detriment, under section 48 of the Employment Rights Act 1996 or section 56 of the Pensions Act 2008;
(ii)    in relation to parental rights and flexible working, under sections 80 and 80H of the Employment Rights Act 1996;
(iii)    in relation to time off work, under sections 51, 54, 57, 57B, 60, 63 and 63C of the Employment Rights Act 1996;
(iv)    for equal pay or equality of terms under sections 120 and 127 of the Equality Act 2010;
(v)    for direct or indirect discrimination, harassment or victimisation related to sex, marital or civil partnership status under section 120 of the Equality Act 2010;
5

(vi)     for direct or indirect discrimination, harassment or victimisation related to race under section 120 of the Equality Act 2010;
(vii)    for direct or indirect discrimination, harassment or victimisation related to disability, perceived disability, discrimination arising from disability, or failure to make adjustments under section 120 of the Equality Act 2010;
(viii)    for direct or indirect discrimination, harassment or victimisation related to religion or belief under section 120 of the Equality Act 2010;
(ix)    for direct or indirect discrimination, harassment or victimisation related to sexual orientation, under section 120 of the Equality Act 2010;
(x)    for direct or indirect discrimination, harassment or victimisation related to age, under section 120 of the Equality Act 2010;
(xi)    for less favourable treatment on the grounds of part-time status, under regulation 8 of the Part-Time Workers (Prevention of Less Favourable Treatment) Regulations 2000;
(xii)    for less favourable treatment on the grounds of fixed-term status, under regulation 7 of the Fixed-Term Employees (Prevention of Less Favourable Treatment) Regulations 2002;
(xiii)    in relation to the right to be accompanied under section 11 of the Employment Relations Act 1999;
(xiv)    in relation to the right to request time off for study or training under section 63I of the Employment Rights Act 1996;
(xv)    for harassment under the Protection from Harassment Act 1997;
(xvi)    for failure to comply with obligations under the Human Rights Act 1998;
(xvii)    for failure to comply with obligations under the Data Protection Act 2018 and the UK GDPR (as defined in section 3(10) as supplemented by section 205(4) of the Data Protection Act 2018);
(xviii)    arising as a consequence of the United Kingdom's former membership of the European Union,
(c)    any other rights of action whatsoever and howsoever arising (whether under common law, statute, European Union law or otherwise) whether in the United Kingdom or any other country or jurisdiction and whether contemplated or not which You have or may have against the Company or any Group Company or any Connected Person
6

arising out of your employment or its termination or any past or present directorship or office or its or their termination and You irrevocably waive any such claims or rights of action which You now have or may become aware of hereafter.
6.2    You shall on the Leaving Date execute a further agreement in the form appearing at Schedule 2 to this Agreement ("Further Settlement Agreement").
6.3    Save for nothing in this Agreement shall preclude You from pursuing:
6.3.1 any claims by You to enforce this Agreement;
6.3.2 any claims in respect of personal injury (other than claims under discrimination legislation) of which You are not aware and could not reasonably expected to be aware at the date of this Agreement ; and
6.3.3 any claims in relation to accrued pension entitlements.
7.    WARRANTIES
7.1    You warrant that:
7.1.1    You have no claims against the Company, any Group Company or any Connected Person arising out of your employment or its termination or any past or present directorship or office or its or their termination other than those raised in clause 6.1(a), (b) and (c);
7.1.2    You are not guilty of any act or omission which would entitle the Company to summarily dismiss You without notice or compensation; and
7.1.3    As at the date You execute this Agreement, You have not received (either orally or in writing) nor agreed to accept (either orally or in writing) any offer, whether conditional or unconditional:
(a)    of a contract of service or for services;
(b)    to hold any office; or
(c)    of any form of deferred remuneration
to take effect at any time after the Leaving Date.
7.2    You acknowledge that the Company has relied on the warranties set out in this Agreement in entering into this Agreement and that the Company shall be released from any obligation to make any payment or provide any benefit to You hereunder in the event that the information so warranted proves inaccurate.
8.    COMPANY PROPERTY
8.1    You warrant that at the reasonable expense of the Company, (i) You will by no later than 1 March 2023 return to the Company all documents (including copies), software, credit or charge cards and any other property belonging to any of the Group Companies ("Group Company Property"); (ii) You have not downloaded any information or software belonging to the Company or any Group Company; (iii) You
7

have disclosed to the Company any passwords or computer access codes relevant to the business of the Company or any Group Company; and (iv) all correspondence or e-mails belonging to the Company and held on your personal computer have been transferred to compact disc or similar media and returned to the Company and that any copies held on the personal computer are permanently deleted.
8.2    At the reasonable expense of the Company, You undertake to return to the Company forthwith any Group Company Property which may come into your possession or control in the future.
9.    CONFIDENTIAL INFORMATION
9.1    Without prejudice to your common law and contractual obligations, and subject always to clause 9.2 below, You hereby undertake that You will not at any time use or disclose to any person, company, firm, individual or organisation (except with the agreement of the Company or as required by law) any trade secret or Confidential Information belonging or relating to the Company or any Group Company or any Connected Person which You obtained during and in connection with your employment with any such companies.
9.2    The parties both acknowledge and understand that the purpose of this Agreement is not to prevent, discourage or improperly influence the reporting of matters that are properly disclosable to the courts, to other law enforcement bodies, or under regulatory law or under the Public Interest Disclosure Act 1998 and nothing in this Agreement will restrict your right to disclose information on the terms of the settlement if required:
9.2.1    by any order of any court of competent jurisdiction or any regulatory, judicial, governmental or similar body or taxation authority of competent jurisdiction;
9.2.2    by any law or reporting requirement;
9.2.3    where reasonably necessary in order to instruct legal, medical, financial, tax or professional advisers provided that You procure that any such adviser agrees to keep the information confidential;
9.2.4    in order to disclose any matter that may reasonably be considered to be a criminal or professional or regulatory offence in the laws or regulations of any country, or to assist in the investigation of any such offence;
9.2.5    in order to make a protected disclosure pursuant to the Public Interest Disclosure Act 1998 (as amended);
9.2.6    to a spouse, civil partner, partner or immediate family provided that they agree to keep the information confidential; or
9.2.7    where reasonably necessary to a recruitment consultant or prospective employer to the extent necessary to discuss your employment history provided that you do not disclose any Confidential Information belonging or relating to the Company or any Group Company or any Connected Person in so doing.
8

10.    INDEPENDENT LEGAL ADVICE
10.1    You warrant that:
10.1.1    You have received independent legal advice from the Adviser who is a qualified lawyer acting in their professional capacity and who holds a current practising certificate, as to the terms and effect of this Agreement and, in particular, its effect on your ability to pursue your rights before an Employment Tribunal or court of competent jurisdiction in England and Wales;
10.1.2    that there was in force, when that lawyer gave the advice referred to in this paragraph, a policy of insurance covering claims in respect of any loss which may arise in consequence of the advice, as required by section 203 of the Employment Rights Act 1996 and section 147 of the Equality Act 2010, and also that, that lawyer is an independent adviser for the purposes of section 147 of the Equality Act 2010; and
10.1.3    You shall provide the Company with a letter in the form set out in schedule 1 signed by the Adviser.
11.    COMPLIANCE WITH LEGISLATION
The conditions regulating compromise contracts, compromise agreements and settlement agreements (as applicable) under section 147(3) of the Equality Act 2010, section 203(3) of the Employment Rights Act 1996, regulation 35(3) of the Working Time Regulations 1998, section 14 of the Employment Relations Act 1999, regulation 9 of the Part-time Workers (Prevention of Less Favourable Treatment) Regulations 2000, regulation 10 of the Fixed Term Employees (Prevention of Less Favourable Treatment) Regulations 2002 and section 58 of the Pensions Act 2008 are satisfied.
12.    REPAYMENT PROVISIONS
If You:
(a)    breach any material term of this Agreement; or
(b)    raise any grievance in writing with the Company or any Group Company within four months of the Leaving Date;
(c)    lodge a subject access request under Article 15 of the General Data Protection Regulation ((EU) 2016/679) with any Group Company as it forms part of the laws of England and Wales, Scotland and Northern Ireland by virtue of section 3 of the European Union (Withdrawal) Act 2018 with any Group Company; or
(d)    commence proceedings against the Company or any Group Company in breach of this Agreement
then, without prejudice to the rights of the Company or any Group Company to enforce the terms of this Agreement, You will pay to the Company on demand by way of liquidated damages an amount equivalent to: (i) in the case of (a) above, the damages suffered by the Company as a result of the breach; or (ii) in the case of (b) or (c) above, a sum equivalent to the net amount of your 2022 bonus; or (iii), in the case
9

of (d) above, the value of any damages, account of profits or other compensation sought by You, or the amount which could be awarded in such proceedings, and in both cases the Company's costs in connection with such breach or proceedings subject, however to a maximum of the amount of any payments made under this Agreement and any such payment shall be recoverable as a debt.
13.    DISPARAGING STATEMENTS
Subject always to clause 9.2 above, You warrant that you will not hold yourself out as representing the Company or make to any third party any misleading, untrue or derogatory statements (whether orally or in writing) about the Company, any Group Company or any Connected Person. The Company shall neither instruct nor authorize its officers, employees or workers to make adverse or derogatory comment about You or do anything that shall, or may, bring You into disrepute.
14.    RESTRICTIVE COVENANTS
14.1    You acknowledge that because of the nature of your duties and the particular responsibilities arising as a result of such duties owed to the Company and any Group Companies, You have acquired knowledge of trade secrets and Confidential Information concerning the Company, the Group Companies and certain Connected Persons and are therefore in a position to harm their legitimate business interests if You were to make use of such trade secrets or confidential business information for your own purposes or the purposes of another. Accordingly, having regard to the above and in consideration of the sum of £1,000 which shall be paid to You within 14 days of the date hereof, and having taken independent legal advice, You accept that the restrictions in this clause 14 are reasonable.
14.2    In this clause, the following terms have the following meanings:
14.2.1    "Customer" means any person who or that was a customer of or in the habit of dealing with the Company or any Relevant Group Company for the sale or supply of Relevant Products and/or Relevant Services, in each case at any time during the 24 months prior to the Leaving Date, and:
(a)    with whom or which You were materially concerned or had material contact or dealings (in each case at any time during the 24 months prior to the Leaving Date); or
(b)    in relation to whom or which You were, at the Leaving Date, in possession of Confidential Information;
14.2.2    "Investment" means a holding of shares or securities of a company any of whose shares or securities are quoted or dealt in on any recognised investment exchange and which holding shall not exceed one per cent. of the issued share capital of the company concerned and which is held by way of bona fide investment only;
14.2.3    "Key Person" means any person with whom You worked closely or who directly reported to You, in each case at any time during the period of 24 months prior to the Leaving Date, and who:
10

(a)    was an employee, worker, agent, director, consultant or independent contractor employed, appointed or engaged by the Company or any Relevant Group Company in a senior, managerial, technical, professional, sales, distribution, marketing or product development position; or
(b)    was or was likely to be able to influence the Customer or Supplier relationships or trade connections of the Company or any Relevant Group Company; or
(c)    at the Leaving Date was in possession of Confidential Information relating to the Company or any Relevant Group Company;
14.2.4    "Prospective Customer" means any person with whom or which the Company or any Relevant Group Company has been in negotiations for the supply of Relevant Products and/or Relevant Services or that the Company or any Relevant Group Company has actively solicited for the supply of Relevant Products and/or Relevant Services, in each case at any time during the 24 months prior to the Leaving Date and where such activities have involved more than nominal expense or time commitment; and:
(i)    with whom or which You were materially concerned or had personal contact, in each case at any time during the 24 months prior to the Leaving Date; or
(ii)    in relation to whom or which You were, at the Leaving Date, in possession of Confidential Information;
14.2.5    "Relevant Group Company" means any Group Company (and, if applicable, its predecessors in business):
(a)    for which You performed services or in which You held office, in each case at any time during the 24 months prior to the Leaving Date; or
(b)    in relation to which You were, at the Leaving Date, in possession of Confidential Information;
14.2.6    "Relevant Services" and "Relevant Products" means those services and products (as the context requires) which are directly or indirectly competitive with those:
(a)    acetyl chain products supplied or developed by the Company or any Relevant Group Company that is within the Company's manufacturing portfolio as at 1 March 2023; and
(b)    with the supply or development of directly or indirectly competing acetyl chain products within the Company's manufacturing portfolio as at 1 March 2023 which You were materially concerned at any time during the 24 months prior to the Leaving Date;
14.2.7    "Relevant Territory" means any area or territory:
(a)    in which You worked during the 24 months prior to the Leaving Date under the terms of this agreement; and/or
11

(b)    in relation to which You were responsible for, or involved in, the supply of Relevant Products and/or Services in the 24 months prior to the Leaving Date; and
14.2.8    "Supplier" means any person or business which at any time during the 24 months prior to the Leaving Date has supplied products or services to the Company or any Relevant Group Company in relation to Relevant Services or Relevant Products which are not readily available to the Company or any Relevant Group Company from another source or in relation to which the Company or any Relevant Group Company has exclusive, special or favourable terms which the Company or any Relevant Group Company could not easily obtain from another supplier and in each case:
(a)    with whom You had material contact or dealings, in each case during the 24 months prior to the Leaving Date and in the course of your employment; or
(b)    in relation to which You were, at the Leaving Date, in possession of Confidential Information.
14.3    You covenant to the Company (for itself and as trustee for each Relevant Group Company) that You shall not at any time prior to 1 March 2024 directly or indirectly, either alone or jointly with or on behalf of any third party and whether on your own account or as principal, partner, shareholder, director, employee, consultant or in any other capacity whatsoever:
14.3.1    in the Relevant Territory and in competition with the Company or any Relevant Group Company, engage, assist or be interested in the provision or development of, or any plans to provide or develop, Relevant Services and/or Relevant Products on behalf of any undertaking which is not a Group Company;
14.3.2    in competition with the Company or any Relevant Group Company, solicit or interfere with or endeavour to entice away from the Company or any Relevant Group Company any Customer or Prospective Customer in relation to the supply of Relevant Services and/or Relevant Products;
14.3.3    in the Relevant Territory and in competition with the Company or any Relevant Group Company, be concerned with the supply of Relevant Services and/or Relevant Products to any Customer or Prospective Customer;
14.3.4    in competition with the Company or any Relevant Group Company, solicit or interfere with or endeavour to entice away from the Company or any Relevant Group Company any Supplier;
14.3.5    solicit or attempt to solicit the employment, engagement or appointment of; or entice away or attempt to entice away from the Company or any Relevant Group Company any person who at the time of the conduct prohibited in this clause 14.3.5 had been a Key Person (whether or not such person would breach their contract of employment, engagement or appointment by reason of leaving the service of the business in which they work);
12

14.3.6    employ, engage or appoint or offer to employ, engage or appoint any person who immediately prior to the date of such offer of employment, engagement or appointment had been a Key Person (whether or not such person would breach their contract of employment, engagement or appointment by reason of leaving the service of the business in which they work); and
14.3.7    at any time following the Leaving Date represent yourself as being in any way connected with or interested in the business of the Company or any Relevant Group Company other than as a former employee.
14.4    Each of the obligations in this clause is an entire, separate and independent restriction on You, despite the fact that it may be contained in the same phrase and if any part is found to be invalid or unenforceable, the remainder will remain valid and enforceable.
14.5    You acknowledge that each and every restriction contained within this clause is intended by the parties to apply after the Leaving Date whether the termination is lawful or otherwise. The restrictions which are acknowledged to be ancillary in nature will apply even where the termination results from a breach of a provision within this agreement.
14.6    While the restrictions are considered by the parties to be fair and reasonable in the circumstances, it is agreed that if any of them should be judged to be void or ineffective for any reason, but would be treated as valid and effective if part of the wording (including part of any defined term) was deleted, they shall apply with such modifications as necessary to make them valid and effective and each defined term shall be deemed to be repeated each time it is used.
14.7    The provisions of this clause will not prevent You from holding an Investment.
15.    FUTURE COOPERATION
You acknowledge that You possess Confidential Information and agrees that You shall reasonably cooperate with the Company in order to effectuate a smooth and orderly transition of your knowledge, expertise and experience, including, without limitation, responding to the Company's requests for information, identifying outstanding matters and the status thereof, and identifying and explaining the location of files and materials (including computer files) You maintained during your employment with the Company. Subject always to clause 9.2 above, You agree to cooperate with and make yourself readily available to the Company or its professional advisers, as the Company may request, to assist in any matter, including but not limited to giving truthful testimony in any litigation or potential litigation, over which You may have knowledge, information or expertise and without requiring payment or compensation save for reimbursement of out of pocket expenses and to notify of any contact by any party or an advisor (or their insurer) to any party involved in any such dispute or litigation. You agree that You will not counsel or assist any legal representatives, other advisors or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges or complaints by any third party against the Company or any Group Company or any Connected Person, unless under a subpoena or other court order to do so, and then only to the extent required by law. You further agree as soon as is reasonably practicable and in any event within three working days of receipt to (a) notify the Company upon receipt of any court order, subpoena or legal discovery device that seeks or might require the disclosure or
13

production of the existence or terms of this Agreement; and (b) furnish a copy of such subpoena or legal discovery device to the Company.
16.    WITHOUT PREJUDICE STATUS
Once executed by both parties this Agreement will form an open and binding agreement notwithstanding the fact that the front sheet is marked "without prejudice" and "subject to contract".
17.    THIRD PARTIES RIGHTS
The Contracts (Rights of Third Parties) Act 1999 shall only apply to this Agreement in relation to the Company or any Group Company or any Connected Person. No person other than the parties to this Agreement and any Group Company or Connected Person shall have any rights under it and it will not be enforceable by any person other than those parties.
18.    ENTIRE AGREEMENT
18.1    The terms of this Agreement constitute the entire agreement between the parties in respect of the termination of your employment and supersede any previous agreement between them linked to the termination of your employment. The parties acknowledge that they are not entering into this Agreement in reliance upon any representation, warranty or undertaking which is not contained or referred to in this Agreement. The terms of this Agreement do not replace or supersede any provision of your contract of employment that remains in force after the Leaving Date, except where otherwise stated in this Agreement.
18.2    No variation of this Agreement shall be binding on either party unless and to the extent that the same is recorded in a written document executed by the parties. No waiver by the Company or any Group Company of any term, provision or condition of this Agreement or of any breach by You of any such term, provision or condition shall be effective unless it is in writing (excluding e-mail) and signed by the Company. No failure to exercise nor any delay in exercising any right or remedy hereunder by the Company or any Group Company shall operate as a waiver thereof or of any other right or remedy hereunder, nor shall any single or partial exercise of any right or remedy by the Company or any Group Company prevent any further or other exercise thereof or the exercise of any other right or remedy.
19.    SEVERABILITY
If any provision or part of a provision of this Agreement shall be or become void or unenforceable for any reason, this shall not affect the validity of that provision or any remaining provisions of this Agreement in this or any other jurisdiction and the provision may be severable and if any provision would be treated as valid and effective if part of the wording was deleted, it shall apply with such modifications as necessary to make it valid and effective.
20.     COUNTERPARTS
This Agreement may be executed by counterparts which together shall constitute one agreement. Either party may enter into this Agreement by executing a counterpart and this Agreement shall not take effect until it has been executed by both parties.
14

Delivery of an executed counterpart or a signature page by facsimile or scanned via email shall take effect as delivery of an executed counterpart of this Agreement following which the relevant party shall give the other the original of such page as soon as reasonably practicable thereafter.
21.    ELECTRONIC SIGNATURE
This Agreement may be executed by electronic signature (whatever form the electronic signature takes as agreed between the parties) and the parties agree that this method of signature is as conclusive of their intention to be bound by this Agreement as if signed by each party's manuscript signature.
22.    GOVERNING LAW AND JURISDICTION
22.1    This Agreement shall be governed by and construed in accordance with the law of England and Wales.
22.2    Each party irrevocably agrees to submit to the exclusive jurisdiction of the courts of England and Wales over any claim or matter arising under or in connection with this Agreement.
1.1    IN WITNESS whereof this Agreement has been executed as a deed and delivered on the date first above written.
Signed and Delivered as a deed by)
JOHN FOTHERINGHAM)
in the presence of:)/s/ John Fotheringham

Witness Signature:/s/ Joanna McGarrigle
Witness name:Joanna McGarrigle
Witness address:43 Highfield Close, Amersham, Buckinghamshire, HP6 6HQ
Witness occupation:Occupational Therapy Assistant
15

Signed and Delivered by)
Lynne Puckett for and
)
on behalf of CELANESE CORPORATION
)
in the presence of:)/s/ Lynne Puckett
Witness Signature:/s/ Alex Bednar
Witness name:Alex Bednar
Witness address:701 Millstone Lane, Nashville, TN 3705
Witness occupation:Contracts Coordinator & Notary Public
16

SCHEDULE 1
Letter from Adviser
[To be typed on the headed notepaper of [the law firm acting for the Executive]]
______ 202_
Dear Sirs
Re: [insert name of employer] (the "Company") and [insert name of employee] (the "Executive")
We refer to the agreement between the Company and the Executive, our client, dated ______ 202_, a copy of which is attached (the "Settlement Agreement") and confirm that:
1.    [name of adviser] has given the Executive independent [legal] advice as to the terms and effect of the Settlement Agreement and, in particular, (i) its effect on their ability to pursue their rights before an employment tribunal or court;
2.    [name of adviser] is [a solicitor of the Senior Courts of England and Wales and holds (and held at the time the advice was given) a current practising certificate issued by The Solicitors Regulation Authority];
3.    [firm] holds, and held at the time the advice was given, a current policy of insurance or an indemnity provided for members of a profession or professional body covering the risk of a claim by the Executive in respect of any loss arising in consequence of the advice; and
4.    neither [firm] nor [name of adviser] acted for the Company or any Group Company in relation to the termination of the Executive's employment with the Company or the Settlement Agreement and we consider [name of adviser] to be an independent adviser for the purposes of section 147 of the Equality Act 2010.
Yours faithfully

[Name of adviser]
for and on behalf of
[firm]
17

SCHEDULE 2
Dated              2023
(1) CELANESE CORPORATION
– and –
(2) JOHN FOTHERINGHAM
Without Prejudice
Subject to Contract

FURTHER SETTLEMENT AGREEMENT


GIBSON DUNN

Gibson, Dunn & Crutcher LLP
Telephone House 2-4 Temple Avenue
London EC4Y 0HB

FURTHER SETTLEMENT AGREEMENT
THIS FURTHER SETTLEMENT AGREEMENT is made on 2023
BETWEEN:
(1)    CELANESE CORPORATION, of 222 W. Las Colinas Blvd., Suite 900N, Irving, TX 75039 (the "Company"); and
(2)    JOHN FOTHERINGHAM, whose address is 5 Westminster Avenue, Chester, CH4 8JB ("You").
RECITALS
(A)    You and the Company entered into a settlement agreement dated __ February 2023 (the "Original Settlement Agreement").
(B)    The parties are entering into this Further Settlement Agreement in accordance with the provisions of clause 6.2 of the Original Settlement Agreement.
(C)    You have received independent legal advice from the Adviser a qualified lawyer as such term is defined in Section 203 of the Employment Rights Act 1996 as to the terms and effect of this Further Settlement Agreement and are aware that You have those potential claims against the Company which are listed and have been raised in clause 3.
THE PARTIES AGREE AS FOLLOWS:
1.    DEFINITIONS
1.1    In this Further Settlement Agreement capitalised terms shall have the meanings given to them in the Original Settlement Agreement unless otherwise defined herein:
"Adviser" means Kate Venables of Brabners LLP.
"Leaving Date" means [INSERT 1 SEPTEMBER 2023 OR SUCH EARLIER DATE AS APPLICABLE].
1.2    The headings in this Further Settlement Agreement are inserted for convenience only and shall not affect its construction.
1.3    A reference to a particular law is a reference to it as it is in force for the time being taking account of any amendment, extension, or re-enactment and includes any subordinate legislation for the time being in force made under it.
1.4    Unless the context otherwise requires, words in the singular include the plural and in the plural include the singular.
1.5    The schedules to this Further Settlement Agreement form part of (and are incorporated into) this Further Settlement Agreement.

1

2.    TERMINATION OF EMPLOYMENT
2.1    You accept and confirm the termination of your employment with Celanese Services UK Limited and any Group Companies with effect from the Leaving Date in accordance with the terms of the Original Settlement Agreement.
3.    WAIVER OF CLAIMS
3.1    You agree that You have carefully considered facts and circumstances relating to your employment and its termination and agree to accept the sum of £100 and other terms of this Further Settlement Agreement in full and final settlement of:
(a)    the following particular claims against the Company or any Group Company or any Connected Person (each of which is hereby intimated and waived):
(i)    for breach of contract or wrongful dismissal;
(ii)    for unfair dismissal, under section 111 of the Employment Rights Act 1996;
(iii)    for unfair dismissal under section 103A of the Employment Rights Act 1996;
(iv)    in relation to the right to a written statement of reasons for dismissal, under section 93 of the Employment Rights Act 1996;
(v)    for a statutory redundancy payment, under section 163 of the Employment Rights Act 1996;
(vi)    in relation to an unlawful deduction from wages or unlawful payment, under section 23 of the Employment Rights Act 1996;
(vii)    in relation to working time or holiday pay, under regulation 30 of the Working Time Regulations 1998; and
(viii)    in relation to personal injury of which You are aware or ought reasonably to be aware at the date of this Further Settlement Agreement,
(b)    the following additional claims against the Company or any Group Company or any Connected Person (each of which is hereby intimated and waived):
(i)    for unlawful detriment, under section 48 of the Employment Rights Act 1996 or section 56 of the Pensions Act 2008;
(ii)    in relation to parental rights and flexible working, under sections 80 and 80H of the Employment Rights Act 1996;
(iii)    in relation to time off work, under sections 51, 54, 57, 57B, 60, 63 and 63C of the Employment Rights Act 1996;
2

(iv)    for equal pay or equality of terms under sections 120 and 127 of the Equality Act 2010;
(v)    for direct or indirect discrimination, harassment or victimisation related to sex, marital or civil partnership status under section 120 of the Equality Act 2010;
(vi)    for direct or indirect discrimination, harassment or victimisation related to race under section 120 of the Equality Act 2010;
(vii)    for direct or indirect discrimination, harassment or victimisation related to disability, perceived disability, discrimination arising from disability, or failure to make adjustments under section 120 of the Equality Act 2010;
(viii)    for direct or indirect discrimination, harassment or victimisation related to religion or belief under section 120 of the Equality Act 2010;
(ix)    for direct or indirect discrimination, harassment or victimisation related to sexual orientation, under section 120 of the Equality Act 2010;
(x)    for direct or indirect discrimination, harassment or victimisation related to age, under section 120 of the Equality Act 2010;
(xi)    for less favourable treatment on the grounds of part-time status, under regulation 8 of the Part-Time Workers (Prevention of Less Favourable Treatment) Regulations 2000;
(xii)    for less favourable treatment on the grounds of fixed-term status, under regulation 7 of the Fixed-Term Employees (Prevention of Less Favourable Treatment) Regulations 2002;
(xiii) in relation to the right to be accompanied under section 11 of the Employment Relations Act 1999;
(xiv)    in relation to the right to request time off for study or training under section 63I of the Employment Rights Act 1996;
(xv)    for harassment under the Protection from Harassment Act 1997;
(xvi)    for failure to comply with obligations under the Human Rights Act 1998;
(xvii)    for failure to comply with obligations under the Data Protection Act 2018 and the UK GDPR (as defined in section 3(10) as supplemented by section 205(4) of the Data Protection Act 2018);
3

(xviii)    arising as a consequence of the United Kingdom's former membership of the European Union,
(c)    any other rights of action whatsoever and howsoever arising (whether under common law, statute, European Union law or otherwise) whether in the United Kingdom or any other country or jurisdiction and whether contemplated or not which You have or may have against the Company or any Group Company or any Connected Person arising out of your employment or its termination or any past or present directorship or office or its or their termination and You irrevocably waive any such claims or rights of action which You now have or may become aware of hereafter.
3.2    Save for nothing in this Further Settlement Agreement shall preclude You from pursuing:
3.2.1 any claims by You to enforce the Original Settlement Agreement or this Further Settlement Agreement;
3.2.2 any claims in respect of personal injury (other than claims under discrimination legislation) of which You are not aware and could not reasonably expected to be aware at the date of this Further Settlement Agreement ; and
3.2.3 any claims in relation to accrued pension entitlements.
4.    WARRANTIES
4.1    You warrant that:
4.1.1    You have no claims against the Company, any Group Company or any Connected Person arising out of your employment or its termination or any past or present directorship or office or its or their termination other than those raised in clause 3.1(a), (b) and (c); and
4.1.2    You are not guilty of any act or omission which would entitle the Company to summarily dismiss You without notice or compensation.
5.    INDEPENDENT LEGAL ADVICE
5.1    You warrant that:
5.1.1    You have received independent legal advice from the Adviser who is a qualified lawyer acting in their professional capacity and who holds a current practising certificate, as to the terms and effect of this Further Settlement Agreement and, in particular, its effect on your ability to pursue your rights before an Employment Tribunal or court of competent jurisdiction in England and Wales;
5.1.2    that there was in force, when that lawyer gave the advice referred to in this paragraph, a policy of insurance covering claims in respect of any loss which may arise in consequence of the advice, as required by section 203 of the Employment Rights Act 1996 and section 147 of the Equality Act 2010, and also that, that lawyer is an independent adviser for the purposes of section 147 of the Equality Act 2010; and
4

5.1.3    You shall provide the Company with a letter in the form set out in schedule 1 signed by the Adviser.
6.    COMPLIANCE WITH LEGISLATION
The conditions regulating compromise contracts, compromise agreements and Further Settlement Agreements (as applicable) under section 147(3) of the Equality Act 2010, section 203(3) of the Employment Rights Act 1996, regulation 35(3) of the Working Time Regulations 1998, section 14 of the Employment Relations Act 1999, regulation 9 of the Part-time Workers (Prevention of Less Favourable Treatment) Regulations 2000, regulation 10 of the Fixed Term Employees (Prevention of Less Favourable Treatment) Regulations 2002 and section 58 of the Pensions Act 2008 are satisfied.
7.    WITHOUT PREJUDICE STATUS
Once executed by both parties this Further Settlement Agreement will form an open and binding agreement notwithstanding the fact that the front sheet is marked "without prejudice" and "subject to contract".
8.    THIRD PARTIES RIGHTS
The Contracts (Rights of Third Parties) Act 1999 shall only apply to this Further Settlement Agreement in relation to the Company or any Group Company or any Connected Person. No person other than the parties to this Further Settlement Agreement and any Group Company or Connected Person shall have any rights under it and it will not be enforceable by any person other than those parties.
9.    ENTIRE AGREEMENT
9.1    The terms of the Original Settlement Agreement and this Further Settlement Agreement constitute the entire agreement between the parties in respect of the termination of your employment and supersede any previous agreement between them linked to the termination of your employment. The parties acknowledge that they are not entering into this Further Settlement Agreement in reliance upon any representation, warranty or undertaking which is not contained or referred to in the Original Settlement Agreement or this Further Settlement Agreement. The terms of this Further Settlement Agreement do not replace or supersede any provision of your contract of employment that remains in force after the Leaving Date or the terms of the Original Settlement Agreement which remain in full force and effect, except where otherwise stated in this Further Settlement Agreement.
9.2    No variation of this Further Settlement Agreement shall be binding on either party unless and to the extent that the same is recorded in a written document executed by the parties. No waiver by the Company or any Group Company of any term, provision or condition of this Further Settlement Agreement or of any breach by You of any such term, provision or condition shall be effective unless it is in writing (excluding e-mail) and signed by the Company. No failure to exercise nor any delay in exercising any right or remedy hereunder by the Company or any Group Company shall operate as a waiver thereof or of any other right or remedy hereunder, nor shall any single or partial exercise of any right or remedy by the Company or any Group Company prevent any further or other exercise thereof or the exercise of any other right or remedy.
5

10.    SEVERABILITY
If any provision or part of a provision of this Further Settlement Agreement shall be or become void or unenforceable for any reason, this shall not affect the validity of that provision or any remaining provisions of this Further Settlement Agreement in this or any other jurisdiction and the provision may be severable and if any provision would be treated as valid and effective if part of the wording was deleted, it shall apply with such modifications as necessary to make it valid and effective.
11.    COUNTERPARTS
This Further Settlement Agreement may be executed by counterparts which together shall constitute one agreement. Either party may enter into this Further Settlement Agreement by executing a counterpart and this Further Settlement Agreement shall not take effect until it has been executed by both parties. Delivery of an executed counterpart or a signature page by facsimile or scanned via email shall take effect as delivery of an executed counterpart of this Further Settlement Agreement following which the relevant party shall give the other the original of such page as soon as reasonably practicable thereafter.
12.    ELECTRONIC SIGNATURE
This Further Settlement Agreement may be executed by electronic signature (whatever form the electronic signature takes as agreed between the parties) and the parties agree that this method of signature is as conclusive of their intention to be bound by this Further Settlement Agreement as if signed by each party's manuscript signature.
13.    GOVERNING LAW AND JURISDICTION
13.1    This Further Settlement Agreement shall be governed by and construed in accordance with the law of England and Wales.
13.2    Each party irrevocably agrees to submit to the exclusive jurisdiction of the courts of England and Wales over any claim or matter arising under or in connection with this Further Settlement Agreement.
IN WITNESS whereof this Further Settlement Agreement has been executed as a deed and delivered on the date first above written.
Signed and Delivered as a deed by)
JOHN FOTHERINGHAM)
in the presence of:)
Witness Signature:
Witness name:
Witness address:
Witness occupation:
6



Signed and Delivered by)
______________ for and
)
on behalf of CELANESE CORPORATION
)
in the presence of:)
Witness Signature:
Witness name:
Witness address:
Witness occupation:
7

SCHEDULE 1
Letter from Adviser
[To be typed on the headed notepaper of [the law firm acting for the Executive]]
______ 202_
Dear Sirs
Re: [insert name of employer] (the "Company") and [insert name of employee] (the "Executive")
We refer to the agreement between the Company and the Executive, our client, dated ______ 202_, a copy of which is attached (the "Further Settlement Agreement") and confirm that:
1.    [name of adviser] has given the Executive independent [legal] advice as to the terms and effect of the Further Settlement Agreement and, in particular, (i) its effect on their ability to pursue their rights before an employment tribunal or court;
2.    [name of adviser] is [a solicitor of the Senior Courts of England and Wales and holds (and held at the time the advice was given) a current practising certificate issued by The Solicitors Regulation Authority];
3.    [firm] holds, and held at the time the advice was given, a current policy of insurance or an indemnity provided for members of a profession or professional body covering the risk of a claim by the Executive in respect of any loss arising in consequence of the advice; and
4.    neither [firm] nor [name of adviser] acted for the Company or any Group Company in relation to the termination of the Executive's employment with the Company or the Further Settlement Agreement and we consider [name of adviser] to be an independent adviser for the purposes of section 147 of the Equality Act 2010.
Yours faithfully

[Name of adviser]
for and on behalf of
[firm]
8
 EX-31.1 4 ex31106302310-q.htm EX-31.1 Document

Exhibit 31.1
 
CERTIFICATION
PURSUANT TO 17 CFR 240.13a-14
PROMULGATED UNDER
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 

I, Lori J. Ryerkerk, certify that:
 
1. I have reviewed this quarterly report on Form 10-Q of Celanese Corporation;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 
 /s/ LORI J. RYERKERK
Lori J. Ryerkerk
Chair of the Board of Directors,
Chief Executive Officer and President
August 8, 2023

 EX-31.2 5 ex31206302310-q.htm EX-31.2 Document

Exhibit 31.2
 
CERTIFICATION
PURSUANT TO 17 CFR 240.13a-14
PROMULGATED UNDER
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 

I, Scott A. Richardson, certify that:
 
1. I have reviewed this quarterly report on Form 10-Q of Celanese Corporation;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 /s/ SCOTT A. RICHARDSON
Scott A. Richardson
Executive Vice President and
Chief Financial Officer
August 8, 2023

 EX-32.1 6 ex32106302310-q.htm EX-32.1 Document

Exhibit 32.1
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 
In connection with the Quarterly Report of Celanese Corporation (the "Company") on Form 10-Q for the period ending June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Lori J. Ryerkerk, Chairman of the Board of Directors, Chief Executive Officer and President of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
 
1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 /s/ LORI J. RYERKERK
Lori J. Ryerkerk
Chair of the Board of Directors,
Chief Executive Officer and President
August 8, 2023









 EX-32.2 7 ex32206302310-q.htm EX-32.2 Document

Exhibit 32.2
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 
In connection with the Quarterly Report of Celanese Corporation (the "Company") on Form 10-Q for the period ending June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Scott A. Richardson, Executive Vice President and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
 
1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 /s/ SCOTT A. RICHARDSON
Scott A. Richardson
Executive Vice President and
Chief Financial Officer
August 8, 2023





 EX-101.SCH 8 ce-20230630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Unaudited Interim Consolidated Statement of Operations link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Unaudited Interim Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Unaudited Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Unaudited Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Unaudited Interim Consolidated Statement Equity link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - Unaudited Interim Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - Description of the Company and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Acquisitions, Dispositions and Plant Closures link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Goodwill and Intangible Assets, net link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Current Other Liabilities link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Benefit Obligations link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Environmental link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Other (Charges) Gains, Net link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Derivative Financial Instruments link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Earnings (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 9954701 - Disclosure - Recent Accounting Pronouncements (Policies) link:presentationLink link:calculationLink link:definitionLink 9954702 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures (Tables) link:presentationLink link:calculationLink link:definitionLink 9954703 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 9954704 - Disclosure - Goodwill and Intangible Assets, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 9954705 - Disclosure - Current Other Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954706 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 9954707 - Disclosure - Benefit Obligations (Tables) link:presentationLink link:calculationLink link:definitionLink 9954708 - Disclosure - Environmental (Tables) link:presentationLink link:calculationLink link:definitionLink 9954709 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 9954710 - Disclosure - Other (Charges) Gains, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 9954711 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 9954712 - Disclosure - Derivative Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 9954713 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 9954714 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954715 - Disclosure - Revenue Recognition (Tables) link:presentationLink link:calculationLink link:definitionLink 9954716 - Disclosure - Earnings (Loss) Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954717 - Disclosure - Description of the Company and Basis of Presentation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954718 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954719 - Disclosure - Acquisitions, Dispositions and Plant Closures - Business Acquisition, Pro Forma Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954720 - Disclosure - Acquisitions, Dispositions and Plant Closures - Disposal Groups, Including Discontinued Operations (Details) link:presentationLink link:calculationLink link:definitionLink 9954721 - Disclosure - Inventories - Schedule of Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 9954722 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 9954723 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954724 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Indefinite-Lived Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954725 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954726 - Disclosure - Current Other Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954727 - Disclosure - Debt - Schedule of Short-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954728 - Disclosure - Debt - Schedule of Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954729 - Disclosure - Debt - Senior Credit Facilities Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954730 - Disclosure - Debt - Schedule of Revolving Credit Facility (Details) link:presentationLink link:calculationLink link:definitionLink 9954731 - Disclosure - Debt - Senior Notes Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954732 - Disclosure - Debt - Accounts Receivable Securitization Facility Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954733 - Disclosure - Debt - Factoring and Discounting Agreements Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954734 - Disclosure - Benefit Obligations - Schedule of Net Periodic Benefit Costs Recognized (Details) link:presentationLink link:calculationLink link:definitionLink 9954735 - Disclosure - Benefit Obligations - Schedule of Company Commitments to Fund Benefit Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 9954736 - Disclosure - Benefit Obligations - Schedule of Defined Benefit Plans Disclosures (Details) link:presentationLink link:calculationLink link:definitionLink 9954737 - Disclosure - Environmental (Schedule of Environmental Remediation Reserves) (Details) link:presentationLink link:calculationLink link:definitionLink 9954738 - Disclosure - Environmental - US Superfund Sites Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954739 - Disclosure - Stockholders' Equity - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954740 - Disclosure - Stockholders' Equity - Schedule of Treasury Stock (Details) link:presentationLink link:calculationLink link:definitionLink 9954741 - Disclosure - Stockholders' Equity - Schedule of Components of Other Comprehensive Income (Loss), Net (Details) link:presentationLink link:calculationLink link:definitionLink 9954742 - Disclosure - Stockholders' Equity - Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net (Details) link:presentationLink link:calculationLink link:definitionLink 9954743 - Disclosure - Other (Charges) Gains, Net - Schedule of Other (Charges) Gains, Net (Details) link:presentationLink link:calculationLink link:definitionLink 9954744 - Disclosure - Other (Charges) Gains, Net - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954745 - Disclosure - Other (Charges) Gains, Net - Schedule of Restructuring Reserve by Type of Cost (Details) link:presentationLink link:calculationLink link:definitionLink 9954746 - Disclosure - Income Taxes - Schedule of Effective Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 9954747 - Disclosure - Derivative Financial Instruments (Schedule of Interest Rate Swap Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954748 - Disclosure - Derivative Financial Instruments Derivative Financial Instruments (Schedule of Net Investment Hedges) (Details) link:presentationLink link:calculationLink link:definitionLink 9954749 - Disclosure - Derivative Financial Instruments Derivative Financial Instruments (Schedule of Foreign Currency Forwards) (Details) link:presentationLink link:calculationLink link:definitionLink 9954750 - Disclosure - Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details) link:presentationLink link:calculationLink link:definitionLink 9954751 - Disclosure - Derivative Financial Instruments (Schedule of Offsetting Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 9954752 - Disclosure - Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 9954753 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 9954754 - Disclosure - Fair Value Measurements - Schedule of Carrying Values and Fair Values of Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 9954755 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954756 - Disclosure - Segment Information - Schedule of Business Segments (Details) link:presentationLink link:calculationLink link:definitionLink 9954757 - Disclosure - Revenue Recognition - Disaggregation of net sales (Details) link:presentationLink link:calculationLink link:definitionLink 9954758 - Disclosure - Revenue Recognition Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 9954758 - Disclosure - Revenue Recognition Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 9954759 - Disclosure - Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954760 - Disclosure - Earnings (Loss) Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 ce-20230630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 ce-20230630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 ce-20230630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Capital expenditures Property, Plant and Equipment, Additions Variable Rate [Domain] Variable Rate [Domain] Net (earnings) loss attributable to noncontrolling interests Net earnings (loss) attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Pay vs Performance Disclosure [Line Items] Other Noncurrent Liabilities [Member] Other Noncurrent Liabilities [Member] Discontinued operations - diluted (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Statistical Measurement [Domain] Statistical Measurement [Domain] Maximum borrowing base Line of Credit Facility, Maximum Borrowing Capacity Research and development expenses Research and Development Expense Changes in operating assets and liabilities Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Raw materials and supplies Inventory, Raw Materials and Supplies, Net of Reserves Indemnification ceiling amount Indemnification ceiling amount Ceiling amount above which the Company will indemnify Hoechst for. All Award Types Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Revenue, remaining performance obligation, expected timing of satisfaction, period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Investment, Name [Domain] Investment, Name [Domain] Repayments of short-term borrowings Repayments of Short-Term Debt Debt Debt Disclosure [Text Block] Current Other liabilities Other Current Liabilities [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Payments to acquire businesses, gross Payments to Acquire Businesses, Gross Revolving Credit Facility Revolving Credit Facility [Member] Transfer of financial assets accounted for as sales, amount derecognized Transfer of Financial Assets Accounted for as Sales, Amount Derecognized Exchange rate effects on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Deferred income taxes Deferred Income Tax Liabilities, Net MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Business Combination, Pro Forma Information, Interest Expense and Debt Issuance Cost Amortization Business Combination, Pro Forma Information, Interest Expense and Debt Issuance Cost Amortization Amount of pro forma interest expense and debt issuance cost amortization related to borrowings under the Term Loan Facility and the issuance of Acquisition notes as if the business combination had been completed at the beginning of a period. Expected Proceeds from Sale of Interest in Joint Venture Expected Proceeds from Sale of Interest in Joint Venture The expected proceeds from the sale of interest in an newly formed joint venture. Segment Reporting [Abstract] Segment Reporting [Abstract] Trade payables - third party and affiliates Accounts Payable, Current Restatement Determination Date: Restatement Determination Date [Axis] Foreign currency translation gain (loss), income tax (provision) benefit Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax Investment, Name [Axis] Investment, Name [Axis] Commitments and Contingencies Commitments and Contingencies Insider Trading Policies and Procedures [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Stockholders' Equity Equity [Text Block] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Geographical [Axis] Geographical [Axis] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Senior Unsecured Notes Due 2024 Senior Unsecured Notes Due 2024 [Member] USD Senior Unsecured Notes Due May 8, 2024 Income Taxes Income Tax Disclosure [Text Block] Description of the Company and Basis of Presentation Business Description and Basis of Presentation [Text Block] Environmental Environmental Loss Contingency Disclosure [Text Block] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Variable Interest Entity [Line Items] Variable Interest Entity [Line Items] Ownership [Axis] Ownership [Axis] Stock awards (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Current Liabilities Liabilities, Current [Abstract] Acquisitions, Dispositions and Plant Closures [Abstract] Acquisitions, Dispositions and Plant Closures [Abstract] Acquisitions, Dispositions and Plant Closures [Abstract]. Goodwill, impaired, accumulated impairment loss Goodwill, Impaired, Accumulated Impairment Loss Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, $0.01 par value, 100,000,000 shares authorized (2023 and 2022: 0 issued and outstanding) Preferred Stock, Value, Issued Eliminations Intersegment Eliminations Intersegment Eliminations [Member] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Common stock dividends Payments of Ordinary Dividends, Common Stock Net earnings (loss) - diluted (in dollars per share) Earnings Per Share, Diluted Gross amount recognized Derivative Liability, Subject to Master Netting Arrangement, before Offset PEO Total Compensation Amount PEO Total Compensation Amount Hedging Relationship [Axis] Hedging Relationship [Axis] Treasury stock, at cost (2023: 61,611,401 shares; 2022: 61,661,493 shares) Treasury Stock, Value Trade receivables - third party and affiliates Accounts Receivable, after Allowance for Credit Loss, Current Foreign currency forwards and swaps Foreign Currency Contracts, Liability, Fair Value Disclosure Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Treasury Stock, Common, Shares Treasury Stock, Common, Shares Variable Interbank Interest Rate Variable Interbank Interest Rate [Member] Certain interbank rates at current Company credit ratings Schedule of Net Periodic Benefit Costs Recognized Schedule of Net Benefit Costs [Table Text Block] Other comprehensive income (loss) before reclassifications Other Comprehensive Income (Loss), before Reclassifications, before Tax Loans Payable Short-Term Debt [Member] Derivative Asset, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Statement of Financial Position [Extensible Enumeration] Trading Symbol Trading Symbol Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Long-term debt, including current installments of long-term debt, fair value Long-Term Debt, Fair Value Cash flows between transferor and transferee, proceeds from new transfers Trade Receivables Pledged As Collateral The amount of trade receivables pledged as collateral. Total other comprehensive income (loss), tax Income tax (provision) benefit Other Comprehensive Income (Loss), Tax Net earnings (loss) attributable to Celanese Corporation Net earnings (loss) Net earnings (loss) attributable to Celanese Corporation Net Income (Loss) Unrecorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year Unrecorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year Total current liabilities Liabilities, Current Schedule of Notional Amounts of Derivative and Nonderivative Instruments Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Derivative Contract [Domain] Derivative Contract [Domain] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name China Revolving Credit Facility China Revolving Credit Facility [Member] Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount. Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Interest (Note 7) Interest Payable, Current Balance as of the beginning of the period (in shares) Balance as of the end of the period (in shares) Shares, Issued LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Gain (Loss) Recognized in Other Comprehensive Income (Loss) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Trade receivables - third party and affiliates, net Increase (Decrease) in Receivables Covenants Not to Compete and Other Other Intangible Assets [Member] Schedule of Earnings (Loss) Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Cost of sales Cost of Goods and Services Sold Foreign Currency Denominated Debt [Member] Foreign Currency Denominated Debt [Member] Foreign Currency Denominated Debt [Member] Service cost Defined Benefit Plan, Service Cost Derivative liability, statement of financial position [Extensible Enumeration] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Proceeds from sale of businesses and assets, net Proceeds from Sale of Productive Assets Executive Category: Executive Category [Axis] Schedule of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Foreign Exchange Contract [Member] Foreign Exchange Contract [Member] Name Measure Name Name Forgone Recovery, Individual Name Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three Guarantor obligations, maximum exposure Guarantor Obligations, Maximum Exposure, Undiscounted Senior Notes [Abstract] Senior Notes [Abstract] Goodwill As of December 31, 2022 As of June 30, 2023(2) Goodwill Equity Components [Axis] Equity Components [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Hedging Relationship [Domain] Hedging Relationship [Domain] Proceeds collected on accounts receivable sold under factoring facilities Proceeds Collected on Accounts Receivable Sold under Factoring Facilities Proceeds Collected on Accounts Receivable Sold under Factoring Facilities Underlying Securities Award Underlying Securities Amount Small Reporting Company Entity Small Business 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Four Local Phone Number Local Phone Number Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Net change in short-term borrowings with maturities of 3 months or less Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less Derivative, notional amount Derivative, Notional Amount Common stock, dividends, declared (in dollar per share) Common Stock, Dividends, Per Share, Declared Measurement Frequency [Axis] Measurement Frequency [Axis] Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates Debt, Current [Abstract] Mitsubishi Gas Chemical Company Mitsubishi Gas Chemical Company [Member] Mitsubishi Gas Chemical Company Engineered Materials Engineered Materials [Member] Engineered Materials Operating lease liabilities Operating Lease, Liability, Noncurrent Retirement Plan Type [Domain] Retirement Plan Type [Domain] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Debt instrument, term Debt Instrument, Term Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Amounts reclassified from accumulated other comprehensive income (loss) Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Line of Credit Facility [Table] Line of Credit Facility [Table] Schedule of Long-term Debt Schedule of Long-Term Debt Instruments [Table Text Block] Gross amount not offset in the consolidated balance sheets Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Offset China Working Capital Term Loan China Working Capital Term Loan [Member] CSIT senior unsecured working capital loan contract for CNY 800 million payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates. Site Contingency [Table] Site Contingency [Table] Goodwill and intangible assets, net Intangible Assets, Net (Including Goodwill) Exchange rate changes Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments Disposal Group, Including Discontinued Operation, Other Assets Disposal Group, Including Discontinued Operation, Other Assets, Current Income taxes payable Accrued Income Taxes, Current Schedule of Carrying Values and Fair Values of Financial Instruments Fair Value, by Balance Sheet Grouping [Table Text Block] Finite-Lived Intangible Assets, Cost Incurred to Renew or Extend Finite-Lived Intangible Assets, Cost Incurred to Renew or Extend Other Performance Measure, Amount Other Performance Measure, Amount Short-term Debt [Line Items] Short-Term Debt [Line Items] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Inventories Increase (Decrease) in Inventories Number of parties included in USEPA order Number of Parties included in USEPA order Number of Parties included in USEPA order. Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Beginning balance Ending balance Restructuring Reserve Award Type Award Type [Axis] Antidilutive securities excluded from computation of earnings per share, amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Acquisition Notes Due March 2025 USD Senior Unsecured Notes Due 2025 [Member] USD 1.75 Billion 6.050% Senior Unsecured Notes Due 2025 Schedule of Other (Charges) Gains, Net Schedule of Other (Charges) Gains, Net [Table Text Block] Schedule of Other (Charges) Gains, Net [Table Text Block]. Document Quarterly Report Document Quarterly Report Gross amount not offset in the consolidated balance sheets Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash, Offset Against Derivative Asset Number of divestiture agreements Number of divestiture agreements Number of divestiture agreements. Interest expense Interest Expense Common stock dividends Dividends, Common Stock Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Hedging Designation [Axis] Hedging Designation [Axis] Goodwill [Line Items] Goodwill [Line Items] Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Trading Arrangement: Trading Arrangement [Axis] Total contributions year-to-date Defined Benefit Plan, Plan Assets, Contributions by Employer Estimates and Assumptions Use of Estimates, Policy [Policy Text Block] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity File Number Entity File Number Loss Contingencies [Table] Loss Contingencies [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Operating leases Operating Lease, Liability, Current Environmental Remediation Obligations [Abstract] Environmental Remediation Obligations [Abstract] Demerger obligations (Note 14) Demerger obligations Demerger obligations. Amortization of intangible assets Amortization Amortization of Intangible Assets Entity Shell Company Entity Shell Company Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Net book value Finite-Lived Intangible Assets, Net New Accounting Pronouncements, Policy New Accounting Pronouncements, Policy [Policy Text Block] Restatement Determination Date Restatement Determination Date Offsetting Liabilities Offsetting Liabilities [Table Text Block] Average purchase price (in dollar per share) Shares Acquired, Average Cost Per Share Other liabilities Increase (Decrease) in Other Operating Liabilities Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Cash and cash equivalents Cash and cash equivalents as of beginning of period Cash and cash equivalents as of end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents As of December 31, 2022 As of June 30, 2023 Finite-Lived Intangible Assets, Accumulated Amortization Interest income Investment Income, Interest Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Loans Payable Loans Payable [Member] Common stock, shares issued (in shares) Common Stock, Shares, Issued Gross profit Gross Profit Current installments of long-term debt Long-Term Debt and Lease Obligation, Current Long-Term Debt and Lease Obligation, Current Security Exchange Name Security Exchange Name Long-term debt, including current installments of long-term debt, carrying amount Long-Term Debt Total assets Assets, Fair Value Disclosure Selling, general and administrative expenses Selling, General and Administrative Expense Accumulated other comprehensive income (loss), net As of December 31, 2022 As of June 30, 2023 Accumulated Other Comprehensive Income (Loss), Net of Tax Share-Based Payment Arrangement, Option Employee Stock Option [Member] Foreign Currency Translation Gain (Loss) Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Derivative Financial Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Foreign currency forwards and swaps Foreign Currency Contract, Asset, Fair Value Disclosure Benefit obligations Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent Other, net Proceeds from (Payments for) Other Financing Activities Maximum Maximum [Member] Comprehensive income (loss) attributable to Celanese Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Depreciation, amortization and accretion Depreciation, Amortization and Accretion, Net Document Type Document Type Unrecorded Unconditional Purchase Obligation, to be Paid, Year Four Unrecorded Unconditional Purchase Obligation, to be Paid, Year Four Net amount recognized Defined Benefit Plan, Funded (Unfunded) Status of Plan Tabular List, Table Tabular List [Table Text Block] Currency Swap Currency Swap [Member] Discontinued operations - basic (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Europe and Africa EMEA [Member] Entity Address, Address Line One Entity Address, Address Line One 364 Day Delayed-Draw Term Loan 364 Day Delayed-Draw Term Loan [Member] 364 Day Delayed-Draw Term Loan Purchases of treasury stock, including related fees Shares repurchased (in $ millions) Treasury Stock, Value, Acquired, Cost Method Payments to equity method investment Payments to Equity Method Investment The cash outflow associated with payments to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence. Exchange rate changes Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss) Pension and postretirement net periodic benefit cost Pension and Other Postretirement Benefits Cost (Reversal of Cost) Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Derivatives (Note 12) Derivative Liability, Current Noncontrolling interest, ownership percentage by parent Subsidiary, Ownership Percentage, Parent Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration] Equity method investment, increase Equity Method Investment, Increase Increase in an equity method investment, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence. Active sites Active sites Active sites. Nutrinova Joint Venture Nutrinova Joint Venture [Member] Food Ingredients joint venture under the name Nutrinova Business Acquisition [Axis] Business Acquisition [Axis] Insurance contracts in nonqualified trusts, carrying amount Cash Surrender Value of Life Insurance Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Trademarks and Trade Names Trademarks and Trade Names [Member] Subsequent Event Subsequent Event [Member] Schedule of Balances Available for Borrowing Schedule of Line of Credit Facilities [Table Text Block] Derivative [Table] Derivative [Table] Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Other liabilities Total Other Liabilities, Current Variable Rate [Axis] Variable Rate [Axis] Other (charges) gains, net Total Other (charges) gains, net (Note 14) Other Nonrecurring (Income) Expense Income Statement [Abstract] Income Statement [Abstract] Title of 12(b) Security Title of 12(b) Security Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Schedule of Restructuring Reserve by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Net amount Commodity swaps Derivative Liability As of December 31, 2022 As of June 30, 2023 Indefinite-Lived Intangible Assets (Excluding Goodwill) Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Number of equal annual investments restructuring payment Number of Payments to Equity Method Investments Number of Payments to Equity Method Investments Operating Segments Operating Segments [Member] Issuance of treasury stock under stock plans Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Other assets Other Assets, Current Business Combination, Pro Forma Information, Inventory Step Up Amortization Business Combination, Pro Forma Information, Inventory Step Up Amortization Amount of pro forma inventory step-up amortization as if the business combination had been completed at the beginning of a period. Class of Stock [Line Items] Class of Stock [Line Items] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Noncurrent Other assets Assets for Plan Benefits, Defined Benefit Plan Earnings (loss) per common share - diluted Earnings Per Share, Diluted [Abstract] Entity Tax Identification Number Entity Tax Identification Number Inventories Total Inventory, Net Amended restated receivable securitization facility Amended Restated Receivable Securitization Facility [Member] An accounts receivable securitization facility which allows a wholly owned, bankruptcy-remote subsidiary to sell an undivided interest in a pool of trade receivables (received through contribution from certain subsidiaries that retain the responsibility of servicing the receivables) to financial institutions participating in the facility. Statistical Measurement [Axis] Statistical Measurement [Axis] Distributions to noncontrolling interests Proceeds from (Payments to) Noncontrolling Interests Balance Sheet Location [Domain] Balance Sheet Location [Domain] Entity Interactive Data Current Entity Interactive Data Current Mobility & Materials Mobility & Materials [Member] Mobility & Materials Divestiture obligations (Note 14) Divestiture obligations Divestiture obligations. Total Shareholder Return Amount Total Shareholder Return Amount Purchases of treasury stock, including related fees Payments for Repurchase of Common Stock Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Pension and postretirement benefits gain (loss), income tax (provision) benefit Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax Segments [Domain] Segments [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Revenue Recognition and Deferred Revenue [Abstract] Revenue Recognition and Deferred Revenue [Abstract] Retained earnings Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Earnings (loss) from operation of discontinued operations Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax Debt instrument, face amount Debt Instrument, Face Amount Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current Assets Assets, Current [Abstract] Other long-term debt Other Long-Term Debt Disposal Group, Including Discontinued Operation, Assets Disposal Group, Including Discontinued Operation, Assets Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Disposal Group, Including Discontinued Operation, Goodwill Disposal Group, Including Discontinued Operation, Goodwill Goodwill, Transfers Goodwill, Transfers Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Continuing operations - basic (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share 2024 Finite-Lived Intangible Asset, Expected Amortization, Year One Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Acetyl Chain Acetyl Chain [Member] Acetyl Chain [Member] Acetyl Chain [Member] Disposal Group Name [Domain] Disposal Group Name [Domain] Earnings (loss) per common share - basic Earnings Per Share, Basic [Abstract] Interest cost Defined Benefit Plan, Interest Cost PEO PEO [Member] Environmental Remediation Site [Domain] Environmental Remediation Site [Domain] Schedule of Components of Other Comprehensive Income (Loss), Net Comprehensive Income (Loss) [Table Text Block] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Benefit Obligations Retirement Benefits [Text Block] Proceeds from short-term borrowings Proceeds from Short-Term Debt Other, net Other Operating Activities, Cash Flow Statement Earnings (loss) from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Accumulated Other Comprehensive Income (Loss), net [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Schedule of Variable Interest Entities [Table] Schedule of Variable Interest Entities [Table] Gross amount recognized Derivative Asset, Subject to Master Netting Arrangement, before Offset Short-term borrowings, including amounts due to affiliates(1) Other Short-Term Borrowings Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share South America South America [Member] Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Class of Stock [Domain] Class of Stock [Domain] Current Other Liabilities [Line Items] Current Other Liabilities [Line Items] Current Other Liabilities [Line Items] Schedule of Inventories Schedule of Inventory, Current [Table Text Block] Interest Rate Swap [Member] Interest Rate Swap [Member] Debt Instrument [Axis] Debt Instrument [Axis] Earnings (loss) from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Disposal Group, Including Discontinued Operation, Liabilities Disposal Group, Including Discontinued Operation, Liabilities Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent Indemnification Agreements Hoechst Indemnification Agreements Hoechst [Member] Indemnification Agreements Hoechst [Member]. Pension and postretirement benefits gain (loss), gross amount Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Credit Facility [Axis] Credit Facility [Axis] Uncertain tax positions Liability for Uncertainty in Income Taxes, Noncurrent Gain (loss) on cash flow hedges, income tax (provision) benefit Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Environmental Remediation Site [Axis] Environmental Remediation Site [Axis] Aggregate Board of Directors repurchase authorizations during the period (in $ millions) StockRepurchaseProgramAuthorizedAmountInPeriod Amount of stock repurchase plan authorized in the period. Accumulated Other Comprehensive Income (Loss), Net AOCI Attributable to Parent [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Divestiture Agreements Divestiture Agreements [Member] Divestiture Agreements [Member]. Measurement Frequency [Domain] Measurement Frequency [Domain] All Executive Categories All Executive Categories [Member] Unrecorded Unconditional Purchase Obligation, to be Paid, Year One Unrecorded Unconditional Purchase Obligation, to be Paid, Year One Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Non-trade receivables, net Nontrade Receivables, Current Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Pension and Postretirement Benefits Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Debt Disclosure [Abstract] Debt Disclosure [Abstract] North America North America [Member] Site Contingency [Line Items] Site Contingency [Line Items] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Foreign currency translation gain (loss), gross amount Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Common stock, $0.0001 par value, 400,000,000 shares authorized (2023: 170,458,836 issued and 108,847,435 outstanding; 2022: 170,135,425 issued and 108,473,932 outstanding) Common Stock, Value, Issued Total other comprehensive income (loss), before tax Other Comprehensive Income (Loss), before Tax Debt instrument, redemption price, percentage Debt Instrument, Redemption Price, Percentage Unrecorded unconditional purchase obligations Unrecorded Unconditional Purchase Obligation Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Legal (Note 14) Loss Contingency, Accrual, Current Weighted average interest rate, short-term borrowings Short-Term Debt, Weighted Average Interest Rate, at Point in Time Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Total current assets Assets, Current Schedule of Short-term Debt Schedule of Short-Term Debt [Table Text Block] Investments in affiliates Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Total Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Transfer of financial assets accounted for as sales, non-recourse basis, account receivable percentage Transfer Of Financial Assets Accounted For As Sales, Non-recourse Basis, Account Receivable Percentage Transfer Of Financial Assets Accounted For As Sales, Non-recourse Basis, Account Receivable Percentage All Individuals All Individuals [Member] Non-operating pension and other postretirement employee benefit (expense) income Non-operating pension and other postretirement employee benefit (expense) income Non-operating pension and other postretirement employee benefit (expense) income Other income (expense), net Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Derivative liability, statement of financial position [Extensible Enumeration] Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] Restructuring Type [Axis] Restructuring Type [Axis] Schedule of Treasury Stock Class of Treasury Stock [Table Text Block] Dividend income - equity investments Investment Income, Dividend Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Short-term Debt, Type [Domain] Short-Term Debt, Type [Domain] Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Disposal Group, Held-for-Sale, Not Discontinued Operations Disposal Group, Held-for-Sale, Not Discontinued Operations [Member] Subtotal Long-Term Debt and Lease Obligation, Including Current Maturities Goodwill and Intangible Assets, Net Goodwill and Intangible Assets Disclosure [Text Block] Sales and use tax/foreign withholding tax payable Sales and Excise Tax Payable, Current Recent Accounting Pronouncements Accounting Standards Update and Change in Accounting Principle [Text Block] Europe and Singapore Factoring Agreement Europe and Singapore Factoring Agreements [Member] Europe and Singapore Factoring Agreements Schedule of Effective Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Other (Charges) Gains, Net Other (Charges) Gains, Net [Text Block] Other (Charges) Gains, Net [Text Block]. PEO Name PEO Name Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Term Loan Facility Term Loan Facility [Member] Term Loan Facility Other Sundry Liabilities, Current Other Sundry Liabilities, Current Asia-Pacific Asia Pacific [Member] Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Insurance contracts in nonqualified trusts, fair value Cash Surrender Value, Fair Value Disclosure Senior Unsecured Term Loan Due 2025 Senior Unsecured Term Loan Due 2025 [Member] Senior unsecured term loan due 2025 Senior Unsecured Notes Due 2025 EUR Senior Unsecured Notes Due 2025 [Member] Senior Unsecured Notes Due 2025 [Member] 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Five Indemnification percentage, other Indemnification percentage, other Percentage of other liabilities the Company has agreed to indemnify Hoechst for as part of the Demerger Agreement. Schedule of Goodwill Schedule of Goodwill [Table Text Block] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Post-retirement Benefits Benefit payments to other postretirement benefit plans Other Postretirement Benefits Plan [Member] Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two Exchange rate changes Goodwill, Translation and Purchase Accounting Adjustments Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Class of Stock [Axis] Class of Stock [Axis] Entities [Table] Entities [Table] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Corporate, Non-Segment Corporate, Non-Segment [Member] Senior unsecured debt Unsecured Debt USD Senior Unsecured Notes Due 2032 USD Senior Unsecured Notes Due 2032 [Member] USD 1 Billion 6.379% Senior Unsecured Notes Due 2032 Revolving credit facilities(2) Line of Credit, Current Depreciation and amortization Depreciation, Depletion and Amortization Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Interest Rate, Stated Percentage Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Net amount presented in the consolidated balance sheets Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral Number of patents Number Of Patents Represents the number of patents. Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Information [Line Items] Entity Information [Line Items] Income tax (provision) benefit from discontinued operations Discontinued Operation, Tax Effect of Discontinued Operation Postemployment Benefits [Abstract] Benefit payments to nonqualified pension plans Other Pension Plan [Member] Business Combination and Asset Acquisition [Abstract] Total Celanese Corporation shareholders' equity Celanese Corporation stockholders' equity Equity, Attributable to Parent Disposal Group, Including Discontinued Operation, Assets, Current Disposal Group, Including Discontinued Operation, Assets, Current Passaic River, New Jersey Passaic River, New Jersey [Member] Passaic River, New Jersey [Member]. Consolidation Items [Axis] Consolidation Items [Axis] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Proforma Net sales Business Acquisition, Pro Forma Revenue Accounts Receivable Securitization Facility [Abstract] Accounts Receivable Securitization Facility [Abstract] Accounts Receivable Securitization Facility [Abstract] Entity number of employees Entity Number of Employees Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Foreign currency translation gain (loss) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Schedule of Defined Benefit Plans Disclosures Schedule of Defined Benefit Plans Disclosures [Table Text Block] Total Long-Term Debt and Lease Obligation Earnings (loss) from continuing operations before tax Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Indemnification amount Indemnification floor amount The amount that the Company will indemnify Hoechst for in full. Equity investments without readily determinable fair values, carrying amount Equity Securities without Readily Determinable Fair Value, Amount Amounts attributable to Celanese Corporation Income Amounts Attributable to Parent, Disclosures [Abstract] Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Current Other liabilities Liability, Defined Benefit Plan, Current Hedging Designation [Domain] Hedging Designation [Domain] Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Refunding loan for pollution control and industrial revenue bonds Refunding loan for pollution control and industrial revenue bonds [Member] Refunding loan for pollution control and industrial revenue bonds [Member] Net Investment Hedging [Member] Net Investment Hedging [Member] Emerging Growth Company Entity Emerging Growth Company Korea Engineering Plastics Co., Ltd. Korea Engineering Plastics Co., Ltd. [Member] Korea Engineering Plastics Co., Ltd. [Member]. Unamortized debt issuance costs Debt Issuance Costs, Net Transfer(1) Finite-Lived Intangible Assets, Transferred Amount of transfers into (out of) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Noncurrent Other assets Other Noncurrent Assets [Member] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Schedule of Changes in Fair Value of Derivatives Derivative Instruments, Gain (Loss) [Table Text Block] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Available for borrowing Line of Credit Facility, Remaining Borrowing Capacity Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Title Trading Arrangement, Individual Title Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Position [Domain] Position [Domain] Common Stock Common Stock [Member] Pension and postretirement benefits Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Individual: Individual [Axis] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Earnings (Loss) Per Share Earnings Per Share [Text Block] Acquisition Notes Acquisition Notes [Member] Acquisition Notes Equity method investment, ownership percentage Equity Method Investment, Ownership Percentage Senior Unsecured Notes Due 2026 USD Senior Unsecured Notes Due 2026 [Member] USD Senior Unsecured Notes Due 2026 [Member] Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Total equity Balance as of the beginning of the period Balance as of the end of the period Equity, Including Portion Attributable to Noncontrolling Interest Customer rebates Accrued Marketing Costs, Current Distributions/dividends to noncontrolling interests Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Consolidated Ventures Consolidated Ventures [Member] Consolidated Ventures Minimum Minimum [Member] Property, plant and equipment (net of accumulated depreciation - 2023: $3,830; 2022: $3,687) Property, Plant and Equipment, Net Gain (Loss) Recognized in Other Comprehensive Income (Loss) Gain (Loss) On Non-Derivatives and Derivatives Used In Net Investment Hedge Adjustment in other comprehensive income reflecting gains (losses) on foreign currency transactions that are designated as, and are effective as, hedges of net investment in foreign entity, gross of tax effect. Exercise Price Award Exercise Price Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Total other comprehensive income (loss), net of tax Other comprehensive income (loss), net of tax Total other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Disposal Group Classification [Axis] Disposal Group Classification [Axis] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Dividends, common stock, cash Dividends, Common Stock, Cash ASSETS Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Commodity swaps Commodity Contract [Member] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Total liabilities Liabilities, Fair Value Disclosure Foreign exchange gain (loss), net Gain (Loss), Foreign Currency Transaction, before Tax Derivative Liabilities [Abstract] Derivative Liability [Abstract] Current Other assets Current Other assets Other Current Assets [Member] Net earnings (loss) Net earnings (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Schedule of Environmental Remediation Reserves Environmental Exit Costs by Cost [Table Text Block] Earnings (loss) from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Deferred income taxes Deferred Income Tax Assets, Net Retirement Plan Type [Axis] Retirement Plan Type [Axis] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Continuing operations - diluted (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Other, net Payments for (Proceeds from) Other Investing Activities Developed Technology Developed Technology Rights [Member] Business Acquisition, Percentage of Voting Interests Acquired Business Acquisition, Percentage of Voting Interests Acquired Retained Earnings Retained Earnings [Member] Acquisition Notes Due July 2024 USD Senior Unsecured Notes Due 2024 [Member] USD 2 Billion 5.900% Senior Unsecured Notes Due 2024 Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Total liabilities and equity Liabilities and Equity Other assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Ownership [Domain] Ownership [Domain] Operating Lease, Right-of-Use Asset Operating Lease, Right-of-Use Asset Gain (loss) on cash flow hedges Gain (loss) on cash flow hedges, net amount Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Net earnings (loss) - basic (in dollars per share) Earnings Per Share, Basic Equity investments without readily determinable fair values, fair value Equity Securities, FV-NI and without Readily Determinable Fair Value Disposal Group, Including Discontinued Operation, Other Liabilities Disposal Group, Including Discontinued Operation, Other Liabilities Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Mitsui & Co. Ltd. Mitsui & Co. Ltd. [Member] Mitsui & Co. Ltd. Derivative Asset, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Indefinite-lived Intangible Assets [Line Items] Indefinite-Lived Intangible Assets [Line Items] U.S. Superfund sites US Superfund sites US Superfund sites. Arrangement Duration Trading Arrangement Duration Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Schedule of Business Segments Schedule of Segment Reporting Information, by Segment [Table Text Block] Current Other Liabilities [Table] Current Other Liabilities [Table] Current Other Liabilities [Table] Senior Unsecured Term Loan Due 2027 Senior Unsecured Term Loan Due 2027 [Member] Senior Unsecured Term Loan Due 2027 Restructuring(1) Restructuring Charges Additions Restructuring Charges Indefinite-Lived Intangible Assets, Transferred Indefinite-Lived Intangible Assets, Transferred Amount of increase (decrease) of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit, from transfers. Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Acquisitions (Note 3) Goodwill, Purchase Accounting Adjustments Undistributed earnings in unconsolidated affiliates Income (Loss) from Equity Method Investments, Net of Dividends or Distributions Termination Date Trading Arrangement Termination Date Trade payables - third party and affiliates Increase (Decrease) in Accounts Payable Common stock, shares authorized (in shares) Common Stock, Shares Authorized Environmental liability percentage Environmental Liability Percentage Estimated ultimate allocable share of cleanup costs. Current Other Liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Benefit obligations (Note 8) Liability, Pension and Other Postretirement and Postemployment Benefits, Current Number of facilities Number Of Facilities Represents the number of facilities. Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Indefinite-lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Other environmental remediation liabilities Other environmental remediation reserves Other environmental remediation reserves. 5 Year Delayed-Draw Term Loan 5 Year Delayed-Draw Term Loan [Member] 5 Year Delayed-Draw Term Loan Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Instrument [Axis] Gain (loss) on cash flow hedges, gross amount Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] All Trading Arrangements All Trading Arrangements [Member] All Adjustments to Compensation All Adjustments to Compensation [Member] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Derivative [Line Items] Derivative [Line Items] Award Timing Disclosures [Line Items] Derivative Financial Instruments (Schedule of Interset Rate Swap Narrative) [Abstract] Derivative Financial Instruments (Schedule of Interset Rate Swap Narrative) [Abstract] Derivative Financial Instruments (Schedule of Interset Rate Swap Narrative) [Abstract] Schedule of Company Commitments to Fund Benefit Obligations Schedule of Company Commitments to Fund Benefit Obligations [Table Text Block] Schedule of Company Commitments to Fund Benefit Obligations [Table Text Block]. Compensation Amount Outstanding Recovery Compensation Amount Indemnification percentage exceeding ceiling amount Indemnification percentage exceeding ceiling amount The percentage of the amount above the ceiling that the Company will indemnify Hoechst for. Senior Unsecured Notes Due 2028 EUR Senior Unsecured Notes Due 2028 [Member] EUR Senior Unsecured Notes Due 2028 Comprehensive (income) loss attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Additional paid-in capital Additional Paid in Capital Net amount Derivative Asset Derivative Asset Deferred income taxes, net Deferred Income Tax Expense (Benefit) Subsequent Event Type [Axis] Subsequent Event Type [Axis] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] 3 Year Delayed-Draw Term Loan 3 Year Delayed-Draw Term Loan [Member] 3 Year Delayed-Draw Term Loan Investment in affiliates Equity Method Investment Liability, Current Equity Method Investment Liability, Current Gain (loss) on disposition of businesses and assets, net Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Exchange rate changes Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss) Short-term Debt, Type [Axis] Short-Term Debt, Type [Axis] Total debt Finance Lease, Liability Net amount presented in the consolidated balance sheets Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral Food Ingredients Food Ingredients [Member] Food Ingredients ("FI") business of CE's Engineered Material segment Short-term borrowings and current installments of long-term debt - third party and affiliates Total Debt, Current 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Three Proforma Earnings (loss) from continuing operations before tax Business Acquisition, Pro Forma Income (Loss) From Continuing Operations Before Income Taxes, Noncontrolling Interest Amount before tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period. Increase (decrease) in accrued capital expenditures Increase (Decrease) of Accrued Capital Expenditures Increase (Decrease) of Accrued Capital Expenditures. Insider Trading Arrangements [Line Items] USD Senior Unsecured Notes Due 2027 USD Senior Unsecured Notes Due 2027 [Member] USD 2 Billion 6.165% Senior Unsecured Notes Due 2027 Total expected contributions in current fiscal year Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year Restructuring (Note 18) Restructuring Reserve, Current Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Issuance of treasury stock under stock plans (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Revenue, Major Customer [Line Items] Revenue, Major Customer [Line Items] Other Liabilities, Current [Abstract] Other Liabilities, Current [Abstract] Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Incremental shares attributable to equity awards(1) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Long-term debt, weighted average interest rate, at point in time Long-Term Debt, Weighted Average Interest Rate, at Point in Time Other assets Increase (Decrease) in Other Operating Assets 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Two Total Accrual for Environmental Loss Contingencies Adjustment to Compensation, Amount Adjustment to Compensation Amount Employee Severance Employee Severance [Member] Noncontrolling interests Balance as of the beginning of the period, noncontrolling interest Balance as of the end of the period, noncontrolling interest Equity, Attributable to Noncontrolling Interest Cash payments Payments for Restructuring Document Period End Date Document Period End Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Adoption Date Trading Arrangement Adoption Date Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Stock awards Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Accumulated depreciation, depletion and amortization, property, plant, and equipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Disposal Group Name [Axis] Disposal Group Name [Axis] Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] EUR Senior Unsecured Notes Due 2029 EUR Senior Unsecured Notes Due 2029 [Member] EUR 500 Million 5.337% Senior Unsecured Notes Due 2029 [Member] Other Activities Corporate and Other [Member] Europe Factoring Agreements Europe Factoring Agreements [Member] Europe Factoring Agreements Repayments of long-term debt Repayments of Long-Term Debt Senior Unsecured Notes Due 2023 EUR Senior Unsecured Notes Due 2023 [Member] Senior Unsecured Notes Due 2023 [Member] Business Acquisition, Pro Forma Information Business Acquisition, Pro Forma Information [Table Text Block] Treasury Stock, Common Treasury Stock, Common [Member] Entity Central Index Key Entity Central Index Key Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Gain (Loss) Recognized in Earnings (Loss) Derivative, Gain (Loss) on Derivative, Net (Gain) loss on disposition of businesses and assets, net Gain (Loss) on Disposition of Property Plant Equipment Finite-Lived Intangible Assets, Transferred, Accumulated Amortization Finite-Lived Intangible Assets, Transferred, Accumulated Amortization Amount of transfers (into) out of Accumulated Amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Loss Contingencies by Nature of Contingency [Axis] Loss Contingency Nature [Axis] As of December 31, 2022 As of June 30, 2023 Finite-Lived Intangible Assets, Gross Income tax (provision) benefit Income Tax Expense (Benefit) Finished goods Inventory, Finished Goods, Net of Reserves Designated as Hedging Instrument Designated as Hedging Instrument [Member] Singapore Factoring Agreements Singapore Factoring Agreements [Member] Singapore Factoring Agreements Salaries and benefits Employee-related Liabilities, Current Fair Value Measurements Fair Value Disclosures [Text Block] Issuance cost of bridge facility Payments of Financing Costs Name Trading Arrangement, Individual Name Notional Amount of Nonderivative Instruments Notional Amount of Nonderivative Instruments Operating cash provided by (used in) discontinued operations Cash Provided by (Used in) Operating Activities, Discontinued Operations Schedule of Revenue by Major Customers by Reporting Segments Disaggregation of Revenue [Table Text Block] Inventories Inventory Disclosure [Text Block] Celanese Corporation Celanese Corporation [Member] Celanese Corporation Net sales Revenue from Contract with Customer, Excluding Assessed Tax Benefit obligations Liability, Defined Benefit Plan Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Notes offering related costs Notes Offering Related Costs Fees and expenses related to the notes offering, inclusive of underwriting discounts. Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Gross amount offset in the consolidated balance sheets Derivative Liability, Subject to Master Netting Arrangement, Asset Offset Cost of EPA's plan estimate environmental Loss exposure for environmental contingencies at an individual site for which no accrual has been recorded based upon EPA determination. Acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Licenses Licensing Agreements [Member] Total comprehensive income (loss), net of tax Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Credit Facility [Domain] Credit Facility [Domain] Purchases of treasury stock (in shares) Shares repurchased (in shares) Treasury Stock, Shares, Acquired Acquisition Notes Due July 2029 USD Senior Unsecured Notes Due 2029 [Member] USD 750 Million 6.330% Senior Unsecured Notes Due 2029 Disposal Group, Including Discontinued Operation, Liabilities, Current Disposal Group, Including Discontinued Operation, Liabilities, Current Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Long-term debt, net of unamortized deferred financing costs Long-Term Debt, Excluding Current Maturities Gain (Loss) Recognized in Other Comprehensive Income (Loss) Gain (Loss) On Non-Derivative Used In Net Investment Hedge Adjustment in other comprehensive income reflecting gains or losses on foreign currency transactions that are designated as, and are effective as, hedges of net investment in foreign entity, gross of tax effect. Weighted average shares - diluted (in shares) Weighted average shares - diluted Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Derivative Assets [Abstract] Derivative Asset [Abstract] Disposal Groups, Including Discontinued Operations Disposal Groups, Including Discontinued Operations [Table Text Block] Revenue Recognition Revenue from Contract with Customer [Text Block] Capital expenditures on property, plant and equipment Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Acquisitions, Dispositions and Plant Closures Acquisitions, Dispositions and Plant Closures [Text Block] Acquisitions, Dispositions and Plant Closures [Text Block]. Additional Paid-In Capital Additional Paid-in Capital [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Total assets Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Equity in net earnings (loss) of affiliates Income (Loss) from Equity Method Investments Loss Contingencies [Line Items] Loss Contingencies [Line Items] Cover [Abstract] Cover [Abstract] Gain (Loss) Recognized in Earnings (Loss) Amount of Ineffectiveness on Net Investment Hedges Position [Axis] Position [Axis] Recent Accounting Pronouncements [Abstract] Recent Accounting Pronouncements [Abstract] Recent Accounting Pronouncements [Abstract] Percentage of fair value of sales receivables Percentage of Fair Value of Sales Receivables Percentage of fair value of sales receivables. Stock-based compensation, net of tax APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Fair Value, Recurring Fair Value, Recurring [Member] Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Schedule of Current Other Liabilities Other Current Liabilities [Table Text Block] Other liabilities Other Liabilities, Noncurrent Non-NEOs Non-NEOs [Member] Revenue, remaining performance obligation, amount Revenue, Remaining Performance Obligation, Amount EUR Senior Unsecured Notes Due 2026 EUR Senior Unsecured Notes Due 2026 [Member] EUR 1 Billion 4.777% Senior Unsecured Notes Due 2026 Derivatives Designated as Cash Flow Hedges Cash Flow Hedging [Member] Pension Benefits Cash contributions to defined benefit pension plans Pension Plan [Member] Loss contingency accrual, carrying value, payments Loss Contingency Accrual, Payments Segment Information Segment Reporting Disclosure [Text Block] Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Secured Debt Secured Debt [Member] Non-PEO NEO Non-PEO NEO [Member] Equity Component [Domain] Equity Component [Domain] Adjustment to Compensation: Adjustment to Compensation [Axis] Offsetting Assets Offsetting Assets [Table Text Block] Work-in-process Inventory, Work in Process, Net of Reserves Pension and postretirement contributions Payment for Pension and Other Postretirement Benefits Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Gross amount offset in the consolidated balance sheets Derivative Asset, Subject to Master Netting Arrangement, Liability Offset Debt Instrument [Line Items] Debt Instrument [Line Items] Weighted average shares - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Operating profit (loss) Operating profit (loss) Operating Income (Loss) Schedule of Short-term Debt [Table] Schedule of Short-Term Debt [Table] Plant Closures [Abstract] Plant Closures [Abstract] Plant Closures [Abstract] Schedule of Indefinite-Lived Intangible Assets [Table] Schedule of Indefinite-Lived Intangible Assets [Table] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Segments [Axis] Segments [Axis] Statement [Line Items] Statement [Line Items] Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax [Abstract] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Customer- Related Intangible Assets Customer Relationships [Member] Senior Unsecured Notes Due 2027 EUR Senior Unsecured Notes Due 2027 [Member] EUR Senior Unsecured Notes Due 2027 [Member] Type of Restructuring [Domain] Type of Restructuring [Domain] Shareholders' Equity Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Noncontrolling Interests Noncontrolling Interest [Member] Earnings (loss) from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent EX-101.PRE 12 ce-20230630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 13 ce-20230630_g1.jpg begin 644 ce-20230630_g1.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X1$817AI9@ 34T *@ @ ! $[ ( M : (2H=I 0 ! (9)R= $ T 0W.H< < @, /@ M FMC.60G/SX-"CQX.GAM<&UE=&$@>&UL M;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR9&8Z4D1&('AM;&YS.G)D9CTB:'1T M<#HO+W=W=RYW,RYO&UL;G,Z#IX;7!M971A/@T*(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" \/WAP M86-K970@96YD/2=W)S\^_]L 0P '!04&!00'!@4&" <'" H1"PH)"0H5#Q , M$1@5&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL*QH@+S,O*C(G*BLJ_]L 0P$' M" @*"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\ $0@! 3O P$B (1 0,1 ?_$ !\ $% M 0$! 0$! ! @,$!08'" D*"__$ +40 (! P,"! ,%!00$ ! M?0$" P $$042(3%!!A-180'EZ M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V]_CY^O_$ !\! ,! 0$! 0$! 0$ M ! @,$!08'" D*"__$ +41 (! @0$ P0'!00$ $"=P ! @,1! 4A M,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB) MBI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9 MVN+CY.7FY^CIZO+S]/7V]_CY^O_: P# 0 "$0,1 #\ ^D:*** "BBB@ HHH MH **** "BBB@ HHJ&ZO+:Q@,U[<1V\8ZO(X4?K2;25V-)MV1-17&:E\4-#LF M*6@FOG'>-=J_F?Z UR]_\6-5GR-/M+>U4]"V9&'X\#]*\ZKFF$I:.5WY:_\ M /6HY/C:VJA9>>G_ ?P/6Z*\'N?'7B2Z_UFJS(/2(+'_P"@@5ERZMJ,[$S: MA=2$]2TS'^M>?+/J2^&#?X?YGI0X;K/XYI>EW_D?1E%?-3RR2??D9OJQ-"32 MQ_/?$EHPVZF\J]UF57S^)&?UK:&?47\4&OQ_R,)\-UU\$T_6Z_P S MW6BO*+'XMW\; :CI]O.O']094EFDLI&XQ<+A<_[PR/S MQ7H4)9()$EC;E71@0?Q%/KT=SRM MM&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1102%4EC@#DD]J "J&K:WI^B6WGZGT\/A)Y1PURW*+_NC^+Z]/K7F-[?W6I73W-].\\SGEW.?_U#VKPL M9G%.C>%'WG^'_!/I,!D-6O:=?W8_B_\ +^M#NM>^*EU<;H=!@^RQ]//E 9S] M!T'Z_A7"WE_=ZC.9KZYEN)#_ !2.6-5Z*^7KXNMB'>I*_P"7W'V&&P6'PJM2 MC;SZ_>%%%%2V[9R0C<-]1T M/XUZ!H?Q7R4AU^V YP;F =/945V8?&U\,_P!W+3MT.'%9?AL6OWL= M>_7[SZ0LK^UU*U6YL+B.XA;H\;9'T]C[58KYXT34-5TV^$VBO,)N 5B4L''H M1W%>T^&-=OM8M<:II-S87"C)9XRL;_[N>1]#^=?6X',HXKW9*TOP/B,QRF6# M]Z,KQ_'[O\C>HHHKUCQ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH ***KWU];:;8RW=[*(H(EW,Q_P ]?:DVDKL<8N3LMQ;V M]MM/LY+J]F6&&,99V. *\<\7>.[O7Y'M;,M;:<#@(#AI?=O;VJEXK\6W?B:] M.XM%91M^Y@ST]SZG^5<]7QV8YI*NW3I:1_/_ (!]YE63QPZ56NKS_+_@A111 M7A'T84444 %%%% !1110 445MZ7X/UW6-K6EA(L3?\M91L7'KD]?PS6E.G.H M^6"N_(SJ5:=*/-4DDO,Q**].TSX2(-KZQJ)8_P 45LN!_P!]'_"NOTWP=H.E M8-KIT32#GS)AYC9]'7S_"4](7D_+;\3Q*PT#5=4 MQ_9^GW$ZG^-4.W_OH\5T]A\*];N<->2V]FIZAFWL/P''ZU[" , =!17KT MLCH1_B-O\/Z^\\2MQ%B9Z4XJ/XO^OD<#9?";2XL&^OKFY(ZA (U/\S^M=#9^ M"_#MC@PZ5 Q'>4&3_P!"S6[17I4\#AJ7PP7Y_F>15S'%UOCJ/\OR&10Q6\8C M@C2)!T5% _ 4^BBNS8XFV]6%%%% @HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBFR2)%&TDKJB("S,QP% ZDF@!U M%9/_ E7A[_H/:9_X&1_XT?\)5X>_P"@]IG_ (&1_P"- &M163_PE7A[_H/: M9_X&1_XU;L=5T[4]_P#9M_:WGEXW_9YEDVYSC.#QG!_*@"W1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 -D=8HVDD8(B@LS,< =Z\3\;^+I?$6HM!;N M5TZ!OW2CCS#_ 'S_ $]!71_$WQ45)T&P?' -TZG\D_J?P]Z\RKY/.,>YR^KT MWHM_\C[;(LM4(K$U5J]O)=_G^04445\X?5!1110 4444 %%7]*T34=;N/)TR MUDG8?>8#"K]6/ KT;0_A3:PA9==N#2U[+?\ KU/-+#3;W5+@0:?;27$A_AC7./<^@]S7<:/\*+R?;)K5 MTMJG4PQ?._T)Z#]:]/L[&UT^W$%C;QV\2]$C4 5/7T>'R2C#6J^9__YGI^&*VJ**]RG3A37+!61\]4JU M*LN:HVWYA1115F84444 %%%9FI>)-'T@'^T-0@B8?P;MS?\ ?(R:F4XP5Y.R M+A3G4?+!7?D:=%1A&I_F?Y5S%_P#$_7[O(MF@LU_Z M91[F_-LUYE7-\)3VE?T_JQZ]'(\;5U<>5>?]7/9JSKOQ!I%@2+S4K6)A_"TH MW?EUKP:]UO5-1S]NU"YG!_A>4D?ETJC7F5,^_P"?G)&*Z*OF>O9?AYXK.MZ<;"]?-[:*/F8\RI MT!^HX!_ ]ZZ*/VE;J5G@\(Z6L"9P+J^^9S[A <#\2:\GUWQWXH\2 MY&M:Y>7,9ZP^9LC_ .^%POZ4#L?86J>./"^BEAJFOZ?;NIP8VN%+C_@(.?TK MF+OX[?#^U.%UB2X/I#:RG]2H%?(E% 6/JF3]HOP2C$*FJ2>ZVR_U84)^T7X) M;[R:HG^];+_1J^5J*!V/KBU^/7@"X($FJS6V?^>MI+_[*IKHM-^(W@[5F"6/ MB33G=CA4><1LWT5L$U\2T4"L??R.LB!XV#*PR&4Y!%+7PIH_B76_#TOF:)JM MY8GN()F56^HZ'\:]^^"WQ4\3^,=>DT;7(K>[BAMFF:]5/+D7! ('RG)/8#O MUH"Q[;1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q=_R).N?] M@ZX_]%M6Q6/XN_Y$G7/^P=_U?B?ZVO_ +5KY]KZ M"_9>_P!7XG^MK_[5H!GOM%%%!(4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^*-> MC\.Z#->MAI?N0H?XG/3\NOT%;%>-_$O7O[3U_P"P0/FWLGE>#^MXE0?PK5^G_!./N)Y;JXDGN',DLC%W8]23U-1T45\ M"VV[L_3$DE9!1112&%%%=5X6\!W_ (A*W$^;2P_YZLOS/_NCO]>GUK:C1J5Y M\E-79A7Q%+#P=2J[(YRTL[F_NDMK*%YYG.%1!DFO2/#OPLC54N/$4A9^OV6) ML ?[S=_H/SKM]&T#3M M?)TVW6/(P\AY=_J>]:5?58/)J=+WJWO/MT_X)\7C ML^JU;PP_NKOU_P" 0VEG;6%LMO901P0KT2-< 5-117O))*R/FVVW=A1113$% M%%% !16%KOC'1] #)=W(DN!TMX?F?\?3\:\ZUOXGZM?EH],5=/@/ *_-(1_O M=OP'XUY^)S'#X?23N^R/4PF58K%:QC9=WHO^">J:GK6FZ/%OU*\BMP>BLWS- M]!U-<1J_Q8MXBT>BV;3GM-/\J_@HY/Z5YA-/+II37*OO9]3AN'\/3UJOF?W+^OF;VJ>-=>U?(N+]XXS_RR@_=K^G)_$FL M&BBO&J59U7S3;;\SWJ=&G2CRTXI+R"BBBLS4**** "KNCZI/HNK6]_:']Y"V M=N>''=3[$<52HJHR<9*4=T3*,9Q<9*Z9]'Z;J$&JZ;!?6C;H9T#KGJ/8^X/% M6:\R^%.O8>?1+AN#F:WSZ_Q+_7\Z]-K]"P>(6)H1J=>OJ?E^/PKPF(E2>W3T M"BBBNLX0HHHH **** "BBB@ HHHH **** "FNZ11M)(RHB@LS,< =232331 M6\#S7$BQ11J6=W.%4#J2>PKY>^+OQBG\5W$VB>'I7@T1&VR2J<->$=SZ)Z#O MU/H #K_B-^T#'8R3:7X&,=Q,N5DU)QN1#_TS4\-_O'CT!KY_U'4KW5[^6]U. MZEN[J8[GEFLWW[.7C.VR;6;3+P8R!%<,K'_ +Z4#]:Y M#6?AEXST%&?4O#MZL:\M)"@F11ZED) _&@#E:^D?V:-$%OXI?%K4S%I]EIL;?ZYS+(!Z+P/U)_*O M*Z^-SNOSUU36T?S?](^]X?P_L\,ZKWD_P7],****\(^C"GQ123S+%"C22.=J MHHR6/H!4VGZ?=:I>QVEA"TTTAP%4?J?0>]>S>$/!-KXX"SZBP^:7J(_9 M?\>]>A@L#4Q9F&94L%#WM9/9?UT,3PG\-8K=8[WQ"JRS<,EKU5/\ M>]3[=/K7H8 50J@ 8 ':EHK[;#X6EAH*\M\0_$ M?5-7W0Z>3I]L>,1M^\;ZMV^@_6N3N;J>\N7N+N9YIG.6=VR3^-15\CB\VK5_ M=A[L?Q^\^XP.28?#6E/WI>>WR0I))))R3U-)117CGNA1110 4444 %%%% !1 M110 4444 7-(U&32-8M;^'[UO('Q_>'>.ZMHKB!MT4J!T;U!& M0:^:Z]K^&NI_;_!\4+',EF[0MD]1U7]#C\*^CR*O:I*B^NO]?UT/E>(\.I4H MUUNM'Z/_ (/YG6T445]8?$A1110 4444 %%%% !1110 445Q'Q9\;?\ "$>! M[BZMW U&Z/V>S'<.1R__ $9/UP.] 'E7QZ^)KWEY+X0T.?%M"<:A*A_UC@_ MZL'T'?U/':O#*<[O+(TDC,[L2S,QR23U)--H*"BBM?POX9U'Q=X@M]'T>+S) MYCRQ^[&HZNQ[ ?\ UNIH AT/0=3\2:M%INB6I/0 >IXKZ&\$? ML\:5ID<5YXPE_M.\X8VL9*P1GT)ZO^@]C7H'@7P#I'@+15L],C$ERX'VF\=1 MYD[>_HOHO;W.2>HH%<@LK&TTZT2UT^VAM;>,82*&,(J_0#BIZ**!!1110 44 M44 _F7]]+UQ_LCV'ZG\*ZL!@98NI;:*W9R9EF,,#2OO)[+]?0E\)^%; M;PSI^Q<2W_O[;3+&2[OI5A@C&69OY>Y]J6^OK?3;&6[O9!%!$NYV/:O#?%?BN[\37 MY9R8K2,_N8 >![GU->;C\?#"0[R>R/6RW+9XZ?:*W?Z+S+GBSQU>^(9'MK;= M;:>#Q$#\TGNQ_IT^MEAX*G25D%%%%8FX4444 % M%%% !1110 4444 %%%% !1110 5Z%\)+_P O5KZQ8\30B5?JIQ_)OTKSVNC\ M 71M?&^GG.%D9HF]]RD#]<5VX"I[/%0EY_GH>?F5+VN#J1\K_=J>ZT445^A' MY>%%%% !1110 4444 %%%% !7R9\=_%;>(OB)/8POFST@&VC Z&3_EHWUW?+ M_P !%?3_ (FUE/#WA;4M7DP19VSS '^)@.!^)P*^&)II+BXDFGTMC]KN01P43!P?8L5'XU]DT"84444""BBB@ HHHH **** "BBB M@ HHHH ***Y7Q]X_TKP!H?VW43YUS+E;6S1L/,W]%'=NWN2!0!T&HZG8Z/82 M7NJ7<-I:Q#+RS.%4?B:\8\6?M(Z?:,]OX1T]K^0$C[5=92+ZA1\S#Z[:\5\9 M>.]<\ZE>7!/4S3L_\ ,U1HH&2I<31MN2:16SG(8@UK:=XR M\2Z2P.FZ_J5N!_"ET^T_5&_'2B+3[AK74,9:QN<+)[E3T8?0Y]0*^-*?#-);S)-!(\4L;!D M=&(92.A!'0T!8^_**\5^#OQF.OR0^'/%DRC4L;;6\;@7/^PWH_H?XOK][VJ@ MD**** "L?Q=_R).N?]@ZX_\ 1;5L5C^+O^1)US_L'7'_ *+:@#X8HHHH*"OH M+]E[_5^)_K:_^U:^?:^@OV7O]7XG^MK_ .U: 9[[11102%%%-D4O&RJY0L" MR]5]^: ,[7/$FC>&K/[5KVI6]C$<[3,^"^.RKU8^P!KR;Q#^TIH]IOB\-Z7< M:@XX$UPWDQ_4#EC^.*\#\4RZN_B>_B\17DUWJ%O.\$TDTA<[D8J0">W'&.*R M*!V/3=6^/_CG4F(M;JUTQ#_#:VX)_-]Q_+%^/?%NHY^V>)=5D4]4^UN%_ M[Y!Q7/T4#+4NIW\[;I[VXD;U>5B?U-$>I7T)S#>W$9SG*RL/ZU5HH Z+3OB! MXNTDC[!XDU*-1T1KEG3_ +Y8D?I7>^'_ -HWQ1I\B)KUM:ZO!_$VWR)?P9?E M_P#':\@HH ^SO!7Q1\->.5$6F71@O]N6L;D!9!ZD=F'T/UQ78U\!PS26\R30 M2/%+&P9'1B&4CH01T-?2_P &OC"WB4Q^'/$\H_M95/V:Z. +H 9VMZ.!W[@> MO4%8]EHHHH$%%%% !7R]JGQ_\;66KWEK&=/V03O&N;8YP&(]?:OJ&OAGQA%Y M/CG78O[FHW"_E(U T=W_ ,-$>./73O\ P%/_ ,51_P -$>./73O_ %/_P 5 M7E=% S[;^'VOW/BCP#I6LWWE_:;J(F7RQA=P8J<#\*W;V^M=-LI;O4+B.VMX MEW22RL%51[DUYG\'-?LM*^!-K?ZK.MO::>UP)9&[#S6;\3\V ._2O#/B1\4- M5\?:DR,[VND1/FWLE/!]&?\ O-^@[>X(]2\8_M'VMK)):>#+$7C#C[;= K'G M_93@M]21]#7DFM?%7QMKLC&[\07<2'_EE:/Y"8],)C/XYKCZ*!EB>^N[IR]S M=33,3DM)(6)_.G6NIW]DP:ROKFW8'(,4S(0?P-5:* .]T'XT^.=!==NL/J$0 M/,6H#S@WU8_/^3"O;_ ?QVT'Q5+%8:P@T;4W(51(^89F]%?C!/HWJ "37RG1 M0!]_T5\^?!/XOS?:;?PIXJN#(DA$=A>RMRI[1.3U!Z*>H/'0C'T'02%%%% ! M1110 445YM\4OBY9>!+(>)_VEIW9H?".DK&N<"ZO_ )F/N$4X'XD_2O%M M7+_QR'A1Z*.BCV'%9U ['7:K\5/&^LL3=^)+Y%/!2V?R M%QZ83%Z^$_'.@>-;'[1H%\LSJH,MN_RRQ?[R_U&1Z&OB"KFE:M?Z'J<.H:1 M=RVEW"=%><_"CXJVWCW3C9W_EV^N6R9FB'"SK_ ,]$ M'\QV^AKT:@D**** "BBB@ KAO&_Q;\->!R]O=3F]U%1_QY6Q!9?]X]%_'GVK M@_C+\99M,N+CPSX3GV7*_)>7R'F(]T0]F]3VZ#FOG=W:21GD8L['+,QR2?6@ M=CU7Q#^T-XNU61UT?[/HUN>%$2"63'NS@C\@*X+4/&/B7579M1U[4;C=U5[I M]OY9P*Q:*!DCSRR-N>5V/J6)JQ;ZOJ5F0;34+J @Y!BF9A>'/VEM2@=(O%.D0W<6<-/9'RY /7:258 M_0K7AM% 'W#X1\::+XWTMK[0+AI4C;9+'(A1XFZX(_PR*WJ\[^!FA?V)\*K! MW7;+J#->/QV;A?\ QQ5/XUZ)02%%%% !1165XD\2:9X4T.;5=:N!!;1#ZL[= ME4=R?2@#3EEC@B>69UCC0%F=S@*!U)/:O)?%W[0OA[1))+7P_"^M72Y'F*VR M!3_O'EOP&/>O&?B'\6-;\=W3P>8]CI ;]W8QMPPSP9#_ !']!V'>N"H'8]%U MOXZ>.=99Q%J2:;"W_+*QB"8_X$^)-)M=TUP^GZUJ%JPZ&&Z=/Y&LNB@#TK0/CSXVT9U%W>1 M:M .L=Y&"?P=<-GZDU[7X)^.'AKQ:\=I>,=&U%\ 0W3CRY#Z))P#]#@GL#7R M510%C[_HKYK^$GQLN-)N(=!\8733:YCW6-H0\F>CM_"O\ 4^P]Z_.:-&5>HJ<-V?JN M(KPP]*56>R.N^'/@_P#L^W76-2C_ -*E7,",/]4A'7ZG]!]:[ZBBOT'#8>&& MI*G _,,7BJF*JNK4Z_AY!11170W3?#MF#Q)-/*1_NA /_0S7SO0 M4@HHHH ^A?V8](46>N:RXR[21VD9] !O;\]R?E7O5>9?L_6@MOA):2@8-U);'PCX;NM9 MU1L0VZ\(#\TCG[J#W)_QKXQ\5^*=2\8^(;C5]7EWS2G"(/NQ)V11V _Q/4UZ M%\?O&[:]XN_L&SES8:22K@'B2?\ B/\ P'[OUW>M>24%(***[CX6_#N?X@>) M/)E+PZ9:X>\F4*O!D M$EY!1\MM-C.!Z*P!('8@CI@5Y)0,BBB@D*Q_%W_(DZY_V#KC_T6U;%8_B[ M_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ %?B?ZVO M_M6@&>^T444$A1110!\H?M >'_['^)DE[$FV#585N >V\?*X_-0W_ J\Q1'E MD5(U9W8X55&23]*^Q_B/\-+/XBII2W=Y):&QG9F>-0S/&P^91GH257GG&#P: MT_#'@'PUX0A5=#TJ&&4#FY<;YF^KGG\!@>U [GRUHOP?\<:X ]OH4UM$?^6E MZ1 /R;#'\!7:67[,VORJ#J&MZ=;D]1$KRX_,+7TI10%SYZ;]F"YV?+XJB+>A ML2!^>^L'6?V)5_ZB MMR?SE8U]NU\4?$L;?BAXC&,?\3&8_P#CQH&CEZ***!FU)XIU&3P9!X8#A-/B MNGNF"DYD=@ WL,$CW/TK%HKJ_ /P_U3Q_KGV+3_ -S;18:ZO'7*0K_5CV7O M[#)H Y4 D@ 9)Z 5KP>$?$EU");7P]JLT9&0\=E(P(^H6OKSP?\ #;PUX*MT M&E6"/=@?/>S@/,Q^I^Z/88%=70*Y\$7FGWFG2"/4+2>U(H3^!%5Z^]K M_3K+5;-[34[2&[MI/O13QAU/X&OG'XP?!B+PS9R>(?"HD.FJP^TV9)8VP/1E M)Y*9X(/(SW'0"YXO1110,4$@@@X(Z$5]B?"'QJ?&O@2"XNY-^HV9^S7>>K,! MP_\ P)<'ZY]*^.J]<_9T\0'3?B!+I#L?)U:W*@9X\R,%U/\ WSO'XT SZCHH MHH)"BBFNZQ1M)(P5%!9F)P !WH XOXI?$&#P!X7:>/;)J=WF.RA/]['+G_97 M(/N<#O7Q]?7UUJ=_/>W\[W%S<.9)99#EG8]2:Z7XE^,I?&_C:[U'P_!+X4Q^*9O^$A\01;M*MY-L$##BZ<=<_[ _4\ M=C0!RO@WX2^*?&J+<6-HMI8-TO+LE$;_ '1@EOJ!CWKTVR_9AA$(.H^)I#)C ME8+0 #\2W/Y"O>41(HUCC5410%55& .@ IU KGS]J/[,+",MI/B8,_:.YM< M _\ E8X_*O*/%_P]\1^!YU77;$K [;8[N%M\,A]F'0^S 'VK[8JKJ6FV>L: M=-8:G;1W5K.NR2*1H(/>OAZO9_P!G+Q8VG>*KCPW;Q5I.D*W[JUM#<$?[-T$^D62Q66[:;RY;RXL^W4M_P$&J/@'P]'XJ\>Z3HTY(AN9_ MWN.I1078#ZJI%?;%K;065I%:VD20P0H$CC085% P !0!\\0_LQ:FT6;CQ):1 MR?W8[9F'YDC^55+[]F?Q%$I.G:SIMSC^&4/$3^C"OI>B@5SXO\0?"OQGX:5I M-1T.X>!>3/:XF0#U)3.T?[V*YS2--EUG6[+3+;_6WEPD"<="S ?UK[SKGKGP M'X:NO$UIX@;28(]4M9#(EQ"-A1@SMAMAMXE MBC'HJC _05/110(**** (;N[@L+*:[O)5AMX(S)+(YP$4#))_"OCOXG?$.Z\ M?^)&G!:+3+8E+.W)Z+_?/^TW7VZ=J]4_:-\:FVL[;PE82X>X N+W:>B _(A^ MI!)'LOK7SM0-!116]X-\)WWC7Q/;:/IPVM(=TLI&5AC'WG/T_4D"@95T#PWK M'BC4A8Z#837LYY81CA!ZLQX4>Y->OZ-^S-J4\2OKVO6]HQ&3%:PF8CV+$J,_ MG7N7A3PEI/@W0X],T2W$4:@&20\O,W=F/<_H.@P*VJ!7/"9OV8;%H\6_B>X1 M_5[16'Y!A_.N%\5? 7Q9X=@>ZL5BUJU098VF?-4>IC/)_P" YKZPHH"Y\ D$ M$@C!'4&DKZ%^/?PQ@-G+XPT&W$N<]B3\]4#"OI M+]G[XAOJNGMX3U>;==64>ZQ=CS)".J?5>,?[)_V:^;:T_#FN7/AKQ)8:S8DB M:SF60#.-P_B4^Q&0?8T ?=E%5M.O[?5-,M;^S??;W42S1-ZJPR/T-6:"0JCK MB>9X?U%,9W6LHQ_P U>J.XA%Q:RPMTD0H?Q&*F:YHM%TY??"W0/.U.XU: MY7Y;0F*('_GH1R?P'_H5>JUX&2X7DINO+=[>A]+Q!C74JK#Q>D=_7_@!1117 MT)\N%%%% !1110 5X3X[U0ZKXOO BMV\B/'HO!_7)KV^^N/LFG7-S_ ,\8 MFD_($U\WLQ=RSG+,+N@HHHJ2@JSIJ>;JMI'_?F1?S85 M6K4\-0&Y\4Z9$/XKJ//T# G]!6E-?.K>'D[+!.?S9/\*\)KWG]I^,C4/#DO9HKA1^!C M_P :\&H*"BBB@#[#^"8 ^#>@XQ]R8\?]=I*[RO._@1<"?X.Z2@ZPO/&?^_SM M_)A7HE!(4444 %%%% !1110 4444 %%%% !6-XNUY/#'@_5-9DP?L=NSH#_$ M_1!^+$#\:V:\?_:0UZ("Q_\ 'ME 'S)//+=7$D]P[22R MN7=V/+,3DD_C4=%%!05]F?"CPFGA'X>V%HR;;NY075T< M%X;.X\7:3%JDT<%DUY$+B25@%6/>-Q)/3C-?8G_"R/!?_0U:1_X&)_C0)G34 M5S/_ LCP7_T-6D?^!B?XT?\+(\%_P#0U:1_X&)_C0(Z:BN9_P"%D>"_^AJT MC_P,3_&C_A9'@O\ Z&K2/_ Q/\: )/'_ (?3Q1X"U?2F3?)+;LT'M*OS)_X\ M!^&:^(J^V?\ A9'@O_H:M(_\#$_QKXPU184U>\6U96A6=Q&RG(*[CC!],4#1 M5ILB_*__ (\K5T%>6?L[W[7?PK$# M'/V.^FA4>@.V3^;FO4Z"0K'\7?\ (DZY_P!@ZX_]%M6Q6/XN_P"1)US_ +!U MQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_P#M6OGVOH+]E[_5^)_K:_\ M6@&>^T4 M44$A1110 4444 %%<_XA\=^&/"H(UW6;:VE SY&[?*?^ +EOTKS/6?VE]$ML MKH>C7E\P.-]PZP*?<8W$_D* /;**^8M0_:3\57#$:?IVF6:=MR/(P_$L!^E8 M%S\=?B#<9VZVL()Z16D(Q^)4F@=CZ\KY'^/-A'9?%S4'B4*+J*&<@# R4"D_ MB5S]366_Q=\>2$EO$UV,_P!T*O\ (5SFM:[J?B+4/MVMWLM[<[ GFRG)VCH/ MUH SZ***!G8?"C4#IGQ7\/3@XWWBP?\ ?P&/_P!GK[/KX7\)R-%XTT21/O)J M$#+CU$BU]T4"84444""OBKXG?\E2\1_]?\O\Z^U:^*OB=_R5+Q'_ -?\O\Z! MHY6BBB@9);P2W5S%;VZ&2:5PD:+U9B< ?G7VK\/_ ?;^"/!UGI,*KYX4274 MH_Y:3$?,?H.@]@*^6_A!8IJ/Q,M4T5R2+.X9(V;JT9Y0G MZJ0:Q*]6_:*L5M/BD)E'-Y813,?4@LG\D%>4T%!71> -0.E?$70+P' 2_A#G M_99@K?H37.U8L)3!J5M*ND;;_*/]: /#Z* M**"B]HNE7&NZ[9:59C,]Y.D*<9P6.,GV'6ON31M)M="T6STO3TV6UI$L48]@ M.I]SU-?)GP5GTFR^)EKJ&O7UO96]G#+*DEQ($4N1M R>_P Q/X5]-?\ "R/! M?_0U:1_X&)_C0)G345S/_"R/!?\ T-6D?^!B?XT?\+(\%_\ 0U:1_P"!B?XT M".FHKF?^%D>"_P#H:M(_\#$_QH_X61X+_P"AJTC_ ,#$_P : .1_:$T"/5/A MJVI!1Y^E3I*K8YV.0C+]/F4_\!KY4KZX\?\ CCP?JOP[UZRM_$FESS2V$HBB MCND9G<*2H SR<@5\CT%(*TO#VKR:#XET[5H2=]EAIU#?M+^&Y)K72?$=O%N6#=:7+#JH)W1GZ9W MCZD>M T?/-%%% SH_A_XBB\*>/\ 2-9N03!;3XFP,D1LI1B!W(5B<>U?:]K= M07MI%=600>XKX%KM_ OQ6\1> R(+&5;O32Q9K&XY0$]2I MZH?IQZ@T ?9%%>9^%OCQX0\0A(K^X;1+L\&.]($9/M(/EQ[MM^E>DPSQ7,*3 M6\J2Q.,J\;!E8>H(ZT$CZ*** "BBB@ ILLJ0PO+*P2-%+,QZ #DFG5QOQ:U< MZ+\*],/$$OBGQAJ6LS$G[5.S(#_"@X1?P M4 5BT44%!7U'^SSX372/!+ZY<1XN]6?*D]5A4D*/Q.X^XV^E?+E?96A>-?!& MC>'=/TR+Q1HX6SMHX!B\3^%0/7VH$SM:*YG_ (61X+_Z&K2/_ Q/\:/^%D>" M_P#H:M(_\#$_QH$=-17,_P#"R/!?_0U:1_X&)_C1_P +(\%_]#5I'_@8G^- M&_>V=OJ-A<65[$LMO<1M%+&W1U88(_(U\*ZUIDFBZ]?Z9/S)9W$D#''4JQ&? MTK[+_P"%D>"_^AJTC_P,3_&OE3XJ75C>_%#6[K2KJ&[M)IED2:!PR/E%)P1[ MY% T4YDTVX>UR>I7AU_1\?\!KTVOG[]F&^(D\0Z M>S<$03HOI]]6/ZK^5?0-!(4444 4]+TR#2;+[-:CY/,>0D]268D_SQ^%7*** MF,5%**V*E)SDY2W844451(4444 %%%% %#7HFG\.:E%&,M):2JH]24(KYVKZ M8KY_\4Z%)X?\07%F580[M\#'^)#TY[XZ'W%?,Y]2DU"JMMCZ_ANM%.=%[NS7 MZF/1117RQ]B%%%% !1110 4444 %%%:FE^'-7UEA_9UA-*A/^L*[4'_ CQ5P MA*;Y8J[(G4A3CS3=EYF73D1I'"1J79C@*HR2:](TCX2L=LFMWP4=X;89/XL? M\/QKN=(\-:3H:XTZRCC?O*PW.?\ @1YKV,/DV(J:U/=7X_<>#B<_PM+2G[S_ M ^\\LT7X;:UJF)+Q1IT![S#+GZ+_CBO1]!\$Z/H&V2"#S[D?\O$_P S ^PZ M#\*Z&BOHL-EN'P^J5WW9\MB\VQ6*]V3M'LOZU/-/C!]W2/K-_P"R5YE7IOQ@ M^[I'UF_]DKS*OELV_P!]G\OR1]EDG^X4_G^;"BBBO+/8"NJ^'%M]H\;VC=H4 M>0_]\D#]2*Y6O2_A'I^7U#46'0+ A_\ 'F_]EKORZG[3%07G?[M3S'_M.61D\-Z'?8XANY(<_ M[Z9_]IU\X5]=_'726U7X3:BT:[I+)X[I1CLK88_@K,:^1*"D%%%% 'TS^S3J M8N/!.IZ<6S):7WF8]$D08_5&KV:OE3]GSQ$-'^(_]G32;8-6@:#!( \U?F0G M\F4>[5]5T"84444""BBB@ HHHH **** "BBB@ KYU_:=NV?6= L\_+%;RRX] MV91_[)7T57S/^TP3_P )SI0[?V<,?]_'H&CQBBBB@84444 %%%% !1110 44 M44 %%%% 'TI^S+(3X0UB/LM\&_.,?X5[77C'[,\17P3JTW9]1VC\(T/_ +-7 ML] F%8_B[_D2=<_[!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0(^&****"@KZ"_9>_ MU?B?ZVO_ +5KY]KZ"_9>_P!7XG^MK_[5H!GOM%%%!(445A^,?%=AX+\,W.L: MFV4B&(H@<--(?NH/K^@R>U !XK\8:-X,TAM0UVZ$*=(XEYDF;^ZJ]S^@[U\V M^-OCOXD\3-);:.[:+IQXV6[?OG'^U)U'T7'XUQ7B[Q=JGC37I=5UF;<[<11+ M]R%.RJ/3^=8=!5ATDCRR-)*[.['+,QR2?4FFT44 %%==X?\ A=XR\2HLFF:' M<"!N1/<8A0CU!?&?PS7<6'[-/B6= VH:MIMIG^%"\I'Z ?K0!XS17OT7[+[E M?W_BQ0?1-/S^IDKSKXH?#I/AUJMC9IJ;:A]JA,N\P>5MPV,8W'- '#4444 ; M'A'_ )';0_\ L(V__HQ:^YZ^&/"/_([:'_V$;?\ ]&+7W/0)A1110(*^*OB= M_P E2\1_]?\ +_.OM6OBKXG?\E2\1_\ 7_+_ #H&CE:***!GH'P-_P"2SZ%_ MV\?^D\E?7]?('P-_Y+/H7_;Q_P"D\E?7] F%%%% @HHHH ^9_P!I@?\ %<:4 M?73@/_(CUXQ7M'[3'_([:3_V#O\ VH]>+T%!4EO_ ,?,7^^/YU'4EO\ \?,7 M^^/YT ??=%%%!(5\B_'B[^U?$SE;>.&(?]^E8_JQKZZKXX^,A)^+^O[NO MG)_Z+2@:.'HHHH&%%%% !1110 4444 %%%% !1110!]B?!20R?!S06;J$E7\ MIG']*[NN(^#=NUM\(- 1A@F%W_!I'8?SKMZ"0JCK>C67B'1+O2=4B\VTNXS' M(O0X]0>Q!P0?4"KU% 'Q-X\\#ZEX#\1R:;J"EX&):UN@N%N(_4>A'<=C[$$\ MS7W3XD\,:3XMT:33-=M%N;=^5)X:-NS*W4$>OX'@XKYG\>? S7_"TDEWHJ2: MSI8)(>%,S1#_ &T'7_>7CCD"@JYY=1110 5L^'_%VO\ A6X\WP_JMS9$G+(C M91C_ +2'*M^(K&HH ^A?!?[1\4K1V?C>S$#$A?M]HI*_5X^H^JY^@KW'3]1L M]5L(KW3;F*ZM9EW1S0N&5A]17P378?#_ .(^L> -6$MDYGT^1@;FQ=ODE'J/ M[K>C#\&W^&UK;KUN=1C5O]T([?S KURO%/VFL_\ "(Z-Z?;C_P"BS0!\UT444%!1 M110 4444 %%%% !1110 4444 >S_ +,\F/'&JQ_WM.+?E(G^-?3%?-G[,MNS M>+M9N!]V.Q6,_5I 1_Z":^DZ!,****!!1110 4444 %%%% !1110 5D>(O#= MCXEL/L]ZI5TR8IE^]&?;U'J*UZ*B<(U(N$U=,TIU)TIJ<'9H\-UOP%K>C2,1 M;->6XY$UNI;CW7J/Y>]"O#D; M972+<_[P)_F:Y/[!K_S+\?\ ([?]9,/;X'^'^9X'5BVL+N];;9VLUP?2*,M_ M*OH"#0-'MCFWTJSC/JL"@_GBM *, 8 ["MH9"_MS^Y&%3B5?8I_>_\ @'AM MC\/?$=\1_H/V=#_'<.%Q^'7]*Z?3OA&.&U;4L^L=LO\ [,W^%>ET5Z%+)L+3 MUDG+U_X!Y=;/L94TBU'T7^=S!TSP5H&E;6M]/CDD'_+2?]XWUYX'X 5O M# '0445ZM.E"FK022\CQJE:I5?-4DV_,****T,@HHHH \T^,'W=(^LW_ +)7 MF5>F_&#[ND?6;_V2O,J^$S;_ 'V?R_)'Z1DG^X4_G^;"BBBO+/8"O=_ NE'2 M?"%I%(,2S#SY!Z%N1^F!7C_A;1VUSQ):6>W,9??-[(.3_A^-?0(&!@=*^FR* MAK*L_1?J?(\1XG2&'7J_T_4****^I/C0HHHH **** "BBB@ HHHH K:C80:K MI=UI]XN^WNH7AE7U5@0?T-?"NKZ7<:)K5YI=ZNVXLYGAD';*G&1[<9%?>=?- M'[1GA!M-\36_B6UC_P!&U-1%.0.%G4<9_P!Y1^:M0-'B]%%% R:SNY["]@N[ M20Q3V\BR1.O564Y!_,5]L>!O%MMXU\(6>LVNU7D79<1*?]5*/O+_ %'L0>]? M$-=[\*?B3/\ #_Q ?M.^;1[PA;N%3G9Z2*/[P].XX]" &?85%06-]:ZG80WN MGSQW%M.@>*6,Y5U/<&IZ"0HHHH **** "BBB@ HHHH *^<_VG;0IKN@7F.); M:6('UV,#_P"SU]&5XW^TGI)N_ ^GZFBY:QO-K''1)%()_P"^E3\Z!H^9**** M!FQX1L+/5/&>CZ?JFXVEW>Q02[&VG:[A>O;K7TO_ ,,]^!?^>%]_X%'_ KY M4MYY+6YBN(&V2Q.'1AV(.0:^Z/#FN6WB7PW8:S8G,-Y"L@&?NG^)3[@Y!]Q0 M)G!?\,]^!?\ GA??^!1_PH_X9[\"_P#/"^_\"C_A7J%% CR__AGOP+_SPOO_ M */^%'_ SWX%_YX7W_ (%'_"O4** /+_\ AGOP+_SPOO\ P*/^%'_#/?@7 M_GA??^!1_P *]0HH \O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*] M0HH Q/"?A+2_!>BG2]#21+8RM,1(^\EB #S^ K;HHH *Q_%W_(DZY_V#KC_T M6U;%8_B[_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ M %?B?ZVO_M6@&>^T444$A7RQ^T#XN?6_'']BV\A-EI V%1T:8@%S^'"_@?6O MJ2:58+>2:3A(U+-] ,U\&ZE?2ZIJMW?W!+2W4SS.3W+,2?YT#15HHHH&6M-T MZ[U?4[?3].A:>ZN9!'%&O5F-?5GP\^#6B>#K6&ZU*&+4M9P&>>5=R0MUQ&IZ M8_O'GZ=*\R_9KT2&]\6ZGJ\R!VTZW5(LC[KRDC=]=J,/Q-?2U F%%%% @KYN M_:;_ .1IT3_KR?\ ]#KZ1KYM_::9#XKT50WSBR8E?0%S@_H?RH&CQ*BBB@9L M>$?^1VT/_L(V_P#Z,6ON>OACPC_R.VA_]A&W_P#1BU]ST"84444""OBKXG?\ ME2\1_P#7_+_.OM6OBKXG?\E2\1_]?\O\Z!HY6BBB@9Z!\#?^2SZ%_P!O'_I/ M)7U_7R!\#?\ DL^A?]O'_I/)7U_0)A1110(**** /FC]IC_D=M)_[!W_ +4> MO%Z]H_:8_P"1VTG_ +!W_M1Z\7H*"I+?_CYB_P!\?SJ.I+?_ (^8O]\?SH ^ M^Z***"0KY$^.UJ;;XPZJY&%G2"5?^_2J?U4U]=U\V_M,:2T/BG2-65,1W5H8 M&8#^*-B>??$@_*@:/$J***!G<_"+PQI'B_QT-)U]96MY+:1T$4FP[UP>OTW5 M[M_PSWX%_P">%]_X%'_"OG/X?^(%\+>/](UB9BL-O< 3$#.(V!1SC_=8U]MJ MRN@=&#*PR"#D$4"9YA_PSWX%_P">%]_X%'_"C_AGOP+_ ,\+[_P*/^%>H44" M/+_^&>_ O_/"^_\ H_X4?\ #/?@7_GA??\ @4?\*]0HH \O_P"&>_ O_/"^ M_P# H_X4?\,]^!?^>%]_X%'_ KU"B@#R_\ X9[\"_\ /"^_\"C_ (4?\,]^ M!?\ GA??^!1_PKU"B@"II.F6NBZ/::9IZ%+:TA6&)2$_&#/+JFF+%=OG-Y:GRI2?4D<,?]X&O'O$O[->K6F^;PMJ M<.H1@9%O';XVFN:?<6,_99D*[AZ@]"/<< M5G5]V:]X=TGQ/I;Z=KMC%>6S_P ,@Y0_WE/53[CFODCXH_#Z7X?>*!:([SZ= M=*9;.=QR5!Y5O]I?&,ND^+V\.7$A-EJH)C4GB M.=1D$?[R@@^IV^E?3U?!^A:@VD^(M.U&/[UI=13CZJX;^E?>% F%>0?M)6AF M^'-E<*,FWU)"3Z*8W'\\5Z_7$_SK7PHUN%!F2"'[4GMY1#G_QT,/QH$?& MU%%%!05]4V7P#\!W=A;W*0WQ6:)9 1='D$9]*^5J^Q/@UXD7Q)\,=-%]_P"!1_PH_P"&>_ O_/"^_P# H_X5 MZA10(\O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*]0HH \O\ ^&>_ M O\ SPOO_ H_X4?\,]^!?^>%]_X%'_"O4** /+_^&>_ O_/"^_\ H_X4?\ M#/?@7_GA??\ @4?\*]0HH Y?P;\/=!\"?;/^$?BF0WFSS3-+O)V[L8]/O&NH MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **R=;\3Z5X?B+:A?BLPH856D[OLOZT/4P65XC&.\5:/=_UJ:/Q5U:ROKJPM;.X6 M:6U,GG!#D(3MP,^O!KSZBBOB<5B'B:SJM6N?H6#PT<+0C1B[V_X<***V_"7A M]_$>O16N"+=#ON''9!V^IZ5E3IRJS4([LVJU848.I-Z(]!^%NA?8M'DU6=,3 M7AVQY[1@_P!3_(5WE,BB2"%(H4"1QJ%55& .@I]?H>&H1P]&-*/0_+<7B98 MJO*K+K^70****Z#E"BBB@ HHHH **** "BBB@ K%\7^&+3QAX5O=%O\ A+A/ MDDQDQ2#E7'T/Y\CO6U10!\'ZWHU[X>UR[TG58C#=VDACD7M[$>H(P0>X(-4* M^L/C)\+5\;:7_:FD1@:Y9QX09P+F,<^6??KM/O@]-K4/HE\IN-NZ2SF^2:/ZKW^HR/>OB:I(9I;>9)K>1XI4.Y'1BK* M?4$=* L??=%?)'A[X[>-M"1(IKV+5H%XVWZ%VQ_O@AB?20_M(>#)%'F6FKQ'N&MXS_)S3I/VCO!2? M=@U:3_=MD_JXH$>LT5XE>?M-:&BG^S]!U"=NPGD2(?H6KEM5_:6\07*LND:/ M86(/1I6:9A_Z"/TH'8^EB0 23@#J317Q+XA^(?BOQ2I36]:N9X3U@0B.,_5% MP#^(K['\-:J-<\*Z7JBG/VRTCF/L64$C\#D4 :=8WB_P_'XI\'ZGHLA ^V0, MB,W17'*-^# '\*V:*!'P+S?M!> FT MCQ /%.GQ?Z#J3!;D*/\ 5SXZ_1@,_4-ZBO&:"@KV/X&_%&+PS='PYX@N/+TN MZDW6\\A^6VD/4$]D;CGH#SW)KQRB@#[^!#*&4@@C(([TM?(_@+XU>(/!<,5A M/MU32H^%MIVPT0]$?J/HD45DVGBKP]?J&LM=TVX#=#%=QM_(U:;5]-49;4+4#WG7_ !H$7**Q;GQE MX8LE)N_$6E0X_OWL8/Y9KFM4^-O@/2U;_B="\D7_ )9VD+2$_0XV_K0!W]%> M!:]^TT@#Q^&=!8G^&>_DQC_MFG_Q5>N^!-?D\4>!-)UF?9YUU;@S>6,+Y@)5 ML#M\P/% '04444 %8_B[_D2=<_[!UQ_Z+:MBL?Q=_P B3KG_ &#KC_T6U 'P MQ11104%?07[+W^K\3_6U_P#:M?/M?07[+W^K\3_6U_\ :M ,]]HHHH),[Q$& M/A?5!'P_V.;;CUV&OA&OOYT62-D=0RL,,"."*^$=?TF70O$6H:5< B2SN'A. M>^UB ?Q'- T9]%%% SW?]F&_CCU3Q#I['][-##.@_P!E&=6_]&+7T17P[X-\ M57G@SQ59ZW8#>T#$21$X$L9X9#]1W['![5]@^$?'.A>-M-6ZT.]1Y-N9;5R! M-"?1EZ]>,]#V- F=#115#5]RA MK4^L:Y^;\26;\:['XK?&Y_$] MM+H?A826^EN=L]RWRR7(_N@?PKZ]S[#(/C= T%%%% S8\(_\CMH?_81M_P#T M8M?<]?"WA5MOC+16Z8OX#_Y$6ONF@3"BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5 M\3O^2I>(_P#K_E_G0-'*T444#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^ MWC_TGDKZ_H$PHHHH$%%%% 'S1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V# MO_:CUXO04%26_P#Q\Q?[X_G4=26__'S%_OC^= 'WW11102%>=_'#PP_B3X9W M;6T>^ZTUA>1 =2%!#C_O@L<=R!7HE(0&4JP!!&"#WH ^ :*[KXM>!)/ WC.: M*",C2[TM/8N!P%SS']5)Q]-I[UPM!05])_ OXI0ZEIMOX3UV=8[^V41V,KMC M[1&.D?\ O*.!ZCW'/S92JQ1@R$JP.00<$&@#[^HKYA\$?M!ZQH<,=CXG@;6+ M1!A;@/BX4>Y/#_C@^]>Q:)\:? NMJH76DL96ZQ7ZF';]6/R?^/4$G>45G0>( M=%NE#6VKV$RD9!CN48?H:DDUK2XO];J5FG^].H_K0!=HK N_'GA*Q4FZ\2Z4 MF.H^V1D_D#FN7U7X\^ ]-5O)U&;4)%_@M+=C_P"/-M7]: /1Z*^=]<_:8O)) M@GAS1(H(@PS+>/O=AGG"K@#CW-?0EO/'=6T4\)W1RH'0^H(R* )**** "BBO M&OV@_&>H>'+70[/0[Z:SO))VN6DA;!"HNT ^H)<\=#B@#V6BOG7PM^TI>6Z) M!XOTL7BC@W=EA)#[E#\I/T*_2O5]$^+?@C7@HM=?MH)6_P"65X3 P/I\^ ?P M)H [.BF0S17$2RV\B2QL,JZ,&!_$4^@ KPS]ITP_V%H ;;Y_VF79QSMVC=^N MW]*]7\1^-/#WA.U:;7=4M[8J,B'=NE?V5!R?RKY0^)WQ!G^(7B87@B:WL+93 M%:0,XCO(U&2N/N MR >JY/'<$]\5P5% 'WQ8WUKJ5C#>V$\=Q;3H'BEC;*NI[@U/7QAX'^)OB'P' M,5TJ=9K)VW265QEHV/OG+_C0 M(N45DW/BSP[9J3=Z_ID '7S+R-?YFN>U'XQ> ],4^;XBMYF[+;*TV?Q4$?K0 M!V]%>'Z[^TOI4"E/#FC7-X_3S+MA$@]P!N)_2NT^$GCNZ\?>%;F_U)(8KN"\ M>)XX%(55P&7&23T)'X&@#O**** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBJ.H:UINDH6U&]AM\#.UW&X_1>I_"IE*,5>3LBHPE-\ ML5=EZBN U7XKZ?!N32;62[<<"23Y$^OJ?TKA]7\ MI_$UY-?.,-2TB^9^7^9[>&R+%UM9+E7G_E_PQZUK7C+1="REW=B2N?$_5-0#0Z6HT^$\;E.Z0CZ]OPY]ZXBBOG\3F^(K:1?*O+_,^G MPF1X7#^])XD'<]@/8?XUA_#_P5_94: MZMJD>+V1?W43#_4J>Y_VB/R%=W7V&4Y>Z,?;5%[SV\E_F?"YWF:KR^KTG[JW M\W_D@HHHKWSYD**** "BBB@ HHHH **** "BBB@ HHHH *\N^*?P;LO&JR:K MHQCLM<5>6(Q'=8' ?T;L&_ YXQZC10!\':QHVHZ!J,]/^R>(+!+@*#YOD.0DZ#_T%OPP?:@JYXW15F_TZ]TN\:UU.TGM+A/O13QE&'X&J MU !1110 4444 %%%% !7UM\!-8_M7X46<3',FGS26K$]\'>O_CKJ/PKY)KZ0 M_9MM=8L=+UB+4-/NK>QF>*:VFFB*+(V&5MN>O 7IZ4 SV^BBB@DI:QI-EKVC MW6EZK L]I=1F.6,]Q['L0>0>Q -?('Q'^'&H_#_6VBF5Y],F8_9+S;PX_NMZ M./3OU%?9E4]6TBPUW2YM.U>UCN[2==LD4@R#_@1V(Y% SX,HKVGQY^SWJ>ER M27O@QFU*S.6-I(0)XO8'HX_(^QZUXW10,B MHHHH **** "BBB@ KZA_9OU4WGP]NK!WRUC>L%7^ZCJ&'_CV^OE_KTKZ!_9O MTG7=,OM6FO=,NK;3+VW1DGF38KNK<8!Y/#MR..* 9[[11102%8_B[_D2=<_[ M!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0!\,4444%!7T%^R]_J_$_UM?_ &K7S[7T M%^R]_J_$_P!;7_VK0#/?:***"0KYS_:*\#RVVJQ^+["(M;W(6&^VC_5R 81S M[$ +]5'K7T95;4=.M-7TVXT_4K=+BUN$,O:@#X)HKTCXF?!_5?! M%U+?:>DE_H9.4N%&7@']V0#IC^]T/'0G%>;T%!4D,TMO,LMO(\4BG*NC%2/H M14=% &\/'7BU8?*'BC61'C&W[?+C_P!"K'NKRYOIC->W$MQ*>KRN78_B:AHH M *N1Z3?3://JD=K(UC;RK#+/CY5=@2%^O!_R17Y(!R30 M!\G4444 7M$E$/B#3Y3T2ZB8_@X-?>-? 2L4<,O!4Y%??%K.+JSAN%^[+&KC MZ$9H$R6BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5\3O^2I>(_P#K_E_G0-'*T444 M#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^WC_TGDKZ_H$PHHHH$%%%% 'S M1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V#O_:CUXO04%26_P#Q\Q?[X_G4 M=26__'S%_OC^= 'WW11102%%%% '/>-_!NG>.?#4VDZF-A/SV\ZC+02 <,/7 MK@CN"?K7QYXL\)ZKX,UZ72M:@,1NQ_0]P:!GPW17I_CCX&>(_"\DESI,;ZUIHR1);I^] MC'^U&.>G<9'TKS$@@D$8(Z@T#$HHHH **** "BBB@ K[.^$^L'6_A7H5T[9D MCM_L[\\YB)CY^H4'\:^-(HI)I5BA1I)'.%1!DL?0"OJGX Z=KFD>!;FRU[3; MBQ3[69K;[0NUF1E&1M/(P1GD#[U F>IT444""OD?X[ZU_;'Q6O8T;=%I\:6B M?4#[N;1BUI<2P,>ICJ:FHVHP^:"'J%/H6/)'T'8UZQ1102%%%% ".BR1LDBAD8896&01Z5\L?&# MX1S^$;Z76=!@:709FW,J\FS8G[I_V.>#^![$_5%,EBCGA>&>-9(I%*NCKE6! MX((/44 ? =%?0WQ!_9Y2XDDU'P&R1.QW/ILSX4G_ *9N>G^ZW'N.E>#:KH^I M:%?O9:Q8SV5RG6.>,J?J,]1[C@T%%*BBB@ HHHH **** "O<_P!F351%KFN: M2S:WF*+\]K/'G M?[J01S[&HJ3Y(\UF_0TIT_:34;I7[[&U17E/_"U]6@=HKS2[82H<.OSH0?3! M)Q4J_%^<#YM'C)]IR/\ V6O,6;X/K+\&>L\CQW2-_FCU&BO+S\7YNVCQ_P#@ M0?\ XFH9/B[?G_5:9;+_ +SL?\*'F^#7VOP8+(\>_L?BO\SU:BO'IOBMKLG^ MJALHA[1L3^K5G3_$/Q-/D?VCY8](XD'ZXS64L[PJV3?R_P"";PX>QDMVE\_^ M >Y55N]4L+ $WM[;V^/^>LH7^=> W.OZO>9%UJ=W*#U5IFQ^6<50)))).2>I MKCGGR^Q#[V=U/AI_\O*GW(]NOOB-XO M4O O@$VCQ:MKD8\X8:"W8?ZL]F;W]!V^O30\'?#^'0V6^U,I<7_\"CE(?IZG MW_+UKM:^KRW*>1JK76O1?YGQ>:YU[1.AAGIU??T"BBBOHSY0**** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH I:IHNF:Y:_9]9T^UOX>R7,*R M >XR.#[BO/M8_9_\#ZF7:UM[K2Y&YS:3DKG_ '7W#'L,5Z=10!\_ZA^S"=Q; M2O$W'9+FTZ?\"5OZ5BS_ +-'BE6/V;5M(D7L9'E0G\D-?35% [GRY_PS=XS_ M .?S1O\ P(D_^-U/#^S3XK;_ %^JZ/&/]F25C_Z+%?3E% 7/GFT_9ANV(^W^ M)X8QW$-F7S^)85TVF?LW>%+5E?4K[4;]AU3>L2'\ ,_K7L%% 7.:T/X=>$?# MA#:3H-G%(,8ED3S9!CT9\D?@:Z6BB@04444 %%%% !6/K_A/0?%,(B\0:5;7 MP4;5>1/G0?[+CYE_ UL44 >.ZO\ LV^&+QR^DZA?Z:3_ $B9!] <-_X]7)W MG[,>K(Q^P>(K*<=C/ \6?R+5]'44#N?,)_9I\7[CMU/1".V9YA_[2J2+]FCQ M22//U?2$'?8\K?S05]-44!<^>K/]F&X+ ZAXGB0=Q!:%OU+#^5=1IG[.'A*T M*MJ-WJ.H,#RK2K&A_!1G]:]=HH YW0_ 'A7PVROHVA6=O*GW9C'OD'_ VRWZ MUT5%% @HHHH *KW]E%J6FW-C<[O)NH7ADVG!VL"#C\#5BB@#RK_AG7P1_>U/ M_P "1_\ $T?\,Z^"/[VI_P#@2/\ XFO5:* /*O\ AG7P1_>U/_P)'_Q-=7X) M^'>B> 5O1H)N3]M*&7[1*'^YNQC@8^\:ZJB@ HHHH **** $90ZE7 92,$$9 M!%>:^)_@/X/\0RO<6D$NCW+'):Q($9/O&00/^ [:]+HH ^;]0_9DUJ-C_96O MV%PO;[3$\)_\=WUFK^S;XR+8-]HP'K]HE_\ C=?45% [GSOIG[,=\[ ZSXBM MXE[K:0-(3^+%?Y5Z/X8^"?@WPS*EP+)]3ND.5FOV$FT^R !?T)]Z]!HH$ M P!T JIJVFV^LZ/>:9>AC;WD#P2[3@[64@X/8X-6Z* /*O^&=?!'][4_P#P M)'_Q-'_#.O@C^]J?_@2/_B:]5HH \J_X9U\$?WM3_P# D?\ Q->FV%E'IVFV MUC 6,5M"D*%SDE5 S[\58HH **** "O.-;^!GA'7]JT4 >? M^&?@OX6\)^(K76]*-\;NUW^7YLX9?F0HJ44 %%%% !1110 M4444 %_;]28')$]QL4_@@4_K7JM% C(T3PIH/AR/ M9H>D6ECQ@M%$ Q^K=3^)K7HHH **** "HKFV@O+=[>[ACGAD&'CE0,K#W!X- M2T4 >>:Y\#/ VMLTBZ:^FRL>7T^7RQ^"'*#\%KA-2_9B4DMI'B4@9XCNK7/' M^\K?TKWZB@#YCG_9I\5H3]GU31Y1_M22J?\ T6?YU"O[-OC(MAKW1E'J;B3_ M .-U]144#N?.%E^S)K+L/[1\06, [^1$\O\ /;77Z+^S?X7L7636+V^U1E/* M;A#&WU"_-_X]7L%% 7,W1?#VD>'+/[+H6G6]C#@9$,84MCNQZL?/;(9OSKZ( MHH'<^8G_ &:?%H;]WJFBLOJTTH/_ *+-+'^S3XL+?O=5T51_LRRG_P!IBOIR MB@+GSK:?LQ:@Y_T[Q+;0C_IC:M)_-EKI--_9I\.6Y5M4U;4+PCJL>R%3^&"? MUKV:B@+G):+\+?!>@,KZ?X?M#(O22X!G;/KER,+?ZQX M U[2&9OLIO(1_P M;7+_ )KU'Y8KY;$99B:&KC==T?8X7-\)B=%*S[/3_@', MT4K*58JP(8'!!'2DKS3U@HHHH **** "BBB@ HHI\,,MQ,L5O&\LC<*B*6)_ M 4]P;MJQE%==I/PVUW42K7,:V$1/+3GYL>RCG\\5Z)H7@+1=$"N8?MER.LUP M <'V7H/Y^]>IALJQ-=W:Y5W?^1XV*SG"X=63YGV7^>QYOX;\ ZGKVV>8&RLS M_P M95YF^';8QZ=#AV'[R9SEW^I_H.*U:*^IPF74<+JE> M7=_UH?&X[-,1C':3M'LOU[A1117HGE!1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4-1T+2]67&H MV,%P?[S)\P_X$.:Y>^^%>B7&39RW-FW8*^]?R//ZUV]%57/PBO5S]CU2WE]/-C9/Y9K,F^&'B.)B$CMIAZI-C/YXKVBBN M"63826R:^?\ G<].&?XV.[3]5_E8\.?X=>*%/&FAAZK/'_\ %4Y/AQXG?KIZ MI_O3Q_T->WT5E_8>&[R^]?Y&O^L>+M\,?N?^9XS#\+O$,K8D^RPCU>;/\@:U MK;X0S'!O-6C7U$4);]21_*O4**UADV$CNF_5_P"5C&>?8Z6S2]%_G,/\ GK)A?R7']:Z:QTJPTR,II]G#; ]?+0 GZGO5NBO0I8:C1_AQ M2/,K8O$5_P"+-OY_H%%%%=!RA1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 3!1110 4444 %%%% !1110!__V0$! end GRAPHIC 14 celaneselogo.jpg begin 644 celaneselogo.jpg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htm IDEA: XBRL DOCUMENT v3.23.2
Cover - shares
 6 Months Ended
Jun. 30, 2023
Aug. 04, 2023
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2023  
Document Transition Report false  
Entity File Number 001-32410  
Entity Registrant Name CELANESE CORPORATION  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 98-0420726  
Entity Address, Address Line One 222 W. Las Colinas Blvd., Suite 900N  
Entity Address, City or Town Irving  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 75039-5421  
City Area Code 972  
Local Phone Number 443-4000  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Small Reporting Company false  
Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   108,852,226
Entity Central Index Key 0001306830  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q2  
Amendment Flag false  
Common Stock    
Entity Information [Line Items]    
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol CE  
Security Exchange Name NYSE  
Senior Unsecured Notes Due 2023    
Entity Information [Line Items]    
Title of 12(b) Security 1.125% Senior Notes due 2023  
Trading Symbol CE /23  
Security Exchange Name NYSE  
Senior Unsecured Notes Due 2025    
Entity Information [Line Items]    
Title of 12(b) Security 1.250% Senior Notes due 2025  
Trading Symbol CE /25  
Security Exchange Name NYSE  
EUR Senior Unsecured Notes Due 2026    
Entity Information [Line Items]    
Title of 12(b) Security 4.777% Senior Notes due 2026  
Trading Symbol CE /26A  
Security Exchange Name NYSE  
Senior Unsecured Notes Due 2027    
Entity Information [Line Items]    
Title of 12(b) Security 2.125% Senior Notes due 2027  
Trading Symbol CE /27  
Security Exchange Name NYSE  
Senior Unsecured Notes Due 2028    
Entity Information [Line Items]    
Title of 12(b) Security 0.625% Senior Notes due 2028  
Trading Symbol CE /28  
Security Exchange Name NYSE  
EUR Senior Unsecured Notes Due 2029    
Entity Information [Line Items]    
Title of 12(b) Security 5.337% Senior Notes due 2029  
Trading Symbol CE /29A  
Security Exchange Name NYSE  
XML 16 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Unaudited Interim Consolidated Statement of Operations - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Net sales $ 2,795 $ 2,486 $ 5,648 $ 5,024
Cost of sales (2,109) (1,781) (4,331) (3,574)
Gross profit 686 705 1,317 1,450
Selling, general and administrative expenses (274) (197) (559) (371)
Amortization of intangible assets (42) (11) (83) (22)
Research and development expenses (40) (26) (82) (50)
Other (charges) gains, net (10) 1 (33) 0
Foreign exchange gain (loss), net 15 (1) 21 (2)
Gain (loss) on disposition of businesses and assets, net 0 12 5 9
Operating profit (loss) 335 483 586 1,014
Equity in net earnings (loss) of affiliates 23 60 38 116
Non-operating pension and other postretirement employee benefit (expense) income (2) 25 (1) 49
Interest expense (182) (48) (364) (83)
Interest income 7 1 15 2
Dividend income - equity investments 31 36 65 73
Other income (expense), net 4 (3) (2) (1)
Earnings (loss) from continuing operations before tax 216 554 337 1,170
Income tax (provision) benefit 4 (112) (21) (224)
Earnings (loss) from continuing operations 220 442 316 946
Earnings (loss) from operation of discontinued operations 0 (8) (3) (8)
Income tax (provision) benefit from discontinued operations 1 2 1 2
Earnings (loss) from discontinued operations 1 (6) (2) (6)
Net earnings (loss) 221 436 314 940
Net (earnings) loss attributable to noncontrolling interests (1) (2) (3) (4)
Net earnings (loss) attributable to Celanese Corporation 220 434 311 936
Amounts attributable to Celanese Corporation        
Earnings (loss) from continuing operations 219 440 313 942
Earnings (loss) from discontinued operations 1 (6) (2) (6)
Net earnings (loss) $ 220 $ 434 $ 311 $ 936
Earnings (loss) per common share - basic        
Continuing operations - basic (in dollars per share) $ 2.01 $ 4.06 $ 2.88 $ 8.70
Discontinued operations - basic (in dollars per share) 0.01 (0.06) (0.02) (0.06)
Net earnings (loss) - basic (in dollars per share) 2.02 4.00 2.86 8.64
Earnings (loss) per common share - diluted        
Continuing operations - diluted (in dollars per share) 2.00 4.03 2.86 8.63
Discontinued operations - diluted (in dollars per share) 0.01 (0.05) (0.01) (0.06)
Net earnings (loss) - diluted (in dollars per share) $ 2.01 $ 3.98 $ 2.85 $ 8.57
Weighted average shares - basic (in shares) 108,886,678 108,392,155 108,761,071 108,289,603
Weighted average shares - diluted (in shares) 109,306,331 109,123,349 109,281,364 109,158,055
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Unaudited Interim Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Net earnings (loss) $ 221 $ 436 $ 314 $ 940
Other comprehensive income (loss), net of tax        
Foreign currency translation gain (loss) (201) (131) (188) (152)
Gain (loss) on cash flow hedges 0 26 4 41
Pension and postretirement benefits 1 0 0 2
Total other comprehensive income (loss), net of tax (200) (105) (184) (109)
Total comprehensive income (loss), net of tax 21 331 130 831
Comprehensive (income) loss attributable to noncontrolling interests (1) (2) (3) (4)
Comprehensive income (loss) attributable to Celanese Corporation $ 20 $ 329 $ 127 $ 827
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Unaudited Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 1,296 $ 1,508
Trade receivables - third party and affiliates 1,338 1,379
Non-trade receivables, net 625 675
Inventories 2,514 2,808
Disposal Group, Including Discontinued Operation, Assets, Current 211 0
Other assets 268 241
Total current assets 6,252 6,611
Investments in affiliates 1,028 1,062
Property, plant and equipment (net of accumulated depreciation - 2023: $3,830; 2022: $3,687) 5,541 5,584
Operating Lease, Right-of-Use Asset 403 413
Deferred income taxes 832 808
Other assets 523 547
Goodwill 7,063 [1] 7,142
Intangible assets, net 4,007 4,105
Total assets 25,649 26,272
Current Liabilities    
Short-term borrowings and current installments of long-term debt - third party and affiliates 1,507 1,306
Trade payables - third party and affiliates 1,243 1,518
Disposal Group, Including Discontinued Operation, Liabilities, Current 19 0
Other liabilities 1,146 1,201
Income taxes payable 7 43
Total current liabilities 3,922 4,068
Long-term debt, net of unamortized deferred financing costs 12,889 13,373
Deferred income taxes 1,220 1,242
Uncertain tax positions 285 322
Benefit obligations 406 411
Operating lease liabilities 347 364
Other liabilities 492 387
Commitments and Contingencies
Shareholders' Equity    
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2023 and 2022: 0 issued and outstanding) 0 0
Common stock, $0.0001 par value, 400,000,000 shares authorized (2023: 170,458,836 issued and 108,847,435 outstanding; 2022: 170,135,425 issued and 108,473,932 outstanding) 0 0
Treasury stock, at cost (2023: 61,611,401 shares; 2022: 61,661,493 shares) (5,490) (5,491)
Additional paid-in capital 383 372
Retained earnings 11,433 11,274
Accumulated other comprehensive income (loss), net (702) (518)
Total Celanese Corporation shareholders' equity 5,624 5,637
Noncontrolling interests 464 468
Total equity 6,088 6,105
Total liabilities and equity $ 25,649 $ 26,272
[1] There were no accumulated impairment losses as of June 30, 2023.
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Unaudited Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Accumulated depreciation, depletion and amortization, property, plant, and equipment $ 3,830 $ 3,687
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 100,000,000 100,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 400,000,000 400,000,000
Common stock, shares issued (in shares) 170,458,836 170,135,425
Common stock, shares outstanding (in shares) 108,847,435 108,473,932
Treasury Stock, Common, Shares 61,611,401 61,661,493
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Unaudited Interim Consolidated Statement Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss), Net
Noncontrolling Interests
Treasury Stock, Common
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Celanese Corporation stockholders' equity   $ 0 $ 333 $ 9,677 $ (329)   $ (5,492)
Balance as of the beginning of the period (in shares) at Dec. 31, 2021   108,023,735         61,736,289
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation, net of tax     11        
Purchases of treasury stock (in shares) 0            
Issuance of treasury stock under stock plans             $ 0
Issuance of treasury stock under stock plans (in shares)             (32,243)
Stock awards (in shares)   322,300          
Stock awards   $ 0          
Net earnings (loss) attributable to Celanese Corporation $ 936     936      
Common stock dividends       (147)      
Other comprehensive income (loss), net of tax (109)       (109)    
Balance as of the beginning of the period, noncontrolling interest at Dec. 31, 2021           $ 348  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) attributable to noncontrolling interests 4         4  
Distributions/dividends to noncontrolling interests           (7)  
Balance as of the end of the period, noncontrolling interest at Jun. 30, 2022           345  
Balance as of the end of the period (in shares) at Jun. 30, 2022   108,346,035         61,704,046
Balance as of the end of the period at Jun. 30, 2022 5,225            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Celanese Corporation stockholders' equity   $ 0 326 10,106 (333)   $ (5,492)
Balance as of the beginning of the period (in shares) at Mar. 31, 2022   108,307,341         61,736,289
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation, net of tax     18        
Issuance of treasury stock under stock plans             $ 0
Issuance of treasury stock under stock plans (in shares)             (32,243)
Stock awards (in shares)   38,694          
Stock awards   $ 0          
Net earnings (loss) attributable to Celanese Corporation 434     434      
Common stock dividends       (74)      
Other comprehensive income (loss), net of tax (105)       (105)    
Balance as of the beginning of the period, noncontrolling interest at Mar. 31, 2022           346  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) attributable to noncontrolling interests 2         2  
Distributions/dividends to noncontrolling interests           (3)  
Balance as of the end of the period, noncontrolling interest at Jun. 30, 2022           345  
Balance as of the end of the period (in shares) at Jun. 30, 2022   108,346,035         61,704,046
Balance as of the end of the period at Jun. 30, 2022 5,225            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Celanese Corporation stockholders' equity 4,880 $ 0 344 10,466 (438)   $ (5,492)
Celanese Corporation stockholders' equity 5,637 $ 0 372 11,274 (518)   $ (5,491)
Balance as of the beginning of the period (in shares) at Dec. 31, 2022   108,473,932         61,661,493
Balance as of the beginning of the period at Dec. 31, 2022 $ 6,105            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation, net of tax     11        
Purchases of treasury stock (in shares) 0            
Issuance of treasury stock under stock plans             $ 1
Issuance of treasury stock under stock plans (in shares)             (50,092)
Stock awards (in shares)   373,503          
Stock awards   $ 0          
Net earnings (loss) attributable to Celanese Corporation $ 311     311      
Common stock dividends       (152)      
Other comprehensive income (loss), net of tax (184)       (184)    
Balance as of the beginning of the period, noncontrolling interest at Dec. 31, 2022 468         468  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) attributable to noncontrolling interests 3         3  
Distributions/dividends to noncontrolling interests           (7)  
Balance as of the end of the period, noncontrolling interest at Jun. 30, 2023 464         464  
Balance as of the end of the period (in shares) at Jun. 30, 2023   108,847,435         61,611,401
Balance as of the end of the period at Jun. 30, 2023 6,088            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Celanese Corporation stockholders' equity   $ 0 365 11,289 (502)   $ (5,491)
Balance as of the beginning of the period (in shares) at Mar. 31, 2023   108,786,738         61,661,493
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation, net of tax     18        
Issuance of treasury stock under stock plans             $ 1
Issuance of treasury stock under stock plans (in shares)             (50,092)
Stock awards (in shares)   60,697          
Stock awards   $ 0          
Net earnings (loss) attributable to Celanese Corporation 220     220      
Common stock dividends       (76)      
Other comprehensive income (loss), net of tax (200)       (200)    
Balance as of the beginning of the period, noncontrolling interest at Mar. 31, 2023           469  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) attributable to noncontrolling interests 1         1  
Distributions/dividends to noncontrolling interests           (6)  
Balance as of the end of the period, noncontrolling interest at Jun. 30, 2023 464         $ 464  
Balance as of the end of the period (in shares) at Jun. 30, 2023   108,847,435         61,611,401
Balance as of the end of the period at Jun. 30, 2023 6,088            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Celanese Corporation stockholders' equity $ 5,624 $ 0 $ 383 $ 11,433 $ (702)   $ (5,490)
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Unaudited Interim Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Operating Activities    
Net earnings (loss) $ 314 $ 940
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities    
Depreciation, amortization and accretion 359 213
Pension and postretirement net periodic benefit cost 7 (42)
Pension and postretirement contributions (24) (23)
Deferred income taxes, net (3) 15
(Gain) loss on disposition of businesses and assets, net (4) (8)
Stock-based compensation 32 31
Undistributed earnings in unconsolidated affiliates (15) (10)
Other, net (4) 5
Operating cash provided by (used in) discontinued operations (4) (19)
Changes in operating assets and liabilities    
Trade receivables - third party and affiliates, net (10) (216)
Inventories 220 (251)
Other assets 187 22
Trade payables - third party and affiliates (211) 169
Other liabilities (178) (15)
Net cash provided by (used in) operating activities 666 811
Investing Activities    
Capital expenditures on property, plant and equipment (309) (261)
Acquisitions, net of cash acquired 0 (14)
Proceeds from sale of businesses and assets, net 9 16
Other, net (41) (26)
Net cash provided by (used in) investing activities (341) (285)
Financing Activities    
Net change in short-term borrowings with maturities of 3 months or less (300) 19
Proceeds from short-term borrowings 349 0
Repayments of short-term borrowings (370) 0
Repayments of long-term debt (13) (14)
Purchases of treasury stock, including related fees 0 (17)
Common stock dividends (152) (147)
Distributions to noncontrolling interests (7) (7)
Issuance cost of bridge facility 0 (63)
Other, net (23) (25)
Net cash provided by (used in) financing activities (516) (254)
Exchange rate effects on cash and cash equivalents (21) (25)
Net increase (decrease) in cash and cash equivalents (212) 247
Cash and cash equivalents as of beginning of period 1,508 536
Cash and cash equivalents as of end of period $ 1,296 $ 783
XML 22 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Description of the Company and Basis of Presentation
 6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of the Company and Basis of Presentation Description of the Company and Basis of Presentation
Description of the Company
Celanese Corporation and its subsidiaries (collectively, the "Company") is a global chemical and specialty materials company. The Company produces high performance engineered polymers that are used in a variety of high-value applications, as well as acetyl products, which are intermediate chemicals, for nearly all major industries. The Company also engineers and manufactures a wide variety of products essential to everyday living. The Company's broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, consumer and medical, energy storage, filtration, food and beverage, paints and coatings, paper and packaging, performance industrial and textiles.
Definitions
In this Quarterly Report on Form 10-Q ("Quarterly Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The term "Celanese U.S." refers to the Company's subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries.
Basis of Presentation
The unaudited interim consolidated financial statements for the three and six months ended June 30, 2023 and 2022 contained in this Quarterly Report were prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for all periods presented and include the accounts of the Company, its majority owned subsidiaries over which the Company exercises control and, when applicable, variable interest entities in which the Company is the primary beneficiary. The unaudited interim consolidated financial statements and other financial information included in this Quarterly Report, unless otherwise specified, have been presented to separately show the effects of discontinued operations.
In the opinion of management, the accompanying unaudited consolidated balance sheets and related unaudited interim consolidated statements of operations, comprehensive income (loss), cash flows and equity include all adjustments, consisting only of normal recurring items necessary for their fair presentation in conformity with U.S. GAAP. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with rules and regulations of the Securities and Exchange Commission ("SEC"). These unaudited interim consolidated financial statements should be read in conjunction with the Company's consolidated financial statements as of and for the year ended December 31, 2022, filed on February 24, 2023 with the SEC as part of the Company's Annual Report on Form 10-K.
Operating results for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the entire year.
In the ordinary course of business, the Company enters into contracts and agreements relative to a number of topics, including acquisitions, dispositions, joint ventures, supply agreements, product sales and other arrangements. The Company endeavors to describe those contracts or agreements that are material to its business, results of operations or financial position. The Company may also describe some arrangements that are not material but in which the Company believes investors may have an interest or which may have been included in a Form 8-K filing. Investors should not assume the Company has described all contracts and agreements relative to the Company's business in this Quarterly Report.
For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside shareholders' interests are shown as noncontrolling interests.
Estimates and Assumptions
The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of Net sales, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension
and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates.
XML 23 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Recent Accounting Pronouncements
 6 Months Ended
Jun. 30, 2023
Recent Accounting Pronouncements [Abstract]  
Recent Accounting Pronouncements Recent Accounting PronouncementsThere are no recent Accounting Standard Updates issued by the Financial Accounting Standards Board which are expected to materially impact the Company's financial position, operating results or financial disclosures.
XML 24 R10.htm IDEA: XBRL DOCUMENT v3.23.2
Acquisitions, Dispositions and Plant Closures
 6 Months Ended
Jun. 30, 2023
Acquisitions, Dispositions and Plant Closures [Abstract]  
Acquisitions, Dispositions and Plant Closures Acquisitions, Dispositions and Plant Closures
Acquisitions
In November 2022, the Company acquired 100% ownership of entities and assets consisting of a majority of the Mobility & Materials business ("M&M") of DuPont de Nemours, Inc. ("DuPont") (the "M&M Acquisition") for a purchase price of $11.0 billion, subject to transaction adjustments, in an all-cash transaction. The Company acquired a global production network of 29 facilities, including compounding and polymerization, customer and supplier contracts and agreements, an intellectual property portfolio, including approximately 850 patents with associated technical and R&D assets, and approximately 5,000 employees across the manufacturing, technical, and commercial organizations. This acquisition of M&M enhances the engineered materials product portfolio by adding new polymers, brands, product technology, and backward integration in critical polymers, allowing the Company to accelerate growth in high-value applications including future mobility, connectivity and medical. The acquisition was accounted for as a business combination and the acquired operations are included in the Engineered Materials segment.
The Company preliminarily allocated the purchase price of the acquisition to identifiable assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date. The purchase price allocation was based upon preliminary information and is subject to change if additional information about the facts and circumstances that existed at the acquisition date becomes available. The Company is in the ongoing process of conducting a valuation of the assets acquired and liabilities assumed related to the acquisition, including trade names and customer relationships, personal and real property, investment in equity affiliates and deferred taxes. The final fair value of the net assets acquired may result in adjustments to these assets and liabilities, including goodwill. During the measurement period to date, there were no adjustments that materially impacted the Company's goodwill initially recorded.
The following unaudited pro forma financial information presents the consolidated results of operations as if the M&M Acquisition had occurred at the beginning of 2022. M&M's pre-acquisition results have been added to the Company's historical results. The pro forma results contained in the table below include adjustments for (i) increased depreciation expense as a result of acquisition date fair value adjustments, (ii) amortization of acquired intangibles, (iii) interest expense and amortization of debt issuance costs of $171 million and $343 million related to borrowings under the U.S. Term Loan Facility (defined below) and the issuance of Acquisition Notes (defined below) as if these had taken place at the beginning of 2022 for the three and six months ended June 30, 2022, respectively and (iv) net total inventory step up of inventory amortized to Cost of sales of $33 million and $131 million for the three and six months ended June 30, 2022, respectively.
These pro forma results have been prepared for comparative purposes only and are not necessarily indicative of the results of operations as they would have been had the acquisitions occurred on the assumed dates, nor are they necessarily an indication of future operating results.
Three Months Ended
June 30, 2022		Six Months Ended
June 30, 2022
(In $ millions)
Unaudited Consolidated Pro Forma Results
Proforma Net sales
3,397 6,824 
Proforma Earnings (loss) from continuing operations before tax
285 597 
Nutrinova Joint Venture
On June 22, 2023, the Company announced the signing of a definitive agreement with Mitsui & Co., Ltd. ("Mitsui") to form a food ingredients joint venture under the name Nutrinova. The Company will contribute receivables, inventory, property, plant and equipment, certain intangible assets, other assets, other liabilities, technology and employees of its food ingredients business while retaining a 30% stake in the joint venture. Mitsui will acquire the remaining 70% stake at a purchase price of
$473 million. The parties expect to close the transaction in the second half of 2023, pending regulatory approvals. The Company will account for its remaining investment in the food ingredients business as an equity method investment.
As of June 30, 2023, the food ingredients business, currently included in the Engineered Materials segment, was classified as held for sale and measured and reported at the lower of its carrying amount or fair value less costs to sell. The assets and liabilities classified as held for sale in the unaudited consolidated balance sheet are as follows:
As of
June 30,
2023
(In $ millions)
Current assets83 
Goodwill80 
Other long-term assets48 
Assets held for sale211 
Other liabilities19 
Liabilities held for sale19 
Korea Engineering Plastics Co. Restructuring
In April 2022, the Company completed the restructuring of Korea Engineering Plastics Co. ("KEPCO"), a joint venture owned 50% by the Company and 50% by Mitsubishi Gas Chemical Company, Inc. KEPCO was first formed in 1987 to manufacture and market polyoxymethylene ("POM") in Asia, with a particular focus on serving domestic demand in South Korea. KEPCO will now focus solely on manufacturing and supplying high quality products to its shareholders, who will independently market them globally. As part of the restructuring of KEPCO, the Company paid KEPCO $5 million and will pay 5 equal annual installments of €24 million on October 1 of each year beginning in 2022. This resulted in an increase to the Company's investment in KEPCO of $134 million. The Company's joint venture partner will make similar payments to KEPCO. The restructuring did not result in a change in ownership percentage of KEPCO, nor a change in control, and KEPCO will continue to be accounted for as an equity method investment.
XML 25 R11.htm IDEA: XBRL DOCUMENT v3.23.2
Inventories
 6 Months Ended
Jun. 30, 2023
Inventory Disclosure [Abstract]  
Inventories Inventories
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Finished goods1,632 1,820 
Work-in-process202 202 
Raw materials and supplies680 786 
Total2,514 2,808 
XML 26 R12.htm IDEA: XBRL DOCUMENT v3.23.2
Goodwill and Intangible Assets, net
 6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, Net Goodwill and Intangible Assets, Net
Goodwill
Engineered
Materials		Acetyl ChainTotal
(In $ millions)
As of December 31, 20226,775 367 7,142 
Acquisitions (Note 3)
8 — 8 
Transfer(1)
(80)— (80)
Exchange rate changes(11)4 (7)
As of June 30, 2023(2)
6,692 371 7,063 
______________________________
(1)Related to goodwill reclassified to assets held for sale (Note 3).
(2)There were no accumulated impairment losses as of June 30, 2023.
Intangible Assets, Net
Finite-lived intangible assets are as follows:
LicensesCustomer-
Related
Intangible
Assets		Developed
Technology		Covenants
Not to
Compete
and Other		Total
(In $ millions)
Gross Asset Value
As of December 31, 202242 2,455 601 55 3,153 
Transfer(1)
— (58)(1)— (59)
Exchange rate changes(2)9 (6)— 1 
As of June 30, 202340 2,406 594 55 3,095 
Accumulated Amortization
As of December 31, 2022(39)(567)(50)(40)(696)
Amortization— (63)(20)— (83)
Transfer(1)
— 58 1 — 59 
Exchange rate changes2 (7)(1)— (6)
As of June 30, 2023(37)(579)(70)(40)(726)
Net book value3 1,827 524 15 2,369 
______________________________
(1)Related to finite-lived intangible assets reclassified to assets held for sale (Note 3).
Indefinite-lived intangible assets are as follows:
Trademarks
and Trade Names
(In $ millions)
As of December 31, 20221,648 
Transfer(1)
(14)
Exchange rate changes4 
As of June 30, 20231,638 
______________________________
(1)Related to indefinite-lived intangible assets reclassified to assets held for sale (Note 3).
During the six months ended June 30, 2023, the Company did not renew or extend any intangible assets.
Estimated amortization expense for the succeeding five fiscal years is as follows:
(In $ millions)
2024160 
2025160 
2026160 
2027160 
2028160 
XML 27 R13.htm IDEA: XBRL DOCUMENT v3.23.2
Current Other Liabilities
 6 Months Ended
Jun. 30, 2023
Other Liabilities, Current [Abstract]  
Current Other Liabilities Current Other Liabilities
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Benefit obligations (Note 8)
25 25 
Customer rebates88 101 
Derivatives (Note 12)
64 63 
Interest (Note 7)
290 265 
Legal (Note 14)
25 21 
Operating leases89 83 
Restructuring (Note 18)
21 6 
Salaries and benefits132 151 
Sales and use tax/foreign withholding tax payable99 108 
Investment in affiliates87 79 
Other(1)
226 299 
Total1,146 1,201 
____________________________
(1)Includes $115 million and $166 million payable to DuPont related to the M&M Acquisition and transition activities as of June 30, 2023 and December 31, 2022, respectively.
XML 28 R14.htm IDEA: XBRL DOCUMENT v3.23.2
Debt
 6 Months Ended
Jun. 30, 2023
Debt Disclosure [Abstract]  
Debt Debt
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates
Current installments of long-term debt1,050 506 
Short-term borrowings, including amounts due to affiliates(1)
250 500 
Revolving credit facilities(2)
207 300 
Total1,507 1,306 
______________________________
(1)The weighted average interest rate was 4.9% and 5.8% as of June 30, 2023 and December 31, 2022, respectively.
(2)The weighted average interest rate was 3.4% and 5.8% as of June 30, 2023 and December 31, 2022, respectively.
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Long-Term Debt
Senior unsecured notes due 2023, interest rate of 1.125%
489 480 
Senior unsecured notes due 2024, interest rate of 3.500%
500 499 
Senior unsecured notes due 2024, interest rate of 5.900%
2,000 2,000 
Senior unsecured notes due 2025, interest rate of 1.250%
326 320 
Senior unsecured notes due 2025, interest rate of 6.050%
1,750 1,750 
Senior unsecured term loan due 2025, interest rate of 6.760%
750 750 
Senior unsecured notes due 2026, interest rate of 1.400%
400 400 
Senior unsecured notes due 2026, interest rate of 4.777%
1,087 1,067 
Senior unsecured notes due 2027, interest rate of 2.125%
541 531 
Senior unsecured notes due 2027, interest rate of 6.165%
2,000 2,000 
Senior unsecured term loan due 2027, interest rate of 6.760%
1,000 1,000 
Senior unsecured notes due 2028, interest rate of 0.625%
543 533 
Senior unsecured notes due 2029, interest rate of 5.337%
543 533 
Senior unsecured notes due 2029, interest rate of 6.330%
750 750 
Senior unsecured notes due 2032, interest rate of 6.379%
1,000 1,000 
Pollution control and industrial revenue bonds due at various dates through 2030, interest rates ranging from 4.05% to 5.00%
163 164 
Bank loans due at various dates through 2026(1)
4 4 
Obligations under finance leases due at various dates through 2054
157 172 
Subtotal14,003 13,953 
Unamortized debt issuance costs(2)
(64)(74)
Current installments of long-term debt(1,050)(506)
Total12,889 13,373 
______________________________
(1)The weighted average interest rate was 1.3% and 1.3% as of June 30, 2023 and December 31, 2022, respectively.
(2)Related to the Company's long-term debt, excluding obligations under finance leases.
Senior Credit Facilities
In March 2022, Celanese, Celanese U.S. and certain subsidiaries entered into a term loan credit agreement (the "March 2022 U.S. Term Loan Credit Agreement"), pursuant to which lenders provided a tranche of delayed-draw term loans due 364 days from issuance in an amount equal to $500 million and a tranche of delayed-draw term loans due 5 years from issuance in an amount equal to $1.0 billion. In September 2022, Celanese, Celanese U.S. and certain subsidiaries entered into an additional term loan credit agreement (the "September 2022 U.S. Term Loan Credit Agreement" and, together with the March 2022 U.S. Term Loan Credit Agreement, the "U.S. Term Loan Credit Agreements"), pursuant to which lenders have provided delayed-draw term loans due 3 years from issuance in an amount equal to $750 million (the term loans represented by the U.S. Term Loan Credit Agreements collectively, the "U.S. Term Loan Facility"). The U.S. Term Loan Facility was fully drawn during the three months ended December 31, 2022.
Also in March 2022, Celanese, Celanese U.S. and certain subsidiaries entered into a new revolving credit agreement (the "U.S. Revolving Credit Agreement" and, together with the U.S. Term Loan Credit Agreements, the "U.S. Credit Agreements") consisting of a $1.75 billion senior unsecured revolving credit facility (with a letter of credit sublimit), maturing in 2027 (the "U.S. Revolving Credit Facility").
On February 21, 2023, the Company amended certain covenants in the U.S. Credit Agreements, including financial ratio maintenance covenants. The U.S. Credit Agreements are guaranteed by Celanese, Celanese U.S. and domestic subsidiaries together representing substantially all of the Company's U.S. assets and business operations (the "Subsidiary Guarantors"). The Subsidiary Guarantors are listed in Exhibit 22.1 to this Quarterly Report.
On January 4, 2023, Celanese (Shanghai) International Trading Co., Ltd ("CSIT"), a fully consolidated subsidiary, entered into a restatement of an existing credit facility agreement (the "China Revolving Credit Agreement") to upsize and modify the facility thereunder to consist of an aggregate CNY1.75 billion uncommitted senior unsecured revolving credit facility available under two tranches (with overdraft, bank guarantee and documentary credit sublimits) (the "China Revolving Credit Facility"). Obligations bear interest at certain fixed and floating rates. The China Revolving Credit Agreement is guaranteed by Celanese U.S.
On January 6, 2023, CSIT entered into a senior unsecured working capital loan contract for CNY800 million (the "China Working Capital Term Loan Agreement," together with the China Revolving Credit Agreement, the "China Credit Agreements," and the China Credit Agreements together with the U.S. Credit Agreements, the "Global Credit Agreements"), payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates. The loan under the China Working Capital Term Loan Agreement was fully drawn on January 10, 2023 and is supported by a letter of comfort from the Company. The Company expects that the China Credit Agreements will facilitate its efficient repatriation of cash to the U.S. to repay debt and effectively redomicile a portion of its U.S. debt to China at a lower average interest rate.
The Company's debt balances and amounts available for borrowing under its senior unsecured revolving credit facilities are as follows:
As of
June 30,
2023
(In $ millions)
U.S. Revolving Credit Facility
Borrowings outstanding— 
Available for borrowing1,750 
China Revolving Credit Facility
Borrowings outstanding207 
Available for borrowing34 
Senior Notes
The Company has outstanding senior unsecured notes, issued in public offerings registered under the Securities Act of 1933 ("Securities Act"), as amended (collectively, the "Senior Notes"). The Senior Notes were issued by Celanese U.S. and are guaranteed on a senior unsecured basis by Celanese and the Subsidiary Guarantors. Celanese U.S. may redeem some or all of each of the Senior Notes, prior to their respective maturity dates, at a redemption price of 100% of the principal amount, plus a "make-whole" premium as specified in the applicable indenture, plus accrued and unpaid interest, if any, to the redemption date.
In July 2022, Celanese U.S. completed an offering of $7.5 billion aggregate principal amount of notes of various maturities in a public offering registered under the Securities Act (the "Acquisition USD Notes"). In July 2022, Celanese U.S. completed an offering of €1.5 billion in aggregate principal amount of euro-denominated senior unsecured notes due in 2026 and 2029 in a public offering registered under the Securities Act (collectively, the "Acquisition Euro Notes" and together with the Acquisition USD Notes, the "Acquisition Notes"). Certain of the Acquisition Notes were issued at a discount to par, which will be amortized to Interest expense in the consolidated statements of operations over the terms of the applicable Acquisition Notes. Fees and expenses of the offering of the Acquisition Notes, inclusive of underwriting discounts, were $65 million.
Accounts Receivable Purchasing Facility
On June 1, 2023, the Company entered into an amendment to the amended and restated receivables purchase agreement (the "Amended Receivables Purchase Agreement") under its U.S. accounts receivable purchasing facility among certain of the Company's subsidiaries, its wholly-owned, "bankruptcy remote" special purpose subsidiary ("SPE") and certain global financial institutions ("Purchasers"). The Amended Receivables Purchase Agreement extends the term of the accounts receivable purchasing facility such that the SPE may sell certain receivables until June 18, 2025. Under the Amended Receivables Purchase Agreement, transfers of U.S. accounts receivable from the SPE are treated as sales and are accounted for as a reduction in accounts receivable because the agreement transfers effective control over and risk related to the U.S. accounts receivable to the SPE. The Company and related subsidiaries have no continuing involvement in the transferred U.S. accounts receivable, other than collection and administrative responsibilities and, once sold, the U.S. accounts receivable are no longer available to satisfy creditors of the Company or the related subsidiaries. These sales are transacted at 100% of the face value of the relevant U.S. accounts receivable, resulting in derecognition of the U.S. accounts receivables from the Company's unaudited consolidated balance sheet. The Company de-recognized $663 million and $1.1 billion of accounts receivable under this agreement for the six months ended June 30, 2023 and year ended December 31, 2022, respectively, and collected $565 million and $1.1 billion of accounts receivable sold under this agreement during the same periods. Unsold U.S. accounts receivable of $86 million were pledged by the SPE as collateral to the Purchasers as of June 30, 2023.
Factoring and Discounting Agreements
The Company has factoring agreements in Europe and Singapore with financial institutions to sell 100% and 90% of certain accounts receivable, respectively, on a non-recourse basis. These transactions are treated as sales and are accounted for as reductions in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyer. The Company has no continuing involvement in the transferred receivables, other than collection and administrative responsibilities and, once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. The Company de-recognized $196 million and $320 million of accounts receivable under these factoring agreements for the six months ended June 30, 2023 and year ended December 31, 2022, respectively, and collected $189 million and $325 million of accounts receivable sold under these factoring agreements during the same periods.
Covenants
The Company's material financing arrangements contain customary covenants, such as events of default and change of control provisions, and in the case of the U.S. Credit Agreements the maintenance of certain financial ratios (subject to adjustment following certain qualifying acquisitions and dispositions, as set forth in the U.S. Credit Agreements, as amended). Failure to comply with these covenants, or the occurrence of any other event of default, could result in acceleration of the borrowings and other financial obligations. The Company is in compliance with the covenants in its material financing arrangements as of June 30, 2023.
XML 29 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Benefit Obligations
 6 Months Ended
Jun. 30, 2023
Retirement Benefits [Abstract]  
Benefit Obligations Benefit Obligations
The components of net periodic benefit cost are as follows:
Three Months Ended June 30, Six Months Ended June 30,
2023202220232022
Pension
Benefits		Post-retirement
Benefits		Pension
Benefits		Post-retirement
Benefits		Pension
Benefits		Post-retirement
Benefits		Pension
Benefits		Post-retirement
Benefits
(In $ millions)
Service cost2 — 4 — 6 — 7 — 
Interest cost34 1 16 1 66 1 33 1 
Expected return on plan assets
(33)— (42)— (66)— (83)— 
Total3 1 (22)1 6 1 (43)1 
Benefit obligation funding is as follows:
As of
June 30,
2023
Total
Expected
2023
(In $ millions)
Cash contributions to defined benefit pension plans13 27 
Benefit payments to nonqualified pension plans9 18 
Benefit payments to other postretirement benefit plans2 4 
The Company's estimates of its U.S. defined benefit pension plan contributions reflect the provisions of the Pension Protection Act of 2006.
Pension and postretirement benefit plan balances recognized in the unaudited consolidated balance sheets consist of the following:
As of June 30, 2023As of December 31, 2022
Pension
Benefits		Post-retirement
Benefits		Pension
Benefits		Post-retirement
Benefits
(In $ millions)
Noncurrent Other assets164 — 160 — 
Current Other liabilities(21)(3)(21)(3)
Benefit obligations(366)(35)(372)(35)
Net amount recognized(223)(38)(233)(38)
XML 30 R16.htm IDEA: XBRL DOCUMENT v3.23.2
Environmental
 6 Months Ended
Jun. 30, 2023
Environmental Remediation Obligations [Abstract]  
Environmental Environmental
The Company is subject to environmental laws and regulations worldwide that impose limitations on the discharge of pollutants into the air and water, establish standards for the treatment, storage and disposal of solid and hazardous wastes, and impose record keeping and notification requirements. Failure to timely comply with these laws and regulations may expose the Company to penalties. The Company believes that it is in substantial compliance with all applicable environmental laws and regulations and engages in an ongoing process of updating its controls to mitigate compliance risks. The Company is also subject to retained environmental obligations specified in various contractual agreements arising from the divestiture of certain businesses by the Company or one of its predecessor companies.
The components of environmental remediation liabilities are as follows:
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Demerger obligations (Note 14)
18 20 
Divestiture obligations (Note 14)
13 14 
Active sites20 21 
U.S. Superfund sites8 10 
Other environmental remediation liabilities2 2 
Total61 67 
Remediation
Due to its industrial history and through retained contractual and legal obligations, the Company has the obligation to remediate specific areas on its own sites as well as on divested, demerger, orphan or U.S. Superfund sites (defined below). In addition, as part of the demerger agreement between the Company and Hoechst AG ("Hoechst"), a specified portion of the responsibility for environmental liabilities from a number of Hoechst divestitures was transferred to the Company (Note 14). Certain of these sites, at which the Company maintains continuing involvement, were and continue to be designated as discontinued operations when closed. The Company provides for such obligations when the event of loss is probable and reasonably estimable. The Company believes that environmental remediation costs will not have a material adverse effect on the financial position of the Company, but may have a material adverse effect on the results of operations or cash flows in any given period.
U.S. Superfund Sites
In the U.S., the Company may be subject to substantial claims brought by U.S. federal or state regulatory agencies or private individuals pursuant to statutory authority or common law. In particular, the Company has a potential liability under the U.S. Federal Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, and related state laws (collectively referred to as "Superfund") for investigation and cleanup costs at certain sites. At most of these sites, numerous companies, including the Company, or one of its predecessor companies, have been notified that the U.S. Environmental Protection Agency ("EPA"), state governing bodies or private individuals consider such companies to be potentially responsible parties ("PRP") under Superfund or related laws. The proceedings relating to these sites are in various stages. The cleanup process has not been completed at most sites, and the status of the insurance coverage for some of these proceedings is uncertain. Consequently, the Company cannot accurately determine its ultimate liability for investigation or cleanup costs at these sites.
As events progress at each site for which it has been named a PRP, the Company accrues any probable and reasonably estimable liabilities. In establishing these liabilities, the Company considers the contaminants of concern, the potential impact thereof, the relationship of the contaminants of concern to its current and historic operations, its shipment of waste to a site, its percentage of total waste shipped to the site, the types of wastes involved, the conclusions of any studies, the magnitude of any remedial actions that may be necessary and the number and viability of other PRPs. Often the Company joins with other PRPs to sign joint defense agreements that settle, among PRPs, each party's percentage allocation of costs at the site. Although the ultimate liability may differ from the estimate, the Company routinely reviews the liabilities and revises the estimate, as appropriate, based on the most current information available.
One such site is the Diamond Alkali Superfund Site, which is comprised of a number of sub-sites, including the Lower Passaic River Study Area ("LPRSA"), which is the lower 17-mile stretch of the Passaic River ("Lower Passaic River Site"), and the Newark Bay Study Area. The Company and 70 other companies are parties to a May 2007 Administrative Order on Consent with the EPA to perform a Remedial Investigation/Feasibility Study ("RI/FS") at the Lower Passaic River Site in order to identify the levels of contaminants and potential cleanup actions, including the potential migration of contaminants between the LPRSA and the Newark Bay Area.
In March 2016, the EPA issued its final Record of Decision concerning the remediation of the lower 8.3 miles of the Lower Passaic River Site ("Lower 8.3 Miles"). Pursuant to the EPA's Record of Decision, the Lower 8.3 Miles must be dredged bank to bank and an engineered cap must be installed at an EPA estimated cost of approximately $1.4 billion. In September 2021, the EPA issued a Record of Decision selecting an interim remedial plan for the upper 9 miles of the Lower Passaic River ("Upper 9 Miles"). Pursuant to the EPA's Record of Decision, targeted dredging will be conducted in the Upper 9 Miles to address surface sediments with elevated contamination followed by the installation of an engineered cap at an EPA estimated cost of $441 million.
The Company owned and/or operated facilities in the vicinity of the Lower 8.3 Miles, but has found no evidence that it contributed any of the contaminants of concern to the Passaic River. In June 2018, Occidental Chemical Corporation ("OCC"), the successor to the Diamond Alkali Company, sued a subsidiary of the Company and 119 other parties alleging claims for joint and several damages, contribution and declaratory relief under Section 107 and 113 of Superfund for costs to clean up the LPRSA portion of the Diamond Alkali Superfund Site, Occidental Chemical Corporation v. 21st Century Fox America, Inc., et al, No. 2:18-CV-11273 (MCA) (LDW) (U.S. District Court New Jersey) (the "2018 OCC Lawsuit"), alleging that each of the defendants owned or operated a facility that contributed contamination to the LPRSA. With respect to the Company, the 2018 OCC lawsuit is limited to the former Celanese facility that Essex County, New Jersey has agreed to indemnify the Company for and does not change the Company's estimated liability for LPRSA cleanup costs.
Separately, the United States lodged a Consent Decree in U.S. District Court for the District of New Jersey on December 16, 2022 that will resolve the Company's liability (and that of more than 80 other settling defendants) to the EPA for costs to clean up both the Lower 8.3 Miles and Upper 9 Miles of the Lower Passaic River Site in exchange for a collective payment of $150 million, United States v. Alden Leeds, Inc., No. 2:22-7326 (MCA) (LDW) (U.S. District Court New Jersey) ("Consent Decree Action"). The Consent Decree also will provide the Company protection from contribution claims by others for costs incurred to clean up both the Lower 8.3 Miles and Upper 9 Miles of the Lower Passaic River Site. The Company's proposed payment toward the $150 million collective settlement payment is not material to the Company's results of operations, cash flows or financial position. The Consent Decree is still subject to public comment and court approval.
On March 7, 2023, the U.S. District Court for the District of New Jersey entered an order staying and administratively terminating the 2018 OCC Lawsuit, pending resolution of the request for judicial approval of the Consent Decree in the Consent Decree Action. On March 24, 2023, OCC filed a new lawsuit against 40 parties, including a subsidiary of the Company, seeking to recover costs for remedial design work the EPA has ordered OCC to undertake for a portion of the LPRSA at an estimated cost of $71 million, Occidental Chemical Corporation v. Givaudan Fragrances Corporation, No. 2:23-cv-1699 (U.S. District Court New Jersey) (the "2023 OCC Lawsuit"). Like the earlier lawsuit, the 2023 OCC Lawsuit concerns the facility Essex County, New Jersey purchased and for which Essex County, New Jersey has agreed to defend and indemnify the Company. This new lawsuit does not change the Company's estimated liability for LPRSA cleanup costs.
The Company will continue to vigorously defend these matters and continues to believe that its ultimate allocable share of the cleanup costs with respect to the Lower Passaic River Site, previously estimated at less than 1%, will not be material.
Other Environmental Matters
In April 2022, a methanol leak on a pipeline to our Bishop, Texas facility was discovered. The release has been contained, the leak has been repaired and the pipeline has resumed operation. The Company promptly disclosed the incident to state and federal authorities, including the Texas Commission on Environmental Quality and the EPA, and remediation activities are now completed. While the Company has not received a notice of violation nor been assessed any fines or penalties to date, the Company recorded a reserve in Other current liabilities based on anticipated clean-up costs and possible penalties to state or federal authorities. The Company does not believe that resolution of this matter will have a material impact on our financial condition or results of operations.
XML 31 R17.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity
 6 Months Ended
Jun. 30, 2023
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Shareholders' Equity
Common Stock
The Company's Board of Directors follows a policy of declaring, subject to legally available funds, a quarterly cash dividend on each share of the Company's Common Stock, par value $0.0001 per share ("Common Stock"), unless the Company's Board of Directors, in its sole discretion, determines otherwise. The amount available to the Company to pay cash dividends is not currently restricted by its existing Global Credit Agreements and its indentures governing its senior unsecured notes. Any decision to declare and pay dividends in the future will be made at the discretion of the Company's Board of Directors and will depend on, among other things, the results of operations, cash requirements, financial condition, contractual restrictions and other factors that the Company's Board of Directors may deem relevant.
The Company declared a quarterly cash dividend of $0.70 per share on its Common Stock on July 19, 2023, amounting to $76 million. The cash dividend will be paid on August 14, 2023 to holders of record as of July 31, 2023.
Treasury Stock
The Company's Board of Directors authorizes repurchases of Common Stock from time to time. These authorizations give management discretion in determining the timing and conditions under which shares may be repurchased. This repurchase program does not have an expiration date.
Total From
February 2008
Through
June 30, 2023
Shares repurchased69,324,429 
Average purchase price per share$83.71 
Shares repurchased (in $ millions)$5,803 
Aggregate Board of Directors repurchase authorizations during the period (in $ millions)
$6,866 
The purchase of treasury stock reduces the number of shares outstanding. The repurchased shares may be used by the Company for compensation programs utilizing the Company's stock and other corporate purposes. The Company accounts for treasury stock using the cost method and includes treasury stock as a component of shareholders' equity.
The Company did not repurchase any Common Stock during the six months ended June 30, 2023 or 2022.
Other Comprehensive Income (Loss), Net
Three Months Ended June 30,
20232022
Gross
Amount		Income
Tax
(Provision)
Benefit		Net
Amount		Gross
Amount		Income
Tax
(Provision)
Benefit		Net
Amount
(In $ millions)
Foreign currency translation gain (loss)(214)13 (201)(107)(24)(131)
Gain (loss) on cash flow hedges(1)1 — 33 (7)26 
Pension and postretirement benefits gain (loss)— 1 1 — — — 
Total(215)15 (200)(74)(31)(105)
Six Months Ended June 30,
20232022
Gross
Amount		Income
Tax
(Provision)
Benefit		Net
Amount		Gross
Amount		Income
Tax
(Provision)
Benefit		Net
Amount
(In $ millions)
Foreign currency translation gain (loss)(218)30 (188)(122)(30)(152)
Gain (loss) on cash flow hedges3 1 4 52 (11)41 
Pension and postretirement benefits gain (loss)(1)1 — 2 — 2 
Total(216)32 (184)(68)(41)(109)
Adjustments to Accumulated other comprehensive income (loss), net, are as follows:
Foreign
Currency
Translation Gain (Loss)
Gain (Loss)
on Cash
Flow
Hedges
Pension and
Postretirement
Benefits Gain (Loss)
Accumulated
Other
Comprehensive
Income
(Loss), Net
(In $ millions)
As of December 31, 2022(488)(22)(8)(518)
Other comprehensive income (loss) before reclassifications(218)(2)(1)(221)
Amounts reclassified from accumulated other comprehensive income (loss)
— 5 — 5 
Income tax (provision) benefit30 1 1 32 
As of June 30, 2023(676)(18)(8)(702)
XML 32 R18.htm IDEA: XBRL DOCUMENT v3.23.2
Other (Charges) Gains, Net
 6 Months Ended
Jun. 30, 2023
Restructuring and Related Activities [Abstract]  
Other (Charges) Gains, Net Other (Charges) Gains, Net
Three Months Ended
June 30, 		Six Months Ended
June 30,
2023202220232022
(In $ millions)
Restructuring(1)
(10)1 (33)— 
Total(10)1 (33)— 
______________________________
(1)Includes employee termination benefits primarily related to Company-wide business optimization projects during the three and six months ended June 30, 2023.
The changes in the restructuring liabilities by business segment are as follows:
Engineered
Materials		Acetyl
Chain		OtherTotal
(In $ millions)
Employee Termination Benefits
As of December 31, 20224 1 1 6 
Additions29 1 3 33 
Cash payments(14)(1)(3)(18)
As of June 30, 202319 1 1 21 
XML 33 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Income Taxes
 6 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Three Months Ended
June 30, 		Six Months Ended
June 30,
2023202220232022
(In percentages)
Effective income tax rate(2)20 6 19 
The effective income tax rate for the three months ended June 30, 2023 was lower compared to the same period in 2022, primarily due to decreased earnings in high taxed jurisdictions related to current demand conditions and a decrease in valuation allowances on U.S. foreign tax credit carryforwards due to revised forecasts of foreign sourced income and expenses during the carryforward period. The effective income tax rate for the six months ended June 30, 2023 was lower compared to the same period in 2022, primarily due to decreased earnings in high taxed jurisdictions related to current demand conditions.
In December 2017, the Tax Cuts and Jobs Act (the "TCJA") was enacted and was effective January 1, 2018. The U.S. Treasury has issued various final and proposed regulatory packages supplementing the TCJA provisions since 2018. There have been no material proposed or final regulatory packages during the three months ended June 30, 2023.
In August 2022, the Inflation Reduction Act (the "IRA") was enacted and included a 1% excise tax on share repurchases in excess of $1 million, and a corporate minimum tax of 15% on adjusted book earnings. The corporate minimum tax paid is creditable in future years to the extent that regular tax liability exceeds the minimum tax in any given year. The Company does not expect these provisions and any newly issued administrative guidance to have a material impact to future income tax expense. The IRA also provides various beneficial credits for energy efficient related manufacturing, transportation and fuels, hydrogen/carbon recapture and renewable energy, which the Company is evaluating in regards to planned projects.
The Company will continue to monitor the expected impacts of any new guidance on the Company's filing positions and will record the impacts as discrete income tax expense or benefit in the period the guidance is finalized or becomes effective.
Due to the TCJA and uncertainty as to future foreign source income, the Company previously recorded a valuation allowance on a substantial portion of its foreign tax credit carryforwards. The Company is currently evaluating tax planning strategies to enable the use of the Company's foreign tax credit carryforwards that may decrease the Company's effective tax rate in future periods as the valuation allowance is reversed.
The Company's tax returns have been under joint audit for the years 2013 through 2015 by the United States, Netherlands and Germany (the "Authorities"). In September 2021, the Company received a draft joint audit report proposing adjustments to transfer pricing and the reallocation of income between the related jurisdictions. The Authorities also proposed to apply these adjustments to open tax years through 2019. The Company and the Authorities were unable to reach an agreement jointly and therefore the audits continued on a separate jurisdictional basis. In the fourth quarter of 2022, the Company concluded settlement discussions with the Dutch tax authorities. The Company is engaged in discussions with the other authorities regarding the ongoing examinations and will evaluate all additional potential remedies as the discussions progress.
In addition, the Company's income tax returns in Mexico are under audit for the year 2018, and in Canada for the years 2016 through 2018. In January 2022, the Mexico tax authorities issued preliminary findings for disallowance of operating expenses on several of the applicable tax returns. The Company has analyzed the preliminary findings, engaged in preliminary discussions with the Mexico tax authorities and has recorded the appropriate tax reserves as of June 30, 2023. The Company will continue discussions with the Mexico authorities in 2023. Related to Canada, the Company is in ongoing discussions regarding the audit findings with the Canadian authorities and does not expect a material impact to income tax expense.
As of June 30, 2023, the Company believes that an adequate provision for income taxes has been made for all open tax years related to the examinations by government authorities. However, the outcome of tax audits cannot be predicted with certainty. If any issues raised in the audits described above are resolved in a manner inconsistent with the Company's expectations or the Company is unsuccessful in defending its positions, the Company could be required to adjust its provision for income taxes in the period such resolution occurs. If required, any such adjustments could be material to the statements of operations and cash flows in the period(s) recorded.
XML 34 R20.htm IDEA: XBRL DOCUMENT v3.23.2
Derivative Financial Instruments
 6 Months Ended
Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
Derivatives Designated As Hedges
Net Investment Hedges
The total notional amount of foreign currency denominated debt and cross-currency swaps designated as net investment hedges are as follows:
As of
June 30,
2023		As of
December 31,
2022
(In € millions)
Total5,591 5,639 
Concurrently with the offering of the Acquisition USD Notes in July 2022 (Note 7), the Company entered into cross-currency swaps to effectively convert $2.0 billion and $500 million of the Acquisition USD Notes into a euro-denominated borrowing at prevailing euro interest rates, maturing on July 15, 2027 and July 15, 2032, respectively. The swaps and €1.5 billion of the Acquisition Euro Notes qualify and have been designated as net investment hedges of the Company's foreign currency exchange rate exposure on the net investments of certain of its euro-denominated subsidiaries.
Derivatives Not Designated As Hedges
Foreign Currency Forwards and Swaps
Gross notional values of the foreign currency forwards and swaps not designated as hedges are as follows:
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Total1,715 1,314 
Information regarding changes in the fair value of the Company's derivative and non-derivative instruments is as follows:
Gain (Loss) Recognized in Other Comprehensive Income (Loss)Gain (Loss) Recognized in Earnings (Loss)
Three Months Ended June 30, Statement of Operations Classification
2023202220232022
(In $ millions)
Designated as Cash Flow Hedges
Commodity swaps(7)42 — 11 Cost of sales
Interest rate swaps— — (2)(2)Interest expense
Foreign currency forwards2 — (1)— Cost of sales
Total(5)42 (3)9 
Designated as Net Investment Hedges
Foreign currency denominated debt (Note 7)
(5)93 — — N/A
Cross-currency swaps(74)25 — — N/A
Total(79)118 — — 
Not Designated as Hedges
Foreign currency forwards and swaps
— — (1)(3)Foreign exchange gain (loss), net; Other income (expense), net
Total— — (1)(3)
Gain (Loss) Recognized in Other Comprehensive Income (Loss)Gain (Loss) Recognized in Earnings (Loss)
Six Months Ended June 30, Statement of Operations Classification
2023202220232022
(In $ millions)
Designated as Cash Flow Hedges
Commodity swaps(7)59 1 11 Cost of sales
Interest rate swaps— — (4)(4)Interest expense
Foreign currency forwards4 — (2)— Cost of sales
Total(3)59 (5)7 
Designated as Net Investment Hedges
Foreign currency denominated debt (Note 7)
(61)121 — — N/A
Cross-currency swaps(93)27 — — N/A
Total(154)148 — — 
Not Designated as Hedges
Foreign currency forwards and swaps— — 1 (4)Foreign exchange gain (loss), net; Other income (expense), net
Total— — 1 (4)
See Note 13 for additional information regarding the fair value of the Company's derivative instruments.
Certain of the Company's commodity swaps, interest rate swaps, cross-currency swaps and foreign currency forwards and swaps permit the Company to net settle all contracts with the counterparty through a single payment in an agreed upon currency in the event of default or early termination of the contract, similar to a master netting arrangement.
Information regarding the gross amounts of the Company's derivative instruments and the amounts offset in the unaudited consolidated balance sheets is as follows:
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Derivative Assets
Gross amount recognized156 169 
Gross amount offset in the consolidated balance sheets— — 
Net amount presented in the consolidated balance sheets156 169 
Gross amount not offset in the consolidated balance sheets17 16 
Net amount139 153 
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Derivative Liabilities
Gross amount recognized279 189 
Gross amount offset in the consolidated balance sheets— — 
Net amount presented in the consolidated balance sheets279 189 
Gross amount not offset in the consolidated balance sheets17 16 
Net amount262 173 
XML 35 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Measurements
 6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The Company's financial assets and liabilities are measured at fair value on a recurring basis as follows:
Derivative financial instruments include interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps and are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 fair value measurement inputs such as interest rates and foreign currency exchange rates. These market inputs are utilized in the discounted cash flow calculation considering the instrument's term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation for interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps are observable in the active markets and are classified as Level 2 in the fair value measurement hierarchy.
Fair Value Measurement
Significant Other Observable Inputs
(Level 2)		Balance Sheet Classification
(In $ millions)
As of June 30, 2023
Derivatives Designated as Cash Flow Hedges
Commodity swaps6 Current Other assets
Commodity swaps34 Noncurrent Other assets
Foreign currency forwards and swaps4 Current Other assets
Derivatives Designated as Net Investment Hedges
Cross-currency swaps101 Current Other assets
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps11 Current Other assets
Total assets156 
Derivatives Designated as Net Investment Hedges
Cross-currency swaps(60)Current Other liabilities
Cross-currency swaps(207)Noncurrent Other liabilities
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps(4)Current Other liabilities
Foreign currency forwards and swaps(8)Noncurrent Other liabilities
Total liabilities(279)
Fair Value Measurement
Significant Other Observable Inputs
(Level 2)		Balance Sheet Classification
(In $ millions)
As of December 31, 2022
Derivatives Designated as Cash Flow Hedges
Commodity swaps9 Current Other assets
Commodity swaps39 Noncurrent Other assets
Derivatives Designated as Net Investment Hedges
Cross-currency swaps99 Current Other assets
Cross-currency swaps13 Noncurrent Other assets
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps9 Current Other assets
Total assets169 
Derivatives Designated as Cash Flow Hedges
Commodity swaps(2)Current Other liabilities
Derivatives Designated as Net Investment Hedges
Cross-currency swaps(58)Current Other liabilities
Cross-currency swaps(126)Noncurrent Other liabilities
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps(3)Current Other liabilities
Total liabilities(189)
Carrying values and fair values of financial instruments that are not carried at fair value are as follows:
Fair Value Measurement
Carrying
Amount		Significant Other
Observable
Inputs
(Level 2)		Unobservable
Inputs
(Level 3)		Total
(In $ millions)
As of June 30, 2023
Equity investments without readily determinable fair values
170 — — — 
Insurance contracts in nonqualified trusts21 21 — 21 
Long-term debt, including current installments of long-term debt
14,003 13,650 157 13,807 
As of December 31, 2022
Equity investments without readily determinable fair values
170 — — — 
Insurance contracts in nonqualified trusts22 23 — 23 
Long-term debt, including current installments of long-term debt
13,953 13,247 172 13,419 
In general, the equity investments included in the table above are not publicly traded and their fair values are not readily determinable. The Company believes the carrying values approximate fair value. Insurance contracts in nonqualified trusts consist of long-term fixed income securities, which are valued using independent vendor pricing models with observable inputs in the active market and therefore represent a Level 2 fair value measurement. The fair value of long-term debt is based on valuations from third-party banks and market quotations and is classified as Level 2 in the fair value measurement hierarchy. The fair value of obligations under finance leases, which are included in long-term debt, is based on lease payments and discount rates, which are not observable in the market and therefore represents a Level 3 fair value measurement.
As of June 30, 2023, and December 31, 2022, the fair values of cash and cash equivalents, receivables, marketable securities, trade payables, short-term borrowings and the current installments of long-term debt approximate carrying values due to the short-term nature of these instruments. These items have been excluded from the table with the exception of the current installments of long-term debt.
XML 36 R22.htm IDEA: XBRL DOCUMENT v3.23.2
Commitments and Contingencies
 6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Commitments
Guarantees
The Company has agreed to guarantee or indemnify third parties for environmental and other liabilities pursuant to a variety of agreements, including asset and business divestiture agreements, leases, settlement agreements and various agreements with affiliated companies. Although many of these obligations contain monetary and/or time limitations, others do not provide such limitations.
The Company has accrued for all probable and reasonably estimable losses associated with all known matters or claims. These known obligations include the following:
•Demerger Obligations
In connection with the Hoechst demerger, the Company agreed to indemnify Hoechst, and its legal successors, for various liabilities under the demerger agreement, including for environmental liabilities associated with contamination arising either from environmental damage in general ("Category A") or under 19 divestiture agreements entered into by Hoechst prior to the demerger ("Category B") (Note 9).
The Company's obligation to indemnify Hoechst, and its legal successors, is capped under Category B at €250 million. If and to the extent the environmental damage should exceed €750 million in aggregate, the Company's obligation to indemnify Hoechst and its legal successors applies, but is then limited to 33.33% of the remediation cost without further limitations. Cumulative
payments under the divestiture agreements as of June 30, 2023 are $110 million. Though the Company is significantly under its obligation cap under Category B, most of the divestiture agreements have become time barred and/or any notified environmental damage claims have been partially settled.
The Company has also undertaken in the demerger agreement to indemnify Hoechst and its legal successors for (i) 33.33% of any and all Category A liabilities that result from Hoechst being held as the responsible party pursuant to public law or current or future environmental law or by third parties pursuant to private or public law related to contamination and (ii) liabilities that Hoechst is required to discharge, including tax liabilities, which are associated with businesses that were included in the demerger but were not demerged due to legal restrictions on the transfers of such items. These indemnities do not provide for any monetary or time limitations. The Company has not been requested by Hoechst to make any payments in connection with this indemnification. Accordingly, the Company has not made any payments to Hoechst and its legal successors.
Based on the Company's evaluation of currently available information, including the lack of requests for indemnification, the Company cannot estimate the remaining demerger obligations, if any, in excess of amounts accrued.
•Divestiture Obligations
The Company and its predecessor companies agreed to indemnify third-party purchasers of former businesses and assets for various pre-closing conditions, as well as for breaches of representations, warranties and covenants. Such liabilities also include environmental liability, product liability, antitrust and other liabilities. These indemnifications and guarantees represent standard contractual terms associated with typical divestiture agreements and, other than environmental liabilities, the Company does not believe that they expose the Company to significant risk (Note 9).
The Company has divested numerous businesses, investments and facilities through agreements containing indemnifications or guarantees to the purchasers. Many of the obligations contain monetary and/or time limitations, which extend through 2037. The aggregate amount of outstanding indemnifications and guarantees provided for under these agreements is $116 million as of June 30, 2023. Other agreements do not provide for any monetary or time limitations.
Based on the Company's evaluation of currently available information, including the number of requests for indemnification or other payment received by the Company, the Company cannot estimate the remaining divestiture obligations, if any, in excess of amounts accrued.
Purchase Obligations
In the normal course of business, the Company enters into various purchase commitments for goods and services. The Company maintains a number of "take-or-pay" contracts for purchases of raw materials, utilities and other services. Certain of the contracts contain a contract termination buy-out provision that allows for the Company to exit the contracts for amounts less than the remaining take-or-pay obligations. Additionally, the Company has other outstanding commitments representing maintenance and service agreements, energy and utility agreements, consulting contracts and software agreements. As of June 30, 2023, the Company had unconditional purchase obligations of $4.1 billion, of which $355 million will be paid in 2023, $665 million in 2024, $558 million in 2025, $436 million in 2026, $355 million in 2027 and the balance thereafter through 2042.
Contingencies
The Company is involved in legal and regulatory proceedings, lawsuits, claims and investigations incidental to the normal conduct of business, relating to such matters as product liability, land disputes, insurance coverage disputes, contracts, employment, antitrust or competition, intellectual property, personal injury and other actions in tort, workers' compensation, chemical exposure, asbestos exposure, taxes, trade compliance, acquisitions and divestitures, claims of current and legacy shareholders, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where the Company is named as a defendant and, based on the current facts, does not believe the outcomes from these matters would be material to the Company's results of operations, cash flows or financial position.
XML 37 R23.htm IDEA: XBRL DOCUMENT v3.23.2
Segment Information
 6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Segment Information Segment Information
Engineered
Materials		Acetyl
Chain		Other
Activities		EliminationsConsolidated
(In $ millions)
Three Months Ended June 30, 2023
Net sales1,585 1,233 — (23)(1)2,795 
Other (charges) gains, net (Note 18)
(8)— (2)— (10)
Operating profit (loss)158 295 (118)— 335 
Equity in net earnings (loss) of affiliates
18 2 3 — 23 
Depreciation and amortization112 54 6 — 172 
Capital expenditures58 67 27 — 152 (2)
Three Months Ended June 30, 2022
Net sales
948 1,559 — (21)(1)2,486 
Other (charges) gains, net (Note 18)
1 — — — 1 
Operating profit (loss)
166 428 (111)— 483 
Equity in net earnings (loss) of affiliates
53 3 4 — 60 
Depreciation and amortization
45 52 6 — 103 
Capital expenditures
35 87 10 — 132 (2)
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes an increase in accrued capital expenditures of $7 million and $8 million for the three months ended June 30, 2023 and 2022, respectively.
Engineered
Materials		Acetyl
Chain		Other
Activities		EliminationsConsolidated
(In $ millions)
Six Months Ended June 30, 2023
Net sales3,215 2,483 — (50)(1)5,648 
Other (charges) gains, net (Note 18)
(29)(1)(3)— (33)
Operating profit (loss)270 573 (257)— 586 
Equity in net earnings (loss) of affiliates
29 3 6 — 38 
Depreciation and amortization224 108 12 — 344 
Capital expenditures103 118 39 — 260 (2)
As of June 30, 2023
Goodwill and intangible assets, net
10,646 424 — — 11,070 
Total assets
18,146 5,589 1,914 — 25,649 
Six Months Ended June 30, 2022
Net sales
1,858 

3,211 

— (45)(1)5,024 
Operating profit (loss)
290 931 (207)— 1,014 
Equity in net earnings (loss) of affiliates
102 7 7 — 116 
Depreciation and amortization
91 108 10 — 209 
Capital expenditures
65 157 24 — 246 (2)
As of December 31, 2022
Goodwill and intangible assets, net
10,826 421 — — 11,247 
Total assets
20,611 5,471 190 — 26,272 
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes a decrease in accrued capital expenditures of $49 million and $15 million for the six months ended June 30, 2023 and 2022, respectively.
XML 38 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue Recognition
 6 Months Ended
Jun. 30, 2023
Revenue Recognition and Deferred Revenue [Abstract]  
Revenue Recognition Revenue Recognition
The Company has certain contracts that represent take-or-pay revenue arrangements in which the Company's performance obligations extend over multiple years. As of June 30, 2023, the Company had $1.3 billion of remaining performance obligations related to take-or-pay contracts. The Company expects to recognize approximately $272 million of its remaining performance obligations as Net sales in 2023, $481 million in 2024, $324 million in 2025 and the balance thereafter.
Contract Balances
Contract liabilities primarily relate to advances or deposits received from the Company's customers before revenue is recognized. These amounts are recorded as deferred revenue and are included in Current and Noncurrent Other liabilities in the unaudited consolidated balance sheets.
The Company does not have any material contract assets as of June 30, 2023.
Disaggregated Revenue
In general, the Company's business segmentation is aligned according to the nature and economic characteristics of its products and customer relationships and provides meaningful disaggregation of each business segment's results of operations.
The Company manages its Engineered Materials business segment through its project management pipeline, which is comprised of a broad range of projects which are solutions-based and are tailored to each customer's unique needs. Projects are identified and selected based on success rate and may involve a number of different polymers per project for use in multiple end-use applications. Therefore, the Company is agnostic toward products and end-use markets for the Engineered Materials business segment.
The Company manages its Acetyl Chain business segment by leveraging its ability to sell chemicals externally to end-use markets or downstream to its acetate tow, intermediate chemistry, emulsion polymers, redispersible powders and ethylene vinyl acetate polymers businesses. Decisions to sell externally and geographically or downstream and along the Acetyl Chain are based on market demand, trade flows and maximizing the value of its chemicals. Therefore, the Company's strategic focus is on executing within this integrated chain model and less on driving product-specific revenue.
Further disaggregation of Net sales by business segment and geographic destination is as follows:
Three Months Ended
June 30, 		Six Months Ended
June 30,
2023202220232022
(In $ millions)
Engineered Materials
North America471 284 950 573 
Europe and Africa519 380 1,079 757 
Asia-Pacific554 256 1,102 477 
South America41 28 84 51 
Total1,585 948 3,215 1,858 
Acetyl Chain
North America361 451 726 876 
Europe and Africa437 545 897 1,137 
Asia-Pacific379 510 746 1,071 
South America33 32 64 82 
Total(1)
1,210 1,538 2,433 3,166 
______________________________
(1)Excludes intersegment sales of $23 million and $21 million for the three months ended June 30, 2023 and 2022, respectively. Excludes intersegment sales of $50 million and $45 million for the six months ended June 30, 2023 and 2022, respectively.
XML 39 R25.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings (Loss) Per Share
 6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share Earnings (Loss) Per Share
Three Months Ended
June 30, 		Six Months Ended
June 30,
2023202220232022
(In $ millions, except share data)
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations219 440 313 942 
Earnings (loss) from discontinued operations1 (6)(2)(6)
Net earnings (loss)220 434 311 936 
Weighted average shares - basic108,886,678 108,392,155 108,761,071 108,289,603 
Incremental shares attributable to equity awards(1)
419,653 731,194 520,293 868,452 
Weighted average shares - diluted109,306,331 109,123,349 109,281,364 109,158,055 
______________________________
(1)Excludes options to purchase 242,421 and 0 shares of Common Stock for the three months ended June 30, 2023 and 2022, respectively, and 164,739 and 0 shares of Common Stock for the six months ended June 30, 2023 and 2022, respectively, as their effect would have been antidilutive. Excludes 102,773 and 107,287 equity award shares for the three months ended June 30, 2023 and 2022, respectively, and 46,008 and 82,887 equity award shares for the six months ended June 30, 2023 and 2022, respectively, as their effect would have been antidilutive.
XML 40 R26.htm IDEA: XBRL DOCUMENT v3.23.2
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Pay vs Performance Disclosure        
Net earnings (loss) attributable to Celanese Corporation $ 220 $ 434 $ 311 $ 936
XML 41 R27.htm IDEA: XBRL DOCUMENT v3.23.2
Insider Trading Arrangements
 3 Months Ended
Jun. 30, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 42 R28.htm IDEA: XBRL DOCUMENT v3.23.2
Recent Accounting Pronouncements (Policies)
 6 Months Ended
Jun. 30, 2023
Recent Accounting Pronouncements [Abstract]  
Estimates and Assumptions
Estimates and Assumptions
The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of Net sales, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension
and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates.
New Accounting Pronouncements, Policy There are no recent Accounting Standard Updates issued by the Financial Accounting Standards Board which are expected to materially impact the Company's financial position, operating results or financial disclosures.
XML 43 R29.htm IDEA: XBRL DOCUMENT v3.23.2
Acquisitions, Dispositions and Plant Closures Plant Closures (Tables)
 6 Months Ended
Jun. 30, 2023
Plant Closures [Abstract]  
Business Acquisition, Pro Forma Information
Three Months Ended
June 30, 2022		Six Months Ended
June 30, 2022
(In $ millions)
Unaudited Consolidated Pro Forma Results
Proforma Net sales
3,397 6,824 
Proforma Earnings (loss) from continuing operations before tax
285 597 
Disposal Groups, Including Discontinued Operations The assets and liabilities classified as held for sale in the unaudited consolidated balance sheet are as follows:
As of
June 30,
2023
(In $ millions)
Current assets83 
Goodwill80 
Other long-term assets48 
Assets held for sale211 
Other liabilities19 
Liabilities held for sale19 
XML 44 R30.htm IDEA: XBRL DOCUMENT v3.23.2
Inventories (Tables)
 6 Months Ended
Jun. 30, 2023
Inventory Disclosure [Abstract]  
Schedule of Inventories
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Finished goods1,632 1,820 
Work-in-process202 202 
Raw materials and supplies680 786 
Total2,514 2,808 
XML 45 R31.htm IDEA: XBRL DOCUMENT v3.23.2
Goodwill and Intangible Assets, Net (Tables)
 6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
Engineered
Materials		Acetyl ChainTotal
(In $ millions)
As of December 31, 20226,775 367 7,142 
Acquisitions (Note 3)
8 — 8 
Transfer(1)
(80)— (80)
Exchange rate changes(11)4 (7)
As of June 30, 2023(2)
6,692 371 7,063 
______________________________
(1)Related to goodwill reclassified to assets held for sale (Note 3).
(2)There were no accumulated impairment losses as of June 30, 2023.
Schedule of Finite-Lived Intangible Assets
Finite-lived intangible assets are as follows:
LicensesCustomer-
Related
Intangible
Assets		Developed
Technology		Covenants
Not to
Compete
and Other		Total
(In $ millions)
Gross Asset Value
As of December 31, 202242 2,455 601 55 3,153 
Transfer(1)
— (58)(1)— (59)
Exchange rate changes(2)9 (6)— 1 
As of June 30, 202340 2,406 594 55 3,095 
Accumulated Amortization
As of December 31, 2022(39)(567)(50)(40)(696)
Amortization— (63)(20)— (83)
Transfer(1)
— 58 1 — 59 
Exchange rate changes2 (7)(1)— (6)
As of June 30, 2023(37)(579)(70)(40)(726)
Net book value3 1,827 524 15 2,369 
______________________________
(1)Related to finite-lived intangible assets reclassified to assets held for sale (Note 3).
Schedule of Indefinite-Lived Intangible Assets
Indefinite-lived intangible assets are as follows:
Trademarks
and Trade Names
(In $ millions)
As of December 31, 20221,648 
Transfer(1)
(14)
Exchange rate changes4 
As of June 30, 20231,638 
______________________________
(1)Related to indefinite-lived intangible assets reclassified to assets held for sale (Note 3).
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
Estimated amortization expense for the succeeding five fiscal years is as follows:
(In $ millions)
2024160 
2025160 
2026160 
2027160 
2028160 
XML 46 R32.htm IDEA: XBRL DOCUMENT v3.23.2
Current Other Liabilities (Tables)
 6 Months Ended
Jun. 30, 2023
Other Liabilities, Current [Abstract]  
Schedule of Current Other Liabilities
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Benefit obligations (Note 8)
25 25 
Customer rebates88 101 
Derivatives (Note 12)
64 63 
Interest (Note 7)
290 265 
Legal (Note 14)
25 21 
Operating leases89 83 
Restructuring (Note 18)
21 6 
Salaries and benefits132 151 
Sales and use tax/foreign withholding tax payable99 108 
Investment in affiliates87 79 
Other(1)
226 299 
Total1,146 1,201 
____________________________
(1)Includes $115 million and $166 million payable to DuPont related to the M&M Acquisition and transition activities as of June 30, 2023 and December 31, 2022, respectively.
XML 47 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Debt (Tables)
 6 Months Ended
Jun. 30, 2023
Debt Disclosure [Abstract]  
Schedule of Short-term Debt
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates
Current installments of long-term debt1,050 506 
Short-term borrowings, including amounts due to affiliates(1)
250 500 
Revolving credit facilities(2)
207 300 
Total1,507 1,306 
______________________________
(1)The weighted average interest rate was 4.9% and 5.8% as of June 30, 2023 and December 31, 2022, respectively.
(2)The weighted average interest rate was 3.4% and 5.8% as of June 30, 2023 and December 31, 2022, respectively.
Schedule of Long-term Debt
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Long-Term Debt
Senior unsecured notes due 2023, interest rate of 1.125%
489 480 
Senior unsecured notes due 2024, interest rate of 3.500%
500 499 
Senior unsecured notes due 2024, interest rate of 5.900%
2,000 2,000 
Senior unsecured notes due 2025, interest rate of 1.250%
326 320 
Senior unsecured notes due 2025, interest rate of 6.050%
1,750 1,750 
Senior unsecured term loan due 2025, interest rate of 6.760%
750 750 
Senior unsecured notes due 2026, interest rate of 1.400%
400 400 
Senior unsecured notes due 2026, interest rate of 4.777%
1,087 1,067 
Senior unsecured notes due 2027, interest rate of 2.125%
541 531 
Senior unsecured notes due 2027, interest rate of 6.165%
2,000 2,000 
Senior unsecured term loan due 2027, interest rate of 6.760%
1,000 1,000 
Senior unsecured notes due 2028, interest rate of 0.625%
543 533 
Senior unsecured notes due 2029, interest rate of 5.337%
543 533 
Senior unsecured notes due 2029, interest rate of 6.330%
750 750 
Senior unsecured notes due 2032, interest rate of 6.379%
1,000 1,000 
Pollution control and industrial revenue bonds due at various dates through 2030, interest rates ranging from 4.05% to 5.00%
163 164 
Bank loans due at various dates through 2026(1)
4 4 
Obligations under finance leases due at various dates through 2054
157 172 
Subtotal14,003 13,953 
Unamortized debt issuance costs(2)
(64)(74)
Current installments of long-term debt(1,050)(506)
Total12,889 13,373 
______________________________
(1)The weighted average interest rate was 1.3% and 1.3% as of June 30, 2023 and December 31, 2022, respectively.
(2)Related to the Company's long-term debt, excluding obligations under finance leases.
Schedule of Balances Available for Borrowing The Company's debt balances and amounts available for borrowing under its senior unsecured revolving credit facilities are as follows:
As of
June 30,
2023
(In $ millions)
U.S. Revolving Credit Facility
Borrowings outstanding— 
Available for borrowing1,750 
China Revolving Credit Facility
Borrowings outstanding207 
Available for borrowing34 
XML 48 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Benefit Obligations (Tables)
 6 Months Ended
Jun. 30, 2023
Retirement Benefits [Abstract]  
Schedule of Net Periodic Benefit Costs Recognized
The components of net periodic benefit cost are as follows:
Three Months Ended June 30, Six Months Ended June 30,
2023202220232022
Pension
Benefits		Post-retirement
Benefits		Pension
Benefits		Post-retirement
Benefits		Pension
Benefits		Post-retirement
Benefits		Pension
Benefits		Post-retirement
Benefits
(In $ millions)
Service cost2 — 4 — 6 — 7 — 
Interest cost34 1 16 1 66 1 33 1 
Expected return on plan assets
(33)— (42)— (66)— (83)— 
Total3 1 (22)1 6 1 (43)1 
Schedule of Company Commitments to Fund Benefit Obligations
Benefit obligation funding is as follows:
As of
June 30,
2023
Total
Expected
2023
(In $ millions)
Cash contributions to defined benefit pension plans13 27 
Benefit payments to nonqualified pension plans9 18 
Benefit payments to other postretirement benefit plans2 4 
Schedule of Defined Benefit Plans Disclosures
Pension and postretirement benefit plan balances recognized in the unaudited consolidated balance sheets consist of the following:
As of June 30, 2023As of December 31, 2022
Pension
Benefits		Post-retirement
Benefits		Pension
Benefits		Post-retirement
Benefits
(In $ millions)
Noncurrent Other assets164 — 160 — 
Current Other liabilities(21)(3)(21)(3)
Benefit obligations(366)(35)(372)(35)
Net amount recognized(223)(38)(233)(38)
XML 49 R35.htm IDEA: XBRL DOCUMENT v3.23.2
Environmental (Tables)
 6 Months Ended
Jun. 30, 2023
Environmental Remediation Obligations [Abstract]  
Schedule of Environmental Remediation Reserves
The components of environmental remediation liabilities are as follows:
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Demerger obligations (Note 14)
18 20 
Divestiture obligations (Note 14)
13 14 
Active sites20 21 
U.S. Superfund sites8 10 
Other environmental remediation liabilities2 2 
Total61 67 
XML 50 R36.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2023
Stockholders' Equity Note [Abstract]  
Schedule of Treasury Stock
Total From
February 2008
Through
June 30, 2023
Shares repurchased69,324,429 
Average purchase price per share$83.71 
Shares repurchased (in $ millions)$5,803 
Aggregate Board of Directors repurchase authorizations during the period (in $ millions)
$6,866 
Schedule of Components of Other Comprehensive Income (Loss), Net
Three Months Ended June 30,
20232022
Gross
Amount		Income
Tax
(Provision)
Benefit		Net
Amount		Gross
Amount		Income
Tax
(Provision)
Benefit		Net
Amount
(In $ millions)
Foreign currency translation gain (loss)(214)13 (201)(107)(24)(131)
Gain (loss) on cash flow hedges(1)1 — 33 (7)26 
Pension and postretirement benefits gain (loss)— 1 1 — — — 
Total(215)15 (200)(74)(31)(105)
Six Months Ended June 30,
20232022
Gross
Amount		Income
Tax
(Provision)
Benefit		Net
Amount		Gross
Amount		Income
Tax
(Provision)
Benefit		Net
Amount
(In $ millions)
Foreign currency translation gain (loss)(218)30 (188)(122)(30)(152)
Gain (loss) on cash flow hedges3 1 4 52 (11)41 
Pension and postretirement benefits gain (loss)(1)1 — 2 — 2 
Total(216)32 (184)(68)(41)(109)
Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net
Adjustments to Accumulated other comprehensive income (loss), net, are as follows:
Foreign
Currency
Translation Gain (Loss)
Gain (Loss)
on Cash
Flow
Hedges
Pension and
Postretirement
Benefits Gain (Loss)
Accumulated
Other
Comprehensive
Income
(Loss), Net
(In $ millions)
As of December 31, 2022(488)(22)(8)(518)
Other comprehensive income (loss) before reclassifications(218)(2)(1)(221)
Amounts reclassified from accumulated other comprehensive income (loss)
— 5 — 5 
Income tax (provision) benefit30 1 1 32 
As of June 30, 2023(676)(18)(8)(702)
XML 51 R37.htm IDEA: XBRL DOCUMENT v3.23.2
Other (Charges) Gains, Net (Tables)
 6 Months Ended
Jun. 30, 2023
Restructuring and Related Activities [Abstract]  
Schedule of Other (Charges) Gains, Net
Three Months Ended
June 30, 		Six Months Ended
June 30,
2023202220232022
(In $ millions)
Restructuring(1)
(10)1 (33)— 
Total(10)1 (33)— 
Schedule of Restructuring Reserve by Type of Cost
The changes in the restructuring liabilities by business segment are as follows:
Engineered
Materials		Acetyl
Chain		OtherTotal
(In $ millions)
Employee Termination Benefits
As of December 31, 20224 1 1 6 
Additions29 1 3 33 
Cash payments(14)(1)(3)(18)
As of June 30, 202319 1 1 21 
XML 52 R38.htm IDEA: XBRL DOCUMENT v3.23.2
Income Taxes (Tables)
 6 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
Schedule of Effective Tax Rate
Three Months Ended
June 30, 		Six Months Ended
June 30,
2023202220232022
(In percentages)
Effective income tax rate(2)20 6 19 
XML 53 R39.htm IDEA: XBRL DOCUMENT v3.23.2
Derivative Financial Instruments (Tables)
 6 Months Ended
Jun. 30, 2023
Derivative [Line Items]  
Schedule of Changes in Fair Value of Derivatives
Information regarding changes in the fair value of the Company's derivative and non-derivative instruments is as follows:
Gain (Loss) Recognized in Other Comprehensive Income (Loss)Gain (Loss) Recognized in Earnings (Loss)
Three Months Ended June 30, Statement of Operations Classification
2023202220232022
(In $ millions)
Designated as Cash Flow Hedges
Commodity swaps(7)42 — 11 Cost of sales
Interest rate swaps— — (2)(2)Interest expense
Foreign currency forwards2 — (1)— Cost of sales
Total(5)42 (3)9 
Designated as Net Investment Hedges
Foreign currency denominated debt (Note 7)
(5)93 — — N/A
Cross-currency swaps(74)25 — — N/A
Total(79)118 — — 
Not Designated as Hedges
Foreign currency forwards and swaps
— — (1)(3)Foreign exchange gain (loss), net; Other income (expense), net
Total— — (1)(3)
Gain (Loss) Recognized in Other Comprehensive Income (Loss)Gain (Loss) Recognized in Earnings (Loss)
Six Months Ended June 30, Statement of Operations Classification
2023202220232022
(In $ millions)
Designated as Cash Flow Hedges
Commodity swaps(7)59 1 11 Cost of sales
Interest rate swaps— — (4)(4)Interest expense
Foreign currency forwards4 — (2)— Cost of sales
Total(3)59 (5)7 
Designated as Net Investment Hedges
Foreign currency denominated debt (Note 7)
(61)121 — — N/A
Cross-currency swaps(93)27 — — N/A
Total(154)148 — — 
Not Designated as Hedges
Foreign currency forwards and swaps— — 1 (4)Foreign exchange gain (loss), net; Other income (expense), net
Total— — 1 (4)
Offsetting Assets
Information regarding the gross amounts of the Company's derivative instruments and the amounts offset in the unaudited consolidated balance sheets is as follows:
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Derivative Assets
Gross amount recognized156 169 
Gross amount offset in the consolidated balance sheets— — 
Net amount presented in the consolidated balance sheets156 169 
Gross amount not offset in the consolidated balance sheets17 16 
Net amount139 153 
Offsetting Liabilities
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Derivative Liabilities
Gross amount recognized279 189 
Gross amount offset in the consolidated balance sheets— — 
Net amount presented in the consolidated balance sheets279 189 
Gross amount not offset in the consolidated balance sheets17 16 
Net amount262 173 
Net Investment Hedging [Member]  
Derivative [Line Items]  
Schedule of Notional Amounts of Derivative and Nonderivative Instruments
The total notional amount of foreign currency denominated debt and cross-currency swaps designated as net investment hedges are as follows:
As of
June 30,
2023		As of
December 31,
2022
(In € millions)
Total5,591 5,639 
Not Designated as Hedging Instrument  
Derivative [Line Items]  
Schedule of Notional Amounts of Derivative and Nonderivative Instruments
Gross notional values of the foreign currency forwards and swaps not designated as hedges are as follows:
As of
June 30,
2023		As of
December 31,
2022
(In $ millions)
Total1,715 1,314 
XML 54 R40.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Measurements (Tables)
 6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis
Fair Value Measurement
Significant Other Observable Inputs
(Level 2)		Balance Sheet Classification
(In $ millions)
As of June 30, 2023
Derivatives Designated as Cash Flow Hedges
Commodity swaps6 Current Other assets
Commodity swaps34 Noncurrent Other assets
Foreign currency forwards and swaps4 Current Other assets
Derivatives Designated as Net Investment Hedges
Cross-currency swaps101 Current Other assets
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps11 Current Other assets
Total assets156 
Derivatives Designated as Net Investment Hedges
Cross-currency swaps(60)Current Other liabilities
Cross-currency swaps(207)Noncurrent Other liabilities
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps(4)Current Other liabilities
Foreign currency forwards and swaps(8)Noncurrent Other liabilities
Total liabilities(279)
Fair Value Measurement
Significant Other Observable Inputs
(Level 2)		Balance Sheet Classification
(In $ millions)
As of December 31, 2022
Derivatives Designated as Cash Flow Hedges
Commodity swaps9 Current Other assets
Commodity swaps39 Noncurrent Other assets
Derivatives Designated as Net Investment Hedges
Cross-currency swaps99 Current Other assets
Cross-currency swaps13 Noncurrent Other assets
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps9 Current Other assets
Total assets169 
Derivatives Designated as Cash Flow Hedges
Commodity swaps(2)Current Other liabilities
Derivatives Designated as Net Investment Hedges
Cross-currency swaps(58)Current Other liabilities
Cross-currency swaps(126)Noncurrent Other liabilities
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps(3)Current Other liabilities
Total liabilities(189)
Schedule of Carrying Values and Fair Values of Financial Instruments
Carrying values and fair values of financial instruments that are not carried at fair value are as follows:
Fair Value Measurement
Carrying
Amount		Significant Other
Observable
Inputs
(Level 2)		Unobservable
Inputs
(Level 3)		Total
(In $ millions)
As of June 30, 2023
Equity investments without readily determinable fair values
170 — — — 
Insurance contracts in nonqualified trusts21 21 — 21 
Long-term debt, including current installments of long-term debt
14,003 13,650 157 13,807 
As of December 31, 2022
Equity investments without readily determinable fair values
170 — — — 
Insurance contracts in nonqualified trusts22 23 — 23 
Long-term debt, including current installments of long-term debt
13,953 13,247 172 13,419 
XML 55 R41.htm IDEA: XBRL DOCUMENT v3.23.2
Segment Information (Tables)
 6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Schedule of Business Segments
Engineered
Materials		Acetyl
Chain		Other
Activities		EliminationsConsolidated
(In $ millions)
Three Months Ended June 30, 2023
Net sales1,585 1,233 — (23)(1)2,795 
Other (charges) gains, net (Note 18)
(8)— (2)— (10)
Operating profit (loss)158 295 (118)— 335 
Equity in net earnings (loss) of affiliates
18 2 3 — 23 
Depreciation and amortization112 54 6 — 172 
Capital expenditures58 67 27 — 152 (2)
Three Months Ended June 30, 2022
Net sales
948 1,559 — (21)(1)2,486 
Other (charges) gains, net (Note 18)
1 — — — 1 
Operating profit (loss)
166 428 (111)— 483 
Equity in net earnings (loss) of affiliates
53 3 4 — 60 
Depreciation and amortization
45 52 6 — 103 
Capital expenditures
35 87 10 — 132 (2)
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes an increase in accrued capital expenditures of $7 million and $8 million for the three months ended June 30, 2023 and 2022, respectively.
Engineered
Materials		Acetyl
Chain		Other
Activities		EliminationsConsolidated
(In $ millions)
Six Months Ended June 30, 2023
Net sales3,215 2,483 — (50)(1)5,648 
Other (charges) gains, net (Note 18)
(29)(1)(3)— (33)
Operating profit (loss)270 573 (257)— 586 
Equity in net earnings (loss) of affiliates
29 3 6 — 38 
Depreciation and amortization224 108 12 — 344 
Capital expenditures103 118 39 — 260 (2)
As of June 30, 2023
Goodwill and intangible assets, net
10,646 424 — — 11,070 
Total assets
18,146 5,589 1,914 — 25,649 
Six Months Ended June 30, 2022
Net sales
1,858 

3,211 

— (45)(1)5,024 
Operating profit (loss)
290 931 (207)— 1,014 
Equity in net earnings (loss) of affiliates
102 7 7 — 116 
Depreciation and amortization
91 108 10 — 209 
Capital expenditures
65 157 24 — 246 (2)
As of December 31, 2022
Goodwill and intangible assets, net
10,826 421 — — 11,247 
Total assets
20,611 5,471 190 — 26,272 
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes a decrease in accrued capital expenditures of $49 million and $15 million for the six months ended June 30, 2023 and 2022, respectively.
XML 56 R42.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue Recognition (Tables)
 6 Months Ended
Jun. 30, 2023
Revenue Recognition and Deferred Revenue [Abstract]  
Schedule of Revenue by Major Customers by Reporting Segments
Further disaggregation of Net sales by business segment and geographic destination is as follows:
Three Months Ended
June 30, 		Six Months Ended
June 30,
2023202220232022
(In $ millions)
Engineered Materials
North America471 284 950 573 
Europe and Africa519 380 1,079 757 
Asia-Pacific554 256 1,102 477 
South America41 28 84 51 
Total1,585 948 3,215 1,858 
Acetyl Chain
North America361 451 726 876 
Europe and Africa437 545 897 1,137 
Asia-Pacific379 510 746 1,071 
South America33 32 64 82 
Total(1)
1,210 1,538 2,433 3,166 
______________________________
(1)Excludes intersegment sales of $23 million and $21 million for the three months ended June 30, 2023 and 2022, respectively. Excludes intersegment sales of $50 million and $45 million for the six months ended June 30, 2023 and 2022, respectively.
XML 57 R43.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings (Loss) Per Share (Tables)
 6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings (Loss) Per Share
Three Months Ended
June 30, 		Six Months Ended
June 30,
2023202220232022
(In $ millions, except share data)
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations219 440 313 942 
Earnings (loss) from discontinued operations1 (6)(2)(6)
Net earnings (loss)220 434 311 936 
Weighted average shares - basic108,886,678 108,392,155 108,761,071 108,289,603 
Incremental shares attributable to equity awards(1)
419,653 731,194 520,293 868,452 
Weighted average shares - diluted109,306,331 109,123,349 109,281,364 109,158,055 
______________________________
(1)Excludes options to purchase 242,421 and 0 shares of Common Stock for the three months ended June 30, 2023 and 2022, respectively, and 164,739 and 0 shares of Common Stock for the six months ended June 30, 2023 and 2022, respectively, as their effect would have been antidilutive. Excludes 102,773 and 107,287 equity award shares for the three months ended June 30, 2023 and 2022, respectively, and 46,008 and 82,887 equity award shares for the six months ended June 30, 2023 and 2022, respectively, as their effect would have been antidilutive.
XML 58 R44.htm IDEA: XBRL DOCUMENT v3.23.2
Description of the Company and Basis of Presentation (Narrative) (Details)
Jun. 30, 2023
Consolidated Ventures  
Variable Interest Entity [Line Items]  
Noncontrolling interest, ownership percentage by parent 100.00%
XML 59 R45.htm IDEA: XBRL DOCUMENT v3.23.2
Acquisitions, Dispositions and Plant Closures Plant Closures - Narrative (Details)
€ in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 22, 2023
USD ($)
Nov. 01, 2022
USD ($)
employees
facility
patent
Apr. 01, 2022
USD ($)
annualInstallment
Apr. 01, 2022
EUR (€)
annualInstallment
Jun. 30, 2022
USD ($)
Jun. 30, 2022
USD ($)
Korea Engineering Plastics Co., Ltd.            
Restructuring Cost and Reserve [Line Items]            
Payments to equity method investment     $ 5 € 24    
Number of equal annual investments restructuring payment | annualInstallment     5 5    
Equity method investment, increase     $ 134      
Celanese Corporation | Nutrinova Joint Venture            
Restructuring Cost and Reserve [Line Items]            
Equity method investment, ownership percentage 30.00%          
Celanese Corporation | Korea Engineering Plastics Co., Ltd.            
Restructuring Cost and Reserve [Line Items]            
Equity method investment, ownership percentage     50.00% 50.00%    
Mitsui & Co. Ltd. | Nutrinova Joint Venture            
Restructuring Cost and Reserve [Line Items]            
Equity method investment, ownership percentage 70.00%          
Expected Proceeds from Sale of Interest in Joint Venture $ 473          
Mitsubishi Gas Chemical Company | Korea Engineering Plastics Co., Ltd.            
Restructuring Cost and Reserve [Line Items]            
Equity method investment, ownership percentage     50.00% 50.00%    
Mobility & Materials            
Restructuring Cost and Reserve [Line Items]            
Business Acquisition, Percentage of Voting Interests Acquired   100.00%        
Payments to acquire businesses, gross   $ 11,000        
Number of facilities | facility   29        
Number of patents | patent   850        
Entity number of employees | employees   5,000        
Business Combination, Pro Forma Information, Interest Expense and Debt Issuance Cost Amortization         $ 171 $ 343
Business Combination, Pro Forma Information, Inventory Step Up Amortization         $ 33 $ 131
XML 60 R46.htm IDEA: XBRL DOCUMENT v3.23.2
Acquisitions, Dispositions and Plant Closures - Business Acquisition, Pro Forma Information (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2022
Restructuring and Related Activities [Abstract]    
Proforma Net sales $ 3,397 $ 6,824
Proforma Earnings (loss) from continuing operations before tax $ 285 $ 597
XML 61 R47.htm IDEA: XBRL DOCUMENT v3.23.2
Acquisitions, Dispositions and Plant Closures - Disposal Groups, Including Discontinued Operations (Details) - Disposal Group, Held-for-Sale, Not Discontinued Operations - Food Ingredients
$ in Millions
Jun. 30, 2023
USD ($)
Restructuring Cost and Reserve [Line Items]  
Disposal Group, Including Discontinued Operation, Other Assets $ 83
Disposal Group, Including Discontinued Operation, Goodwill 80
Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent 48
Disposal Group, Including Discontinued Operation, Assets 211
Disposal Group, Including Discontinued Operation, Other Liabilities 19
Disposal Group, Including Discontinued Operation, Liabilities $ 19
XML 62 R48.htm IDEA: XBRL DOCUMENT v3.23.2
Inventories - Schedule of Inventories (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Finished goods $ 1,632 $ 1,820
Work-in-process 202 202
Raw materials and supplies 680 786
Total $ 2,514 $ 2,808
XML 63 R49.htm IDEA: XBRL DOCUMENT v3.23.2
Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details)
$ in Millions
 6 Months Ended
Jun. 30, 2023
USD ($)
Goodwill [Line Items]  
As of December 31, 2022 $ 7,142
Acquisitions (Note 3) 8
Goodwill, Transfers (80) [1]
Exchange rate changes (7)
As of June 30, 2023(2) 7,063 [2]
Goodwill, impaired, accumulated impairment loss 0
Engineered Materials  
Goodwill [Line Items]  
As of December 31, 2022 6,775
Acquisitions (Note 3) 8
Goodwill, Transfers (80) [1]
Exchange rate changes (11)
As of June 30, 2023(2) 6,692 [2]
Acetyl Chain  
Goodwill [Line Items]  
As of December 31, 2022 367
Acquisitions (Note 3) 0
Goodwill, Transfers 0 [1]
Exchange rate changes 4
As of June 30, 2023(2) $ 371 [2]
[1] Related to goodwill reclassified to assets held for sale (Note 3).
[2] There were no accumulated impairment losses as of June 30, 2023.
XML 64 R50.htm IDEA: XBRL DOCUMENT v3.23.2
Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Finite-Lived Intangible Assets [Line Items]        
As of December 31, 2022     $ 3,153  
Transfer(1) [1]     59  
Exchange rate changes     1  
As of June 30, 2023 $ 3,095   3,095  
As of December 31, 2022     (696)  
Amortization (42) $ (11) (83) $ (22)
Finite-Lived Intangible Assets, Transferred, Accumulated Amortization [1]     (59)  
Exchange rate changes     (6)  
As of June 30, 2023 (726)   (726)  
Net book value 2,369   2,369  
Finite-Lived Intangible Assets, Cost Incurred to Renew or Extend     0  
Licenses        
Finite-Lived Intangible Assets [Line Items]        
As of December 31, 2022     42  
Transfer(1) [1]     0  
Exchange rate changes     (2)  
As of June 30, 2023 40   40  
As of December 31, 2022     (39)  
Amortization     0  
Finite-Lived Intangible Assets, Transferred, Accumulated Amortization [1]     0  
Exchange rate changes     2  
As of June 30, 2023 (37)   (37)  
Net book value 3   3  
Customer- Related Intangible Assets        
Finite-Lived Intangible Assets [Line Items]        
As of December 31, 2022     2,455  
Transfer(1) [1]     58  
Exchange rate changes     9  
As of June 30, 2023 2,406   2,406  
As of December 31, 2022     (567)  
Amortization     (63)  
Finite-Lived Intangible Assets, Transferred, Accumulated Amortization [1]     (58)  
Exchange rate changes     (7)  
As of June 30, 2023 (579)   (579)  
Net book value 1,827   1,827  
Developed Technology        
Finite-Lived Intangible Assets [Line Items]        
As of December 31, 2022     601  
Transfer(1) [1]     1  
Exchange rate changes     (6)  
As of June 30, 2023 594   594  
As of December 31, 2022     (50)  
Amortization     (20)  
Finite-Lived Intangible Assets, Transferred, Accumulated Amortization [1]     (1)  
Exchange rate changes     (1)  
As of June 30, 2023 (70)   (70)  
Net book value 524   524  
Covenants Not to Compete and Other        
Finite-Lived Intangible Assets [Line Items]        
As of December 31, 2022     55  
Transfer(1) [1]     0  
Exchange rate changes     0  
As of June 30, 2023 55   55  
As of December 31, 2022     (40)  
Amortization     0  
Finite-Lived Intangible Assets, Transferred, Accumulated Amortization [1]     0  
Exchange rate changes     0  
As of June 30, 2023 (40)   (40)  
Net book value $ 15   $ 15  
[1] Related to finite-lived intangible assets reclassified to assets held for sale (Note 3).
XML 65 R51.htm IDEA: XBRL DOCUMENT v3.23.2
Goodwill and Intangible Assets, Net - Schedule of Indefinite-Lived Intangible Assets (Details) - Trademarks and Trade Names
$ in Millions
 6 Months Ended
Jun. 30, 2023
USD ($)
Indefinite-lived Intangible Assets [Line Items]  
As of December 31, 2022 $ 1,648
Indefinite-Lived Intangible Assets, Transferred (14) [1]
Exchange rate changes 4
As of June 30, 2023 $ 1,638
[1] Related to indefinite-lived intangible assets reclassified to assets held for sale (Note 3).
XML 66 R52.htm IDEA: XBRL DOCUMENT v3.23.2
Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)
$ in Millions
Jun. 30, 2023
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2024 $ 160
2025 160
2026 160
2027 160
2028 $ 160
XML 67 R53.htm IDEA: XBRL DOCUMENT v3.23.2
Current Other Liabilities (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Current Other Liabilities [Line Items]    
Benefit obligations (Note 8) $ 25 $ 25
Customer rebates 88 101
Derivatives (Note 12) 64 63
Interest (Note 7) 290 265
Legal (Note 14) 25 21
Operating leases 89 83
Restructuring (Note 18) 21 6
Salaries and benefits 132 151
Sales and use tax/foreign withholding tax payable 99 108
Investment in affiliates 87 79
Other Sundry Liabilities, Current [1] 226 299
Total 1,146 1,201
Mobility & Materials    
Current Other Liabilities [Line Items]    
Other Sundry Liabilities, Current $ 115 $ 166
[1] Includes $115 million and $166 million payable to DuPont related to the M&M Acquisition and transition activities as of June 30, 2023 and December 31, 2022, respectively.
XML 68 R54.htm IDEA: XBRL DOCUMENT v3.23.2
Debt - Schedule of Short-term Debt (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates    
Current installments of long-term debt $ 1,050 $ 506
Short-term borrowings, including amounts due to affiliates(1) [1] 250 500
Total $ 1,507 $ 1,306
Loans Payable    
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates    
Weighted average interest rate, short-term borrowings 4.90% 5.80%
Revolving Credit Facility    
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates    
Weighted average interest rate, short-term borrowings 3.40% 5.80%
Revolving Credit Facility    
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates    
Revolving credit facilities(2) [2] $ 207 $ 300
Revolving Credit Facility | Revolving Credit Facility    
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates    
Revolving credit facilities(2) $ 0  
[1] The weighted average interest rate was 4.9% and 5.8% as of June 30, 2023 and December 31, 2022, respectively.
[2] The weighted average interest rate was 3.4% and 5.8% as of June 30, 2023 and December 31, 2022, respectively.
XML 69 R55.htm IDEA: XBRL DOCUMENT v3.23.2
Debt - Schedule of Long-term Debt (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Total debt $ 157 $ 172
Subtotal 14,003 13,953
Unamortized debt issuance costs [1] (64) (74)
Long-Term Debt and Lease Obligation, Current (1,050) (506)
Total 12,889 13,373
Senior Unsecured Notes Due 2023    
Debt Instrument [Line Items]    
Senior unsecured debt $ 489 480
Debt Instrument, Interest Rate, Stated Percentage 1.125%  
Senior Unsecured Notes Due 2024    
Debt Instrument [Line Items]    
Senior unsecured debt $ 500 499
Debt Instrument, Interest Rate, Stated Percentage 3.50%  
Acquisition Notes Due July 2024    
Debt Instrument [Line Items]    
Senior unsecured debt $ 2,000 2,000
Debt Instrument, Interest Rate, Stated Percentage 5.90%  
Senior Unsecured Notes Due 2025    
Debt Instrument [Line Items]    
Senior unsecured debt $ 326 320
Debt Instrument, Interest Rate, Stated Percentage 1.25%  
Acquisition Notes Due March 2025    
Debt Instrument [Line Items]    
Senior unsecured debt $ 1,750 1,750
Debt Instrument, Interest Rate, Stated Percentage 6.05%  
Senior Unsecured Term Loan Due 2025    
Debt Instrument [Line Items]    
Senior unsecured debt $ 750 750
Debt Instrument, Interest Rate, Stated Percentage 6.76%  
Senior Unsecured Notes Due 2026    
Debt Instrument [Line Items]    
Senior unsecured debt $ 400 400
Debt Instrument, Interest Rate, Stated Percentage 1.40%  
EUR Senior Unsecured Notes Due 2026    
Debt Instrument [Line Items]    
Senior unsecured debt $ 1,087 1,067
Debt Instrument, Interest Rate, Stated Percentage 4.777%  
Senior Unsecured Notes Due 2027    
Debt Instrument [Line Items]    
Senior unsecured debt $ 541 531
Debt Instrument, Interest Rate, Stated Percentage 2.125%  
USD Senior Unsecured Notes Due 2027    
Debt Instrument [Line Items]    
Senior unsecured debt $ 2,000 2,000
Debt Instrument, Interest Rate, Stated Percentage 6.165%  
Senior Unsecured Term Loan Due 2027    
Debt Instrument [Line Items]    
Senior unsecured debt $ 1,000 1,000
Debt Instrument, Interest Rate, Stated Percentage 6.76%  
Senior Unsecured Notes Due 2028    
Debt Instrument [Line Items]    
Senior unsecured debt $ 543 533
Debt Instrument, Interest Rate, Stated Percentage 0.625%  
EUR Senior Unsecured Notes Due 2029    
Debt Instrument [Line Items]    
Senior unsecured debt $ 543 533
Debt Instrument, Interest Rate, Stated Percentage 5.337%  
Acquisition Notes Due July 2029    
Debt Instrument [Line Items]    
Senior unsecured debt $ 750 750
Debt Instrument, Interest Rate, Stated Percentage 6.33%  
USD Senior Unsecured Notes Due 2032    
Debt Instrument [Line Items]    
Senior unsecured debt $ 1,000 1,000
Debt Instrument, Interest Rate, Stated Percentage 6.379%  
Refunding loan for pollution control and industrial revenue bonds    
Debt Instrument [Line Items]    
Other long-term debt $ 163 164
Refunding loan for pollution control and industrial revenue bonds | Minimum    
Debt Instrument [Line Items]    
Debt Instrument, Interest Rate, Stated Percentage 4.05%  
Refunding loan for pollution control and industrial revenue bonds | Maximum    
Debt Instrument [Line Items]    
Debt Instrument, Interest Rate, Stated Percentage 5.00%  
Loans Payable    
Debt Instrument [Line Items]    
Other long-term debt [2] $ 4 $ 4
Long-term debt, weighted average interest rate, at point in time 1.30% 1.30%
[1] Related to the Company's long-term debt, excluding obligations under finance leases.
[2] The weighted average interest rate was 1.3% and 1.3% as of June 30, 2023 and December 31, 2022, respectively.
XML 70 R56.htm IDEA: XBRL DOCUMENT v3.23.2
Debt - Senior Credit Facilities Narrative (Details)
¥ in Millions, $ in Millions
Jan. 06, 2023
CNY (¥)
Sep. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
Jan. 04, 2023
CNY (¥)
364 Day Delayed-Draw Term Loan | Term Loan Facility        
Debt Instrument [Line Items]        
Debt instrument, term     364 days  
Debt instrument, face amount     $ 500  
5 Year Delayed-Draw Term Loan | Term Loan Facility        
Debt Instrument [Line Items]        
Debt instrument, term     5 years  
Debt instrument, face amount     $ 1,000  
3 Year Delayed-Draw Term Loan | Term Loan Facility        
Debt Instrument [Line Items]        
Debt instrument, term   3 years    
Debt instrument, face amount   $ 750    
Revolving Credit Facility | Revolving Credit Facility        
Debt Instrument [Line Items]        
Maximum borrowing base     $ 1,750  
China Revolving Credit Facility | Revolving Credit Facility        
Debt Instrument [Line Items]        
Maximum borrowing base | ¥       ¥ 1,750
China Working Capital Term Loan | China Working Capital Term Loan        
Debt Instrument [Line Items]        
Debt instrument, term 12 months      
Debt instrument, face amount | ¥ ¥ 800      
China Working Capital Term Loan | China Working Capital Term Loan | Variable Interbank Interest Rate        
Debt Instrument [Line Items]        
Debt instrument, basis spread on variable rate 0.50%      
XML 71 R57.htm IDEA: XBRL DOCUMENT v3.23.2
Debt - Schedule of Revolving Credit Facility (Details) - Revolving Credit Facility - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Line of Credit Facility [Line Items]    
Revolving credit facilities(2) [1] $ 207 $ 300
Revolving Credit Facility    
Line of Credit Facility [Line Items]    
Revolving credit facilities(2) 0  
Available for borrowing 1,750  
China Revolving Credit Facility    
Line of Credit Facility [Line Items]    
Revolving credit facilities(2) 207  
Available for borrowing $ 34  
[1] The weighted average interest rate was 3.4% and 5.8% as of June 30, 2023 and December 31, 2022, respectively.
XML 72 R58.htm IDEA: XBRL DOCUMENT v3.23.2
Debt - Senior Notes Narrative (Details)
$ in Millions, € in Billions
 6 Months Ended
Jul. 31, 2022
USD ($)
Jun. 30, 2023
Jul. 31, 2022
EUR (€)
Debt Instrument [Line Items]      
Debt instrument, redemption price, percentage   100.00%  
Acquisition Notes      
Debt Instrument [Line Items]      
Debt instrument, face amount $ 7,500   € 1.5
Notes offering related costs $ 65    
XML 73 R59.htm IDEA: XBRL DOCUMENT v3.23.2
Debt - Accounts Receivable Securitization Facility Narrative (Details) - USD ($)
$ in Millions
 6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Amended restated receivable securitization facility | Secured Debt    
Line of Credit Facility [Line Items]    
Percentage of fair value of sales receivables 100.00%  
Secured Debt | Amended restated receivable securitization facility    
Line of Credit Facility [Line Items]    
Transfer of financial assets accounted for as sales, amount derecognized $ 663 $ 1,100
Proceeds collected on accounts receivable sold under factoring facilities 565 $ 1,100
Cash flows between transferor and transferee, proceeds from new transfers $ 86  
XML 74 R60.htm IDEA: XBRL DOCUMENT v3.23.2
Debt - Factoring and Discounting Agreements Narrative (Details) - USD ($)
$ in Millions
 6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Europe Factoring Agreements    
Debt Instrument [Line Items]    
Transfer of financial assets accounted for as sales, non-recourse basis, account receivable percentage 100.00%  
Singapore Factoring Agreements    
Debt Instrument [Line Items]    
Transfer of financial assets accounted for as sales, non-recourse basis, account receivable percentage 90.00%  
Europe and Singapore Factoring Agreement    
Debt Instrument [Line Items]    
Transfer of financial assets accounted for as sales, amount derecognized $ 196 $ 320
Proceeds collected on accounts receivable sold under factoring facilities $ 189 $ 325
XML 75 R61.htm IDEA: XBRL DOCUMENT v3.23.2
Benefit Obligations - Schedule of Net Periodic Benefit Costs Recognized (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Pension Benefits        
Defined Benefit Plan Disclosure [Line Items]        
Service cost $ 2 $ 4 $ 6 $ 7
Interest cost 34 16 66 33
Expected return on plan assets (33) (42) (66) (83)
Total 3 (22) 6 (43)
Post-retirement Benefits        
Defined Benefit Plan Disclosure [Line Items]        
Service cost 0 0 0 0
Interest cost 1 1 1 1
Expected return on plan assets 0 0 0 0
Total $ 1 $ 1 $ 1 $ 1
XML 76 R62.htm IDEA: XBRL DOCUMENT v3.23.2
Benefit Obligations - Schedule of Company Commitments to Fund Benefit Obligations (Details)
$ in Millions
 6 Months Ended
Jun. 30, 2023
USD ($)
Cash contributions to defined benefit pension plans  
Defined Benefit Plan Disclosure [Line Items]  
Total contributions year-to-date $ 13
Total expected contributions in current fiscal year 27
Benefit payments to nonqualified pension plans  
Defined Benefit Plan Disclosure [Line Items]  
Total contributions year-to-date 9
Total expected contributions in current fiscal year 18
Benefit payments to other postretirement benefit plans  
Defined Benefit Plan Disclosure [Line Items]  
Total contributions year-to-date 2
Total expected contributions in current fiscal year $ 4
XML 77 R63.htm IDEA: XBRL DOCUMENT v3.23.2
Benefit Obligations - Schedule of Defined Benefit Plans Disclosures (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Pension Benefits    
Defined Benefit Plan Disclosure [Line Items]    
Noncurrent Other assets $ 164 $ 160
Current Other liabilities (21) (21)
Benefit obligations (366) (372)
Net amount recognized (223) (233)
Post-retirement Benefits    
Defined Benefit Plan Disclosure [Line Items]    
Noncurrent Other assets 0 0
Current Other liabilities (3) (3)
Benefit obligations (35) (35)
Net amount recognized $ (38) $ (38)
XML 78 R64.htm IDEA: XBRL DOCUMENT v3.23.2
Environmental (Schedule of Environmental Remediation Reserves) (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Environmental Remediation Obligations [Abstract]    
Demerger obligations (Note 14) $ 18 $ 20
Divestiture obligations (Note 14) 13 14
Active sites 20 21
U.S. Superfund sites 8 10
Other environmental remediation liabilities 2 2
Total $ 61 $ 67
XML 79 R65.htm IDEA: XBRL DOCUMENT v3.23.2
Environmental - US Superfund Sites Narrative (Details) - Passaic River, New Jersey
$ in Millions
 6 Months Ended
Mar. 24, 2023
USD ($)
Dec. 16, 2022
USD ($)
Sep. 30, 2021
USD ($)
Mar. 31, 2016
USD ($)
Jun. 30, 2023
Site Contingency [Line Items]          
Number of parties included in USEPA order 40       70
Cost of EPA's plan estimate $ 71 $ 150 $ 441 $ 1,400  
Environmental liability percentage         1.00%
XML 80 R66.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
Jul. 19, 2023
Jun. 30, 2023
Dec. 31, 2022
Class of Stock [Line Items]      
Common stock, par value (in dollars per share)   $ 0.0001 $ 0.0001
Subsequent Event      
Class of Stock [Line Items]      
Common stock, dividends, declared (in dollar per share) $ 0.70    
Dividends, common stock, cash $ 76    
XML 81 R67.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity - Schedule of Treasury Stock (Details) - USD ($)
$ / shares in Units, $ in Millions
 6 Months Ended 185 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Stockholders' Equity Note [Abstract]      
Shares repurchased (in shares) 0 0 69,324,429
Average purchase price (in dollar per share)     $ 83.71
Shares repurchased (in $ millions)     $ 5,803
Aggregate Board of Directors repurchase authorizations during the period (in $ millions)     $ 6,866
XML 82 R68.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity - Schedule of Components of Other Comprehensive Income (Loss), Net (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Stockholders' Equity Note [Abstract]        
Foreign currency translation gain (loss), gross amount $ (214) $ (107) $ (218) $ (122)
Foreign currency translation gain (loss), income tax (provision) benefit 13 (24) 30 (30)
Foreign currency translation gain (loss) (201) (131) (188) (152)
Gain (loss) on cash flow hedges, gross amount (1) 33 3 52
Gain (loss) on cash flow hedges, income tax (provision) benefit 1 (7) 1 (11)
Gain (loss) on cash flow hedges, net amount 0 26 4 41
Total other comprehensive income (loss), before tax (215) (74) (216) (68)
Total other comprehensive income (loss), tax (15) 31 (32) 41
Total other comprehensive income (loss), net of tax (200) (105) (184) (109)
Pension and postretirement benefits gain (loss), gross amount 0 0 (1) 2
Pension and postretirement benefits gain (loss), income tax (provision) benefit 1 0 1 0
Pension and postretirement benefits $ 1 $ 0 $ 0 $ 2
XML 83 R69.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity - Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Accumulated Other Comprehensive Income (Loss), net [Line Items]        
As of December 31, 2022     $ (518)  
Other comprehensive income (loss) before reclassifications     (221)  
Amounts reclassified from accumulated other comprehensive income (loss)     5  
Income tax (provision) benefit $ 15 $ (31) 32 $ (41)
As of June 30, 2023 (702)   (702)  
Foreign Currency Translation Gain (Loss)        
Accumulated Other Comprehensive Income (Loss), net [Line Items]        
As of December 31, 2022     (488)  
Other comprehensive income (loss) before reclassifications     (218)  
Amounts reclassified from accumulated other comprehensive income (loss)     0  
Income tax (provision) benefit     30  
As of June 30, 2023 (676)   (676)  
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent        
Accumulated Other Comprehensive Income (Loss), net [Line Items]        
As of December 31, 2022     (22)  
Other comprehensive income (loss) before reclassifications     (2)  
Amounts reclassified from accumulated other comprehensive income (loss)     5  
Income tax (provision) benefit     1  
As of June 30, 2023 (18)   (18)  
Pension and Postretirement Benefits        
Accumulated Other Comprehensive Income (Loss), net [Line Items]        
As of December 31, 2022     (8)  
Other comprehensive income (loss) before reclassifications     (1)  
Amounts reclassified from accumulated other comprehensive income (loss)     0  
Income tax (provision) benefit     1  
As of June 30, 2023 $ (8)   $ (8)  
XML 84 R70.htm IDEA: XBRL DOCUMENT v3.23.2
Other (Charges) Gains, Net - Schedule of Other (Charges) Gains, Net (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Restructuring and Related Activities [Abstract]        
Restructuring(1) $ (10) [1] $ 1 $ (33) [1] $ 0
Total $ (10) $ 1 $ (33) $ 0
[1] Includes employee termination benefits primarily related to Company-wide business optimization projects during the three and six months ended June 30, 2023.
XML 85 R71.htm IDEA: XBRL DOCUMENT v3.23.2
Other (Charges) Gains, Net - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Restructuring and Related Activities [Abstract]        
Restructuring Charges $ (10) [1] $ 1 $ (33) [1] $ 0
[1] Includes employee termination benefits primarily related to Company-wide business optimization projects during the three and six months ended June 30, 2023.
XML 86 R72.htm IDEA: XBRL DOCUMENT v3.23.2
Other (Charges) Gains, Net - Schedule of Restructuring Reserve by Type of Cost (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Restructuring Reserve [Roll Forward]        
Additions $ 10 [1] $ (1) $ 33 [1] $ 0
Employee Severance        
Restructuring Reserve [Roll Forward]        
Beginning balance     6  
Additions     33  
Cash payments     (18)  
Ending balance 21   21  
Employee Severance | Engineered Materials        
Restructuring Reserve [Roll Forward]        
Beginning balance     4  
Additions     29  
Cash payments     (14)  
Ending balance 19   19  
Employee Severance | Acetyl Chain [Member]        
Restructuring Reserve [Roll Forward]        
Beginning balance     1  
Additions     1  
Cash payments     (1)  
Ending balance 1   1  
Employee Severance | Other Activities        
Restructuring Reserve [Roll Forward]        
Beginning balance     1  
Additions     3  
Cash payments     (3)  
Ending balance $ 1   $ 1  
[1] Includes employee termination benefits primarily related to Company-wide business optimization projects during the three and six months ended June 30, 2023.
XML 87 R73.htm IDEA: XBRL DOCUMENT v3.23.2
Income Taxes - Schedule of Effective Tax Rate (Details)
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Tax Disclosure [Abstract]        
Effective income tax rate (2.00%) 20.00% 6.00% 19.00%
XML 88 R74.htm IDEA: XBRL DOCUMENT v3.23.2
Derivative Financial Instruments Derivative Financial Instruments (Schedule of Net Investment Hedges) (Details)
€ in Millions, $ in Millions
Jun. 30, 2023
EUR (€)
Dec. 31, 2022
EUR (€)
Jul. 31, 2022
EUR (€)
Jun. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Jul. 31, 2022
USD ($)
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument            
Derivative [Line Items]            
Derivative, notional amount       $ 1,715 $ 1,314  
Foreign Currency Denominated Debt [Member] | Net Investment Hedging [Member]            
Derivative [Line Items]            
Notional Amount of Nonderivative Instruments | € € 5,591 € 5,639        
USD Senior Unsecured Notes Due 2027 | Currency Swap            
Derivative [Line Items]            
Derivative, notional amount           $ 2,000
USD Senior Unsecured Notes Due 2032 | Currency Swap            
Derivative [Line Items]            
Derivative, notional amount           $ 500
Acquisition Notes | Net Investment Hedging [Member]            
Derivative [Line Items]            
Notional Amount of Nonderivative Instruments | €     € 1,500      
XML 89 R75.htm IDEA: XBRL DOCUMENT v3.23.2
Derivative Financial Instruments Derivative Financial Instruments (Schedule of Foreign Currency Forwards) (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Not Designated as Hedging Instrument | Foreign Exchange Contract [Member]    
Derivative [Line Items]    
Derivative, notional amount $ 1,715 $ 1,314
XML 90 R76.htm IDEA: XBRL DOCUMENT v3.23.2
Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Not Designated as Hedging Instrument        
Derivative [Line Items]        
Gain (Loss) Recognized in Other Comprehensive Income (Loss) $ 0 $ 0 $ 0 $ 0
Gain (Loss) Recognized in Earnings (Loss) (1) (3) 1 (4)
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument        
Derivative [Line Items]        
Gain (Loss) Recognized in Other Comprehensive Income (Loss) 0 0 0 0
Gain (Loss) Recognized in Earnings (Loss) $ (1) $ (3) $ 1 $ (4)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Foreign exchange gain (loss), net, Other income (expense), net Foreign exchange gain (loss), net, Other income (expense), net Foreign exchange gain (loss), net, Other income (expense), net Foreign exchange gain (loss), net, Other income (expense), net
Derivatives Designated as Cash Flow Hedges        
Derivative [Line Items]        
Gain (Loss) Recognized in Other Comprehensive Income (Loss) $ (5) $ 42 $ (3) $ 59
Gain (Loss) Recognized in Earnings (Loss) (3) 9 (5) 7
Derivatives Designated as Cash Flow Hedges | Commodity swaps        
Derivative [Line Items]        
Gain (Loss) Recognized in Other Comprehensive Income (Loss) (7) 42 (7) 59
Gain (Loss) Recognized in Earnings (Loss) $ 0 $ 11 $ 1 $ 11
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Cost of Goods and Services Sold Cost of Goods and Services Sold Cost of Goods and Services Sold Cost of Goods and Services Sold
Derivatives Designated as Cash Flow Hedges | Foreign Exchange Contract [Member]        
Derivative [Line Items]        
Gain (Loss) Recognized in Other Comprehensive Income (Loss) $ 2 $ 0 $ 4 $ 0
Gain (Loss) Recognized in Earnings (Loss) $ (1) $ 0 $ (2) $ 0
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Cost of Goods and Services Sold Cost of Goods and Services Sold Cost of Goods and Services Sold Cost of Goods and Services Sold
Derivatives Designated as Cash Flow Hedges | Interest Rate Swap [Member]        
Derivative [Line Items]        
Gain (Loss) Recognized in Other Comprehensive Income (Loss) $ 0 $ 0 $ 0 $ 0
Gain (Loss) Recognized in Earnings (Loss) $ (2) $ (2) $ (4) $ (4)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Interest Expense Interest Expense Interest Expense Interest Expense
Net Investment Hedging [Member]        
Derivative [Line Items]        
Gain (Loss) Recognized in Other Comprehensive Income (Loss) $ (79) $ 118 $ (154) $ 148
Gain (Loss) Recognized in Earnings (Loss) 0 0 0 0
Net Investment Hedging [Member] | Currency Swap        
Derivative [Line Items]        
Gain (Loss) Recognized in Earnings (Loss) 0 0 0 0
Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax (74) 25 (93) 27
Foreign Currency Denominated Debt [Member] | Net Investment Hedging [Member]        
Derivative [Line Items]        
Gain (Loss) Recognized in Other Comprehensive Income (Loss) (5) 93 (61) 121
Gain (Loss) Recognized in Earnings (Loss) $ 0 $ 0 $ 0 $ 0
XML 91 R77.htm IDEA: XBRL DOCUMENT v3.23.2
Derivative Financial Instruments (Schedule of Offsetting Assets) (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Derivative Assets [Abstract]    
Gross amount recognized $ 156 $ 169
Gross amount offset in the consolidated balance sheets 0 0
Net amount presented in the consolidated balance sheets 156 169
Gross amount not offset in the consolidated balance sheets 17 16
Net amount $ 139 $ 153
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other assets, Other Assets, Noncurrent Other assets, Other Assets, Noncurrent
XML 92 R78.htm IDEA: XBRL DOCUMENT v3.23.2
Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Derivative Liabilities [Abstract]    
Gross amount recognized $ 279 $ 189
Gross amount offset in the consolidated balance sheets 0 0
Net amount presented in the consolidated balance sheets 279 189
Gross amount not offset in the consolidated balance sheets 17 16
Net amount $ 262 $ 173
Derivative liability, statement of financial position [Extensible Enumeration] Other liabilities, Other liabilities Other liabilities, Other liabilities
XML 93 R79.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Asset $ 139 $ 153
Commodity swaps $ (262) $ (173)
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other assets Other assets
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other Assets, Noncurrent Other Assets, Noncurrent
Derivative liability, statement of financial position [Extensible Enumeration]   Other liabilities
Fair Value, Recurring | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets $ 156 $ 169
Total liabilities (279) (189)
Current Other assets | Fair Value, Recurring | Not Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps 11 9
Current Other liabilities | Fair Value, Recurring | Not Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps (4) (3)
Other Noncurrent Liabilities [Member] | Fair Value, Recurring | Not Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps (8)  
Derivatives Designated as Cash Flow Hedges | Current Other assets | Fair Value, Recurring | Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps 4  
Commodity swaps | Derivatives Designated as Cash Flow Hedges | Fair Value, Recurring | Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Commodity swaps   (2)
Commodity swaps | Derivatives Designated as Cash Flow Hedges | Current Other assets | Fair Value, Recurring | Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Asset 6 9
Commodity swaps | Derivatives Designated as Cash Flow Hedges | Noncurrent Other assets | Fair Value, Recurring | Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Asset 34 39
Currency Swap | Net Investment Hedging [Member] | Current Other assets | Fair Value, Recurring | Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps 101 99
Currency Swap | Net Investment Hedging [Member] | Noncurrent Other assets | Fair Value, Recurring | Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps   13
Currency Swap | Net Investment Hedging [Member] | Current Other liabilities | Fair Value, Recurring | Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps (60) (58)
Currency Swap | Net Investment Hedging [Member] | Other Noncurrent Liabilities [Member] | Fair Value, Recurring | Designated as Hedging Instrument | Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency forwards and swaps $ (207) $ (126)
XML 94 R80.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Measurements - Schedule of Carrying Values and Fair Values of Financial Instruments (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Jun. 30, 2022
Dec. 31, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Equity investments without readily determinable fair values, carrying amount $ 170 $ 170    
Equity investments without readily determinable fair values, fair value 0 0    
Insurance contracts in nonqualified trusts, carrying amount 21 22    
Insurance contracts in nonqualified trusts, fair value 21 23    
Long-term debt, including current installments of long-term debt, carrying amount 14,003 13,953    
Long-term debt, including current installments of long-term debt, fair value 13,807 13,419    
Cash and cash equivalents 1,296 1,508 $ 783 $ 536
Significant Other Observable Inputs (Level 2)        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Equity investments without readily determinable fair values, fair value 0 0    
Insurance contracts in nonqualified trusts, fair value 21 23    
Long-term debt, including current installments of long-term debt, fair value 13,650 13,247    
Unobservable Inputs (Level 3)        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Equity investments without readily determinable fair values, fair value 0 0    
Insurance contracts in nonqualified trusts, fair value 0 0    
Long-term debt, including current installments of long-term debt, fair value $ 157 $ 172    
XML 95 R81.htm IDEA: XBRL DOCUMENT v3.23.2
Commitments and Contingencies - Narrative (Details) - 284 months ended Jun. 30, 2023
€ in Millions, $ in Millions
USD ($)
EUR (€)
USD ($)
Loss Contingencies [Line Items]      
Unrecorded unconditional purchase obligations     $ 4,100
Unrecorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year     355
Unrecorded Unconditional Purchase Obligation, to be Paid, Year One     665
Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two     558
Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three     436
Unrecorded Unconditional Purchase Obligation, to be Paid, Year Four     $ 355
Indemnification Agreements Hoechst      
Loss Contingencies [Line Items]      
Number of divestiture agreements   19 19
Indemnification amount | €   € 250  
Indemnification ceiling amount | €   € 750  
Indemnification percentage exceeding ceiling amount   33.33% 33.33%
Loss contingency accrual, carrying value, payments $ 110    
Indemnification percentage, other   33.33% 33.33%
Divestiture Agreements      
Loss Contingencies [Line Items]      
Guarantor obligations, maximum exposure     $ 116
XML 96 R82.htm IDEA: XBRL DOCUMENT v3.23.2
Segment Information - Schedule of Business Segments (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Segment Reporting Information [Line Items]          
Net sales $ 2,795 $ 2,486 $ 5,648 $ 5,024  
Other (charges) gains, net (Note 14) (10) 1 (33) 0  
Operating profit (loss) 335 483 586 1,014  
Equity in net earnings (loss) of affiliates 23 60 38 116  
Depreciation and amortization 172 103 344 209  
Capital expenditures 152 [1] 132 [1] 260 [2] 246 [2]  
Goodwill and intangible assets, net 11,070   11,070   $ 11,247
Total assets 25,649   25,649   26,272
Increase (decrease) in accrued capital expenditures 7 8 (49) (15)  
Engineered Materials          
Segment Reporting Information [Line Items]          
Net sales 1,585 948 3,215 1,858  
Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales [3] 1,210 1,538 2,433 3,166  
Operating Segments | Engineered Materials          
Segment Reporting Information [Line Items]          
Net sales 1,585 948 3,215 1,858  
Other (charges) gains, net (Note 14) (8) 1 (29)    
Operating profit (loss) 158 166 270 290  
Equity in net earnings (loss) of affiliates 18 53 29 102  
Depreciation and amortization 112 45 224 91  
Capital expenditures 58 35 103 65  
Goodwill and intangible assets, net 10,646   10,646   10,826
Total assets 18,146   18,146   20,611
Operating Segments | Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales 1,233 1,559 2,483 3,211  
Other (charges) gains, net (Note 14) 0 0 (1)    
Operating profit (loss) 295 428 573 931  
Equity in net earnings (loss) of affiliates 2 3 3 7  
Depreciation and amortization 54 52 108 108  
Capital expenditures 67 87 118 157  
Goodwill and intangible assets, net 424   424   421
Total assets 5,589   5,589   5,471
Corporate, Non-Segment | Other Activities          
Segment Reporting Information [Line Items]          
Net sales 0 0 0 0  
Other (charges) gains, net (Note 14) (2) 0 (3)    
Operating profit (loss) (118) (111) (257) (207)  
Equity in net earnings (loss) of affiliates 3 4 6 7  
Depreciation and amortization 6 6 12 10  
Capital expenditures 27 10 39 24  
Goodwill and intangible assets, net 0   0   0
Total assets 1,914   1,914   190
Eliminations          
Segment Reporting Information [Line Items]          
Net sales (23) [4] (21) [4] (50) [5] (45) [5]  
Other (charges) gains, net (Note 14) 0 0 0    
Operating profit (loss) 0 0 0 0  
Equity in net earnings (loss) of affiliates 0 0 0 0  
Depreciation and amortization 0 0 0 0  
Capital expenditures 0 0 0 0  
Goodwill and intangible assets, net 0   0   0
Total assets 0   0   $ 0
Eliminations | Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales $ 23 $ 21 $ 50 $ 45  
[1] Includes an increase in accrued capital expenditures of $7 million and $8 million for the three months ended June 30, 2023 and 2022, respectively.
[2] Includes a decrease in accrued capital expenditures of $49 million and $15 million for the six months ended June 30, 2023 and 2022, respectively.
[3] Excludes intersegment sales of $23 million and $21 million for the three months ended June 30, 2023 and 2022, respectively. Excludes intersegment sales of $50 million and $45 million for the six months ended June 30, 2023 and 2022, respectively.
[4] Includes intersegment sales primarily related to the Acetyl Chain.
[5] Includes intersegment sales primarily related to the Acetyl Chain.
XML 97 R83.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue Recognition - Disaggregation of net sales (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenue, Major Customer [Line Items]        
Net sales $ 2,795 $ 2,486 $ 5,648 $ 5,024
Engineered Materials        
Revenue, Major Customer [Line Items]        
Net sales 1,585 948 3,215 1,858
Acetyl Chain        
Revenue, Major Customer [Line Items]        
Net sales [1] 1,210 1,538 2,433 3,166
Intersegment Eliminations        
Revenue, Major Customer [Line Items]        
Net sales (23) [2] (21) [2] (50) [3] (45) [3]
Intersegment Eliminations | Acetyl Chain        
Revenue, Major Customer [Line Items]        
Net sales 23 21 50 45
North America | Engineered Materials        
Revenue, Major Customer [Line Items]        
Net sales 471 284 950 573
North America | Acetyl Chain        
Revenue, Major Customer [Line Items]        
Net sales 361 451 726 876
Europe and Africa | Engineered Materials        
Revenue, Major Customer [Line Items]        
Net sales 519 380 1,079 757
Europe and Africa | Acetyl Chain        
Revenue, Major Customer [Line Items]        
Net sales 437 545 897 1,137
Asia-Pacific | Engineered Materials        
Revenue, Major Customer [Line Items]        
Net sales 554 256 1,102 477
Asia-Pacific | Acetyl Chain        
Revenue, Major Customer [Line Items]        
Net sales 379 510 746 1,071
South America | Engineered Materials        
Revenue, Major Customer [Line Items]        
Net sales 41 28 84 51
South America | Acetyl Chain        
Revenue, Major Customer [Line Items]        
Net sales $ 33 $ 32 $ 64 $ 82
[1] Excludes intersegment sales of $23 million and $21 million for the three months ended June 30, 2023 and 2022, respectively. Excludes intersegment sales of $50 million and $45 million for the six months ended June 30, 2023 and 2022, respectively.
[2] Includes intersegment sales primarily related to the Acetyl Chain.
[3] Includes intersegment sales primarily related to the Acetyl Chain.
XML 98 R84.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue Recognition Remaining Performance Obligations (Details)
$ in Millions
Jun. 30, 2023
USD ($)
Revenue, Major Customer [Line Items]  
Revenue, remaining performance obligation, amount $ 1,300
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-01  
Revenue, Major Customer [Line Items]  
Revenue, remaining performance obligation, amount $ 272
Revenue, remaining performance obligation, expected timing of satisfaction, period 6 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01  
Revenue, Major Customer [Line Items]  
Revenue, remaining performance obligation, amount $ 481
Revenue, remaining performance obligation, expected timing of satisfaction, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01  
Revenue, Major Customer [Line Items]  
Revenue, remaining performance obligation, amount $ 324
Revenue, remaining performance obligation, expected timing of satisfaction, period 1 year
XML 99 R85.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Amounts attributable to Celanese Corporation        
Earnings (loss) from continuing operations $ 219 $ 440 $ 313 $ 942
Earnings (loss) from discontinued operations 1 (6) (2) (6)
Net earnings (loss) $ 220 $ 434 $ 311 $ 936
Weighted average shares - basic (in shares) 108,886,678 108,392,155 108,761,071 108,289,603
Incremental shares attributable to equity awards(1) [1] 419,653 731,194 520,293 868,452
Weighted average shares - diluted 109,306,331 109,123,349 109,281,364 109,158,055
[1] Excludes options to purchase 242,421 and 0 shares of Common Stock for the three months ended June 30, 2023 and 2022, respectively, and 164,739 and 0 shares of Common Stock for the six months ended June 30, 2023 and 2022, respectively, as their effect would have been antidilutive. Excludes 102,773 and 107,287 equity award shares for the three months ended June 30, 2023 and 2022, respectively, and 46,008 and 82,887 equity award shares for the six months ended June 30, 2023 and 2022, respectively, as their effect would have been antidilutive.
XML 100 R86.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings (Loss) Per Share - Narrative (Details) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Share-Based Payment Arrangement, Option        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share, amount 242,421 0 164,739 0
Antidilutive securities excluded from computation of earnings per share, amount 242,421 0 164,739 0
Restricted Stock Units (RSUs)        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share, amount 102,773 107,287 46,008 82,887
Antidilutive securities excluded from computation of earnings per share, amount 102,773 107,287 46,008 82,887
XML 101 ce-20230630_htm.xml IDEA: XBRL DOCUMENT 0001306830 2023-01-01 2023-06-30 0001306830 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001306830 ce:EURSeniorUnsecuredNotesDue2023Member 2023-01-01 2023-06-30 0001306830 ce:EURSeniorUnsecuredNotesDue2025Member 2023-01-01 2023-06-30 0001306830 ce:EURSeniorUnsecuredNotesDue2026Member 2023-01-01 2023-06-30 0001306830 ce:EURSeniorUnsecuredNotesDue2027Member 2023-01-01 2023-06-30 0001306830 ce:EURSeniorUnsecuredNotesDue2028Member 2023-01-01 2023-06-30 0001306830 ce:EURSeniorUnsecuredNotesDue2029Member 2023-01-01 2023-06-30 0001306830 2023-08-04 0001306830 2023-04-01 2023-06-30 0001306830 2022-04-01 2022-06-30 0001306830 2022-01-01 2022-06-30 0001306830 2023-06-30 0001306830 2022-12-31 0001306830 us-gaap:CommonStockMember 2023-03-31 0001306830 us-gaap:CommonStockMember 2022-03-31 0001306830 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001306830 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001306830 us-gaap:CommonStockMember 2023-06-30 0001306830 us-gaap:CommonStockMember 2022-06-30 0001306830 us-gaap:TreasuryStockCommonMember 2023-03-31 0001306830 us-gaap:TreasuryStockCommonMember 2022-03-31 0001306830 us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0001306830 us-gaap:TreasuryStockCommonMember 2022-04-01 2022-06-30 0001306830 us-gaap:TreasuryStockCommonMember 2023-06-30 0001306830 us-gaap:TreasuryStockCommonMember 2022-06-30 0001306830 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001306830 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001306830 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001306830 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001306830 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001306830 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001306830 us-gaap:RetainedEarningsMember 2023-03-31 0001306830 us-gaap:RetainedEarningsMember 2022-03-31 0001306830 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001306830 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001306830 us-gaap:RetainedEarningsMember 2023-06-30 0001306830 us-gaap:RetainedEarningsMember 2022-06-30 0001306830 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001306830 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001306830 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001306830 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001306830 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001306830 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001306830 2022-06-30 0001306830 us-gaap:NoncontrollingInterestMember 2023-03-31 0001306830 us-gaap:NoncontrollingInterestMember 2022-03-31 0001306830 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0001306830 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0001306830 us-gaap:NoncontrollingInterestMember 2023-06-30 0001306830 us-gaap:NoncontrollingInterestMember 2022-06-30 0001306830 us-gaap:CommonStockMember 2022-12-31 0001306830 us-gaap:CommonStockMember 2021-12-31 0001306830 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001306830 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001306830 us-gaap:TreasuryStockCommonMember 2022-12-31 0001306830 us-gaap:TreasuryStockCommonMember 2021-12-31 0001306830 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-06-30 0001306830 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-06-30 0001306830 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001306830 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001306830 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001306830 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001306830 us-gaap:RetainedEarningsMember 2022-12-31 0001306830 us-gaap:RetainedEarningsMember 2021-12-31 0001306830 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001306830 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001306830 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001306830 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001306830 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0001306830 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0001306830 us-gaap:NoncontrollingInterestMember 2022-12-31 0001306830 us-gaap:NoncontrollingInterestMember 2021-12-31 0001306830 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-06-30 0001306830 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-06-30 0001306830 2021-12-31 0001306830 ce:ConsolidatedVenturesMember 2023-06-30 0001306830 ce:MobilityMaterialsMember 2022-11-01 0001306830 ce:MobilityMaterialsMember 2022-11-01 2022-11-01 0001306830 ce:MobilityMaterialsMember 2022-04-01 2022-06-30 0001306830 ce:MobilityMaterialsMember 2022-01-01 2022-06-30 0001306830 ce:CelaneseCorporationMember ce:NutrinovaJointVentureMember 2023-06-22 0001306830 ce:MitsuiCoLtdMember ce:NutrinovaJointVentureMember 2023-06-22 0001306830 ce:MitsuiCoLtdMember ce:NutrinovaJointVentureMember 2023-06-22 2023-06-22 0001306830 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember ce:FoodIngredientsMember 2023-06-30 0001306830 ce:CelaneseCorporationMember ce:KoreaEngineeringPlasticsCoLtdMember 2022-04-01 0001306830 ce:MitsubishiGasChemicalCompanyMember ce:KoreaEngineeringPlasticsCoLtdMember 2022-04-01 0001306830 ce:KoreaEngineeringPlasticsCoLtdMember 2022-04-01 2022-04-01 0001306830 ce:KoreaEngineeringPlasticsCoLtdMember 2022-04-01 0001306830 ce:EngineeredMaterialsMember 2022-12-31 0001306830 ce:AcetylChainMember 2022-12-31 0001306830 ce:EngineeredMaterialsMember 2023-01-01 2023-06-30 0001306830 ce:AcetylChainMember 2023-01-01 2023-06-30 0001306830 ce:EngineeredMaterialsMember 2023-06-30 0001306830 ce:AcetylChainMember 2023-06-30 0001306830 us-gaap:LicensingAgreementsMember 2022-12-31 0001306830 us-gaap:CustomerRelationshipsMember 2022-12-31 0001306830 us-gaap:DevelopedTechnologyRightsMember 2022-12-31 0001306830 us-gaap:OtherIntangibleAssetsMember 2022-12-31 0001306830 us-gaap:LicensingAgreementsMember 2023-01-01 2023-06-30 0001306830 us-gaap:CustomerRelationshipsMember 2023-01-01 2023-06-30 0001306830 us-gaap:DevelopedTechnologyRightsMember 2023-01-01 2023-06-30 0001306830 us-gaap:OtherIntangibleAssetsMember 2023-01-01 2023-06-30 0001306830 us-gaap:LicensingAgreementsMember 2023-06-30 0001306830 us-gaap:CustomerRelationshipsMember 2023-06-30 0001306830 us-gaap:DevelopedTechnologyRightsMember 2023-06-30 0001306830 us-gaap:OtherIntangibleAssetsMember 2023-06-30 0001306830 us-gaap:TrademarksAndTradeNamesMember 2022-12-31 0001306830 us-gaap:TrademarksAndTradeNamesMember 2023-01-01 2023-06-30 0001306830 us-gaap:TrademarksAndTradeNamesMember 2023-06-30 0001306830 ce:MobilityMaterialsMember 2023-06-30 0001306830 ce:MobilityMaterialsMember 2022-12-31 0001306830 us-gaap:RevolvingCreditFacilityMember 2023-06-30 0001306830 us-gaap:RevolvingCreditFacilityMember 2022-12-31 0001306830 us-gaap:ShortTermDebtMember 2023-06-30 0001306830 us-gaap:ShortTermDebtMember 2022-12-31 0001306830 us-gaap:RevolvingCreditFacilityMember 2023-06-30 0001306830 us-gaap:RevolvingCreditFacilityMember 2022-12-31 0001306830 ce:EURSeniorUnsecuredNotesDue2023Member 2023-06-30 0001306830 ce:EURSeniorUnsecuredNotesDue2023Member 2022-12-31 0001306830 ce:SeniorUnsecuredNotesDue2024Member 2023-06-30 0001306830 ce:SeniorUnsecuredNotesDue2024Member 2022-12-31 0001306830 ce:USDSeniorUnsecuredNotesDue2024Member 2023-06-30 0001306830 ce:USDSeniorUnsecuredNotesDue2024Member 2022-12-31 0001306830 ce:EURSeniorUnsecuredNotesDue2025Member 2023-06-30 0001306830 ce:EURSeniorUnsecuredNotesDue2025Member 2022-12-31 0001306830 ce:USDSeniorUnsecuredNotesDue2025Member 2023-06-30 0001306830 ce:USDSeniorUnsecuredNotesDue2025Member 2022-12-31 0001306830 ce:SeniorUnsecuredTermLoanDue2025Member 2023-06-30 0001306830 ce:SeniorUnsecuredTermLoanDue2025Member 2022-12-31 0001306830 ce:USDSeniorUnsecuredNotesDue2026Member 2023-06-30 0001306830 ce:USDSeniorUnsecuredNotesDue2026Member 2022-12-31 0001306830 ce:EURSeniorUnsecuredNotesDue2026Member 2023-06-30 0001306830 ce:EURSeniorUnsecuredNotesDue2026Member 2022-12-31 0001306830 ce:EURSeniorUnsecuredNotesDue2027Member 2023-06-30 0001306830 ce:EURSeniorUnsecuredNotesDue2027Member 2022-12-31 0001306830 ce:USDSeniorUnsecuredNotesDue2027Member 2023-06-30 0001306830 ce:USDSeniorUnsecuredNotesDue2027Member 2022-12-31 0001306830 ce:SeniorUnsecuredTermLoanDue2027Member 2023-06-30 0001306830 ce:SeniorUnsecuredTermLoanDue2027Member 2022-12-31 0001306830 ce:EURSeniorUnsecuredNotesDue2028Member 2023-06-30 0001306830 ce:EURSeniorUnsecuredNotesDue2028Member 2022-12-31 0001306830 ce:EURSeniorUnsecuredNotesDue2029Member 2023-06-30 0001306830 ce:EURSeniorUnsecuredNotesDue2029Member 2022-12-31 0001306830 ce:USDSeniorUnsecuredNotesDue2029Member 2023-06-30 0001306830 ce:USDSeniorUnsecuredNotesDue2029Member 2022-12-31 0001306830 ce:USDSeniorUnsecuredNotesDue2032Member 2023-06-30 0001306830 ce:USDSeniorUnsecuredNotesDue2032Member 2022-12-31 0001306830 srt:MinimumMember ce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember 2023-06-30 0001306830 srt:MaximumMember ce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember 2023-06-30 0001306830 ce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember 2023-06-30 0001306830 ce:RefundingloanforpollutioncontrolandindustrialrevenuebondsMember 2022-12-31 0001306830 us-gaap:LoansPayableMember 2023-06-30 0001306830 us-gaap:LoansPayableMember 2022-12-31 0001306830 ce:A364DayDelayedDrawTermLoanMember ce:TermLoanFacilityMember 2022-03-31 2022-03-31 0001306830 ce:A364DayDelayedDrawTermLoanMember ce:TermLoanFacilityMember 2022-03-31 0001306830 ce:A5YearDelayedDrawTermLoanMember ce:TermLoanFacilityMember 2022-03-31 2022-03-31 0001306830 ce:A5YearDelayedDrawTermLoanMember ce:TermLoanFacilityMember 2022-03-31 0001306830 ce:A3YearDelayedDrawTermLoanMember ce:TermLoanFacilityMember 2022-09-30 2022-09-30 0001306830 ce:A3YearDelayedDrawTermLoanMember ce:TermLoanFacilityMember 2022-09-30 0001306830 us-gaap:RevolvingCreditFacilityMember us-gaap:RevolvingCreditFacilityMember 2022-03-31 0001306830 us-gaap:RevolvingCreditFacilityMember ce:ChinaRevolvingCreditFacilityMember 2023-01-04 0001306830 ce:ChinaWorkingCapitalTermLoanMember ce:ChinaWorkingCapitalTermLoanMember 2023-01-06 0001306830 ce:ChinaWorkingCapitalTermLoanMember ce:ChinaWorkingCapitalTermLoanMember 2023-01-06 2023-01-06 0001306830 ce:ChinaWorkingCapitalTermLoanMember ce:ChinaWorkingCapitalTermLoanMember ce:VariableInterbankInterestRateMember 2023-01-06 2023-01-06 0001306830 us-gaap:RevolvingCreditFacilityMember us-gaap:RevolvingCreditFacilityMember 2023-06-30 0001306830 us-gaap:RevolvingCreditFacilityMember ce:ChinaRevolvingCreditFacilityMember 2023-06-30 0001306830 ce:AcquisitionNotesMember 2022-07-31 0001306830 ce:AcquisitionNotesMember 2022-07-31 2022-07-31 0001306830 ce:AmendedRestatedReceivableSecuritizationFacilityMember us-gaap:SecuredDebtMember 2023-01-01 2023-06-30 0001306830 us-gaap:SecuredDebtMember ce:AmendedRestatedReceivableSecuritizationFacilityMember 2023-06-30 0001306830 us-gaap:SecuredDebtMember ce:AmendedRestatedReceivableSecuritizationFacilityMember 2022-12-31 0001306830 us-gaap:SecuredDebtMember ce:AmendedRestatedReceivableSecuritizationFacilityMember 2023-01-01 2023-06-30 0001306830 us-gaap:SecuredDebtMember ce:AmendedRestatedReceivableSecuritizationFacilityMember 2022-01-01 2022-12-31 0001306830 ce:EuropeFactoringAgreementsMember 2023-06-30 0001306830 ce:SingaporeFactoringAgreementsMember 2023-06-30 0001306830 ce:EuropeAndSingaporeFactoringAgreementsMember 2023-06-30 0001306830 ce:EuropeAndSingaporeFactoringAgreementsMember 2022-12-31 0001306830 ce:EuropeAndSingaporeFactoringAgreementsMember 2023-01-01 2023-06-30 0001306830 ce:EuropeAndSingaporeFactoringAgreementsMember 2022-01-01 2022-12-31 0001306830 us-gaap:PensionPlansDefinedBenefitMember 2023-04-01 2023-06-30 0001306830 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-04-01 2023-06-30 0001306830 us-gaap:PensionPlansDefinedBenefitMember 2022-04-01 2022-06-30 0001306830 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-04-01 2022-06-30 0001306830 us-gaap:PensionPlansDefinedBenefitMember 2023-01-01 2023-06-30 0001306830 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-01-01 2023-06-30 0001306830 us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-06-30 0001306830 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-01-01 2022-06-30 0001306830 us-gaap:PensionPlansDefinedBenefitMember 2023-06-30 0001306830 us-gaap:OtherPensionPlansDefinedBenefitMember 2023-01-01 2023-06-30 0001306830 us-gaap:OtherPensionPlansDefinedBenefitMember 2023-06-30 0001306830 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-06-30 0001306830 us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001306830 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-12-31 0001306830 ce:PassaicRiverNewJerseyMember 2023-01-01 2023-06-30 0001306830 ce:PassaicRiverNewJerseyMember 2016-03-31 2016-03-31 0001306830 ce:PassaicRiverNewJerseyMember 2021-09-30 2021-09-30 0001306830 ce:PassaicRiverNewJerseyMember 2022-12-16 2022-12-16 0001306830 ce:PassaicRiverNewJerseyMember 2023-03-24 2023-03-24 0001306830 ce:PassaicRiverNewJerseyMember 2023-06-30 0001306830 us-gaap:SubsequentEventMember 2023-07-19 2023-07-19 0001306830 2008-02-01 2023-06-30 0001306830 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001306830 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0001306830 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0001306830 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-06-30 0001306830 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-06-30 0001306830 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-06-30 0001306830 us-gaap:AccumulatedTranslationAdjustmentMember 2023-06-30 0001306830 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-06-30 0001306830 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-06-30 0001306830 us-gaap:NetInvestmentHedgingMember 2023-01-01 2023-06-30 0001306830 ce:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2023-06-30 2023-06-30 0001306830 ce:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2022-12-31 2022-12-31 0001306830 ce:USDSeniorUnsecuredNotesDue2027Member us-gaap:CurrencySwapMember 2022-07-31 0001306830 ce:USDSeniorUnsecuredNotesDue2032Member us-gaap:CurrencySwapMember 2022-07-31 0001306830 ce:AcquisitionNotesMember us-gaap:NetInvestmentHedgingMember 2022-07-31 2022-07-31 0001306830 us-gaap:NondesignatedMember 2023-01-01 2023-06-30 0001306830 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-06-30 0001306830 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2022-12-31 0001306830 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2023-04-01 2023-06-30 0001306830 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2022-04-01 2022-06-30 0001306830 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2023-04-01 2023-06-30 0001306830 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2022-04-01 2022-06-30 0001306830 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2023-04-01 2023-06-30 0001306830 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2022-04-01 2022-06-30 0001306830 us-gaap:CashFlowHedgingMember 2023-04-01 2023-06-30 0001306830 us-gaap:CashFlowHedgingMember 2022-04-01 2022-06-30 0001306830 ce:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2023-04-01 2023-06-30 0001306830 ce:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2022-04-01 2022-06-30 0001306830 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember 2023-04-01 2023-06-30 0001306830 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember 2022-04-01 2022-06-30 0001306830 us-gaap:NetInvestmentHedgingMember 2023-04-01 2023-06-30 0001306830 us-gaap:NetInvestmentHedgingMember 2022-04-01 2022-06-30 0001306830 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-04-01 2023-06-30 0001306830 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2022-04-01 2022-06-30 0001306830 us-gaap:NondesignatedMember 2023-04-01 2023-06-30 0001306830 us-gaap:NondesignatedMember 2022-04-01 2022-06-30 0001306830 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2023-01-01 2023-06-30 0001306830 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2022-01-01 2022-06-30 0001306830 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2023-01-01 2023-06-30 0001306830 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2022-01-01 2022-06-30 0001306830 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2023-01-01 2023-06-30 0001306830 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2022-01-01 2022-06-30 0001306830 us-gaap:CashFlowHedgingMember 2023-01-01 2023-06-30 0001306830 us-gaap:CashFlowHedgingMember 2022-01-01 2022-06-30 0001306830 ce:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2023-01-01 2023-06-30 0001306830 ce:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2022-01-01 2022-06-30 0001306830 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember 2023-01-01 2023-06-30 0001306830 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember 2022-01-01 2022-06-30 0001306830 us-gaap:NetInvestmentHedgingMember 2022-01-01 2022-06-30 0001306830 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-01-01 2023-06-30 0001306830 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2022-01-01 2022-06-30 0001306830 us-gaap:NondesignatedMember 2022-01-01 2022-06-30 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-06-30 0001306830 us-gaap:OtherNoncurrentAssetsMember us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-06-30 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CashFlowHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-06-30 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-06-30 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2023-06-30 0001306830 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001306830 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-06-30 0001306830 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-06-30 0001306830 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2023-06-30 0001306830 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2023-06-30 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherNoncurrentAssetsMember us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2022-12-31 0001306830 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001306830 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001306830 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2022-12-31 0001306830 us-gaap:FairValueInputsLevel2Member 2023-06-30 0001306830 us-gaap:FairValueInputsLevel3Member 2023-06-30 0001306830 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001306830 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001306830 ce:IndemnificationAgreementsHoechstMember 2023-06-30 0001306830 ce:IndemnificationAgreementsHoechstMember 1999-11-01 2023-06-30 0001306830 ce:DivestitureAgreementsMember 2023-06-30 0001306830 us-gaap:OperatingSegmentsMember ce:EngineeredMaterialsMember 2023-04-01 2023-06-30 0001306830 us-gaap:OperatingSegmentsMember ce:AcetylChainMember 2023-04-01 2023-06-30 0001306830 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2023-04-01 2023-06-30 0001306830 us-gaap:IntersegmentEliminationMember 2023-04-01 2023-06-30 0001306830 us-gaap:OperatingSegmentsMember ce:EngineeredMaterialsMember 2022-04-01 2022-06-30 0001306830 us-gaap:OperatingSegmentsMember ce:AcetylChainMember 2022-04-01 2022-06-30 0001306830 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2022-04-01 2022-06-30 0001306830 us-gaap:IntersegmentEliminationMember 2022-04-01 2022-06-30 0001306830 us-gaap:OperatingSegmentsMember ce:EngineeredMaterialsMember 2023-01-01 2023-06-30 0001306830 us-gaap:OperatingSegmentsMember ce:AcetylChainMember 2023-01-01 2023-06-30 0001306830 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2023-01-01 2023-06-30 0001306830 us-gaap:IntersegmentEliminationMember 2023-01-01 2023-06-30 0001306830 us-gaap:OperatingSegmentsMember ce:EngineeredMaterialsMember 2023-06-30 0001306830 us-gaap:OperatingSegmentsMember ce:AcetylChainMember 2023-06-30 0001306830 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2023-06-30 0001306830 us-gaap:IntersegmentEliminationMember 2023-06-30 0001306830 us-gaap:OperatingSegmentsMember ce:EngineeredMaterialsMember 2022-01-01 2022-06-30 0001306830 us-gaap:OperatingSegmentsMember ce:AcetylChainMember 2022-01-01 2022-06-30 0001306830 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2022-01-01 2022-06-30 0001306830 us-gaap:IntersegmentEliminationMember 2022-01-01 2022-06-30 0001306830 us-gaap:OperatingSegmentsMember ce:EngineeredMaterialsMember 2022-12-31 0001306830 us-gaap:OperatingSegmentsMember ce:AcetylChainMember 2022-12-31 0001306830 us-gaap:CorporateNonSegmentMember us-gaap:CorporateAndOtherMember 2022-12-31 0001306830 us-gaap:IntersegmentEliminationMember 2022-12-31 0001306830 2023-07-01 2023-06-30 0001306830 2024-01-01 2023-06-30 0001306830 2025-01-01 2023-06-30 0001306830 srt:NorthAmericaMember ce:EngineeredMaterialsMember 2023-04-01 2023-06-30 0001306830 srt:NorthAmericaMember ce:EngineeredMaterialsMember 2022-04-01 2022-06-30 0001306830 srt:NorthAmericaMember ce:EngineeredMaterialsMember 2023-01-01 2023-06-30 0001306830 srt:NorthAmericaMember ce:EngineeredMaterialsMember 2022-01-01 2022-06-30 0001306830 us-gaap:EMEAMember ce:EngineeredMaterialsMember 2023-04-01 2023-06-30 0001306830 us-gaap:EMEAMember ce:EngineeredMaterialsMember 2022-04-01 2022-06-30 0001306830 us-gaap:EMEAMember ce:EngineeredMaterialsMember 2023-01-01 2023-06-30 0001306830 us-gaap:EMEAMember ce:EngineeredMaterialsMember 2022-01-01 2022-06-30 0001306830 srt:AsiaPacificMember ce:EngineeredMaterialsMember 2023-04-01 2023-06-30 0001306830 srt:AsiaPacificMember ce:EngineeredMaterialsMember 2022-04-01 2022-06-30 0001306830 srt:AsiaPacificMember ce:EngineeredMaterialsMember 2023-01-01 2023-06-30 0001306830 srt:AsiaPacificMember ce:EngineeredMaterialsMember 2022-01-01 2022-06-30 0001306830 srt:SouthAmericaMember ce:EngineeredMaterialsMember 2023-04-01 2023-06-30 0001306830 srt:SouthAmericaMember ce:EngineeredMaterialsMember 2022-04-01 2022-06-30 0001306830 srt:SouthAmericaMember ce:EngineeredMaterialsMember 2023-01-01 2023-06-30 0001306830 srt:SouthAmericaMember ce:EngineeredMaterialsMember 2022-01-01 2022-06-30 0001306830 ce:EngineeredMaterialsMember 2023-04-01 2023-06-30 0001306830 ce:EngineeredMaterialsMember 2022-04-01 2022-06-30 0001306830 ce:EngineeredMaterialsMember 2022-01-01 2022-06-30 0001306830 srt:NorthAmericaMember ce:AcetylChainMember 2023-04-01 2023-06-30 0001306830 srt:NorthAmericaMember ce:AcetylChainMember 2022-04-01 2022-06-30 0001306830 srt:NorthAmericaMember ce:AcetylChainMember 2023-01-01 2023-06-30 0001306830 srt:NorthAmericaMember ce:AcetylChainMember 2022-01-01 2022-06-30 0001306830 us-gaap:EMEAMember ce:AcetylChainMember 2023-04-01 2023-06-30 0001306830 us-gaap:EMEAMember ce:AcetylChainMember 2022-04-01 2022-06-30 0001306830 us-gaap:EMEAMember ce:AcetylChainMember 2023-01-01 2023-06-30 0001306830 us-gaap:EMEAMember ce:AcetylChainMember 2022-01-01 2022-06-30 0001306830 srt:AsiaPacificMember ce:AcetylChainMember 2023-04-01 2023-06-30 0001306830 srt:AsiaPacificMember ce:AcetylChainMember 2022-04-01 2022-06-30 0001306830 srt:AsiaPacificMember ce:AcetylChainMember 2023-01-01 2023-06-30 0001306830 srt:AsiaPacificMember ce:AcetylChainMember 2022-01-01 2022-06-30 0001306830 srt:SouthAmericaMember ce:AcetylChainMember 2023-04-01 2023-06-30 0001306830 srt:SouthAmericaMember ce:AcetylChainMember 2022-04-01 2022-06-30 0001306830 srt:SouthAmericaMember ce:AcetylChainMember 2023-01-01 2023-06-30 0001306830 srt:SouthAmericaMember ce:AcetylChainMember 2022-01-01 2022-06-30 0001306830 ce:AcetylChainMember 2023-04-01 2023-06-30 0001306830 ce:AcetylChainMember 2022-04-01 2022-06-30 0001306830 ce:AcetylChainMember 2022-01-01 2022-06-30 0001306830 us-gaap:IntersegmentEliminationMember ce:AcetylChainMember 2023-04-01 2023-06-30 0001306830 us-gaap:IntersegmentEliminationMember ce:AcetylChainMember 2022-04-01 2022-06-30 0001306830 us-gaap:IntersegmentEliminationMember ce:AcetylChainMember 2023-01-01 2023-06-30 0001306830 us-gaap:IntersegmentEliminationMember ce:AcetylChainMember 2022-01-01 2022-06-30 0001306830 us-gaap:EmployeeStockOptionMember 2023-04-01 2023-06-30 0001306830 us-gaap:EmployeeStockOptionMember 2022-04-01 2022-06-30 0001306830 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001306830 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001306830 us-gaap:RestrictedStockUnitsRSUMember 2023-04-01 2023-06-30 0001306830 us-gaap:RestrictedStockUnitsRSUMember 2022-04-01 2022-06-30 0001306830 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001306830 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-06-30 0001306830 us-gaap:EmployeeSeveranceMember ce:EngineeredMaterialsMember 2022-12-31 0001306830 us-gaap:EmployeeSeveranceMember ce:AcetylChainMember 2022-12-31 0001306830 us-gaap:EmployeeSeveranceMember us-gaap:CorporateAndOtherMember 2022-12-31 0001306830 us-gaap:EmployeeSeveranceMember 2022-12-31 0001306830 us-gaap:EmployeeSeveranceMember ce:EngineeredMaterialsMember 2023-01-01 2023-06-30 0001306830 us-gaap:EmployeeSeveranceMember ce:AcetylChainMember 2023-01-01 2023-06-30 0001306830 us-gaap:EmployeeSeveranceMember us-gaap:CorporateAndOtherMember 2023-01-01 2023-06-30 0001306830 us-gaap:EmployeeSeveranceMember 2023-01-01 2023-06-30 0001306830 us-gaap:EmployeeSeveranceMember ce:EngineeredMaterialsMember 2023-06-30 0001306830 us-gaap:EmployeeSeveranceMember ce:AcetylChainMember 2023-06-30 0001306830 us-gaap:EmployeeSeveranceMember us-gaap:CorporateAndOtherMember 2023-06-30 0001306830 us-gaap:EmployeeSeveranceMember 2023-06-30 shares iso4217:USD iso4217:USD shares pure ce:facility ce:patent ce:employees ce:annualInstallment iso4217:EUR iso4217:CNY 0001306830 --12-31 2023 Q2 false http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#InterestExpense http://fasb.org/us-gaap/2023#InterestExpense http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2023#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#InterestExpense http://fasb.org/us-gaap/2023#InterestExpense http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2023#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent P6M P1Y P1Y 10-Q true 2023-06-30 false 001-32410 CELANESE CORPORATION DE 98-0420726 222 W. Las Colinas Blvd., Suite 900N Irving TX 75039-5421 972 443-4000 Common Stock, par value $0.0001 per share CE NYSE 1.125% Senior Notes due 2023 CE /23 NYSE 1.250% Senior Notes due 2025 CE /25 NYSE 4.777% Senior Notes due 2026 CE /26A NYSE 2.125% Senior Notes due 2027 CE /27 NYSE 0.625% Senior Notes due 2028 CE /28 NYSE 5.337% Senior Notes due 2029 CE /29A NYSE Yes Yes Large Accelerated Filer false false false 108852226 2795000000 2486000000 5648000000 5024000000 2109000000 1781000000 4331000000 3574000000 686000000 705000000 1317000000 1450000000 274000000 197000000 559000000 371000000 42000000 11000000 83000000 22000000 40000000 26000000 82000000 50000000 10000000 -1000000 33000000 0 15000000 -1000000 21000000 -2000000 0 12000000 5000000 9000000 335000000 483000000 586000000 1014000000 23000000 60000000 38000000 116000000 -2000000 25000000 -1000000 49000000 182000000 48000000 364000000 83000000 7000000 1000000 15000000 2000000 31000000 36000000 65000000 73000000 4000000 -3000000 -2000000 -1000000 216000000 554000000 337000000 1170000000 -4000000 112000000 21000000 224000000 220000000 442000000 316000000 946000000 0 -8000000 -3000000 -8000000 -1000000 -2000000 -1000000 -2000000 1000000 -6000000 -2000000 -6000000 221000000 436000000 314000000 940000000 1000000 2000000 3000000 4000000 220000000 434000000 311000000 936000000 219000000 440000000 313000000 942000000 1000000 -6000000 -2000000 -6000000 220000000 434000000 311000000 936000000 2.01 4.06 2.88 8.70 0.01 -0.06 -0.02 -0.06 2.02 4.00 2.86 8.64 2.00 4.03 2.86 8.63 0.01 -0.05 -0.01 -0.06 2.01 3.98 2.85 8.57 108886678 108392155 108761071 108289603 109306331 109123349 109281364 109158055 221000000 436000000 314000000 940000000 -201000000 -131000000 -188000000 -152000000 0 26000000 4000000 41000000 -1000000 0 0 -2000000 -200000000 -105000000 -184000000 -109000000 21000000 331000000 130000000 831000000 1000000 2000000 3000000 4000000 20000000 329000000 127000000 827000000 1296000000 1508000000 1338000000 1379000000 625000000 675000000 2514000000 2808000000 211000000 0 268000000 241000000 6252000000 6611000000 1028000000 1062000000 3830000000 3687000000 5541000000 5584000000 403000000 413000000 832000000 808000000 523000000 547000000 7063000000 7142000000 4007000000 4105000000 25649000000 26272000000 1507000000 1306000000 1243000000 1518000000 19000000 0 1146000000 1201000000 7000000 43000000 3922000000 4068000000 12889000000 13373000000 1220000000 1242000000 285000000 322000000 406000000 411000000 347000000 364000000 492000000 387000000 0.01 0.01 100000000 100000000 0 0 0 0 0 0 0.0001 0.0001 400000000 400000000 170458836 108847435 170135425 108473932 0 0 61611401 61661493 5490000000 5491000000 383000000 372000000 11433000000 11274000000 -702000000 -518000000 5624000000 5637000000 464000000 468000000 6088000000 6105000000 25649000000 26272000000 108786738 0 108307341 0 60697 0 38694 0 108847435 0 108346035 0 61661493 -5491000000 61736289 -5492000000 -50092 1000000 -32243 0 61611401 -5490000000 61704046 -5492000000 365000000 326000000 18000000 18000000 383000000 344000000 11289000000 10106000000 220000000 434000000 76000000 74000000 11433000000 10466000000 -502000000 -333000000 -200000000 -105000000 -702000000 -438000000 5624000000 4880000000 469000000 346000000 1000000 2000000 6000000 3000000 464000000 345000000 6088000000 5225000000 108473932 0 108023735 0 373503 0 322300 0 108847435 0 108346035 0 61661493 -5491000000 61736289 -5492000000 -50092 1000000 -32243 0 61611401 -5490000000 61704046 -5492000000 372000000 333000000 11000000 11000000 383000000 344000000 11274000000 9677000000 311000000 936000000 152000000 147000000 11433000000 10466000000 -518000000 -329000000 -184000000 -109000000 -702000000 -438000000 5624000000 4880000000 468000000 348000000 3000000 4000000 7000000 7000000 464000000 345000000 6088000000 5225000000 314000000 940000000 359000000 213000000 7000000 -42000000 24000000 23000000 -3000000 15000000 4000000 8000000 32000000 31000000 15000000 10000000 -4000000 5000000 -4000000 -19000000 10000000 216000000 -220000000 251000000 -187000000 -22000000 -211000000 169000000 -178000000 -15000000 666000000 811000000 309000000 261000000 0 14000000 9000000 16000000 41000000 26000000 -341000000 -285000000 -300000000 19000000 349000000 0 370000000 0 13000000 14000000 0 17000000 152000000 147000000 -7000000 -7000000 0 63000000 -23000000 -25000000 -516000000 -254000000 -21000000 -25000000 -212000000 247000000 1508000000 536000000 1296000000 783000000 Description of the Company and Basis of Presentation<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of the Company</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Celanese Corporation and its subsidiaries (collectively, the "Company") is a global chemical and specialty materials company. The Company produces high performance engineered polymers that are used in a variety of high-value applications, as well as acetyl products, which are intermediate chemicals, for nearly all major industries. The Company also engineers and manufactures a wide variety of products essential to everyday living. The Company's broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, consumer and medical, energy storage, filtration, food and beverage, paints and coatings, paper and packaging, performance industrial and textiles.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definitions</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Quarterly Report on Form 10-Q ("Quarterly Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The term "Celanese U.S." refers to the Company's subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim consolidated financial statements for the three and six months ended June 30, 2023 and 2022 contained in this Quarterly Report were prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for all periods presented and include the accounts of the Company, its majority owned subsidiaries over which the Company exercises control and, when applicable, variable interest entities in which the Company is the primary beneficiary. The unaudited interim consolidated financial statements and other financial information included in this Quarterly Report, unless otherwise specified, have been presented to separately show the effects of discontinued operations.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited consolidated balance sheets and related unaudited interim consolidated statements of operations, comprehensive income (loss), cash flows and equity include all adjustments, consisting only of normal recurring items necessary for their fair presentation in conformity with U.S. GAAP. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with rules and regulations of the Securities and Exchange Commission ("SEC"). These unaudited interim consolidated financial statements should be read in conjunction with the Company's consolidated financial statements as of and for the year ended December 31, 2022, filed on February 24, 2023 with the SEC as part of the Company's Annual Report on Form 10-K.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating results for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the entire year.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company enters into contracts and agreements relative to a number of topics, including acquisitions, dispositions, joint ventures, supply agreements, product sales and other arrangements. The Company endeavors to describe those contracts or agreements that are material to its business, results of operations or financial position. The Company may also describe some arrangements that are not material but in which the Company believes investors may have an interest or which may have been included in a Form 8-K filing. Investors should not assume the Company has described all contracts and agreements relative to the Company's business in this Quarterly Report.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside shareholders' interests are shown as noncontrolling interests.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates and Assumptions</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of Net sales, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension </span></div>and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates. 1 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates and Assumptions</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of Net sales, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension </span></div>and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates. Recent Accounting PronouncementsThere are no recent Accounting Standard Updates issued by the Financial Accounting Standards Board which are expected to materially impact the Company's financial position, operating results or financial disclosures. There are no recent Accounting Standard Updates issued by the Financial Accounting Standards Board which are expected to materially impact the Company's financial position, operating results or financial disclosures. Acquisitions, Dispositions and Plant Closures<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, the Company acquired 100% ownership of entities and assets consisting of a majority of the Mobility &amp; Materials business ("M&amp;M") of DuPont de Nemours, Inc. ("DuPont") (the "M&amp;M Acquisition") for a purchase price of $11.0 billion, subject to transaction adjustments, in an all-cash transaction. The Company acquired a global production network of 29 facilities, including compounding and polymerization, customer and supplier contracts and agreements, an intellectual property portfolio, including approximately 850 patents with associated technical and R&amp;D assets, and approximately 5,000 employees across the manufacturing, technical, and commercial organizations. This acquisition of M&amp;M enhances the engineered materials product portfolio by adding new polymers, brands, product technology, and backward integration in critical polymers, allowing the Company to accelerate growth in high-value applications including future mobility, connectivity and medical. The acquisition was accounted for as a business combination and the acquired operations are included in the Engineered Materials segment.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company preliminarily allocated the purchase price of the acquisition to identifiable assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date. The purchase price allocation was based upon preliminary information and is subject to change if additional information about the facts and circumstances that existed at the acquisition date becomes available. The Company is in the ongoing process of conducting a valuation of the assets acquired and liabilities assumed related to the acquisition, including trade names and customer relationships, personal and real property, investment in equity affiliates and deferred taxes. The final fair value of the net assets acquired may result in adjustments to these assets and liabilities, including goodwill. During the measurement period to date, there were no adjustments that materially impacted the Company's goodwill initially recorded.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unaudited pro forma financial information presents the consolidated results of operations as if the M&amp;M Acquisition had occurred at the beginning of 2022. M&amp;M's pre-acquisition results have been added to the Company's historical results. The pro forma results contained in the table below include adjustments for (i) increased depreciation expense as a result of acquisition date fair value adjustments, (ii) amortization of acquired intangibles, (iii) interest expense and amortization of debt issuance costs of $171 million and $343 million related to borrowings under the U.S. Term Loan Facility (defined below) and the issuance of Acquisition Notes (defined below) as if these had taken place at the beginning of 2022 for the three and six months ended June 30, 2022, respectively and (iv) net total inventory step up of inventory amortized to Cost of sales of $33 million and $131 million for the three and six months ended June 30, 2022, respectively.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These pro forma results have been prepared for comparative purposes only and are not necessarily indicative of the results of operations as they would have been had the acquisitions occurred on the assumed dates, nor are they necessarily an indication of future operating results.</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unaudited Consolidated Pro Forma Results</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Proforma </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,397 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,824 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Proforma </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from continuing operations before tax</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nutrinova Joint Venture</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 22, 2023, the Company announced the signing of a definitive agreement with Mitsui &amp; Co., Ltd. ("Mitsui") to form a food ingredients joint venture under the name Nutrinova. The Company will contribute receivables, inventory, property, plant and equipment, certain intangible assets, other assets, other liabilities, technology and employees of its food ingredients business while retaining a 30% stake in the joint venture. Mitsui will acquire the remaining 70% stake at a purchase price of </span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$473 million. The parties expect to close the transaction in the second half of 2023, pending regulatory approvals. The Company will account for its remaining investment in the food ingredients business as an equity method investment.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023, the food ingredients business, currently included in the Engineered Materials segment, was classified as held for sale and measured and reported at the lower of its carrying amount or fair value less costs to sell. The assets and liabilities classified as held for sale in the unaudited consolidated balance sheet are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Korea Engineering Plastics Co. Restructuring</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, the Company completed the restructuring of Korea Engineering Plastics Co. ("KEPCO"), a joint venture owned 50% by the Company and 50% by Mitsubishi Gas Chemical Company, Inc. KEPCO was first formed in 1987 to manufacture and market polyoxymethylene ("POM") in Asia, with a particular focus on serving domestic demand in South Korea. KEPCO will now focus solely on manufacturing and supplying high quality products to its shareholders, who will independently market them globally. As part of the restructuring of KEPCO, the Company paid KEPCO $5 million and will pay 5 equal annual installments of €24 million on October 1 of each year beginning in 2022. This resulted in an increase to the Company's investment in KEPCO of $134 million. The Company's joint venture partner will make similar payments to KEPCO. The restructuring did not result in a change in ownership percentage of KEPCO, nor a change in control, and KEPCO will continue to be accounted for as an equity method investment.</span></div> 1 11000000000 29 850 5000 171000000 343000000 33000000 131000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unaudited Consolidated Pro Forma Results</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Proforma </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,397 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,824 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Proforma </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from continuing operations before tax</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 3397000000 6824000000 285000000 597000000 0.30 0.70 473000000 The assets and liabilities classified as held for sale in the unaudited consolidated balance sheet are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 83000000 80000000 48000000 211000000 19000000 19000000 0.50 0.50 5000000 5 24000000 134000000 Inventories<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,514 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,808 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,514 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,808 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 1632000000 1820000000 202000000 202000000 680000000 786000000 2514000000 2808000000 Goodwill and Intangible Assets, Net<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Engineered<br/>Materials</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acetyl Chain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,775 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,142 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_43" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 3</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of June 30, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,692 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,063 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Related to goodwill reclassified to assets held for sale (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_43" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 3</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">There were no accumulated impairment losses as of June 30, 2023.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets, Net</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangible assets are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:37.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Licenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Customer-<br/>Related<br/>Intangible<br/>Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Developed<br/>Technology</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Covenants<br/>Not to<br/>Compete<br/>and Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Asset Value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,406 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,095 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(567)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(579)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(726)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net book value</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,827 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Related to finite-lived intangible assets reclassified to assets held for sale (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_43" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 3</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trademarks<br/>and Trade Names</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of June 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Related to indefinite-lived intangible assets reclassified to assets held for sale (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_43" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 3</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2023, the Company did not renew or extend any intangible assets.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated amortization expense for the succeeding five fiscal years is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Engineered<br/>Materials</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acetyl Chain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,775 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,142 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_43" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 3</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of June 30, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,692 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,063 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Related to goodwill reclassified to assets held for sale (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_43" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 3</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">There were no accumulated impairment losses as of June 30, 2023.</span></div> 6775000000 367000000 7142000000 8000000 0 8000000 -80000000 0 -80000000 -11000000 4000000 -7000000 6692000000 371000000 7063000000 0 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangible assets are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:37.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Licenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Customer-<br/>Related<br/>Intangible<br/>Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Developed<br/>Technology</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Covenants<br/>Not to<br/>Compete<br/>and Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Asset Value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,406 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,095 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(567)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(579)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(726)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net book value</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,827 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Related to finite-lived intangible assets reclassified to assets held for sale (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_43" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 3</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div> 42000000 2455000000 601000000 55000000 3153000000 0 58000000 1000000 0 59000000 2000000 -9000000 6000000 0 -1000000 40000000 2406000000 594000000 55000000 3095000000 39000000 567000000 50000000 40000000 696000000 0 63000000 20000000 0 83000000 0 -58000000 -1000000 0 -59000000 -2000000 7000000 1000000 0 6000000 37000000 579000000 70000000 40000000 726000000 3000000 1827000000 524000000 15000000 2369000000 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trademarks<br/>and Trade Names</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of June 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Related to indefinite-lived intangible assets reclassified to assets held for sale (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_43" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 3</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div> 1648000000 14000000 4000000 1638000000 0 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated amortization expense for the succeeding five fiscal years is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 160000000 160000000 160000000 160000000 160000000 Current Other Liabilities<div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_79" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_73" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_148" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 18</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and use tax/foreign withholding tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,146 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,201 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">____________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes $115 million and $166 million payable to DuPont related to the M&amp;M Acquisition and transition activities as of June 30, 2023 and December 31, 2022, respectively.</span></div> <div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_79" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_73" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_148" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 18</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and use tax/foreign withholding tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,146 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,201 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">____________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes $115 million and $166 million payable to DuPont related to the M&amp;M Acquisition and transition activities as of June 30, 2023 and December 31, 2022, respectively.</span></div> 25000000 25000000 88000000 101000000 64000000 63000000 290000000 265000000 25000000 21000000 89000000 83000000 21000000 6000000 132000000 151000000 99000000 108000000 87000000 79000000 226000000 299000000 1146000000 1201000000 115000000 166000000 Debt<div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current installments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings, including amounts due to affiliates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit facilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,507 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The weighted average interest rate was 4.9% and 5.8% as of June 30, 2023 and December 31, 2022, respectively.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The weighted average interest rate was 3.4% and 5.8% as of June 30, 2023 and December 31, 2022, respectively.</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2023, interest rate of 1.125%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2024, interest rate of 3.500%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2024, interest rate of 5.900%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2025, interest rate of 1.250%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2025, interest rate of 6.050%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured term loan due 2025, interest rate of 6.760%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2026, interest rate of 1.400%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2026, interest rate of 4.777%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2027, interest rate of 2.125%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2027, interest rate of 6.165%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured term loan due 2027, interest rate of 6.760%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2028, interest rate of 0.625%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2029, interest rate of 5.337%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2029, interest rate of 6.330%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2032, interest rate of 6.379%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pollution control and industrial revenue bonds due at various dates through 2030, interest rates ranging from 4.05% to 5.00%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank loans due at various dates through 2026</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Obligations under finance leases due at various dates through 2054</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,003 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,953 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current installments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(506)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,889 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,373 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The weighted average interest rate was 1.3% and 1.3% as of June 30, 2023 and December 31, 2022, respectively.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Related to the Company's long-term debt, excluding obligations under finance leases.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Credit Facilities</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, Celanese, Celanese U.S. and certain subsidiaries entered into a term loan credit agreement (the "March 2022 U.S. Term Loan Credit Agreement"), pursuant to which lenders provided a tranche of delayed-draw term loans due 364 days from issuance in an amount equal to $500 million and a tranche of delayed-draw term loans due 5 years from issuance in an amount equal to $1.0 billion. In September 2022, Celanese, Celanese U.S. and certain subsidiaries entered into an additional term loan credit agreement (the "September 2022 U.S. Term Loan Credit Agreement" and, together with the March 2022 U.S. Term Loan Credit Agreement, the "U.S. Term Loan Credit Agreements"), pursuant to which lenders have provided delayed-draw term loans due 3 years from issuance in an amount equal to $750 million (the term loans represented by the U.S. Term Loan Credit Agreements collectively, the "U.S. Term Loan Facility"). The U.S. Term Loan Facility was fully drawn during the three months ended December 31, 2022.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in March 2022, Celanese, Celanese U.S. and certain subsidiaries entered into a new revolving credit agreement (the "U.S. Revolving Credit Agreement" and, together with the U.S. Term Loan Credit Agreements, the "U.S. Credit Agreements") consisting of a $1.75 billion senior unsecured revolving credit facility (with a letter of credit sublimit), maturing in 2027 (the "U.S. Revolving Credit Facility").</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 21, 2023, the Company amended certain covenants in the U.S. Credit Agreements, including financial ratio maintenance covenants. The U.S. Credit Agreements are guaranteed by Celanese, Celanese U.S. and domestic subsidiaries together representing substantially all of the Company's U.S. assets and business operations (the "Subsidiary Guarantors"). The Subsidiary Guarantors are listed in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i36f5a702f87b4d18b40e90e9ecc225f9_29-2-1-1-237647" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 22.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to this Quarterly Report.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2023, Celanese (Shanghai) International Trading Co., Ltd ("CSIT"), a fully consolidated subsidiary, entered into a restatement of an existing credit facility agreement (the "China Revolving Credit Agreement") to upsize and modify the facility thereunder to consist of an aggregate CNY1.75 billion uncommitted senior unsecured revolving credit facility available under two tranches (with overdraft, bank guarantee and documentary credit sublimits) (the "China Revolving Credit Facility"). Obligations bear interest at certain fixed and floating rates. The China Revolving Credit Agreement is guaranteed by Celanese U.S.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2023, CSIT entered into a senior unsecured working capital loan contract for CNY800 million (the "China Working Capital Term Loan Agreement," together with the China Revolving Credit Agreement, the "China Credit Agreements," and the China Credit Agreements together with the U.S. Credit Agreements, the "Global Credit Agreements"), payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates. The loan under the China Working Capital Term Loan Agreement was fully drawn on January 10, 2023 and is supported by a letter of comfort from the Company. The Company expects that the China Credit Agreements will facilitate its efficient repatriation of cash to the U.S. to repay debt and effectively redomicile a portion of its U.S. debt to China at a lower average interest rate.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's debt balances and amounts available for borrowing under its senior unsecured revolving credit facilities are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Revolving Credit Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for borrowing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">China Revolving Credit Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for borrowing</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has outstanding senior unsecured notes, issued in public offerings registered under the Securities Act of 1933 ("Securities Act"), as amended (collectively, the "Senior Notes"). The Senior Notes were issued by Celanese U.S. and are guaranteed on a senior unsecured basis by Celanese and the Subsidiary Guarantors. Celanese U.S. may redeem some or all of each of the Senior Notes, prior to their respective maturity dates, at a redemption price of 100% of the principal amount, plus a "make-whole" premium as specified in the applicable indenture, plus accrued and unpaid interest, if any, to the redemption date.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, Celanese U.S. completed an offering of $7.5 billion aggregate principal amount of notes of various maturities in a public offering registered under the Securities Act (the "Acquisition USD Notes"). In July 2022, Celanese U.S. completed an offering of €1.5 billion in aggregate principal amount of euro-denominated senior unsecured notes due in 2026 and 2029 in a public offering registered under the Securities Act (collectively, the "Acquisition Euro Notes" and together with the Acquisition USD Notes, the "Acquisition Notes"). Certain of the Acquisition Notes were issued at a discount to par, which will be amortized to Interest expense in the consolidated statements of operations over the terms of the applicable Acquisition Notes. Fees and expenses of the offering of the Acquisition Notes, inclusive of underwriting discounts, were $65 million.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable Purchasing Facility</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2023, the Company entered into an amendment to the amended and restated receivables purchase agreement (the "Amended Receivables Purchase Agreement") under its U.S. accounts receivable purchasing facility among certain of the Company's subsidiaries, its wholly-owned, "bankruptcy remote" special purpose subsidiary ("SPE") and certain global financial institutions ("Purchasers"). The Amended Receivables Purchase Agreement extends the term of the accounts receivable purchasing facility such that the SPE may sell certain receivables until June 18, 2025. Under the Amended Receivables Purchase Agreement, transfers of U.S. accounts receivable from the SPE are treated as sales and are accounted for as a reduction in accounts receivable because the agreement transfers effective control over and risk related to the U.S. accounts receivable to the SPE. The Company and related subsidiaries have no continuing involvement in the transferred U.S. accounts receivable, other than collection and administrative responsibilities and, once sold, the U.S. accounts receivable are no longer available to satisfy creditors of the Company or the related subsidiaries. These sales are transacted at 100% of the face value of the relevant U.S. accounts receivable, resulting in derecognition of the U.S. accounts receivables from the Company's unaudited consolidated balance sheet. The Company de-recognized $663 million and $1.1 billion of accounts receivable under this agreement for the six months ended June 30, 2023 and year ended December 31, 2022, respectively, and collected $565 million and $1.1 billion of accounts receivable sold under this agreement during the same periods. Unsold U.S. accounts receivable of $86 million were pledged by the SPE as collateral to the Purchasers as of June 30, 2023.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Factoring and Discounting Agreements</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has factoring agreements in Europe and Singapore with financial institutions to sell 100% and 90% of certain accounts receivable, respectively, on a non-recourse basis. These transactions are treated as sales and are accounted for as reductions in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyer. The Company has no continuing involvement in the transferred receivables, other than collection and administrative responsibilities and, once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. The Company de-recognized $196 million and $320 million of accounts receivable under these factoring agreements for the six months ended June 30, 2023 and year ended December 31, 2022, respectively, and collected $189 million and $325 million of accounts receivable sold under these factoring agreements during the same periods.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Covenants</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's material financing arrangements contain customary covenants, such as events of default and change of control provisions, and in the case of the U.S. Credit Agreements the maintenance of certain financial ratios (subject to adjustment following certain qualifying acquisitions and dispositions, as set forth in the U.S. Credit Agreements, as amended). Failure to comply with these covenants, or the occurrence of any other event of default, could result in acceleration of the borrowings and other financial obligations. The Company is in compliance with the covenants in its material financing arrangements as of June 30, 2023.</span></div> <div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current installments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings, including amounts due to affiliates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit facilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,507 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The weighted average interest rate was 4.9% and 5.8% as of June 30, 2023 and December 31, 2022, respectively.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The weighted average interest rate was 3.4% and 5.8% as of June 30, 2023 and December 31, 2022, respectively.</span></div> 1050000000 506000000 250000000 500000000 207000000 300000000 1507000000 1306000000 0.049 0.058 0.034 0.058 <div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2023, interest rate of 1.125%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2024, interest rate of 3.500%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2024, interest rate of 5.900%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2025, interest rate of 1.250%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2025, interest rate of 6.050%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured term loan due 2025, interest rate of 6.760%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2026, interest rate of 1.400%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2026, interest rate of 4.777%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2027, interest rate of 2.125%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2027, interest rate of 6.165%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured term loan due 2027, interest rate of 6.760%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2028, interest rate of 0.625%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2029, interest rate of 5.337%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2029, interest rate of 6.330%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes due 2032, interest rate of 6.379%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pollution control and industrial revenue bonds due at various dates through 2030, interest rates ranging from 4.05% to 5.00%</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank loans due at various dates through 2026</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Obligations under finance leases due at various dates through 2054</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,003 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,953 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current installments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(506)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,889 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,373 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The weighted average interest rate was 1.3% and 1.3% as of June 30, 2023 and December 31, 2022, respectively.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Related to the Company's long-term debt, excluding obligations under finance leases.</span></div> 0.01125 489000000 480000000 0.03500 500000000 499000000 0.05900 2000000000 2000000000 0.01250 326000000 320000000 0.06050 1750000000 1750000000 0.06760 750000000 750000000 0.01400 400000000 400000000 0.04777 1087000000 1067000000 0.02125 541000000 531000000 0.06165 2000000000 2000000000 0.06760 1000000000 1000000000 0.00625 543000000 533000000 0.05337 543000000 533000000 0.06330 750000000 750000000 0.06379 1000000000 1000000000 0.0405 0.0500 163000000 164000000 4000000 4000000 157000000 172000000 14003000000 13953000000 64000000 74000000 1050000000 506000000 12889000000 13373000000 0.013 0.013 P364D 500000000 P5Y 1000000000 P3Y 750000000 1750000000 1750000000 800000000 P12M 0.005 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's debt balances and amounts available for borrowing under its senior unsecured revolving credit facilities are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Revolving Credit Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for borrowing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">China Revolving Credit Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available for borrowing</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table> 0 1750000000 207000000 34000000 1 7500000000 1500000000 65000000 1 663000000 1100000000 565000000 1100000000 86000000 1 0.90 196000000 320000000 189000000 325000000 Benefit Obligations<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.122%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefit obligation funding is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expected </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash contributions to defined benefit pension plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments to nonqualified pension plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments to other postretirement benefit plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's estimates of its U.S. defined benefit pension plan contributions reflect the provisions of the Pension Protection Act of 2006.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension and postretirement benefit plan balances recognized in the unaudited consolidated balance sheets consist of the following:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(366)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(372)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.122%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2000000 0 4000000 0 6000000 0 7000000 0 34000000 1000000 16000000 1000000 66000000 1000000 33000000 1000000 33000000 0 42000000 0 66000000 0 83000000 0 3000000 1000000 -22000000 1000000 6000000 1000000 -43000000 1000000 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefit obligation funding is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expected </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash contributions to defined benefit pension plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments to nonqualified pension plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments to other postretirement benefit plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 13000000 27000000 9000000 18000000 2000000 4000000 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension and postretirement benefit plan balances recognized in the unaudited consolidated balance sheets consist of the following:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-retirement <br/>Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(366)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(372)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 164000000 0 160000000 0 21000000 3000000 21000000 3000000 366000000 35000000 372000000 35000000 -223000000 -38000000 -233000000 -38000000 Environmental<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to environmental laws and regulations worldwide that impose limitations on the discharge of pollutants into the air and water, establish standards for the treatment, storage and disposal of solid and hazardous wastes, and impose record keeping and notification requirements. Failure to timely comply with these laws and regulations may expose the Company to penalties. The Company believes that it is in substantial compliance with all applicable environmental laws and regulations and engages in an ongoing process of updating its controls to mitigate compliance risks. The Company is also subject to retained environmental obligations specified in various contractual agreements arising from the divestiture of certain businesses by the Company or one of its predecessor companies.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of environmental remediation liabilities are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Demerger obligations (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture obligations (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Active sites</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Superfund sites</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other environmental remediation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remediation</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to its industrial history and through retained contractual and legal obligations, the Company has the obligation to remediate specific areas on its own sites as well as on divested, demerger, orphan or U.S. Superfund sites (defined below). In addition, as part of the demerger agreement between the Company and Hoechst AG ("Hoechst"), a specified portion of the responsibility for environmental liabilities from a number of Hoechst divestitures was transferred to the Company (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Certain of these sites, at which the Company maintains continuing involvement, were and continue to be designated as discontinued operations when closed. The Company provides for such obligations when the event of loss is probable and reasonably estimable. The Company believes that environmental remediation costs will not have a material adverse effect on the financial position of the Company, but may have a material adverse effect on the results of operations or cash flows in any given period.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Superfund Sites</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the Company may be subject to substantial claims brought by U.S. federal or state regulatory agencies or private individuals pursuant to statutory authority or common law. In particular, the Company has a potential liability under the U.S. Federal Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, and related state laws (collectively referred to as "Superfund") for investigation and cleanup costs at certain sites. At most of these sites, numerous companies, including the Company, or one of its predecessor companies, have been notified that the U.S. Environmental Protection Agency ("EPA"), state governing bodies or private individuals consider such companies to be potentially responsible parties ("PRP") under Superfund or related laws. The proceedings relating to these sites are in various stages. The cleanup process has not been completed at most sites, and the status of the insurance coverage for some of these proceedings is uncertain. Consequently, the Company cannot accurately determine its ultimate liability for investigation or cleanup costs at these sites.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As events progress at each site for which it has been named a PRP, the Company accrues any probable and reasonably estimable liabilities. In establishing these liabilities, the Company considers the contaminants of concern, the potential impact thereof, the relationship of the contaminants of concern to its current and historic operations, its shipment of waste to a site, its percentage of total waste shipped to the site, the types of wastes involved, the conclusions of any studies, the magnitude of any remedial actions that may be necessary and the number and viability of other PRPs. Often the Company joins with other PRPs to sign joint defense agreements that settle, among PRPs, each party's percentage allocation of costs at the site. Although the ultimate liability may differ from the estimate, the Company routinely reviews the liabilities and revises the estimate, as appropriate, based on the most current information available.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One such site is the Diamond Alkali Superfund Site, which is comprised of a number of sub-sites, including the Lower Passaic River Study Area ("LPRSA"), which is the lower 17-mile stretch of the Passaic River ("Lower Passaic River Site"), and the Newark Bay Study Area. The Company and 70 other companies are parties to a May 2007 Administrative Order on Consent with the EPA to perform a Remedial Investigation/Feasibility Study ("RI/FS") at the Lower Passaic River Site in order to identify the levels of contaminants and potential cleanup actions, including the potential migration of contaminants between the LPRSA and the Newark Bay Area.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2016, the EPA issued its final Record of Decision concerning the remediation of the lower 8.3 miles of the Lower Passaic River Site ("Lower 8.3 Miles"). Pursuant to the EPA's Record of Decision, the Lower 8.3 Miles must be dredged bank to bank and an engineered cap must be installed at an EPA estimated cost of approximately $1.4 billion. In September 2021, the EPA issued a Record of Decision selecting an interim remedial plan for the upper 9 miles of the Lower Passaic River ("Upper 9 Miles"). Pursuant to the EPA's Record of Decision, targeted dredging will be conducted in the Upper 9 Miles to address surface sediments with elevated contamination followed by the installation of an engineered cap at an EPA estimated cost of $441 million.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company owned and/or operated facilities in the vicinity of the Lower 8.3 Miles, but has found no evidence that it contributed any of the contaminants of concern to the Passaic River. In June 2018, Occidental Chemical Corporation ("OCC"), the successor to the Diamond Alkali Company, sued a subsidiary of the Company and 119 other parties alleging claims for joint and several damages, contribution and declaratory relief under Section 107 and 113 of Superfund for costs to clean up the LPRSA portion of the Diamond Alkali Superfund Site, Occidental Chemical Corporation v. 21st Century Fox America, Inc., et al, No. 2:18-CV-11273 (MCA) (LDW) (U.S. District Court New Jersey) (the "2018 OCC Lawsuit"), alleging that each of the defendants owned or operated a facility that contributed contamination to the LPRSA. With respect to the Company, the 2018 OCC lawsuit is limited to the former Celanese facility that Essex County, New Jersey has agreed to indemnify the Company for and does not change the Company's estimated liability for LPRSA cleanup costs.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately, the United States lodged a Consent Decree in U.S. District Court for the District of New Jersey on December 16, 2022 that will resolve the Company's liability (and that of more than 80 other settling defendants) to the EPA for costs to clean up both the Lower 8.3 Miles and Upper 9 Miles of the Lower Passaic River Site in exchange for a collective payment of $150 million, United States v. Alden Leeds, Inc., No. 2:22-7326 (MCA) (LDW) (U.S. District Court New Jersey) ("Consent Decree Action"). The Consent Decree also will provide the Company protection from contribution claims by others for costs incurred to clean up both the Lower 8.3 Miles and Upper 9 Miles of the Lower Passaic River Site. The Company's proposed payment toward the $150 million collective settlement payment is not material to the Company's results of operations, cash flows or financial position. The Consent Decree is still subject to public comment and court approval.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 7, 2023, the U.S. District Court for the District of New Jersey entered an order staying and administratively terminating the 2018 OCC Lawsuit, pending resolution of the request for judicial approval of the Consent Decree in the Consent Decree Action. On March 24, 2023, OCC filed a new lawsuit against 40 parties, including a subsidiary of the Company, seeking to recover costs for remedial design work the EPA has ordered OCC to undertake for a portion of the LPRSA at an estimated cost of $71 million, Occidental Chemical Corporation v. Givaudan Fragrances Corporation, No. 2:23-cv-1699 (U.S. District Court New Jersey) (the "2023 OCC Lawsuit"). Like the earlier lawsuit, the 2023 OCC Lawsuit concerns the facility Essex County, New Jersey purchased and for which Essex County, New Jersey has agreed to defend and indemnify the Company. This new lawsuit does not change the Company's estimated liability for LPRSA cleanup costs.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will continue to vigorously defend these matters and continues to believe that its ultimate allocable share of the cleanup costs with respect to the Lower Passaic River Site, previously estimated at less than 1%, will not be material.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Environmental Matters</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, a methanol leak on a pipeline to our Bishop, Texas facility was discovered. The release has been contained, the leak has been repaired and the pipeline has resumed operation. The Company promptly disclosed the incident to state and federal authorities, including the Texas Commission on Environmental Quality and the EPA, and remediation activities are now completed. While the Company has not received a notice of violation nor been assessed any fines or penalties to date, the Company recorded a reserve in Other current liabilities based on anticipated clean-up costs and possible penalties to state or federal authorities. The Company does not believe that resolution of this matter will have a material impact on our financial condition or results of operations.</span></div> <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of environmental remediation liabilities are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Demerger obligations (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture obligations (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Active sites</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Superfund sites</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other environmental remediation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 18000000 20000000 13000000 14000000 20000000 21000000 8000000 10000000 2000000 2000000 61000000 67000000 70 1400000000 441000000 150000000 150000000 40 71000000 0.01 Shareholders' Equity<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Board of Directors follows a policy of declaring, subject to legally available funds, a quarterly cash dividend on each share of the Company's Common Stock, par value $0.0001 per share ("Common Stock"), unless the Company's Board of Directors, in its sole discretion, determines otherwise. The amount available to the Company to pay cash dividends is not currently restricted by its existing Global Credit Agreements and its indentures governing its senior unsecured notes. Any decision to declare and pay dividends in the future will be made at the discretion of the Company's Board of Directors and will depend on, among other things, the results of operations, cash requirements, financial condition, contractual restrictions and other factors that the Company's Board of Directors may deem relevant.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company declared a quarterly cash dividend of $0.70 per share on its Common Stock on July 19, 2023, amounting to $76 million. The cash dividend will be paid on August 14, 2023 to holders of record as of July 31, 2023.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treasury Stock</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Board of Directors authorizes repurchases of Common Stock from time to time. These authorizations give management discretion in determining the timing and conditions under which shares may be repurchased. This repurchase program does not have an expiration date.</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total From<br/>February 2008<br/>Through<br/>June 30, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,324,429 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average purchase price per share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.71 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased (in $ millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,803 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate Board of Directors repurchase authorizations during the period (in $ millions)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,866 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase of treasury stock reduces the number of shares outstanding. The repurchased shares may be used by the Company for compensation programs utilizing the Company's stock and other corporate purposes. The Company accounts for treasury stock using the cost method and includes treasury stock as a component of shareholders' equity.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not repurchase any Common Stock during the six months ended June 30, 2023 or 2022.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Comprehensive Income (Loss), Net</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.413%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income<br/>Tax<br/>(Provision)<br/>Benefit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income<br/>Tax<br/>(Provision)<br/>Benefit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.413%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income<br/>Tax<br/>(Provision)<br/>Benefit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income<br/>Tax<br/>(Provision)<br/>Benefit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to Accumulated other comprehensive income (loss), net, are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">on Cash </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Flow </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hedges</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Postretirement</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Benefits Gain (Loss)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_79" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Note 8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income<br/>(Loss), Net</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(488)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(518)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (provision) benefit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of June 30, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(676)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(702)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0.0001 0.70 76000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total From<br/>February 2008<br/>Through<br/>June 30, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,324,429 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average purchase price per share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.71 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased (in $ millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,803 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate Board of Directors repurchase authorizations during the period (in $ millions)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,866 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 69324429 83.71 5803000000 6866000000 0 0 <div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.413%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income<br/>Tax<br/>(Provision)<br/>Benefit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income<br/>Tax<br/>(Provision)<br/>Benefit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.413%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income<br/>Tax<br/>(Provision)<br/>Benefit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income<br/>Tax<br/>(Provision)<br/>Benefit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -214000000 -13000000 -201000000 -107000000 24000000 -131000000 -1000000 -1000000 0 33000000 7000000 26000000 0 1000000 -1000000 0 0 0 -215000000 -15000000 -200000000 -74000000 31000000 -105000000 -218000000 -30000000 -188000000 -122000000 30000000 -152000000 3000000 -1000000 4000000 52000000 11000000 41000000 1000000 1000000 0 -2000000 0 -2000000 -216000000 -32000000 -184000000 -68000000 41000000 -109000000 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to Accumulated other comprehensive income (loss), net, are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">on Cash </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Flow </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hedges</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_109" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Postretirement</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Benefits Gain (Loss)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_79" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Note 8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income<br/>(Loss), Net</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(488)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(518)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (provision) benefit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of June 30, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(676)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(702)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -488000000 -22000000 -8000000 -518000000 -218000000 -2000000 -1000000 -221000000 0 5000000 0 5000000 -30000000 -1000000 -1000000 -32000000 -676000000 -18000000 -8000000 -702000000 Income Taxes<div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate for the three months ended June 30, 2023 was lower compared to the same period in 2022, primarily due to decreased earnings in high taxed jurisdictions related to current demand conditions and a decrease in valuation allowances on U.S. foreign tax credit carryforwards due to revised forecasts of foreign sourced income and expenses during the carryforward period. The effective income tax rate for the six months ended June 30, 2023 was lower compared to the same period in 2022, primarily due to decreased earnings in high taxed jurisdictions related to current demand conditions.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the Tax Cuts and Jobs Act (the "TCJA") was enacted and was effective January 1, 2018. The U.S. Treasury has issued various final and proposed regulatory packages supplementing the TCJA provisions since 2018. There have been no material proposed or final regulatory packages during the three months ended June 30, 2023.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Inflation Reduction Act (the "IRA") was enacted and included a 1% excise tax on share repurchases in excess of $1 million, and a corporate minimum tax of 15% on adjusted book earnings. The corporate minimum tax paid is creditable in future years to the extent that regular tax liability exceeds the minimum tax in any given year. The Company does not expect these provisions and any newly issued administrative guidance to have a material impact to future income tax expense. The IRA also provides various beneficial credits for energy efficient related manufacturing, transportation and fuels, hydrogen/carbon recapture and renewable energy, which the Company is evaluating in regards to planned projects.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will continue to monitor the expected impacts of any new guidance on the Company's filing positions and will record the impacts as discrete income tax expense or benefit in the period the guidance is finalized or becomes effective.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the TCJA and uncertainty as to future foreign source income, the Company previously recorded a valuation allowance on a substantial portion of its foreign tax credit carryforwards. The Company is currently evaluating tax planning strategies to enable the use of the Company's foreign tax credit carryforwards that may decrease the Company's effective tax rate in future periods as the valuation allowance is reversed.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's tax returns have been under joint audit for the years 2013 through 2015 by the United States, Netherlands and Germany (the "Authorities"). In September 2021, the Company received a draft joint audit report proposing adjustments to transfer pricing and the reallocation of income between the related jurisdictions. The Authorities also proposed to apply these adjustments to open tax years through 2019. The Company and the Authorities were unable to reach an agreement jointly and therefore the audits continued on a separate jurisdictional basis. In the fourth quarter of 2022, the Company concluded settlement discussions with the Dutch tax authorities. The Company is engaged in discussions with the other authorities regarding the ongoing examinations and will evaluate all additional potential remedies as the discussions progress.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company's income tax returns in Mexico are under audit for the year 2018, and in Canada for the years 2016 through 2018. In January 2022, the Mexico tax authorities issued preliminary findings for disallowance of operating expenses on several of the applicable tax returns. The Company has analyzed the preliminary findings, engaged in preliminary discussions with the Mexico tax authorities and has recorded the appropriate tax reserves as of June 30, 2023. The Company will continue discussions with the Mexico authorities in 2023. Related to Canada, the Company is in ongoing discussions regarding the audit findings with the Canadian authorities and does not expect a material impact to income tax expense.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023, the Company believes that an adequate provision for income taxes has been made for all open tax years related to the examinations by government authorities. However, the outcome of tax audits cannot be predicted with certainty. If any issues raised in the audits described above are resolved in a manner inconsistent with the Company's expectations or the Company is unsuccessful in defending its positions, the Company could be required to adjust its provision for income taxes in the period such resolution occurs. If required, any such adjustments could be material to the statements of operations and cash flows in the period(s) recorded.</span></div> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> -0.02 0.20 0.06 0.19 Derivative Financial Instruments<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives Designated As Hedges</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total notional amount of foreign currency denominated debt and cross-currency swaps designated as net investment hedges are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In € millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the offering of the Acquisition USD Notes in July 2022 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_73" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), the Company entered into cross-currency swaps to effectively convert $2.0 billion and $500 million of the Acquisition USD Notes into a euro-denominated borrowing at prevailing euro interest rates, maturing on July 15, 2027 and July 15, 2032, respectively. The swaps and €1.5 billion of the Acquisition Euro Notes qualify and have been designated as net investment hedges of the Company's foreign currency exchange rate exposure on the net investments of certain of its euro-denominated subsidiaries.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives Not Designated As Hedges</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Forwards and Swaps</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross notional values of the foreign currency forwards and swaps not designated as hedges are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,715 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the fair value of the Company's derivative and non-derivative instruments is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Other Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Earnings (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Statement of Operations Classification</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as Cash Flow Hedges</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-949"><span style="-sec-ix-hidden:f-950">Cost of sales</span></span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-955"><span style="-sec-ix-hidden:f-956">Interest expense</span></span></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-961"><span style="-sec-ix-hidden:f-962">Cost of sales</span></span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as Net Investment Hedges</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_73" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Not Designated as Hedges</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-983"><span style="-sec-ix-hidden:f-984">Foreign exchange gain (loss), net; Other income (expense), net</span></span></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Other Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Earnings (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Statement of Operations Classification</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-993"><span style="-sec-ix-hidden:f-994">Cost of sales</span></span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-999"><span style="-sec-ix-hidden:f-1000">Interest expense</span></span></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1005"><span style="-sec-ix-hidden:f-1006">Cost of sales</span></span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_73" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Not Designated as Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1027"><span style="-sec-ix-hidden:f-1028">Foreign exchange gain (loss), net; Other income (expense), net</span></span></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_115" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 13</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding the fair value of the Company's derivative instruments.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's commodity swaps, interest rate swaps, cross-currency swaps and foreign currency forwards and swaps permit the Company to net settle all contracts with the counterparty through a single payment in an agreed upon currency in the event of default or early termination of the contract, similar to a master netting arrangement.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the gross amounts of the Company's derivative instruments and the amounts offset in the unaudited consolidated balance sheets is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-1034"><span style="-sec-ix-hidden:f-1035">Derivative Assets</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount offset in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount presented in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount not offset in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-1047"><span style="-sec-ix-hidden:f-1048">Derivative Liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount offset in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount presented in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount not offset in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total notional amount of foreign currency denominated debt and cross-currency swaps designated as net investment hedges are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In € millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 5591000000 5639000000 2000000000 500000000 1500000000 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross notional values of the foreign currency forwards and swaps not designated as hedges are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,715 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1715000000 1314000000 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the fair value of the Company's derivative and non-derivative instruments is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Other Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Earnings (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Statement of Operations Classification</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as Cash Flow Hedges</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-949"><span style="-sec-ix-hidden:f-950">Cost of sales</span></span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-955"><span style="-sec-ix-hidden:f-956">Interest expense</span></span></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-961"><span style="-sec-ix-hidden:f-962">Cost of sales</span></span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as Net Investment Hedges</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_73" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Not Designated as Hedges</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-983"><span style="-sec-ix-hidden:f-984">Foreign exchange gain (loss), net; Other income (expense), net</span></span></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Other Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Earnings (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Statement of Operations Classification</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as Cash Flow Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-993"><span style="-sec-ix-hidden:f-994">Cost of sales</span></span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-999"><span style="-sec-ix-hidden:f-1000">Interest expense</span></span></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1005"><span style="-sec-ix-hidden:f-1006">Cost of sales</span></span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as Net Investment Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_73" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Not Designated as Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1027"><span style="-sec-ix-hidden:f-1028">Foreign exchange gain (loss), net; Other income (expense), net</span></span></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div> -7000000 42000000 0 11000000 0 0 -2000000 -2000000 2000000 0 -1000000 0 -5000000 42000000 -3000000 9000000 -5000000 93000000 0 0 -74000000 25000000 0 0 -79000000 118000000 0 0 0 0 -1000000 -3000000 0 0 -1000000 -3000000 -7000000 59000000 1000000 11000000 0 0 -4000000 -4000000 4000000 0 -2000000 0 -3000000 59000000 -5000000 7000000 -61000000 121000000 0 0 -93000000 27000000 0 0 -154000000 148000000 0 0 0 0 1000000 -4000000 0 0 1000000 -4000000 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the gross amounts of the Company's derivative instruments and the amounts offset in the unaudited consolidated balance sheets is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-1034"><span style="-sec-ix-hidden:f-1035">Derivative Assets</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount offset in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount presented in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount not offset in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 156000000 169000000 0 0 156000000 169000000 17000000 16000000 139000000 153000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>June 30, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-1047"><span style="-sec-ix-hidden:f-1048">Derivative Liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount offset in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount presented in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount not offset in the consolidated balance sheets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 279000000 189000000 0 0 279000000 189000000 17000000 16000000 262000000 173000000 Fair Value Measurements<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's financial assets and liabilities are measured at fair value on a recurring basis as follows:</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative financial instruments include interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps and are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 fair value measurement inputs such as interest rates and foreign currency exchange rates. These market inputs are utilized in the discounted cash flow calculation considering the instrument's term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation for interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps are observable in the active markets and are classified as Level 2 in the fair value measurement hierarchy.</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.823%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.704%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedges</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1062">Current Other assets</span></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1064">Noncurrent Other assets</span></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.823%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.704%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1075">Current Other assets</span></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1077">Noncurrent Other assets</span></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedges</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1083">Current Other liabilities</span></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other liabilities</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Carrying values and fair values of financial instruments that are not carried at fair value are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurement</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying <br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other<br/>Observable <br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unobservable <br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts in nonqualified trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current installments of long-term debt</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,003 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,807 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts in nonqualified trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current installments of long-term debt</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,953 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,247 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,419 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, the equity investments included in the table above are not publicly traded and their fair values are not readily determinable. The Company believes the carrying values approximate fair value. Insurance contracts in nonqualified trusts consist of long-term fixed income securities, which are valued using independent vendor pricing models with observable inputs in the active market and therefore represent a Level 2 fair value measurement. The fair value of long-term debt is based on valuations from third-party banks and market quotations and is classified as Level 2 in the fair value measurement hierarchy. The fair value of obligations under finance leases, which are included in long-term debt, is based on lease payments and discount rates, which are not observable in the market and therefore represents a Level 3 fair value measurement.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023, and December 31, 2022, the fair values of cash and cash equivalents, receivables, marketable securities, trade payables, short-term borrowings and the current installments of long-term debt approximate carrying values due to the short-term nature of these instruments. These items have been excluded from the table with the exception of the current installments of long-term debt.</span></div> <div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.823%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.704%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedges</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1062">Current Other assets</span></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1064">Noncurrent Other assets</span></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.823%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.704%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1075">Current Other assets</span></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1077">Noncurrent Other assets</span></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedges</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1083">Current Other liabilities</span></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Net Investment Hedges</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent Other liabilities</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forwards and swaps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Other liabilities</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div> 6000000 34000000 4000000 101000000 11000000 156000000 60000000 207000000 4000000 8000000 279000000 9000000 39000000 99000000 13000000 9000000 169000000 2000000 58000000 126000000 3000000 189000000 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Carrying values and fair values of financial instruments that are not carried at fair value are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurement</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying <br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other<br/>Observable <br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unobservable <br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts in nonqualified trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current installments of long-term debt</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,003 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,807 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts in nonqualified trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current installments of long-term debt</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,953 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,247 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,419 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 170000000 0 0 0 21000000 21000000 0 21000000 14003000000 13650000000 157000000 13807000000 170000000 0 0 0 22000000 23000000 0 23000000 13953000000 13247000000 172000000 13419000000 Commitments and Contingencies<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreed to guarantee or indemnify third parties for environmental and other liabilities pursuant to a variety of agreements, including asset and business divestiture agreements, leases, settlement agreements and various agreements with affiliated companies. Although many of these obligations contain monetary and/or time limitations, others do not provide such limitations.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accrued for all probable and reasonably estimable losses associated with all known matters or claims. These known obligations include the following:</span></div><div style="margin-top:11pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Demerger Obligations</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Hoechst demerger, the Company agreed to indemnify Hoechst, and its legal successors, for various liabilities under the demerger agreement, including for environmental liabilities associated with contamination arising either from environmental damage in general ("Category A") or under 19 divestiture agreements entered into by Hoechst prior to the demerger ("Category B") (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_85" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 9</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's obligation to indemnify Hoechst, and its legal successors, is capped under Category B at €250 million. If and to the extent the environmental damage should exceed €750 million in aggregate, the Company's obligation to indemnify Hoechst and its legal successors applies, but is then limited to 33.33% of the remediation cost without further limitations. Cumulative </span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payments under the divestiture agreements as of June 30, 2023 are $110 million. Though the Company is significantly under its obligation cap under Category B, most of the divestiture agreements have become time barred and/or any notified environmental damage claims have been partially settled.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also undertaken in the demerger agreement to indemnify Hoechst and its legal successors for (i) 33.33% of any and all Category A liabilities that result from Hoechst being held as the responsible party pursuant to public law or current or future environmental law or by third parties pursuant to private or public law related to contamination and (ii) liabilities that Hoechst is required to discharge, including tax liabilities, which are associated with businesses that were included in the demerger but were not demerged due to legal restrictions on the transfers of such items. These indemnities do not provide for any monetary or time limitations. The Company has not been requested by Hoechst to make any payments in connection with this indemnification. Accordingly, the Company has not made any payments to Hoechst and its legal successors.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company's evaluation of currently available information, including the lack of requests for indemnification, the Company cannot estimate the remaining demerger obligations, if any, in excess of amounts accrued.</span></div><div style="margin-top:11pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Divestiture Obligations</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its predecessor companies agreed to indemnify third-party purchasers of former businesses and assets for various pre-closing conditions, as well as for breaches of representations, warranties and covenants. Such liabilities also include environmental liability, product liability, antitrust and other liabilities. These indemnifications and guarantees represent standard contractual terms associated with typical divestiture agreements and, other than environmental liabilities, the Company does not believe that they expose the Company to significant risk (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_85" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 9</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has divested numerous businesses, investments and facilities through agreements containing indemnifications or guarantees to the purchasers. Many of the obligations contain monetary and/or time limitations, which extend through 2037. The aggregate amount of outstanding indemnifications and guarantees provided for under these agreements is $116 million as of June 30, 2023. Other agreements do not provide for any monetary or time limitations.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company's evaluation of currently available information, including the number of requests for indemnification or other payment received by the Company, the Company cannot estimate the remaining divestiture obligations, if any, in excess of amounts accrued.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Obligations</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company enters into various purchase commitments for goods and services. The Company maintains a number of "take-or-pay" contracts for purchases of raw materials, utilities and other services. Certain of the contracts contain a contract termination buy-out provision that allows for the Company to exit the contracts for amounts less than the remaining take-or-pay obligations. Additionally, the Company has other outstanding commitments representing maintenance and service agreements, energy and utility agreements, consulting contracts and software agreements. As of June 30, 2023, the Company had unconditional purchase obligations of $4.1 billion, of which $355 million will be paid in 2023, $665 million in 2024, $558 million in 2025, $436 million in 2026, $355 million in 2027 and the balance thereafter through 2042.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in legal and regulatory proceedings, lawsuits, claims and investigations incidental to the normal conduct of business, relating to such matters as product liability, land disputes, insurance coverage disputes, contracts, employment, antitrust or competition, intellectual property, personal injury and other actions in tort, workers' compensation, chemical exposure, asbestos exposure, taxes, trade compliance, acquisitions and divestitures, claims of current and legacy shareholders, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where the Company is named as a defendant and, based on the current facts, does not believe the outcomes from these matters would be material to the Company's results of operations, cash flows or financial position.</span></div> 19 250000000 750000000 0.3333 110000000 0.3333 116000000 4100000000 355000000 665000000 558000000 436000000 355000000 Segment Information<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Engineered<br/>Materials</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acetyl<br/>Chain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Activities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,585 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,795 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (charges) gains, net (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_148" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 18</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings (loss) of affiliates</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,559 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,486 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (charges) gains, net (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_148" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 18</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings (loss) of affiliates</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes intersegment sales primarily related to the Acetyl Chain.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes an increase in accrued capital expenditures of $7 million and $8 million for the three months ended June 30, 2023 and 2022, respectively.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.145%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Engineered<br/>Materials</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acetyl<br/>Chain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Activities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,215 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,483 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,648 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (charges) gains, net (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_148" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 18</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings (loss) of affiliates</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible assets, net</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,646 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,070 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,589 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,914 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,649 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="padding-left:9pt;text-indent:-9pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,211 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="padding-left:9pt;text-indent:-9pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,024 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,014 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings (loss) of affiliates</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible assets, net</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,826 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,247 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,611 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,471 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes intersegment sales primarily related to the Acetyl Chain.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes a decrease in accrued capital expenditures of $49 million and $15 million for the six months ended June 30, 2023 and 2022, respectively.</span></div> <div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Engineered<br/>Materials</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acetyl<br/>Chain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Activities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,585 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,795 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (charges) gains, net (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_148" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 18</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings (loss) of affiliates</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,559 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,486 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (charges) gains, net (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_148" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 18</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings (loss) of affiliates</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes intersegment sales primarily related to the Acetyl Chain.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes an increase in accrued capital expenditures of $7 million and $8 million for the three months ended June 30, 2023 and 2022, respectively.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.145%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Engineered<br/>Materials</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acetyl<br/>Chain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Activities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,215 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,483 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,648 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (charges) gains, net (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#iff328472e4c345f998428d73e7793b34_148" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 18</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings (loss) of affiliates</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible assets, net</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,646 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,070 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,589 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,914 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,649 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="padding-left:9pt;text-indent:-9pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,211 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="padding-left:9pt;text-indent:-9pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,024 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,014 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings (loss) of affiliates</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible assets, net</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,826 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,247 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,611 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,471 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes intersegment sales primarily related to the Acetyl Chain.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes a decrease in accrued capital expenditures of $49 million and $15 million for the six months ended June 30, 2023 and 2022, respectively.</span></div> 1585000000 1233000000 0 -23000000 2795000000 8000000 0 2000000 0 10000000 158000000 295000000 -118000000 0 335000000 18000000 2000000 3000000 0 23000000 112000000 54000000 6000000 0 172000000 58000000 67000000 27000000 0 152000000 948000000 1559000000 0 -21000000 2486000000 -1000000 0 0 0 -1000000 166000000 428000000 -111000000 0 483000000 53000000 3000000 4000000 0 60000000 45000000 52000000 6000000 0 103000000 35000000 87000000 10000000 0 132000000 7000000 8000000 3215000000 2483000000 0 -50000000 5648000000 29000000 1000000 3000000 0 33000000 270000000 573000000 -257000000 0 586000000 29000000 3000000 6000000 0 38000000 224000000 108000000 12000000 0 344000000 103000000 118000000 39000000 0 260000000 10646000000 424000000 0 0 11070000000 18146000000 5589000000 1914000000 0 25649000000 1858000000 3211000000 0 -45000000 5024000000 290000000 931000000 -207000000 0 1014000000 102000000 7000000 7000000 0 116000000 91000000 108000000 10000000 0 209000000 65000000 157000000 24000000 0 246000000 10826000000 421000000 0 0 11247000000 20611000000 5471000000 190000000 0 26272000000 -49000000 -15000000 Revenue Recognition<div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain contracts that represent take-or-pay revenue arrangements in which the Company's performance obligations extend over multiple years. As of June 30, 2023, the Company had $1.3 billion of remaining performance obligations related to take-or-pay contracts. The Company expects to recognize approximately $272 million of its remaining performance obligations as Net sales in 2023, $481 million in 2024, $324 million in 2025 and the balance thereafter.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily relate to advances or deposits received from the Company's customers before revenue is recognized. These amounts are recorded as deferred revenue and are included in Current and Noncurrent Other liabilities in the unaudited consolidated balance sheets.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have any material contract assets as of June 30, 2023.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregated Revenue</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, the Company's business segmentation is aligned according to the nature and economic characteristics of its products and customer relationships and provides meaningful disaggregation of each business segment's results of operations.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its Engineered Materials business segment through its project management pipeline, which is comprised of a broad range of projects which are solutions-based and are tailored to each customer's unique needs. Projects are identified and selected based on success rate and may involve a number of different polymers per project for use in multiple end-use applications. Therefore, the Company is agnostic toward products and end-use markets for the Engineered Materials business segment.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its Acetyl Chain business segment by leveraging its ability to sell chemicals externally to end-use markets or downstream to its acetate tow, intermediate chemistry, emulsion polymers, redispersible powders and ethylene vinyl acetate polymers businesses. Decisions to sell externally and geographically or downstream and along the Acetyl Chain are based on market demand, trade flows and maximizing the value of its chemicals. Therefore, the Company's strategic focus is on executing within this integrated chain model and less on driving product-specific revenue.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further disaggregation of Net sales by business segment and geographic destination is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Engineered Materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe and Africa</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,585 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,215 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Acetyl Chain</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe and Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,538 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,433 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,166 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Excludes intersegment sales of $23 million and $21 million for the three months ended June 30, 2023 and 2022, respectively. Excludes intersegment sales of $50 million and $45 million for the six months ended June 30, 2023 and 2022, respectively.</span></div> 1300000000 272000000 481000000 324000000 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further disaggregation of Net sales by business segment and geographic destination is as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Engineered Materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe and Africa</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,585 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,215 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Acetyl Chain</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe and Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,538 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,433 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,166 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Excludes intersegment sales of $23 million and $21 million for the three months ended June 30, 2023 and 2022, respectively. Excludes intersegment sales of $50 million and $45 million for the six months ended June 30, 2023 and 2022, respectively.</span></div> 471000000 284000000 950000000 573000000 519000000 380000000 1079000000 757000000 554000000 256000000 1102000000 477000000 41000000 28000000 84000000 51000000 1585000000 948000000 3215000000 1858000000 361000000 451000000 726000000 876000000 437000000 545000000 897000000 1137000000 379000000 510000000 746000000 1071000000 33000000 32000000 64000000 82000000 1210000000 1538000000 2433000000 3166000000 23000000 21000000 50000000 45000000 Earnings (Loss) Per Share<div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions, except share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Celanese Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares - basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,886,678 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,392,155 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,761,071 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,289,603 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental shares attributable to equity awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419,653 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520,293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868,452 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares - diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,306,331 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,123,349 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,281,364 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,158,055 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Excludes options to purchase 242,421 and 0 shares of Common Stock for the three months ended June 30, 2023 and 2022, respectively, and 164,739 and 0 shares of Common Stock for the six months ended June 30, 2023 and 2022, respectively, as their effect would have been antidilutive. Excludes 102,773 and 107,287 equity award shares for the three months ended June 30, 2023 and 2022, respectively, and 46,008 and 82,887 equity award shares for the six months ended June 30, 2023 and 2022, respectively, as their effect would have been antidilutive.</span></div> <div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions, except share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Celanese Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares - basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,886,678 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,392,155 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,761,071 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,289,603 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental shares attributable to equity awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419,653 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520,293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868,452 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares - diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,306,331 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,123,349 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,281,364 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,158,055 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Excludes options to purchase 242,421 and 0 shares of Common Stock for the three months ended June 30, 2023 and 2022, respectively, and 164,739 and 0 shares of Common Stock for the six months ended June 30, 2023 and 2022, respectively, as their effect would have been antidilutive. Excludes 102,773 and 107,287 equity award shares for the three months ended June 30, 2023 and 2022, respectively, and 46,008 and 82,887 equity award shares for the six months ended June 30, 2023 and 2022, respectively, as their effect would have been antidilutive.</span></div> 219000000 440000000 313000000 942000000 1000000 -6000000 -2000000 -6000000 220000000 434000000 311000000 936000000 108886678 108392155 108761071 108289603 419653 731194 520293 868452 109306331 109123349 109281364 109158055 242421 0 164739 0 102773 107287 46008 82887 Other (Charges) Gains, Net<div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes employee termination benefits primarily related to Company-wide business optimization projects during the three and six months ended June 30, 2023.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the restructuring liabilities by business segment are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Engineered<br/>Materials</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acetyl<br/>Chain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Termination Benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 10000000 -1000000 33000000 0 10000000 -1000000 33000000 0 <div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the restructuring liabilities by business segment are as follows:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Engineered<br/>Materials</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acetyl<br/>Chain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In $ millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Termination Benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 4000000 1000000 1000000 6000000 29000000 1000000 3000000 33000000 14000000 1000000 3000000 18000000 19000000 1000000 1000000 21000000 false false false false Includes $115 million and $166 million payable to DuPont related to the M&M Acquisition and transition activities as of June 30, 2023 and December 31, 2022, respectively. The weighted average interest rate was 4.9% and 5.8% as of June 30, 2023 and December 31, 2022, respectively. The weighted average interest rate was 3.4% and 5.8% as of June 30, 2023 and December 31, 2022, respectively. The weighted average interest rate was 1.3% and 1.3% as of June 30, 2023 and December 31, 2022, respectively. Related to the Company's long-term debt, excluding obligations under finance leases. Includes intersegment sales primarily related to the Acetyl Chain. Includes an increase in accrued capital expenditures of $7 million and $8 million for the three months ended June 30, 2023 and 2022, respectively. Includes intersegment sales primarily related to the Acetyl Chain. Includes a decrease in accrued capital expenditures of $49 million and $15 million for the six months ended June 30, 2023 and 2022, respectively. Excludes intersegment sales of $23 million and $21 million for the three months ended June 30, 2023 and 2022, respectively. Excludes intersegment sales of $50 million and $45 million for the six months ended June 30, 2023 and 2022, respectively. Excludes options to purchase 242,421 and 0 shares of Common Stock for the three months ended June 30, 2023 and 2022, respectively, and 164,739 and 0 shares of Common Stock for the six months ended June 30, 2023 and 2022, respectively, as their effect would have been antidilutive. Excludes 102,773 and 107,287 equity award shares for the three months ended June 30, 2023 and 2022, respectively, and 46,008 and 82,887 equity award shares for the six months ended June 30, 2023 and 2022, respectively, as their effect would have been antidilutive. Includes employee termination benefits primarily related to Company-wide business optimization projects during the three and six months ended June 30, 2023. Related to goodwill reclassified to assets held for sale (Note 3). There were no accumulated impairment losses as of June 30, 2023. Related to finite-lived intangible assets reclassified to assets held for sale (Note 3). Related to indefinite-lived intangible assets reclassified to assets held for sale (Note 3). EXCEL 102 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 103 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 104 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 105 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 370 386 1 true 106 0 false 10 false false R1.htm 0000001 - Document - Cover Sheet http://www.celanese.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Statement - Unaudited Interim Consolidated Statement of Operations Sheet http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations Unaudited Interim Consolidated Statement of Operations Statements 2 false false R3.htm 0000003 - Statement - Unaudited Interim Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss Unaudited Interim Consolidated Statements of Comprehensive Income (Loss) Statements 3 false false R4.htm 0000004 - Statement - Unaudited Consolidated Balance Sheets Sheet http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets Unaudited Consolidated Balance Sheets Statements 4 false false R5.htm 0000005 - Statement - Unaudited Consolidated Balance Sheets (Parenthetical) Sheet http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical Unaudited Consolidated Balance Sheets (Parenthetical) Statements 5 false false R6.htm 0000006 - Statement - Unaudited Interim Consolidated Statement Equity Sheet http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity Unaudited Interim Consolidated Statement Equity Statements 6 false false R7.htm 0000007 - Statement - Unaudited Interim Consolidated Statements of Cash Flows Sheet http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows Unaudited Interim Consolidated Statements of Cash Flows Statements 7 false false R8.htm 0000008 - Disclosure - Description of the Company and Basis of Presentation Sheet http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentation Description of the Company and Basis of Presentation Notes 8 false false R9.htm 0000009 - Disclosure - Recent Accounting Pronouncements Sheet http://www.celanese.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements Notes 9 false false R10.htm 0000010 - Disclosure - Acquisitions, Dispositions and Plant Closures Sheet http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosures Acquisitions, Dispositions and Plant Closures Notes 10 false false R11.htm 0000011 - Disclosure - Inventories Sheet http://www.celanese.com/role/Inventories Inventories Notes 11 false false R12.htm 0000012 - Disclosure - Goodwill and Intangible Assets, net Sheet http://www.celanese.com/role/GoodwillandIntangibleAssetsnet Goodwill and Intangible Assets, net Notes 12 false false R13.htm 0000013 - Disclosure - Current Other Liabilities Sheet http://www.celanese.com/role/CurrentOtherLiabilities Current Other Liabilities Notes 13 false false R14.htm 0000014 - Disclosure - Debt Sheet http://www.celanese.com/role/Debt Debt Notes 14 false false R15.htm 0000015 - Disclosure - Benefit Obligations Sheet http://www.celanese.com/role/BenefitObligations Benefit Obligations Notes 15 false false R16.htm 0000016 - Disclosure - Environmental Sheet http://www.celanese.com/role/Environmental Environmental Notes 16 false false R17.htm 0000017 - Disclosure - Stockholders' Equity Sheet http://www.celanese.com/role/StockholdersEquity Stockholders' Equity Notes 17 false false R18.htm 0000018 - Disclosure - Other (Charges) Gains, Net Sheet http://www.celanese.com/role/OtherChargesGainsNet Other (Charges) Gains, Net Notes 18 false false R19.htm 0000019 - Disclosure - Income Taxes Sheet http://www.celanese.com/role/IncomeTaxes Income Taxes Notes 19 false false R20.htm 0000020 - Disclosure - Derivative Financial Instruments Sheet http://www.celanese.com/role/DerivativeFinancialInstruments Derivative Financial Instruments Notes 20 false false R21.htm 0000021 - Disclosure - Fair Value Measurements Sheet http://www.celanese.com/role/FairValueMeasurements Fair Value Measurements Notes 21 false false R22.htm 0000022 - Disclosure - Commitments and Contingencies Sheet http://www.celanese.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 22 false false R23.htm 0000023 - Disclosure - Segment Information Sheet http://www.celanese.com/role/SegmentInformation Segment Information Notes 23 false false R24.htm 0000024 - Disclosure - Revenue Recognition Sheet http://www.celanese.com/role/RevenueRecognition Revenue Recognition Notes 24 false false R25.htm 0000025 - Disclosure - Earnings (Loss) Per Share Sheet http://www.celanese.com/role/EarningsLossPerShare Earnings (Loss) Per Share Notes 25 false false R26.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 26 false false R27.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 27 false false R28.htm 9954701 - Disclosure - Recent Accounting Pronouncements (Policies) Sheet http://www.celanese.com/role/RecentAccountingPronouncementsPolicies Recent Accounting Pronouncements (Policies) Policies http://www.celanese.com/role/RecentAccountingPronouncements 28 false false R29.htm 9954702 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures (Tables) Sheet http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresTables Acquisitions, Dispositions and Plant Closures Plant Closures (Tables) Tables 29 false false R30.htm 9954703 - Disclosure - Inventories (Tables) Sheet http://www.celanese.com/role/InventoriesTables Inventories (Tables) Tables http://www.celanese.com/role/Inventories 30 false false R31.htm 9954704 - Disclosure - Goodwill and Intangible Assets, Net (Tables) Sheet http://www.celanese.com/role/GoodwillandIntangibleAssetsNetTables Goodwill and Intangible Assets, Net (Tables) Tables http://www.celanese.com/role/GoodwillandIntangibleAssetsnet 31 false false R32.htm 9954705 - Disclosure - Current Other Liabilities (Tables) Sheet http://www.celanese.com/role/CurrentOtherLiabilitiesTables Current Other Liabilities (Tables) Tables http://www.celanese.com/role/CurrentOtherLiabilities 32 false false R33.htm 9954706 - Disclosure - Debt (Tables) Sheet http://www.celanese.com/role/DebtTables Debt (Tables) Tables http://www.celanese.com/role/Debt 33 false false R34.htm 9954707 - Disclosure - Benefit Obligations (Tables) Sheet http://www.celanese.com/role/BenefitObligationsTables Benefit Obligations (Tables) Tables http://www.celanese.com/role/BenefitObligations 34 false false R35.htm 9954708 - Disclosure - Environmental (Tables) Sheet http://www.celanese.com/role/EnvironmentalTables Environmental (Tables) Tables http://www.celanese.com/role/Environmental 35 false false R36.htm 9954709 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.celanese.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.celanese.com/role/StockholdersEquity 36 false false R37.htm 9954710 - Disclosure - Other (Charges) Gains, Net (Tables) Sheet http://www.celanese.com/role/OtherChargesGainsNetTables Other (Charges) Gains, Net (Tables) Tables http://www.celanese.com/role/OtherChargesGainsNet 37 false false R38.htm 9954711 - Disclosure - Income Taxes (Tables) Sheet http://www.celanese.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.celanese.com/role/IncomeTaxes 38 false false R39.htm 9954712 - Disclosure - Derivative Financial Instruments (Tables) Sheet http://www.celanese.com/role/DerivativeFinancialInstrumentsTables Derivative Financial Instruments (Tables) Tables http://www.celanese.com/role/DerivativeFinancialInstruments 39 false false R40.htm 9954713 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.celanese.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.celanese.com/role/FairValueMeasurements 40 false false R41.htm 9954714 - Disclosure - Segment Information (Tables) Sheet http://www.celanese.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.celanese.com/role/SegmentInformation 41 false false R42.htm 9954715 - Disclosure - Revenue Recognition (Tables) Sheet http://www.celanese.com/role/RevenueRecognitionTables Revenue Recognition (Tables) Tables http://www.celanese.com/role/RevenueRecognition 42 false false R43.htm 9954716 - Disclosure - Earnings (Loss) Per Share (Tables) Sheet http://www.celanese.com/role/EarningsLossPerShareTables Earnings (Loss) Per Share (Tables) Tables http://www.celanese.com/role/EarningsLossPerShare 43 false false R44.htm 9954717 - Disclosure - Description of the Company and Basis of Presentation (Narrative) (Details) Sheet http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails Description of the Company and Basis of Presentation (Narrative) (Details) Details http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentation 44 false false R45.htm 9954718 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures - Narrative (Details) Sheet http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails Acquisitions, Dispositions and Plant Closures Plant Closures - Narrative (Details) Details http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresTables 45 false false R46.htm 9954719 - Disclosure - Acquisitions, Dispositions and Plant Closures - Business Acquisition, Pro Forma Information (Details) Sheet http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresBusinessAcquisitionProFormaInformationDetails Acquisitions, Dispositions and Plant Closures - Business Acquisition, Pro Forma Information (Details) Details 46 false false R47.htm 9954720 - Disclosure - Acquisitions, Dispositions and Plant Closures - Disposal Groups, Including Discontinued Operations (Details) Sheet http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails Acquisitions, Dispositions and Plant Closures - Disposal Groups, Including Discontinued Operations (Details) Details 47 false false R48.htm 9954721 - Disclosure - Inventories - Schedule of Inventories (Details) Sheet http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails Inventories - Schedule of Inventories (Details) Details 48 false false R49.htm 9954722 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details) Sheet http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details) Details 49 false false R50.htm 9954723 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details) Sheet http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details) Details 50 false false R51.htm 9954724 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Indefinite-Lived Intangible Assets (Details) Sheet http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails Goodwill and Intangible Assets, Net - Schedule of Indefinite-Lived Intangible Assets (Details) Details 51 false false R52.htm 9954725 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) Sheet http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) Details 52 false false R53.htm 9954726 - Disclosure - Current Other Liabilities (Details) Sheet http://www.celanese.com/role/CurrentOtherLiabilitiesDetails Current Other Liabilities (Details) Details http://www.celanese.com/role/CurrentOtherLiabilitiesTables 53 false false R54.htm 9954727 - Disclosure - Debt - Schedule of Short-term Debt (Details) Sheet http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails Debt - Schedule of Short-term Debt (Details) Details 54 false false R55.htm 9954728 - Disclosure - Debt - Schedule of Long-term Debt (Details) Sheet http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails Debt - Schedule of Long-term Debt (Details) Details 55 false false R56.htm 9954729 - Disclosure - Debt - Senior Credit Facilities Narrative (Details) Sheet http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails Debt - Senior Credit Facilities Narrative (Details) Details 56 false false R57.htm 9954730 - Disclosure - Debt - Schedule of Revolving Credit Facility (Details) Sheet http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails Debt - Schedule of Revolving Credit Facility (Details) Details 57 false false R58.htm 9954731 - Disclosure - Debt - Senior Notes Narrative (Details) Notes http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails Debt - Senior Notes Narrative (Details) Details 58 false false R59.htm 9954732 - Disclosure - Debt - Accounts Receivable Securitization Facility Narrative (Details) Sheet http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails Debt - Accounts Receivable Securitization Facility Narrative (Details) Details 59 false false R60.htm 9954733 - Disclosure - Debt - Factoring and Discounting Agreements Narrative (Details) Sheet http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails Debt - Factoring and Discounting Agreements Narrative (Details) Details 60 false false R61.htm 9954734 - Disclosure - Benefit Obligations - Schedule of Net Periodic Benefit Costs Recognized (Details) Sheet http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails Benefit Obligations - Schedule of Net Periodic Benefit Costs Recognized (Details) Details 61 false false R62.htm 9954735 - Disclosure - Benefit Obligations - Schedule of Company Commitments to Fund Benefit Obligations (Details) Sheet http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails Benefit Obligations - Schedule of Company Commitments to Fund Benefit Obligations (Details) Details 62 false false R63.htm 9954736 - Disclosure - Benefit Obligations - Schedule of Defined Benefit Plans Disclosures (Details) Sheet http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails Benefit Obligations - Schedule of Defined Benefit Plans Disclosures (Details) Details 63 false false R64.htm 9954737 - Disclosure - Environmental (Schedule of Environmental Remediation Reserves) (Details) Sheet http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails Environmental (Schedule of Environmental Remediation Reserves) (Details) Details http://www.celanese.com/role/EnvironmentalTables 64 false false R65.htm 9954738 - Disclosure - Environmental - US Superfund Sites Narrative (Details) Sheet http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails Environmental - US Superfund Sites Narrative (Details) Details 65 false false R66.htm 9954739 - Disclosure - Stockholders' Equity - Narrative (Details) Sheet http://www.celanese.com/role/StockholdersEquityNarrativeDetails Stockholders' Equity - Narrative (Details) Details 66 false false R67.htm 9954740 - Disclosure - Stockholders' Equity - Schedule of Treasury Stock (Details) Sheet http://www.celanese.com/role/StockholdersEquityScheduleofTreasuryStockDetails Stockholders' Equity - Schedule of Treasury Stock (Details) Details 67 false false R68.htm 9954741 - Disclosure - Stockholders' Equity - Schedule of Components of Other Comprehensive Income (Loss), Net (Details) Sheet http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails Stockholders' Equity - Schedule of Components of Other Comprehensive Income (Loss), Net (Details) Details 68 false false R69.htm 9954742 - Disclosure - Stockholders' Equity - Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net (Details) Sheet http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails Stockholders' Equity - Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net (Details) Details 69 false false R70.htm 9954743 - Disclosure - Other (Charges) Gains, Net - Schedule of Other (Charges) Gains, Net (Details) Sheet http://www.celanese.com/role/OtherChargesGainsNetScheduleofOtherChargesGainsNetDetails Other (Charges) Gains, Net - Schedule of Other (Charges) Gains, Net (Details) Details http://www.celanese.com/role/OtherChargesGainsNetTables 70 false false R71.htm 9954744 - Disclosure - Other (Charges) Gains, Net - Narrative (Details) Sheet http://www.celanese.com/role/OtherChargesGainsNetNarrativeDetails Other (Charges) Gains, Net - Narrative (Details) Details http://www.celanese.com/role/OtherChargesGainsNetTables 71 false false R72.htm 9954745 - Disclosure - Other (Charges) Gains, Net - Schedule of Restructuring Reserve by Type of Cost (Details) Sheet http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails Other (Charges) Gains, Net - Schedule of Restructuring Reserve by Type of Cost (Details) Details http://www.celanese.com/role/OtherChargesGainsNetTables 72 false false R73.htm 9954746 - Disclosure - Income Taxes - Schedule of Effective Tax Rate (Details) Sheet http://www.celanese.com/role/IncomeTaxesScheduleofEffectiveTaxRateDetails Income Taxes - Schedule of Effective Tax Rate (Details) Details 73 false false R74.htm 9954748 - Disclosure - Derivative Financial Instruments Derivative Financial Instruments (Schedule of Net Investment Hedges) (Details) Sheet http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails Derivative Financial Instruments Derivative Financial Instruments (Schedule of Net Investment Hedges) (Details) Details 74 false false R75.htm 9954749 - Disclosure - Derivative Financial Instruments Derivative Financial Instruments (Schedule of Foreign Currency Forwards) (Details) Sheet http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails Derivative Financial Instruments Derivative Financial Instruments (Schedule of Foreign Currency Forwards) (Details) Details 75 false false R76.htm 9954750 - Disclosure - Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details) Sheet http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details) Details http://www.celanese.com/role/DerivativeFinancialInstrumentsTables 76 false false R77.htm 9954751 - Disclosure - Derivative Financial Instruments (Schedule of Offsetting Assets) (Details) Sheet http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails Derivative Financial Instruments (Schedule of Offsetting Assets) (Details) Details http://www.celanese.com/role/DerivativeFinancialInstrumentsTables 77 false false R78.htm 9954752 - Disclosure - Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details) Sheet http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details) Details http://www.celanese.com/role/DerivativeFinancialInstrumentsTables 78 false false R79.htm 9954753 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 79 false false R80.htm 9954754 - Disclosure - Fair Value Measurements - Schedule of Carrying Values and Fair Values of Financial Instruments (Details) Sheet http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails Fair Value Measurements - Schedule of Carrying Values and Fair Values of Financial Instruments (Details) Details 80 false false R81.htm 9954755 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 81 false false R82.htm 9954756 - Disclosure - Segment Information - Schedule of Business Segments (Details) Sheet http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails Segment Information - Schedule of Business Segments (Details) Details 82 false false R83.htm 9954757 - Disclosure - Revenue Recognition - Disaggregation of net sales (Details) Sheet http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails Revenue Recognition - Disaggregation of net sales (Details) Details 83 false false R84.htm 9954758 - Disclosure - Revenue Recognition Remaining Performance Obligations (Details) Sheet http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails Revenue Recognition Remaining Performance Obligations (Details) Details 84 false false R85.htm 9954759 - Disclosure - Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) Sheet http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) Details http://www.celanese.com/role/EarningsLossPerShareTables 85 false false R86.htm 9954760 - Disclosure - Earnings (Loss) Per Share - Narrative (Details) Sheet http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails Earnings (Loss) Per Share - Narrative (Details) Details http://www.celanese.com/role/EarningsLossPerShareTables 86 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 - ce-20230630.htm 4 ce-20230630.htm ce-20230630.xsd ce-20230630_cal.xml ce-20230630_def.xml ce-20230630_lab.xml ce-20230630_pre.xml ex1026302310-q.htm ex1036302310-q.htm ex31106302310-q.htm ex31206302310-q.htm ex32106302310-q.htm ex32206302310-q.htm ce-20230630_g1.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 108 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ce-20230630.htm": { "axisCustom": 0, "axisStandard": 31, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 1254, "http://xbrl.sec.gov/dei/2023": 48, "http://xbrl.sec.gov/ecd/2023": 4 }, "contextCount": 370, "dts": { "calculationLink": { "local": [ "ce-20230630_cal.xml" ] }, "definitionLink": { "local": [ "ce-20230630_def.xml" ] }, "inline": { "local": [ "ce-20230630.htm" ] }, "labelLink": { "local": [ "ce-20230630_lab.xml" ] }, "presentationLink": { "local": [ "ce-20230630_pre.xml" ] }, "schema": { "local": [ "ce-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] } }, "elementCount": 722, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 28, "http://xbrl.sec.gov/dei/2023": 5, "total": 33 }, "keyCustom": 40, "keyStandard": 346, "memberCustom": 42, "memberStandard": 52, "nsprefix": "ce", "nsuri": "http://www.celanese.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://www.celanese.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "ce:AcquisitionsDispositionsandPlantClosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - Acquisitions, Dispositions and Plant Closures", "menuCat": "Notes", "order": "10", "role": "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosures", "shortName": "Acquisitions, Dispositions and Plant Closures", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "ce:AcquisitionsDispositionsandPlantClosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - Inventories", "menuCat": "Notes", "order": "11", "role": "http://www.celanese.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - Goodwill and Intangible Assets, net", "menuCat": "Notes", "order": "12", "role": "http://www.celanese.com/role/GoodwillandIntangibleAssetsnet", "shortName": "Goodwill and Intangible Assets, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - Current Other Liabilities", "menuCat": "Notes", "order": "13", "role": "http://www.celanese.com/role/CurrentOtherLiabilities", "shortName": "Current Other Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - Debt", "menuCat": "Notes", "order": "14", "role": "http://www.celanese.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - Benefit Obligations", "menuCat": "Notes", "order": "15", "role": "http://www.celanese.com/role/BenefitObligations", "shortName": "Benefit Obligations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EnvironmentalLossContingencyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - Environmental", "menuCat": "Notes", "order": "16", "role": "http://www.celanese.com/role/Environmental", "shortName": "Environmental", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EnvironmentalLossContingencyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - Stockholders' Equity", "menuCat": "Notes", "order": "17", "role": "http://www.celanese.com/role/StockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "ce:OtherChargesGainsNetTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - Other (Charges) Gains, Net", "menuCat": "Notes", "order": "18", "role": "http://www.celanese.com/role/OtherChargesGainsNet", "shortName": "Other (Charges) Gains, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "ce:OtherChargesGainsNetTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "19", "role": "http://www.celanese.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000002 - Statement - Unaudited Interim Consolidated Statement of Operations", "menuCat": "Statements", "order": "2", "role": "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations", "shortName": "Unaudited Interim Consolidated Statement of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": "-6", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - Derivative Financial Instruments", "menuCat": "Notes", "order": "20", "role": "http://www.celanese.com/role/DerivativeFinancialInstruments", "shortName": "Derivative Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - Fair Value Measurements", "menuCat": "Notes", "order": "21", "role": "http://www.celanese.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "22", "role": "http://www.celanese.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000023 - Disclosure - Segment Information", "menuCat": "Notes", "order": "23", "role": "http://www.celanese.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000024 - Disclosure - Revenue Recognition", "menuCat": "Notes", "order": "24", "role": "http://www.celanese.com/role/RevenueRecognition", "shortName": "Revenue Recognition", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000025 - Disclosure - Earnings (Loss) Per Share", "menuCat": "Notes", "order": "25", "role": "http://www.celanese.com/role/EarningsLossPerShare", "shortName": "Earnings (Loss) Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "menuCat": "Notes", "order": "26", "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "shortName": "Pay vs Performance Disclosure", "subGroupType": "", "uniqueAnchor": null }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": null, "first": true, "lang": "en-US", "name": "ecd:Rule10b51ArrAdoptedFlag", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "995445 - Disclosure - Insider Trading Arrangements", "menuCat": "Notes", "order": "27", "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "shortName": "Insider Trading Arrangements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": null, "first": true, "lang": "en-US", "name": "ecd:Rule10b51ArrAdoptedFlag", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954701 - Disclosure - Recent Accounting Pronouncements (Policies)", "menuCat": "Policies", "order": "28", "role": "http://www.celanese.com/role/RecentAccountingPronouncementsPolicies", "shortName": "Recent Accounting Pronouncements (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954702 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures (Tables)", "menuCat": "Tables", "order": "29", "role": "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresTables", "shortName": "Acquisitions, Dispositions and Plant Closures Plant Closures (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - Unaudited Interim Consolidated Statements of Comprehensive Income (Loss)", "menuCat": "Statements", "order": "3", "role": "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss", "shortName": "Unaudited Interim Consolidated Statements of Comprehensive Income (Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": "-6", "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954703 - Disclosure - Inventories (Tables)", "menuCat": "Tables", "order": "30", "role": "http://www.celanese.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954704 - Disclosure - Goodwill and Intangible Assets, Net (Tables)", "menuCat": "Tables", "order": "31", "role": "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetTables", "shortName": "Goodwill and Intangible Assets, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954705 - Disclosure - Current Other Liabilities (Tables)", "menuCat": "Tables", "order": "32", "role": "http://www.celanese.com/role/CurrentOtherLiabilitiesTables", "shortName": "Current Other Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954706 - Disclosure - Debt (Tables)", "menuCat": "Tables", "order": "33", "role": "http://www.celanese.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954707 - Disclosure - Benefit Obligations (Tables)", "menuCat": "Tables", "order": "34", "role": "http://www.celanese.com/role/BenefitObligationsTables", "shortName": "Benefit Obligations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EnvironmentalExitCostsByCostTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954708 - Disclosure - Environmental (Tables)", "menuCat": "Tables", "order": "35", "role": "http://www.celanese.com/role/EnvironmentalTables", "shortName": "Environmental (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EnvironmentalExitCostsByCostTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954709 - Disclosure - Stockholders' Equity (Tables)", "menuCat": "Tables", "order": "36", "role": "http://www.celanese.com/role/StockholdersEquityTables", "shortName": "Stockholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "ce:ScheduleOfOtherChargesGainsNetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954710 - Disclosure - Other (Charges) Gains, Net (Tables)", "menuCat": "Tables", "order": "37", "role": "http://www.celanese.com/role/OtherChargesGainsNetTables", "shortName": "Other (Charges) Gains, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "ce:ScheduleOfOtherChargesGainsNetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954711 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "38", "role": "http://www.celanese.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954712 - Disclosure - Derivative Financial Instruments (Tables)", "menuCat": "Tables", "order": "39", "role": "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "shortName": "Derivative Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - Unaudited Consolidated Balance Sheets", "menuCat": "Statements", "order": "4", "role": "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets", "shortName": "Unaudited Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954713 - Disclosure - Fair Value Measurements (Tables)", "menuCat": "Tables", "order": "40", "role": "http://www.celanese.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954714 - Disclosure - Segment Information (Tables)", "menuCat": "Tables", "order": "41", "role": "http://www.celanese.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954715 - Disclosure - Revenue Recognition (Tables)", "menuCat": "Tables", "order": "42", "role": "http://www.celanese.com/role/RevenueRecognitionTables", "shortName": "Revenue Recognition (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954716 - Disclosure - Earnings (Loss) Per Share (Tables)", "menuCat": "Tables", "order": "43", "role": "http://www.celanese.com/role/EarningsLossPerShareTables", "shortName": "Earnings (Loss) Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-77", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954717 - Disclosure - Description of the Company and Basis of Presentation (Narrative) (Details)", "menuCat": "Details", "order": "44", "role": "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails", "shortName": "Description of the Company and Basis of Presentation (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-77", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-88", "decimals": "-6", "first": true, "lang": "en-US", "name": "ce:PaymentsToEquityMethodInvestment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954718 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures - Narrative (Details)", "menuCat": "Details", "order": "45", "role": "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "shortName": "Acquisitions, Dispositions and Plant Closures Plant Closures - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-88", "decimals": "-6", "first": true, "lang": "en-US", "name": "ce:PaymentsToEquityMethodInvestment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-11", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954719 - Disclosure - Acquisitions, Dispositions and Plant Closures - Business Acquisition, Pro Forma Information (Details)", "menuCat": "Details", "order": "46", "role": "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresBusinessAcquisitionProFormaInformationDetails", "shortName": "Acquisitions, Dispositions and Plant Closures - Business Acquisition, Pro Forma Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-11", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-85", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954720 - Disclosure - Acquisitions, Dispositions and Plant Closures - Disposal Groups, Including Discontinued Operations (Details)", "menuCat": "Details", "order": "47", "role": "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails", "shortName": "Acquisitions, Dispositions and Plant Closures - Disposal Groups, Including Discontinued Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-85", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954721 - Disclosure - Inventories - Schedule of Inventories (Details)", "menuCat": "Details", "order": "48", "role": "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails", "shortName": "Inventories - Schedule of Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-14", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954722 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details)", "menuCat": "Details", "order": "49", "role": "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails", "shortName": "Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": "-6", "lang": "en-US", "name": "us-gaap:GoodwillPurchaseAccountingAdjustments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - Unaudited Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "5", "role": "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical", "shortName": "Unaudited Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-14", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954723 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details)", "menuCat": "Details", "order": "50", "role": "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails", "shortName": "Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-14", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-108", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954724 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Indefinite-Lived Intangible Assets (Details)", "menuCat": "Details", "order": "51", "role": "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails", "shortName": "Goodwill and Intangible Assets, Net - Schedule of Indefinite-Lived Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-108", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954725 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)", "menuCat": "Details", "order": "52", "role": "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails", "shortName": "Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954726 - Disclosure - Current Other Liabilities (Details)", "menuCat": "Details", "order": "53", "role": "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails", "shortName": "Current Other Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShortTermDebtTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954727 - Disclosure - Debt - Schedule of Short-term Debt (Details)", "menuCat": "Details", "order": "54", "role": "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "shortName": "Debt - Schedule of Short-term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShortTermDebtTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OtherShortTermBorrowings", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954728 - Disclosure - Debt - Schedule of Long-term Debt (Details)", "menuCat": "Details", "order": "55", "role": "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "shortName": "Debt - Schedule of Long-term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-155", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954729 - Disclosure - Debt - Senior Credit Facilities Narrative (Details)", "menuCat": "Details", "order": "56", "role": "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "shortName": "Debt - Senior Credit Facilities Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-155", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShortTermDebtTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-113", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LinesOfCreditCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954730 - Disclosure - Debt - Schedule of Revolving Credit Facility (Details)", "menuCat": "Details", "order": "57", "role": "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "shortName": "Debt - Schedule of Revolving Credit Facility (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-166", "decimals": "-6", "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentRedemptionPricePercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954731 - Disclosure - Debt - Senior Notes Narrative (Details)", "menuCat": "Details", "order": "58", "role": "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails", "shortName": "Debt - Senior Notes Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentRedemptionPricePercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-170", "decimals": "2", "first": true, "lang": "en-US", "name": "ce:PercentageOfFairValueOfSalesReceivables", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954732 - Disclosure - Debt - Accounts Receivable Securitization Facility Narrative (Details)", "menuCat": "Details", "order": "59", "role": "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails", "shortName": "Debt - Accounts Receivable Securitization Facility Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-170", "decimals": "2", "first": true, "lang": "en-US", "name": "ce:PercentageOfFairValueOfSalesReceivables", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-53", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - Unaudited Interim Consolidated Statement Equity", "menuCat": "Statements", "order": "6", "role": "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "shortName": "Unaudited Interim Consolidated Statement Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-53", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-175", "decimals": "2", "first": true, "lang": "en-US", "name": "ce:TransferOfFinancialAssetsAccountedForAsSalesNonRecourseBasisAccountReceivablePercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954733 - Disclosure - Debt - Factoring and Discounting Agreements Narrative (Details)", "menuCat": "Details", "order": "60", "role": "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails", "shortName": "Debt - Factoring and Discounting Agreements Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-175", "decimals": "2", "first": true, "lang": "en-US", "name": "ce:TransferOfFinancialAssetsAccountedForAsSalesNonRecourseBasisAccountReceivablePercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-181", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954734 - Disclosure - Benefit Obligations - Schedule of Net Periodic Benefit Costs Recognized (Details)", "menuCat": "Details", "order": "61", "role": "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails", "shortName": "Benefit Obligations - Schedule of Net Periodic Benefit Costs Recognized (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-181", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ce:ScheduleOfCompanyCommitmentsToFundBenefitObligationsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-185", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954735 - Disclosure - Benefit Obligations - Schedule of Company Commitments to Fund Benefit Obligations (Details)", "menuCat": "Details", "order": "62", "role": "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "shortName": "Benefit Obligations - Schedule of Company Commitments to Fund Benefit Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ce:ScheduleOfCompanyCommitmentsToFundBenefitObligationsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-185", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-189", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954736 - Disclosure - Benefit Obligations - Schedule of Defined Benefit Plans Disclosures (Details)", "menuCat": "Details", "order": "63", "role": "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "shortName": "Benefit Obligations - Schedule of Defined Benefit Plans Disclosures (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-189", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:EnvironmentalExitCostsByCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "ce:DemergerObligations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954737 - Disclosure - Environmental (Schedule of Environmental Remediation Reserves) (Details)", "menuCat": "Details", "order": "64", "role": "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails", "shortName": "Environmental (Schedule of Environmental Remediation Reserves) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:EnvironmentalExitCostsByCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "ce:DemergerObligations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-199", "decimals": "INF", "first": true, "lang": "en-US", "name": "ce:NumberOfPartiesIncludedInUsepaOrder", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954738 - Disclosure - Environmental - US Superfund Sites Narrative (Details)", "menuCat": "Details", "order": "65", "role": "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails", "shortName": "Environmental - US Superfund Sites Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-199", "decimals": "INF", "first": true, "lang": "en-US", "name": "ce:NumberOfPartiesIncludedInUsepaOrder", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954739 - Disclosure - Stockholders' Equity - Narrative (Details)", "menuCat": "Details", "order": "66", "role": "http://www.celanese.com/role/StockholdersEquityNarrativeDetails", "shortName": "Stockholders' Equity - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-201", "decimals": "2", "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockSharesAcquired", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954740 - Disclosure - Stockholders' Equity - Schedule of Treasury Stock (Details)", "menuCat": "Details", "order": "67", "role": "http://www.celanese.com/role/StockholdersEquityScheduleofTreasuryStockDetails", "shortName": "Stockholders' Equity - Schedule of Treasury Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-202", "decimals": "INF", "lang": "en-US", "name": "us-gaap:TreasuryStockSharesAcquired", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954741 - Disclosure - Stockholders' Equity - Schedule of Components of Other Comprehensive Income (Loss), Net (Details)", "menuCat": "Details", "order": "68", "role": "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails", "shortName": "Stockholders' Equity - Schedule of Components of Other Comprehensive Income (Loss), Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-14", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954742 - Disclosure - Stockholders' Equity - Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net (Details)", "menuCat": "Details", "order": "69", "role": "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails", "shortName": "Stockholders' Equity - Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000007 - Statement - Unaudited Interim Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "7", "role": "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows", "shortName": "Unaudited Interim Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DepreciationAmortizationAndAccretionNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ce:ScheduleOfOtherChargesGainsNetTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954743 - Disclosure - Other (Charges) Gains, Net - Schedule of Other (Charges) Gains, Net (Details)", "menuCat": "Details", "order": "70", "role": "http://www.celanese.com/role/OtherChargesGainsNetScheduleofOtherChargesGainsNetDetails", "shortName": "Other (Charges) Gains, Net - Schedule of Other (Charges) Gains, Net (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ce:ScheduleOfOtherChargesGainsNetTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954744 - Disclosure - Other (Charges) Gains, Net - Narrative (Details)", "menuCat": "Details", "order": "71", "role": "http://www.celanese.com/role/OtherChargesGainsNetNarrativeDetails", "shortName": "Other (Charges) Gains, Net - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R72": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ce:ScheduleOfOtherChargesGainsNetTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954745 - Disclosure - Other (Charges) Gains, Net - Schedule of Restructuring Reserve by Type of Cost (Details)", "menuCat": "Details", "order": "72", "role": "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails", "shortName": "Other (Charges) Gains, Net - Schedule of Restructuring Reserve by Type of Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-362", "decimals": "-6", "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954746 - Disclosure - Income Taxes - Schedule of Effective Tax Rate (Details)", "menuCat": "Details", "order": "73", "role": "http://www.celanese.com/role/IncomeTaxesScheduleofEffectiveTaxRateDetails", "shortName": "Income Taxes - Schedule of Effective Tax Rate (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-219", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954748 - Disclosure - Derivative Financial Instruments Derivative Financial Instruments (Schedule of Net Investment Hedges) (Details)", "menuCat": "Details", "order": "74", "role": "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "shortName": "Derivative Financial Instruments Derivative Financial Instruments (Schedule of Net Investment Hedges) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-213", "decimals": "-6", "lang": "en-US", "name": "us-gaap:NotionalAmountOfNonderivativeInstruments", "reportCount": 1, "unique": true, "unitRef": "eur", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-219", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954749 - Disclosure - Derivative Financial Instruments Derivative Financial Instruments (Schedule of Foreign Currency Forwards) (Details)", "menuCat": "Details", "order": "75", "role": "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "shortName": "Derivative Financial Instruments Derivative Financial Instruments (Schedule of Foreign Currency Forwards) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-237", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954750 - Disclosure - Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details)", "menuCat": "Details", "order": "76", "role": "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "shortName": "Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-237", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954751 - Disclosure - Derivative Financial Instruments (Schedule of Offsetting Assets) (Details)", "menuCat": "Details", "order": "77", "role": "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails", "shortName": "Derivative Financial Instruments (Schedule of Offsetting Assets) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:OffsettingLiabilitiesTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954752 - Disclosure - Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details)", "menuCat": "Details", "order": "78", "role": "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails", "shortName": "Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:OffsettingLiabilitiesTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954753 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "menuCat": "Details", "order": "79", "role": "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "shortName": "Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-260", "decimals": "-6", "lang": "en-US", "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000008 - Disclosure - Description of the Company and Basis of Presentation", "menuCat": "Notes", "order": "8", "role": "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentation", "shortName": "Description of the Company and Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954754 - Disclosure - Fair Value Measurements - Schedule of Carrying Values and Fair Values of Financial Instruments (Details)", "menuCat": "Details", "order": "80", "role": "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails", "shortName": "Fair Value Measurements - Schedule of Carrying Values and Fair Values of Financial Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954755 - Disclosure - Commitments and Contingencies - Narrative (Details)", "menuCat": "Details", "order": "81", "role": "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails", "shortName": "Commitments and Contingencies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954756 - Disclosure - Segment Information - Schedule of Business Segments (Details)", "menuCat": "Details", "order": "82", "role": "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails", "shortName": "Segment Information - Schedule of Business Segments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954757 - Disclosure - Revenue Recognition - Disaggregation of net sales (Details)", "menuCat": "Details", "order": "83", "role": "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "shortName": "Revenue Recognition - Disaggregation of net sales (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-309", "decimals": "-6", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-8", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954758 - Disclosure - Revenue Recognition Remaining Performance Obligations (Details)", "menuCat": "Details", "order": "84", "role": "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails", "shortName": "Revenue Recognition Remaining Performance Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-13", "decimals": "-8", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperations", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954759 - Disclosure - Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details)", "menuCat": "Details", "order": "85", "role": "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "shortName": "Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-10", "decimals": "INF", "lang": "en-US", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "link:footnote", "span", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-351", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954760 - Disclosure - Earnings (Loss) Per Share - Narrative (Details)", "menuCat": "Details", "order": "86", "role": "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails", "shortName": "Earnings (Loss) Per Share - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000009 - Disclosure - Recent Accounting Pronouncements", "menuCat": "Notes", "order": "9", "role": "http://www.celanese.com/role/RecentAccountingPronouncements", "shortName": "Recent Accounting Pronouncements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ce-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 106, "tag": { "ce_A364DayDelayedDrawTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "364 Day Delayed-Draw Term Loan", "label": "364 Day Delayed-Draw Term Loan [Member]", "terseLabel": "364 Day Delayed-Draw Term Loan" } } }, "localname": "A364DayDelayedDrawTermLoanMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_A3YearDelayedDrawTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "3 Year Delayed-Draw Term Loan", "label": "3 Year Delayed-Draw Term Loan [Member]", "terseLabel": "3 Year Delayed-Draw Term Loan" } } }, "localname": "A3YearDelayedDrawTermLoanMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_A5YearDelayedDrawTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "5 Year Delayed-Draw Term Loan", "label": "5 Year Delayed-Draw Term Loan [Member]", "terseLabel": "5 Year Delayed-Draw Term Loan" } } }, "localname": "A5YearDelayedDrawTermLoanMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_AccountsReceivableSecuritizationFacilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounts Receivable Securitization Facility [Abstract]", "label": "Accounts Receivable Securitization Facility [Abstract]", "terseLabel": "Accounts Receivable Securitization Facility [Abstract]" } } }, "localname": "AccountsReceivableSecuritizationFacilityAbstract", "nsuri": "http://www.celanese.com/20230630", "xbrltype": "stringItemType" }, "ce_AcetylChainMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acetyl Chain [Member]", "label": "Acetyl Chain [Member]", "terseLabel": "Acetyl Chain [Member]", "verboseLabel": "Acetyl Chain" } } }, "localname": "AcetylChainMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails", "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "ce_AcquisitionNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquisition Notes", "label": "Acquisition Notes [Member]", "terseLabel": "Acquisition Notes" } } }, "localname": "AcquisitionNotesMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "ce_AcquisitionsDispositionsandPlantClosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquisitions, Dispositions and Plant Closures [Abstract].", "label": "Acquisitions, Dispositions and Plant Closures [Abstract]", "terseLabel": "Acquisitions, Dispositions and Plant Closures [Abstract]" } } }, "localname": "AcquisitionsDispositionsandPlantClosuresAbstract", "nsuri": "http://www.celanese.com/20230630", "xbrltype": "stringItemType" }, "ce_AcquisitionsDispositionsandPlantClosuresTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquisitions, Dispositions and Plant Closures [Text Block].", "label": "Acquisitions, Dispositions and Plant Closures [Text Block]", "terseLabel": "Acquisitions, Dispositions and Plant Closures" } } }, "localname": "AcquisitionsDispositionsandPlantClosuresTextBlock", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosures" ], "xbrltype": "textBlockItemType" }, "ce_ActiveSites": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails": { "order": 3.0, "parentTag": "us-gaap_AccrualForEnvironmentalLossContingencies", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Active sites.", "label": "Active sites", "terseLabel": "Active sites" } } }, "localname": "ActiveSites", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails" ], "xbrltype": "monetaryItemType" }, "ce_AmendedRestatedReceivableSecuritizationFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An accounts receivable securitization facility which allows a wholly owned, bankruptcy-remote subsidiary to sell an undivided interest in a pool of trade receivables (received through contribution from certain subsidiaries that retain the responsibility of servicing the receivables) to financial institutions participating in the facility.", "label": "Amended Restated Receivable Securitization Facility [Member]", "terseLabel": "Amended restated receivable securitization facility" } } }, "localname": "AmendedRestatedReceivableSecuritizationFacilityMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeIncomeTaxesNoncontrollingInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Income (Loss) From Continuing Operations Before Income Taxes, Noncontrolling Interest", "terseLabel": "Proforma Earnings (loss) from continuing operations before tax" } } }, "localname": "BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeIncomeTaxesNoncontrollingInterest", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresBusinessAcquisitionProFormaInformationDetails" ], "xbrltype": "monetaryItemType" }, "ce_BusinessCombinationProFormaInformationInterestExpenseAndDebtIssuanceCostAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of pro forma interest expense and debt issuance cost amortization related to borrowings under the Term Loan Facility and the issuance of Acquisition notes as if the business combination had been completed at the beginning of a period.", "label": "Business Combination, Pro Forma Information, Interest Expense and Debt Issuance Cost Amortization", "terseLabel": "Business Combination, Pro Forma Information, Interest Expense and Debt Issuance Cost Amortization" } } }, "localname": "BusinessCombinationProFormaInformationInterestExpenseAndDebtIssuanceCostAmortization", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_BusinessCombinationProFormaInformationInventoryStepUpAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of pro forma inventory step-up amortization as if the business combination had been completed at the beginning of a period.", "label": "Business Combination, Pro Forma Information, Inventory Step Up Amortization", "terseLabel": "Business Combination, Pro Forma Information, Inventory Step Up Amortization" } } }, "localname": "BusinessCombinationProFormaInformationInventoryStepUpAmortization", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_CelaneseCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Celanese Corporation", "label": "Celanese Corporation [Member]", "terseLabel": "Celanese Corporation" } } }, "localname": "CelaneseCorporationMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_ChinaRevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "China Revolving Credit Facility [Member]", "terseLabel": "China Revolving Credit Facility" } } }, "localname": "ChinaRevolvingCreditFacilityMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_ChinaWorkingCapitalTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CSIT senior unsecured working capital loan contract for CNY 800 million payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates.", "label": "China Working Capital Term Loan [Member]", "terseLabel": "China Working Capital Term Loan" } } }, "localname": "ChinaWorkingCapitalTermLoanMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_ConsolidatedVenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consolidated Ventures", "label": "Consolidated Ventures [Member]", "terseLabel": "Consolidated Ventures" } } }, "localname": "ConsolidatedVenturesMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_CurrentOtherLiabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Current Other Liabilities [Line Items]", "label": "Current Other Liabilities [Line Items]", "terseLabel": "Current Other Liabilities [Line Items]" } } }, "localname": "CurrentOtherLiabilitiesLineItems", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "ce_CurrentOtherLiabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Current Other Liabilities [Table]", "label": "Current Other Liabilities [Table]", "terseLabel": "Current Other Liabilities [Table]" } } }, "localname": "CurrentOtherLiabilitiesTable", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "ce_DemergerObligations": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails": { "order": 1.0, "parentTag": "us-gaap_AccrualForEnvironmentalLossContingencies", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Demerger obligations.", "label": "Demerger obligations", "verboseLabel": "Demerger obligations (Note\u00a014)" } } }, "localname": "DemergerObligations", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails" ], "xbrltype": "monetaryItemType" }, "ce_DerivativeFinancialInstrumentsScheduleofIntersetRateSwapNarrativeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative Financial Instruments (Schedule of Interset Rate Swap Narrative) [Abstract]", "label": "Derivative Financial Instruments (Schedule of Interset Rate Swap Narrative) [Abstract]", "terseLabel": "Derivative Financial Instruments (Schedule of Interset Rate Swap Narrative) [Abstract]" } } }, "localname": "DerivativeFinancialInstrumentsScheduleofIntersetRateSwapNarrativeAbstract", "nsuri": "http://www.celanese.com/20230630", "xbrltype": "stringItemType" }, "ce_DivestitureAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Divestiture Agreements [Member].", "label": "Divestiture Agreements [Member]", "terseLabel": "Divestiture Agreements" } } }, "localname": "DivestitureAgreementsMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_DivestitureObligations": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails": { "order": 2.0, "parentTag": "us-gaap_AccrualForEnvironmentalLossContingencies", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Divestiture obligations.", "label": "Divestiture obligations", "terseLabel": "Divestiture obligations (Note\u00a014)" } } }, "localname": "DivestitureObligations", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails" ], "xbrltype": "monetaryItemType" }, "ce_EURSeniorUnsecuredNotesDue2023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Notes Due 2023 [Member]", "label": "EUR Senior Unsecured Notes Due 2023 [Member]", "terseLabel": "Senior Unsecured Notes Due 2023" } } }, "localname": "EURSeniorUnsecuredNotesDue2023Member", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_EURSeniorUnsecuredNotesDue2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Notes Due 2025 [Member]", "label": "EUR Senior Unsecured Notes Due 2025 [Member]", "terseLabel": "Senior Unsecured Notes Due 2025" } } }, "localname": "EURSeniorUnsecuredNotesDue2025Member", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_EURSeniorUnsecuredNotesDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EUR 1 Billion 4.777% Senior Unsecured Notes Due 2026", "label": "EUR Senior Unsecured Notes Due 2026 [Member]", "terseLabel": "EUR Senior Unsecured Notes Due 2026" } } }, "localname": "EURSeniorUnsecuredNotesDue2026Member", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_EURSeniorUnsecuredNotesDue2027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EUR Senior Unsecured Notes Due 2027 [Member]", "label": "EUR Senior Unsecured Notes Due 2027 [Member]", "terseLabel": "Senior Unsecured Notes Due 2027" } } }, "localname": "EURSeniorUnsecuredNotesDue2027Member", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_EURSeniorUnsecuredNotesDue2028Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EUR Senior Unsecured Notes Due 2028", "label": "EUR Senior Unsecured Notes Due 2028 [Member]", "terseLabel": "Senior Unsecured Notes Due 2028" } } }, "localname": "EURSeniorUnsecuredNotesDue2028Member", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_EURSeniorUnsecuredNotesDue2029Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EUR 500 Million 5.337% Senior Unsecured Notes Due 2029 [Member]", "label": "EUR Senior Unsecured Notes Due 2029 [Member]", "terseLabel": "EUR Senior Unsecured Notes Due 2029" } } }, "localname": "EURSeniorUnsecuredNotesDue2029Member", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_EngineeredMaterialsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Engineered Materials", "label": "Engineered Materials [Member]", "terseLabel": "Engineered Materials" } } }, "localname": "EngineeredMaterialsMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails", "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails", "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "ce_Environmental": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loss exposure for environmental contingencies at an individual site for which no accrual has been recorded based upon EPA determination.", "label": "environmental", "terseLabel": "Cost of EPA's plan estimate" } } }, "localname": "Environmental", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_EnvironmentalLiabilityPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Estimated ultimate allocable share of cleanup costs.", "label": "Environmental Liability Percentage", "terseLabel": "Environmental liability percentage" } } }, "localname": "EnvironmentalLiabilityPercentage", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ce_EquityMethodInvestmentIncrease": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase in an equity method investment, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Equity Method Investment, Increase", "terseLabel": "Equity method investment, increase" } } }, "localname": "EquityMethodInvestmentIncrease", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_EquityMethodInvestmentLiabilityCurrent": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity Method Investment Liability, Current", "label": "Equity Method Investment Liability, Current", "terseLabel": "Investment in affiliates" } } }, "localname": "EquityMethodInvestmentLiabilityCurrent", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ce_EuropeAndSingaporeFactoringAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Europe and Singapore Factoring Agreements", "label": "Europe and Singapore Factoring Agreements [Member]", "terseLabel": "Europe and Singapore Factoring Agreement" } } }, "localname": "EuropeAndSingaporeFactoringAgreementsMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_EuropeFactoringAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Europe Factoring Agreements", "label": "Europe Factoring Agreements [Member]", "terseLabel": "Europe Factoring Agreements" } } }, "localname": "EuropeFactoringAgreementsMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_ExpectedProceedsFromSaleOfInterestInJointVenture": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The expected proceeds from the sale of interest in an newly formed joint venture.", "label": "Expected Proceeds from Sale of Interest in Joint Venture", "terseLabel": "Expected Proceeds from Sale of Interest in Joint Venture" } } }, "localname": "ExpectedProceedsFromSaleOfInterestInJointVenture", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_FiniteLivedIntangibleAssetsTransferred": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers into (out of) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Transferred", "terseLabel": "Transfer(1)" } } }, "localname": "FiniteLivedIntangibleAssetsTransferred", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ce_FiniteLivedIntangibleAssetsTransferredAccumulatedAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers (into) out of Accumulated Amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Transferred, Accumulated Amortization", "terseLabel": "Finite-Lived Intangible Assets, Transferred, Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsTransferredAccumulatedAmortization", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ce_FoodIngredientsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Food Ingredients (\"FI\") business of CE's Engineered Material segment", "label": "Food Ingredients [Member]", "terseLabel": "Food Ingredients" } } }, "localname": "FoodIngredientsMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails" ], "xbrltype": "domainItemType" }, "ce_ForeignCurrencyDenominatedDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Currency Denominated Debt [Member]", "label": "Foreign Currency Denominated Debt [Member]", "terseLabel": "Foreign Currency Denominated Debt [Member]" } } }, "localname": "ForeignCurrencyDenominatedDebtMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "xbrltype": "domainItemType" }, "ce_GainLossOnNonDerivativeUsedInNetInvestmentHedge": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustment in other comprehensive income reflecting gains or losses on foreign currency transactions that are designated as, and are effective as, hedges of net investment in foreign entity, gross of tax effect.", "label": "Gain (Loss) On Non-Derivative Used In Net Investment Hedge", "terseLabel": "Gain (Loss) Recognized in Other Comprehensive Income (Loss)" } } }, "localname": "GainLossOnNonDerivativeUsedInNetInvestmentHedge", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "ce_GainLossOnNonDerivativesandDerivativesUsedInNetInvestmentHedge": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustment in other comprehensive income reflecting gains (losses) on foreign currency transactions that are designated as, and are effective as, hedges of net investment in foreign entity, gross of tax effect.", "label": "Gain (Loss) On Non-Derivatives and Derivatives Used In Net Investment Hedge", "terseLabel": "Gain (Loss) Recognized in Other Comprehensive Income (Loss)" } } }, "localname": "GainLossOnNonDerivativesandDerivativesUsedInNetInvestmentHedge", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "ce_IncreaseDecreaseOfAccruedCapitalExpenditures": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) of Accrued Capital Expenditures.", "label": "Increase (Decrease) of Accrued Capital Expenditures", "terseLabel": "Increase (decrease) in accrued capital expenditures" } } }, "localname": "IncreaseDecreaseOfAccruedCapitalExpenditures", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "ce_IndefiniteLivedIntangibleAssetsTransferred": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit, from transfers.", "label": "Indefinite-Lived Intangible Assets, Transferred", "negatedTerseLabel": "Indefinite-Lived Intangible Assets, Transferred" } } }, "localname": "IndefiniteLivedIntangibleAssetsTransferred", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ce_IndemnificationAgreementsHoechstMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indemnification Agreements Hoechst [Member].", "label": "Indemnification Agreements Hoechst [Member]", "terseLabel": "Indemnification Agreements Hoechst" } } }, "localname": "IndemnificationAgreementsHoechstMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_IndemnificationCeilingAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Ceiling amount above which the Company will indemnify Hoechst for.", "label": "Indemnification ceiling amount", "terseLabel": "Indemnification ceiling amount" } } }, "localname": "IndemnificationCeilingAmount", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_IndemnificationFloorAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount that the Company will indemnify Hoechst for in full.", "label": "Indemnification floor amount", "terseLabel": "Indemnification amount" } } }, "localname": "IndemnificationFloorAmount", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_IndemnificationPercentageExceedingCeilingAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of the amount above the ceiling that the Company will indemnify Hoechst for.", "label": "Indemnification percentage exceeding ceiling amount", "terseLabel": "Indemnification percentage exceeding ceiling amount" } } }, "localname": "IndemnificationPercentageExceedingCeilingAmount", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ce_IndemnificationPercentageOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of other liabilities the Company has agreed to indemnify Hoechst for as part of the Demerger Agreement.", "label": "Indemnification percentage, other", "terseLabel": "Indemnification percentage, other" } } }, "localname": "IndemnificationPercentageOther", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ce_KoreaEngineeringPlasticsCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Korea Engineering Plastics Co., Ltd. [Member].", "label": "Korea Engineering Plastics Co., Ltd. [Member]", "terseLabel": "Korea Engineering Plastics Co., Ltd." } } }, "localname": "KoreaEngineeringPlasticsCoLtdMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_MitsubishiGasChemicalCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mitsubishi Gas Chemical Company", "label": "Mitsubishi Gas Chemical Company [Member]", "terseLabel": "Mitsubishi Gas Chemical Company" } } }, "localname": "MitsubishiGasChemicalCompanyMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_MitsuiCoLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mitsui & Co. Ltd.", "label": "Mitsui & Co. Ltd. [Member]", "terseLabel": "Mitsui & Co. Ltd." } } }, "localname": "MitsuiCoLtdMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_MobilityMaterialsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mobility & Materials", "label": "Mobility & Materials [Member]", "terseLabel": "Mobility & Materials" } } }, "localname": "MobilityMaterialsMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "ce_Nonoperatingpensionandotherpostretirementemployeebenefitexpenseincome": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 6.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non-operating pension and other postretirement employee benefit (expense) income", "label": "Non-operating pension and other postretirement employee benefit (expense) income", "terseLabel": "Non-operating pension and other postretirement employee benefit (expense) income" } } }, "localname": "Nonoperatingpensionandotherpostretirementemployeebenefitexpenseincome", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "ce_NotesOfferingRelatedCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fees and expenses related to the notes offering, inclusive of underwriting discounts.", "label": "Notes Offering Related Costs", "terseLabel": "Notes offering related costs" } } }, "localname": "NotesOfferingRelatedCosts", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_NumberOfDivestitureAgreements": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of divestiture agreements.", "label": "Number of divestiture agreements", "terseLabel": "Number of divestiture agreements" } } }, "localname": "NumberOfDivestitureAgreements", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "ce_NumberOfFacilities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of facilities.", "label": "Number Of Facilities", "terseLabel": "Number of facilities" } } }, "localname": "NumberOfFacilities", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "integerItemType" }, "ce_NumberOfPartiesIncludedInUsepaOrder": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Parties included in USEPA order.", "label": "Number of Parties included in USEPA order", "terseLabel": "Number of parties included in USEPA order" } } }, "localname": "NumberOfPartiesIncludedInUsepaOrder", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "xbrltype": "integerItemType" }, "ce_NumberOfPatents": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of patents.", "label": "Number Of Patents", "terseLabel": "Number of patents" } } }, "localname": "NumberOfPatents", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "integerItemType" }, "ce_NumberOfPaymentsToEquityMethodInvestments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Payments to Equity Method Investments", "label": "Number of Payments to Equity Method Investments", "terseLabel": "Number of equal annual investments restructuring payment" } } }, "localname": "NumberOfPaymentsToEquityMethodInvestments", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "integerItemType" }, "ce_NutrinovaJointVentureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Food Ingredients joint venture under the name Nutrinova", "label": "Nutrinova Joint Venture [Member]", "terseLabel": "Nutrinova Joint Venture" } } }, "localname": "NutrinovaJointVentureMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_OtherChargesGainsNetTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other (Charges) Gains, Net [Text Block].", "label": "Other (Charges) Gains, Net [Text Block]", "terseLabel": "Other (Charges) Gains, Net" } } }, "localname": "OtherChargesGainsNetTextBlock", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNet" ], "xbrltype": "textBlockItemType" }, "ce_OtherEnvironmentalRemediationReserves": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails": { "order": 5.0, "parentTag": "us-gaap_AccrualForEnvironmentalLossContingencies", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other environmental remediation reserves.", "label": "Other environmental remediation reserves", "terseLabel": "Other environmental remediation liabilities" } } }, "localname": "OtherEnvironmentalRemediationReserves", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails" ], "xbrltype": "monetaryItemType" }, "ce_PassaicRiverNewJerseyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Passaic River, New Jersey [Member].", "label": "Passaic River, New Jersey [Member]", "terseLabel": "Passaic River, New Jersey" } } }, "localname": "PassaicRiverNewJerseyMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_PaymentsToEquityMethodInvestment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with payments to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Payments to Equity Method Investment", "terseLabel": "Payments to equity method investment" } } }, "localname": "PaymentsToEquityMethodInvestment", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_PercentageOfFairValueOfSalesReceivables": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of fair value of sales receivables.", "label": "Percentage of Fair Value of Sales Receivables", "terseLabel": "Percentage of fair value of sales receivables" } } }, "localname": "PercentageOfFairValueOfSalesReceivables", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "ce_PlantClosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plant Closures [Abstract]", "label": "Plant Closures [Abstract]", "terseLabel": "Plant Closures [Abstract]" } } }, "localname": "PlantClosuresAbstract", "nsuri": "http://www.celanese.com/20230630", "xbrltype": "stringItemType" }, "ce_ProceedsCollectedOnAccountsReceivableSoldUnderFactoringFacilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds Collected on Accounts Receivable Sold under Factoring Facilities", "label": "Proceeds Collected on Accounts Receivable Sold under Factoring Facilities", "terseLabel": "Proceeds collected on accounts receivable sold under factoring facilities" } } }, "localname": "ProceedsCollectedOnAccountsReceivableSoldUnderFactoringFacilities", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails", "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_RecentAccountingPronouncementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recent Accounting Pronouncements [Abstract]", "label": "Recent Accounting Pronouncements [Abstract]", "terseLabel": "Recent Accounting Pronouncements [Abstract]" } } }, "localname": "RecentAccountingPronouncementsAbstract", "nsuri": "http://www.celanese.com/20230630", "xbrltype": "stringItemType" }, "ce_RefundingloanforpollutioncontrolandindustrialrevenuebondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refunding loan for pollution control and industrial revenue bonds [Member]", "label": "Refunding loan for pollution control and industrial revenue bonds [Member]", "terseLabel": "Refunding loan for pollution control and industrial revenue bonds" } } }, "localname": "RefundingloanforpollutioncontrolandindustrialrevenuebondsMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_ScheduleOfCompanyCommitmentsToFundBenefitObligationsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Company Commitments to Fund Benefit Obligations [Table Text Block].", "label": "Schedule of Company Commitments to Fund Benefit Obligations [Table Text Block]", "terseLabel": "Schedule of Company Commitments to Fund Benefit Obligations" } } }, "localname": "ScheduleOfCompanyCommitmentsToFundBenefitObligationsTableTextBlock", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/BenefitObligationsTables" ], "xbrltype": "textBlockItemType" }, "ce_ScheduleOfOtherChargesGainsNetTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Other (Charges) Gains, Net [Table Text Block].", "label": "Schedule of Other (Charges) Gains, Net [Table Text Block]", "terseLabel": "Schedule of Other (Charges) Gains, Net" } } }, "localname": "ScheduleOfOtherChargesGainsNetTableTextBlock", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetTables" ], "xbrltype": "textBlockItemType" }, "ce_SeniorUnsecuredNotesDue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "USD Senior Unsecured Notes Due May 8, 2024", "label": "Senior Unsecured Notes Due 2024 [Member]", "terseLabel": "Senior Unsecured Notes Due 2024" } } }, "localname": "SeniorUnsecuredNotesDue2024Member", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_SeniorUnsecuredTermLoanDue2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior unsecured term loan due 2025", "label": "Senior Unsecured Term Loan Due 2025 [Member]", "terseLabel": "Senior Unsecured Term Loan Due 2025" } } }, "localname": "SeniorUnsecuredTermLoanDue2025Member", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_SeniorUnsecuredTermLoanDue2027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Term Loan Due 2027", "label": "Senior Unsecured Term Loan Due 2027 [Member]", "terseLabel": "Senior Unsecured Term Loan Due 2027" } } }, "localname": "SeniorUnsecuredTermLoanDue2027Member", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_SingaporeFactoringAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Singapore Factoring Agreements", "label": "Singapore Factoring Agreements [Member]", "terseLabel": "Singapore Factoring Agreements" } } }, "localname": "SingaporeFactoringAgreementsMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_StockRepurchaseProgramAuthorizedAmountInPeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized in the period.", "label": "StockRepurchaseProgramAuthorizedAmountInPeriod", "terseLabel": "Aggregate Board of Directors repurchase authorizations during the period (in $ millions)" } } }, "localname": "StockRepurchaseProgramAuthorizedAmountInPeriod", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofTreasuryStockDetails" ], "xbrltype": "monetaryItemType" }, "ce_TermLoanFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Loan Facility", "label": "Term Loan Facility [Member]", "terseLabel": "Term Loan Facility" } } }, "localname": "TermLoanFacilityMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ce_TradeReceivablesPledgedAsCollateral": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of trade receivables pledged as collateral.", "label": "Trade Receivables Pledged As Collateral", "terseLabel": "Cash flows between transferor and transferee, proceeds from new transfers" } } }, "localname": "TradeReceivablesPledgedAsCollateral", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ce_TransferOfFinancialAssetsAccountedForAsSalesNonRecourseBasisAccountReceivablePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transfer Of Financial Assets Accounted For As Sales, Non-recourse Basis, Account Receivable Percentage", "label": "Transfer Of Financial Assets Accounted For As Sales, Non-recourse Basis, Account Receivable Percentage", "terseLabel": "Transfer of financial assets accounted for as sales, non-recourse basis, account receivable percentage" } } }, "localname": "TransferOfFinancialAssetsAccountedForAsSalesNonRecourseBasisAccountReceivablePercentage", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "xbrltype": "percentItemType" }, "ce_USDSeniorUnsecuredNotesDue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "USD 2 Billion 5.900% Senior Unsecured Notes Due 2024", "label": "USD Senior Unsecured Notes Due 2024 [Member]", "terseLabel": "Acquisition Notes Due July 2024" } } }, "localname": "USDSeniorUnsecuredNotesDue2024Member", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_USDSeniorUnsecuredNotesDue2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "USD 1.75 Billion 6.050% Senior Unsecured Notes Due 2025", "label": "USD Senior Unsecured Notes Due 2025 [Member]", "terseLabel": "Acquisition Notes Due March 2025" } } }, "localname": "USDSeniorUnsecuredNotesDue2025Member", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_USDSeniorUnsecuredNotesDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "USD Senior Unsecured Notes Due 2026 [Member]", "label": "USD Senior Unsecured Notes Due 2026 [Member]", "terseLabel": "Senior Unsecured Notes Due 2026" } } }, "localname": "USDSeniorUnsecuredNotesDue2026Member", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_USDSeniorUnsecuredNotesDue2027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "USD 2 Billion 6.165% Senior Unsecured Notes Due 2027", "label": "USD Senior Unsecured Notes Due 2027 [Member]", "terseLabel": "USD Senior Unsecured Notes Due 2027" } } }, "localname": "USDSeniorUnsecuredNotesDue2027Member", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "ce_USDSeniorUnsecuredNotesDue2029Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "USD 750 Million 6.330% Senior Unsecured Notes Due 2029", "label": "USD Senior Unsecured Notes Due 2029 [Member]", "terseLabel": "Acquisition Notes Due July 2029" } } }, "localname": "USDSeniorUnsecuredNotesDue2029Member", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "ce_USDSeniorUnsecuredNotesDue2032Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "USD 1 Billion 6.379% Senior Unsecured Notes Due 2032", "label": "USD Senior Unsecured Notes Due 2032 [Member]", "terseLabel": "USD Senior Unsecured Notes Due 2032" } } }, "localname": "USDSeniorUnsecuredNotesDue2032Member", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "ce_UsSuperfundSites": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails": { "order": 4.0, "parentTag": "us-gaap_AccrualForEnvironmentalLossContingencies", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "US Superfund sites.", "label": "US Superfund sites", "terseLabel": "U.S. Superfund sites" } } }, "localname": "UsSuperfundSites", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails" ], "xbrltype": "monetaryItemType" }, "ce_VariableInterbankInterestRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Certain interbank rates at current Company credit ratings", "label": "Variable Interbank Interest Rate [Member]", "terseLabel": "Variable Interbank Interest Rate" } } }, "localname": "VariableInterbankInterestRateMember", "nsuri": "http://www.celanese.com/20230630", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r957" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r990" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r955" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r955" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r955" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r1029" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityNumberOfEmployees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of persons employed by the Entity", "label": "Entity Number of Employees", "terseLabel": "Entity number of employees" } } }, "localname": "EntityNumberOfEmployees", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "decimalItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r955" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r955" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r955" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Small Reporting Company" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r955" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r954" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r956" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "ecd_Additional402vDisclosureTextBlock": { "auth_ref": [ "r991" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "localname": "Additional402vDisclosureTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AdjToCompAmt": { "auth_ref": [ "r997" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "localname": "AdjToCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_AdjToCompAxis": { "auth_ref": [ "r997" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "localname": "AdjToCompAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "auth_ref": [ "r997" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "localname": "AdjToNonPeoNeoCompFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AdjToPeoCompFnTextBlock": { "auth_ref": [ "r997" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "localname": "AdjToPeoCompFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AggtErrCompAmt": { "auth_ref": [ "r962", "r973", "r983", "r1008" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "localname": "AggtErrCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "auth_ref": [ "r965", "r976", "r986", "r1011" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "localname": "AggtErrCompNotYetDeterminedTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AllAdjToCompMember": { "auth_ref": [ "r997" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "localname": "AllAdjToCompMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_AllExecutiveCategoriesMember": { "auth_ref": [ "r1004" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "localname": "AllExecutiveCategoriesMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_AllIndividualsMember": { "auth_ref": [ "r969", "r977", "r987", "r1004", "r1012", "r1016", "r1024" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "localname": "AllIndividualsMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_AllTradingArrangementsMember": { "auth_ref": [ "r1022" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "localname": "AllTradingArrangementsMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "domainItemType" }, "ecd_AwardExrcPrice": { "auth_ref": [ "r1019" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "localname": "AwardExrcPrice", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "perShareItemType" }, "ecd_AwardGrantDateFairValue": { "auth_ref": [ "r1020" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "localname": "AwardGrantDateFairValue", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_AwardTmgDiscLineItems": { "auth_ref": [ "r1015" ], "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "localname": "AwardTmgDiscLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "auth_ref": [ "r1015" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AwardTmgMethodTextBlock": { "auth_ref": [ "r1015" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "localname": "AwardTmgMethodTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AwardTmgMnpiCnsdrdFlag": { "auth_ref": [ "r1015" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "localname": "AwardTmgMnpiCnsdrdFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "booleanItemType" }, "ecd_AwardTmgMnpiDiscTextBlock": { "auth_ref": [ "r1015" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "localname": "AwardTmgMnpiDiscTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AwardTmgPredtrmndFlag": { "auth_ref": [ "r1015" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "localname": "AwardTmgPredtrmndFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "booleanItemType" }, "ecd_AwardUndrlygSecuritiesAmt": { "auth_ref": [ "r1018" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "localname": "AwardUndrlygSecuritiesAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "decimalItemType" }, "ecd_AwardsCloseToMnpiDiscIndName": { "auth_ref": [ "r1017" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "localname": "AwardsCloseToMnpiDiscIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "stringItemType" }, "ecd_AwardsCloseToMnpiDiscTable": { "auth_ref": [ "r1016" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "localname": "AwardsCloseToMnpiDiscTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "stringItemType" }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "auth_ref": [ "r1016" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "localname": "AwardsCloseToMnpiDiscTableTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ChangedPeerGroupFnTextBlock": { "auth_ref": [ "r995" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "localname": "ChangedPeerGroupFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CoSelectedMeasureAmt": { "auth_ref": [ "r996" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "localname": "CoSelectedMeasureAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "decimalItemType" }, "ecd_CoSelectedMeasureName": { "auth_ref": [ "r996" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "localname": "CoSelectedMeasureName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "normalizedStringItemType" }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "auth_ref": [ "r1001" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "auth_ref": [ "r1000" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "localname": "CompActuallyPaidVsNetIncomeTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "auth_ref": [ "r1002" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "auth_ref": [ "r999" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "auth_ref": [ "r998" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ErrCompAnalysisTextBlock": { "auth_ref": [ "r962", "r973", "r983", "r1008" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "localname": "ErrCompAnalysisTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ErrCompRecoveryTable": { "auth_ref": [ "r959", "r970", "r980", "r1005" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "localname": "ErrCompRecoveryTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_ExecutiveCategoryAxis": { "auth_ref": [ "r1004" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "localname": "ExecutiveCategoryAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "auth_ref": [ "r966", "r977", "r987", "r1012" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "auth_ref": [ "r966", "r977", "r987", "r1012" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "auth_ref": [ "r966", "r977", "r987", "r1012" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "auth_ref": [ "r966", "r977", "r987", "r1012" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ForgoneRecoveryIndName": { "auth_ref": [ "r966", "r977", "r987", "r1012" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "localname": "ForgoneRecoveryIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_IndividualAxis": { "auth_ref": [ "r969", "r977", "r987", "r1004", "r1012", "r1016", "r1024" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "localname": "IndividualAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_InsiderTradingArrLineItems": { "auth_ref": [ "r1022" ], "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "localname": "InsiderTradingArrLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_InsiderTradingPoliciesProcLineItems": { "auth_ref": [ "r958", "r1028" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "localname": "InsiderTradingPoliciesProcLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "auth_ref": [ "r958", "r1028" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "localname": "InsiderTrdPoliciesProcAdoptedFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "xbrltype": "booleanItemType" }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "auth_ref": [ "r958", "r1028" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "xbrltype": "textBlockItemType" }, "ecd_MeasureAxis": { "auth_ref": [ "r996" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "localname": "MeasureAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_MeasureName": { "auth_ref": [ "r996" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "localname": "MeasureName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "normalizedStringItemType" }, "ecd_MnpiDiscTimedForCompValFlag": { "auth_ref": [ "r1015" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "localname": "MnpiDiscTimedForCompValFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "booleanItemType" }, "ecd_MtrlTermsOfTrdArrTextBlock": { "auth_ref": [ "r1023" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "localname": "MtrlTermsOfTrdArrTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "textBlockItemType" }, "ecd_NamedExecutiveOfficersFnTextBlock": { "auth_ref": [ "r997" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "localname": "NamedExecutiveOfficersFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_NonGaapMeasureDescriptionTextBlock": { "auth_ref": [ "r996" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "localname": "NonGaapMeasureDescriptionTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_NonNeosMember": { "auth_ref": [ "r966", "r977", "r987", "r1004", "r1012" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "localname": "NonNeosMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "domainItemType" }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "auth_ref": [ "r994" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_NonPeoNeoAvgTotalCompAmt": { "auth_ref": [ "r993" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "localname": "NonPeoNeoAvgTotalCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_NonPeoNeoMember": { "auth_ref": [ "r1004" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "localname": "NonPeoNeoMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_NonRule10b51ArrAdoptedFlag": { "auth_ref": [ "r1023" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "localname": "NonRule10b51ArrAdoptedFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_NonRule10b51ArrTrmntdFlag": { "auth_ref": [ "r1023" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "localname": "NonRule10b51ArrTrmntdFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_OtherPerfMeasureAmt": { "auth_ref": [ "r996" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "localname": "OtherPerfMeasureAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "decimalItemType" }, "ecd_OutstandingAggtErrCompAmt": { "auth_ref": [ "r964", "r975", "r985", "r1010" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "localname": "OutstandingAggtErrCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_OutstandingRecoveryCompAmt": { "auth_ref": [ "r967", "r978", "r988", "r1013" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "localname": "OutstandingRecoveryCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_OutstandingRecoveryIndName": { "auth_ref": [ "r967", "r978", "r988", "r1013" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "localname": "OutstandingRecoveryIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_PayVsPerformanceDisclosureLineItems": { "auth_ref": [ "r992" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "localname": "PayVsPerformanceDisclosureLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_PeerGroupIssuersFnTextBlock": { "auth_ref": [ "r995" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "localname": "PeerGroupIssuersFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_PeerGroupTotalShareholderRtnAmt": { "auth_ref": [ "r995" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "localname": "PeerGroupTotalShareholderRtnAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_PeoActuallyPaidCompAmt": { "auth_ref": [ "r994" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "localname": "PeoActuallyPaidCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_PeoMember": { "auth_ref": [ "r1004" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "localname": "PeoMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_PeoName": { "auth_ref": [ "r997" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "localname": "PeoName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "normalizedStringItemType" }, "ecd_PeoTotalCompAmt": { "auth_ref": [ "r993" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "localname": "PeoTotalCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_PvpTable": { "auth_ref": [ "r992" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "localname": "PvpTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_PvpTableTextBlock": { "auth_ref": [ "r992" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "localname": "PvpTableTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "auth_ref": [ "r959", "r970", "r980", "r1005" ], "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "localname": "RecoveryOfErrCompDisclosureLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_RestatementDateAxis": { "auth_ref": [ "r960", "r971", "r981", "r1006" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "localname": "RestatementDateAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_RestatementDeterminationDate": { "auth_ref": [ "r961", "r972", "r982", "r1007" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "localname": "RestatementDeterminationDate", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "dateItemType" }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "auth_ref": [ "r968", "r979", "r989", "r1014" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "localname": "RestatementDoesNotRequireRecoveryTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_Rule10b51ArrAdoptedFlag": { "auth_ref": [ "r1023" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "localname": "Rule10b51ArrAdoptedFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_Rule10b51ArrTrmntdFlag": { "auth_ref": [ "r1023" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "localname": "Rule10b51ArrTrmntdFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "auth_ref": [ "r963", "r974", "r984", "r1009" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "localname": "StkPrcOrTsrEstimationMethodTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_TabularListTableTextBlock": { "auth_ref": [ "r1003" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "localname": "TabularListTableTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_TotalShareholderRtnAmt": { "auth_ref": [ "r995" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "localname": "TotalShareholderRtnAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "auth_ref": [ "r1002" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_TradingArrAxis": { "auth_ref": [ "r1022" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "localname": "TradingArrAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TradingArrByIndTable": { "auth_ref": [ "r1024" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "localname": "TradingArrByIndTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrAdoptionDate": { "auth_ref": [ "r1025" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "localname": "TrdArrAdoptionDate", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrDuration": { "auth_ref": [ "r1026" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "localname": "TrdArrDuration", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "durationItemType" }, "ecd_TrdArrIndName": { "auth_ref": [ "r1024" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "localname": "TrdArrIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrIndTitle": { "auth_ref": [ "r1024" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "localname": "TrdArrIndTitle", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrSecuritiesAggAvailAmt": { "auth_ref": [ "r1027" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "localname": "TrdArrSecuritiesAggAvailAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "sharesItemType" }, "ecd_TrdArrTerminationDate": { "auth_ref": [ "r1025" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "localname": "TrdArrTerminationDate", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_UndrlygSecurityMktPriceChngPct": { "auth_ref": [ "r1021" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "localname": "UndrlygSecurityMktPriceChngPct", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "pureItemType" }, "srt_AsiaPacificMember": { "auth_ref": [ "r1135", "r1136", "r1137", "r1138" ], "lang": { "en-us": { "role": { "label": "Asia Pacific [Member]", "terseLabel": "Asia-Pacific" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r312", "r357", "r368", "r369", "r370", "r371", "r372", "r374", "r378", "r438", "r439", "r440", "r441", "r443", "r444", "r446", "r448", "r449", "r1099", "r1100" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r312", "r357", "r368", "r369", "r370", "r371", "r372", "r374", "r378", "r438", "r439", "r440", "r441", "r443", "r444", "r446", "r448", "r449", "r1099", "r1100" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [ "r389", "r390", "r391" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r431", "r432", "r434", "r435", "r580", "r719", "r769", "r808", "r809", "r864", "r866", "r868", "r869", "r880", "r900", "r901", "r912", "r922", "r934", "r940", "r1101", "r1116", "r1117", "r1118", "r1119", "r1120", "r1121" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r431", "r432", "r434", "r435", "r580", "r719", "r769", "r808", "r809", "r864", "r866", "r868", "r869", "r880", "r900", "r901", "r912", "r922", "r934", "r940", "r1101", "r1116", "r1117", "r1118", "r1119", "r1120", "r1121" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [ "r1135", "r1136", "r1137", "r1138" ], "lang": { "en-us": { "role": { "label": "North America [Member]", "terseLabel": "North America" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "terseLabel": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "terseLabel": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r431", "r432", "r434", "r435", "r532", "r580", "r606", "r607", "r608", "r715", "r719", "r769", "r808", "r809", "r864", "r866", "r868", "r869", "r880", "r900", "r901", "r912", "r922", "r934", "r940", "r943", "r1088", "r1101", "r1117", "r1118", "r1119", "r1120", "r1121" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r431", "r432", "r434", "r435", "r532", "r580", "r606", "r607", "r608", "r715", "r719", "r769", "r808", "r809", "r864", "r866", "r868", "r869", "r880", "r900", "r901", "r912", "r922", "r934", "r940", "r943", "r1088", "r1101", "r1117", "r1118", "r1119", "r1120", "r1121" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r389", "r390", "r391" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r382", "r383", "r801", "r804", "r806", "r865", "r867", "r870", "r881", "r891", "r892", "r893", "r894", "r895", "r896", "r897", "r898", "r899", "r903", "r923", "r943", "r1103", "r1128" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "xbrltype": "domainItemType" }, "srt_SouthAmericaMember": { "auth_ref": [ "r1135", "r1136", "r1137", "r1138" ], "lang": { "en-us": { "role": { "label": "South America [Member]", "terseLabel": "South America" } } }, "localname": "SouthAmericaMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r382", "r383", "r801", "r804", "r806", "r865", "r867", "r870", "r881", "r889", "r891", "r892", "r893", "r894", "r895", "r896", "r897", "r898", "r899", "r903", "r923", "r943", "r1103", "r1128" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "terseLabel": "Current Other Liabilities" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r40", "r939" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Trade payables\u00a0- third party and affiliates" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r385", "r386" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "verboseLabel": "Trade receivables\u00a0- third party and affiliates" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccrualForEnvironmentalLossContingencies": { "auth_ref": [ "r433", "r915", "r1034", "r1036", "r1089", "r1094" ], "calculation": { "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total costs accrued as of the balance sheet date for environmental loss contingencies.", "label": "Accrual for Environmental Loss Contingencies", "totalLabel": "Total" } } }, "localname": "AccrualForEnvironmentalLossContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r171", "r236" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Income taxes payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedMarketingCostsCurrent": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Marketing Costs, Current", "terseLabel": "Customer rebates" } } }, "localname": "AccruedMarketingCostsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r7", "r21", "r54", "r1052", "r1053", "r1054" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Pension and Postretirement Benefits" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r78", "r269", "r744" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "terseLabel": "Accumulated depreciation, depletion and amortization, property, plant, and equipment" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r290", "r297", "r298", "r648", "r909", "r1052" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "terseLabel": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [ "r296", "r297", "r693", "r695", "r696", "r697", "r698", "r700" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss), net [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r53", "r54", "r186", "r279", "r740", "r774", "r777" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "periodEndLabel": "As of June 30, 2023", "periodStartLabel": "As of December 31, 2022", "terseLabel": "Accumulated other comprehensive income (loss), net" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r296", "r297", "r693", "r695", "r696", "r697", "r698", "r700" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r4", "r21", "r54", "r659", "r662", "r709", "r770", "r771", "r1052", "r1053", "r1054", "r1067", "r1068", "r1069" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r6", "r21", "r54", "r297", "r298", "r695", "r696", "r697", "r698", "r700", "r1052" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation Gain (Loss)" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r175", "r939", "r1131" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r610", "r611", "r612", "r787", "r1067", "r1068", "r1069", "r1110", "r1133" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r101", "r102", "r582" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation, net of tax" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r16", "r71", "r76" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "negatedLabel": "Amortization of intangible assets", "negatedTerseLabel": "Amortization" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmountOfIneffectivenessOnNetInvestmentHedges": { "auth_ref": [ "r232" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain (loss) on hedging derivative instrument or the foreign currency transaction gain (loss) on the nonderivative hedging instrument designated as a hedge of a net investment in foreign operations related to hedge ineffectiveness, which is included in earnings in the period.", "label": "Amount of Ineffectiveness on Net Investment Hedges", "terseLabel": "Gain (Loss) Recognized in Earnings (Loss)" } } }, "localname": "AmountOfIneffectivenessOnNetInvestmentHedges", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r62" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r62" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r234", "r273", "r310", "r355", "r370", "r376", "r392", "r438", "r439", "r441", "r442", "r443", "r445", "r447", "r449", "r450", "r644", "r649", "r683", "r734", "r831", "r939", "r953", "r1099", "r1100", "r1114" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Total assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r267", "r282", "r310", "r392", "r438", "r439", "r441", "r442", "r443", "r445", "r447", "r449", "r450", "r644", "r649", "r683", "r939", "r1099", "r1100", "r1114" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r141" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "terseLabel": "Total assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r3", "r152", "r165", "r215", "r265", "r266" ], "calculation": { "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Assets", "totalLabel": "Disposal Group, Including Discontinued Operation, Assets" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r3", "r152", "r165", "r214", "r215", "r265", "r266" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Assets, Current", "terseLabel": "Disposal Group, Including Discontinued Operation, Assets, Current" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r128", "r133" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r641", "r928", "r931" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r103", "r105", "r641", "r928", "r931" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r104" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Business Acquisition, Percentage of Voting Interests Acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r1044", "r1045" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "terseLabel": "Business Acquisition, Pro Forma Information" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r639", "r640" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition, Pro Forma Revenue", "terseLabel": "Proforma Net sales" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresBusinessAcquisitionProFormaInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r151", "r205", "r206" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description and Basis of Presentation [Text Block]", "terseLabel": "Description of the Company and Basis of Presentation" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r61", "r202", "r307" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents as of end of period", "periodStartLabel": "Cash and cash equivalents as of beginning of period", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r2", "r202" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r125" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Derivatives Designated as Cash Flow Hedges" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": { "auth_ref": [ "r164", "r202" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations", "terseLabel": "Operating cash provided by (used in) discontinued operations" } } }, "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashSurrenderValueFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).", "label": "Cash Surrender Value, Fair Value Disclosure", "terseLabel": "Insurance contracts in nonqualified trusts, fair value" } } }, "localname": "CashSurrenderValueFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashSurrenderValueOfLifeInsurance": { "auth_ref": [ "r1047" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.", "label": "Cash Surrender Value of Life Insurance", "terseLabel": "Insurance contracts in nonqualified trusts, carrying amount" } } }, "localname": "CashSurrenderValueOfLifeInsurance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r260", "r276", "r277", "r278", "r310", "r335", "r339", "r341", "r343", "r349", "r350", "r392", "r438", "r441", "r442", "r443", "r449", "r450", "r480", "r481", "r484", "r487", "r494", "r683", "r779", "r780", "r781", "r782", "r787", "r788", "r789", "r790", "r791", "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r818", "r840", "r859", "r882", "r883", "r884", "r885", "r886", "r1030", "r1062", "r1070" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [ "r276", "r277", "r278", "r349", "r480", "r481", "r482", "r484", "r487", "r492", "r494", "r779", "r780", "r781", "r782", "r922", "r1030", "r1062" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r49", "r148", "r737", "r817" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r217", "r427", "r429", "r890", "r1093" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommodityContractMember": { "auth_ref": [ "r924", "r938" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices.", "label": "Commodity Contract [Member]", "terseLabel": "Commodity swaps" } } }, "localname": "CommodityContractMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Common stock, dividends, declared (in dollar per share)" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r941", "r942", "r943", "r945", "r946", "r947", "r950", "r1067", "r1068", "r1110", "r1129", "r1133" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r174" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r174", "r818" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r174" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r22", "r174", "r818", "r837", "r1133", "r1134" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r174", "r739", "r939" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.0001\u00a0par value, 400,000,000\u00a0shares authorized (2023: 170,458,836 issued and 108,847,435 outstanding; 2022: 170,135,425 issued and 108,473,932 outstanding)" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]", "terseLabel": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r55", "r293", "r295", "r303", "r730", "r755" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income (loss) attributable to Celanese Corporation" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r13", "r112", "r120", "r293", "r295", "r302", "r729", "r754" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "negatedLabel": "Comprehensive (income) loss attributable to noncontrolling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r120", "r228", "r293", "r295", "r301", "r728", "r753" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Total comprehensive income (loss), net of tax" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateAndOtherMember": { "auth_ref": [ "r1072" ], "lang": { "en-us": { "role": { "documentation": "Component of an entity that provides financial and operational oversight and administrative support for other segments and other segments not separately reported due to size or nature of business activities. Excludes intersegment elimination and reconciling items.", "label": "Corporate and Other [Member]", "terseLabel": "Other Activities" } } }, "localname": "CorporateAndOtherMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r29", "r369", "r370", "r371", "r372", "r378", "r1073" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Corporate, Non-Segment" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r194", "r720" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "negatedLabel": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrencySwapMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.", "label": "Currency Swap [Member]", "terseLabel": "Currency Swap" } } }, "localname": "CurrencySwapMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer- Related Intangible Assets" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r274" ], "calculation": { "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of debt and lease obligation, classified as current.", "label": "Debt, Current", "totalLabel": "Total", "verboseLabel": "Short-term borrowings and current installments of long-term debt -\u00a0third party and affiliates" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt, Current [Abstract]", "terseLabel": "Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates" } } }, "localname": "DebtCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r218", "r308", "r451", "r457", "r458", "r459", "r460", "r461", "r462", "r467", "r474", "r475", "r477" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r36", "r170", "r171", "r235", "r238", "r312", "r452", "r453", "r454", "r455", "r456", "r458", "r463", "r464", "r465", "r466", "r468", "r469", "r470", "r471", "r472", "r473", "r703", "r917", "r918", "r919", "r920", "r921", "r1063" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails", "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Debt instrument, basis spread on variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r145", "r147", "r452", "r703", "r918", "r919" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt instrument, face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r46", "r453" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [ "r312", "r452", "r453", "r454", "r455", "r456", "r458", "r463", "r464", "r465", "r466", "r468", "r469", "r470", "r471", "r472", "r473", "r476", "r703", "r917", "r918", "r919", "r920", "r921", "r1063" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r47", "r312", "r452", "r453", "r454", "r455", "r456", "r458", "r463", "r464", "r465", "r466", "r468", "r469", "r470", "r471", "r472", "r473", "r703", "r917", "r918", "r919", "r920", "r921", "r1063" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails", "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Debt instrument, redemption price, percentage" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r47", "r86", "r89", "r144", "r145", "r147", "r149", "r220", "r221", "r312", "r452", "r453", "r454", "r455", "r456", "r458", "r463", "r464", "r465", "r466", "r468", "r469", "r470", "r471", "r472", "r473", "r476", "r703", "r917", "r918", "r919", "r920", "r921", "r1063" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt instrument, term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r146", "r1102" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "negatedTerseLabel": "Unamortized debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r616", "r617" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r16", "r226", "r254", "r630", "r631", "r1065" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred income taxes, net" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r616", "r617", "r735" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": { "auth_ref": [ "r233", "r508", "r509", "r531", "r830", "r926", "r1124" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.", "label": "Assets for Plan Benefits, Defined Benefit Plan", "terseLabel": "Noncurrent Other assets" } } }, "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r525", "r535", "r573", "r924", "r925", "r926", "r927" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "terseLabel": "Total contributions year-to-date" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear": { "auth_ref": [ "r927", "r1105" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contributions received and expected to be received by defined benefit plan from employer in current fiscal year.", "label": "Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year", "terseLabel": "Total expected contributions in current fiscal year" } } }, "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r510", "r547", "r568", "r926", "r927" ], "calculation": { "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "negatedLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": { "auth_ref": [ "r508", "r531", "r926" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.", "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan", "terseLabel": "Net amount recognized" } } }, "localname": "DefinedBenefitPlanFundedStatusOfPlan", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r510", "r514", "r546", "r567", "r926", "r927" ], "calculation": { "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r544", "r565", "r926", "r927" ], "calculation": { "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "totalLabel": "Total" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r512", "r545", "r566", "r926", "r927" ], "calculation": { "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAmortizationAndAccretionNet": { "auth_ref": [ "r16" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Depreciation, Amortization and Accretion, Net", "terseLabel": "Depreciation, amortization and accretion" } } }, "localname": "DepreciationAmortizationAndAccretionNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r16", "r360" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetCollateralObligationToReturnCashOffset": { "auth_ref": [ "r17", "r25" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeAssets", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to return cash collateral under master netting arrangements offset against derivative assets.", "label": "Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash, Offset Against Derivative Asset", "terseLabel": "Gross amount not offset in the consolidated balance sheets" } } }, "localname": "DerivativeAssetCollateralObligationToReturnCashOffset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative asset classified as current.", "label": "Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativeAssetFairValueGrossLiability": { "auth_ref": [ "r25", "r34", "r131", "r876", "r877" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Asset, Subject to Master Netting Arrangement, Liability Offset", "terseLabel": "Gross amount offset in the consolidated balance sheets" } } }, "localname": "DerivativeAssetFairValueGrossLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative asset classified as noncurrent.", "label": "Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative asset.", "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r284", "r286", "r682", "r799", "r800", "r801", "r802", "r803", "r805", "r806", "r807", "r808", "r809", "r824", "r825", "r871", "r874", "r875", "r876", "r878", "r879", "r908", "r943", "r1130" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative Asset", "totalLabel": "Net amount" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Asset [Abstract]", "terseLabel": "Derivative Assets [Abstract]" } } }, "localname": "DerivativeAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [ "r807", "r809", "r823", "r824", "r825", "r826", "r827", "r828", "r829", "r832", "r833", "r834", "r835", "r846", "r847", "r848", "r849", "r852", "r853", "r854", "r855", "r871", "r872", "r875", "r878", "r941", "r943" ], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails", "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "auth_ref": [ "r31", "r131", "r184", "r283", "r908" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset", "terseLabel": "Gross amount recognized" } } }, "localname": "DerivativeFairValueOfDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral": { "auth_ref": [ "r27", "r32", "r35", "r138" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral", "totalLabel": "Net amount presented in the consolidated balance sheets" } } }, "localname": "DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r31", "r131", "r184", "r283", "r908" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "terseLabel": "Gross amount recognized" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral": { "auth_ref": [ "r27", "r32", "r35", "r138" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral", "totalLabel": "Net amount presented in the consolidated balance sheets" } } }, "localname": "DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r1109" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "terseLabel": "Gain (Loss) Recognized in Earnings (Loss)" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": { "auth_ref": [ "r1109" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from derivative.", "label": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "terseLabel": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]" } } }, "localname": "DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r129", "r132", "r134", "r135", "r807", "r809", "r823", "r824", "r825", "r826", "r827", "r828", "r829", "r832", "r833", "r834", "r835", "r846", "r847", "r848", "r849", "r852", "r853", "r854", "r855", "r871", "r872", "r875", "r878", "r908", "r941", "r943" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]", "verboseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails", "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r231", "r656", "r665" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "Derivative Financial Instruments" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r23", "r129", "r134" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r284", "r286", "r682", "r799", "r800", "r801", "r802", "r805", "r806", "r807", "r808", "r809", "r832", "r834", "r835", "r872", "r873", "r874", "r875", "r876", "r878", "r879", "r908", "r1130" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "negatedTerseLabel": "Commodity swaps", "totalLabel": "Net amount" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Liability [Abstract]", "terseLabel": "Derivative Liabilities [Abstract]" } } }, "localname": "DerivativeLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r284" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Derivatives (Note 12)" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset": { "auth_ref": [ "r17", "r25" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of right to receive cash collateral under master netting arrangements offset against derivative liabilities.", "label": "Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Offset", "terseLabel": "Gross amount not offset in the consolidated balance sheets" } } }, "localname": "DerivativeLiabilityCollateralRightToReclaimCashOffset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative liability classified as current.", "label": "Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Derivative liability, statement of financial position [Extensible Enumeration]" } } }, "localname": "DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativeLiabilityFairValueGrossAsset": { "auth_ref": [ "r25", "r34", "r131", "r876", "r877", "r907" ], "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Liability, Subject to Master Netting Arrangement, Asset Offset", "terseLabel": "Gross amount offset in the consolidated balance sheets" } } }, "localname": "DerivativeLiabilityFairValueGrossAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative liability.", "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Derivative liability, statement of financial position [Extensible Enumeration]" } } }, "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [ "r665" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r1107", "r1108" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Derivative, notional amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r23", "r121", "r122", "r124", "r127", "r130", "r134", "r136", "r137", "r140", "r665" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Developed Technology" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r1103" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of Revenue by Major Customers by Reporting Segments" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax": { "auth_ref": [ "r153", "r154", "r163" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax", "terseLabel": "Earnings (loss) from operation of discontinued operations" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": { "auth_ref": [ "r154", "r155", "r156", "r157", "r163", "r167", "r618", "r629", "r634" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.", "label": "Discontinued Operation, Tax Effect of Discontinued Operation", "negatedLabel": "Income tax (provision) benefit from discontinued operations" } } }, "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]", "terseLabel": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]", "terseLabel": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": { "auth_ref": [ "r11", "r24", "r265" ], "lang": { "en-us": { "role": { "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.", "label": "Disposal Group, Held-for-Sale, Not Discontinued Operations [Member]", "terseLabel": "Disposal Group, Held-for-Sale, Not Discontinued Operations" } } }, "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": { "auth_ref": [ "r3", "r152", "r165", "r215" ], "calculation": { "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails": { "order": 3.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Goodwill", "terseLabel": "Disposal Group, Including Discontinued Operation, Goodwill" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets": { "auth_ref": [ "r3", "r152", "r165", "r214", "r215" ], "calculation": { "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Other Assets, Current", "terseLabel": "Disposal Group, Including Discontinued Operation, Other Assets" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities": { "auth_ref": [ "r3", "r152", "r165", "r215" ], "calculation": { "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Other Liabilities", "terseLabel": "Disposal Group, Including Discontinued Operation, Other Liabilities" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets": { "auth_ref": [ "r3", "r9", "r152", "r165", "r215" ], "calculation": { "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent", "terseLabel": "Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r928", "r931" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]", "terseLabel": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DividendsCommonStock": { "auth_ref": [ "r12", "r222" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Common Stock", "negatedLabel": "Common stock dividends" } } }, "localname": "DividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsCommonStockCash": { "auth_ref": [ "r222" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.", "label": "Dividends, Common Stock, Cash", "terseLabel": "Dividends, common stock, cash" } } }, "localname": "DividendsCommonStockCash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EMEAMember": { "auth_ref": [ "r1135", "r1136", "r1137", "r1138" ], "lang": { "en-us": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "EMEA [Member]", "terseLabel": "Europe and Africa" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r304", "r322", "r323", "r324", "r325", "r326", "r333", "r335", "r341", "r342", "r343", "r347", "r669", "r670", "r731", "r756", "r910" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "totalLabel": "Net earnings (loss)\u00a0- basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Earnings (loss) per common share\u00a0- basic" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r304", "r322", "r323", "r324", "r325", "r326", "r335", "r341", "r342", "r343", "r347", "r669", "r670", "r731", "r756", "r910" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "totalLabel": "Net earnings (loss)\u00a0- diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Earnings (loss) per common share\u00a0- diluted" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r332", "r344", "r345", "r346" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings (Loss) Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r692" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Exchange rate effects on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r619" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/IncomeTaxesScheduleofEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r44" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Salaries and benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Employee Severance" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Share-Based Payment Arrangement, Option" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_EntityWideRevenueMajorCustomerLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Major Customer [Line Items]", "terseLabel": "Revenue, Major Customer [Line Items]" } } }, "localname": "EntityWideRevenueMajorCustomerLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EnvironmentalExitCostsByCostTextBlock": { "auth_ref": [ "r1098" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of material liabilities for remediation, site restoration, postclosure, monitoring commitments, or other exit costs that may occur on the sale, disposal or abandonment of a property as a result of unanticipated contamination of the assets.", "label": "Environmental Exit Costs by Cost [Table Text Block]", "terseLabel": "Schedule of Environmental Remediation Reserves" } } }, "localname": "EnvironmentalExitCostsByCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EnvironmentalTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EnvironmentalLossContingencyDisclosureTextBlock": { "auth_ref": [ "r417", "r914", "r915", "r916", "r1031", "r1032", "r1033", "r1035", "r1036", "r1037", "r1038", "r1039", "r1040", "r1041" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for environmental loss contingencies, such as presence of hazardous waste, relevant information from reports issued by regulators, and estimated costs to achieve compliance with regulatory requirements. This element may be used for all of an entity's disclosures about environmental loss contingencies.", "label": "Environmental Loss Contingency Disclosure [Text Block]", "terseLabel": "Environmental" } } }, "localname": "EnvironmentalLossContingencyDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/Environmental" ], "xbrltype": "textBlockItemType" }, "us-gaap_EnvironmentalRemediationObligationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Environmental Remediation Obligations [Abstract]", "terseLabel": "Environmental Remediation Obligations [Abstract]" } } }, "localname": "EnvironmentalRemediationObligationsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EnvironmentalRemediationSiteAxis": { "auth_ref": [ "r914", "r915", "r1034", "r1035", "r1036", "r1097", "r1098" ], "lang": { "en-us": { "role": { "documentation": "Information by location or named area designated for environmental remediation.", "label": "Environmental Remediation Site [Axis]", "terseLabel": "Environmental Remediation Site [Axis]" } } }, "localname": "EnvironmentalRemediationSiteAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EnvironmentalRemediationSiteDomain": { "auth_ref": [ "r914", "r915", "r1034", "r1035", "r1036", "r1097", "r1098" ], "lang": { "en-us": { "role": { "documentation": "Location or named area designated for environmental remediation.", "label": "Environmental Remediation Site [Domain]", "terseLabel": "Environmental Remediation Site [Domain]" } } }, "localname": "EnvironmentalRemediationSiteDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r22", "r261", "r296", "r297", "r298", "r313", "r314", "r315", "r319", "r327", "r329", "r348", "r393", "r396", "r495", "r610", "r611", "r612", "r623", "r624", "r658", "r659", "r660", "r661", "r662", "r664", "r668", "r693", "r695", "r696", "r697", "r698", "r700", "r709", "r770", "r771", "r772", "r787", "r859" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investment, ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue": { "auth_ref": [ "r681" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value.", "label": "Equity Securities, FV-NI and without Readily Determinable Fair Value", "terseLabel": "Equity investments without readily determinable fair values, fair value" } } }, "localname": "EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": { "auth_ref": [ "r387" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Amount", "terseLabel": "Equity investments without readily determinable fair values, carrying amount" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [ "r675", "r676", "r679" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r675", "r676", "r679" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r141", "r142", "r143" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table]", "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "auth_ref": [ "r141", "r142" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "terseLabel": "Schedule of Carrying Values and Fair Values of Financial Instruments" } } }, "localname": "FairValueByBalanceSheetGroupingTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r465", "r535", "r536", "r537", "r538", "r539", "r540", "r676", "r712", "r713", "r714", "r918", "r919", "r924", "r925", "r926" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r675", "r676", "r677", "r678", "r680" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r674" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r465", "r535", "r540", "r676", "r713", "r918", "r919", "r924", "r925", "r926" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Significant Other Observable Inputs (Level 2)" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r465", "r535", "r536", "r537", "r538", "r539", "r540", "r676", "r714", "r918", "r919", "r924", "r925", "r926" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Unobservable Inputs (Level 3)" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r465", "r535", "r536", "r537", "r538", "r539", "r540", "r712", "r713", "r714", "r918", "r919", "r924", "r925", "r926" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r674", "r680" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r707", "r708" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease, Liability", "terseLabel": "Total debt" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r271", "r413" ], "calculation": { "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedPeriodEndLabel": "As of June 30, 2023", "negatedPeriodStartLabel": "As of December 31, 2022" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r212" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r212" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2028" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r212" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r212" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r212" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r410", "r412", "r413", "r415", "r721", "r725" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend": { "auth_ref": [ "r77" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of capitalized costs incurred in the period to renew or extend the term of a recognized finite-lived (amortizing and amortizable) intangible asset.", "label": "Finite-Lived Intangible Assets, Cost Incurred to Renew or Extend", "terseLabel": "Finite-Lived Intangible Assets, Cost Incurred to Renew or Extend" } } }, "localname": "FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)", "negatedTerseLabel": "Exchange rate changes" } } }, "localname": "FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r211", "r725" ], "calculation": { "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "periodEndLabel": "As of June 30, 2023", "periodStartLabel": "As of December 31, 2022" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [ "r721" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r72", "r75" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r211", "r721" ], "calculation": { "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Net book value" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsTranslationAndPurchaseAccountingAdjustments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) to assets, excluding financial assets and goodwill, lacking physical substance with a finite life for foreign currency translation adjustments and purchase accounting adjustments.", "label": "Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments", "negatedTerseLabel": "Exchange rate changes" } } }, "localname": "FiniteLivedIntangibleAssetsTranslationAndPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.", "label": "Foreign Currency Contract, Asset, Fair Value Disclosure", "terseLabel": "Foreign currency forwards and swaps" } } }, "localname": "ForeignCurrencyContractAssetFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.", "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure", "negatedLabel": "Foreign currency forwards and swaps" } } }, "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r687", "r688", "r689", "r691", "r856" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.", "label": "Gain (Loss), Foreign Currency Transaction, before Tax", "terseLabel": "Foreign exchange gain (loss), net" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r908", "r924", "r937" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign Exchange Contract [Member]" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets": { "auth_ref": [ "r1060", "r1086", "r1087" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 7.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property", "terseLabel": "Gain (loss) on disposition of businesses and assets, net" } } }, "localname": "GainLossOnDispositionOfAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r16" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "(Gain) loss on disposition of businesses and assets, net" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r270", "r398", "r726", "r913", "r939", "r1076", "r1083" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "As of June\u00a030, 2023(2)", "periodStartLabel": "As of December 31, 2022", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r210" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Intangible Assets, Net" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsnet" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "auth_ref": [ "r400", "r407", "r913" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impaired, Accumulated Impairment Loss", "negatedTerseLabel": "Goodwill, impaired, accumulated impairment loss" } } }, "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [ "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r913" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "auth_ref": [ "r1", "r1082" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Purchase Accounting Adjustments", "terseLabel": "Acquisitions (Note 3)" } } }, "localname": "GoodwillPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillTransfers": { "auth_ref": [ "r1082" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Transfers", "terseLabel": "Goodwill, Transfers" } } }, "localname": "GoodwillTransfers", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": { "auth_ref": [ "r1", "r1075" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Translation and Purchase Accounting Adjustments", "terseLabel": "Exchange rate changes" } } }, "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r192", "r310", "r355", "r369", "r375", "r378", "r392", "r438", "r439", "r441", "r442", "r443", "r445", "r447", "r449", "r450", "r683", "r911", "r1099" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GuaranteeObligationsMaximumExposure": { "auth_ref": [ "r437" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.", "label": "Guarantor Obligations, Maximum Exposure, Undiscounted", "terseLabel": "Guarantor obligations, maximum exposure" } } }, "localname": "GuaranteeObligationsMaximumExposure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r23", "r655" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Amounts Attributable to Parent, Disclosures [Abstract]", "terseLabel": "Amounts attributable to Celanese Corporation" } } }, "localname": "IncomeAmountsAttributableToReportingEntityDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r111", "r193", "r204", "r322", "r323", "r324", "r325", "r340", "r343" ], "calculation": { "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "terseLabel": "Earnings (loss) from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r0", "r188", "r243", "r355", "r369", "r375", "r378", "r732", "r747", "r911" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Earnings (loss) from continuing operations before tax" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r228", "r310", "r318", "r355", "r369", "r375", "r378", "r392", "r438", "r439", "r441", "r442", "r443", "r445", "r447", "r449", "r450", "r670", "r683", "r747", "r911", "r1099" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Earnings (loss) from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "auth_ref": [ "r187", "r241", "r244", "r304", "r318", "r322", "r323", "r324", "r325", "r335", "r341", "r342", "r670", "r731", "r1127" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 1.0, "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "terseLabel": "Continuing operations - basic (in dollars per share)" } } }, "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "auth_ref": [ "r187", "r304", "r318", "r322", "r323", "r324", "r325", "r335", "r341", "r342", "r343", "r670", "r731", "r1127" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 1.0, "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "terseLabel": "Continuing operations - diluted (in dollars per share)" } } }, "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "auth_ref": [ "r153", "r154", "r155", "r156", "r157", "r167", "r266", "r636", "r748" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Earnings (loss) from discontinued operations" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": { "auth_ref": [ "r153", "r154", "r155", "r156", "r157", "r163", "r167", "r228" ], "calculation": { "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent", "terseLabel": "Earnings (loss) from discontinued operations" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": { "auth_ref": [ "r190", "r304", "r339", "r341", "r342", "r1123", "r1127" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 2.0, "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.", "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share", "terseLabel": "Discontinued operations - basic (in dollars per share)" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": { "auth_ref": [ "r230", "r339", "r341", "r342" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 2.0, "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.", "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share", "terseLabel": "Discontinued operations - diluted (in dollars per share)" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r16", "r189", "r242", "r362", "r388", "r746" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "terseLabel": "Equity in net earnings (loss) of affiliates" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": { "auth_ref": [ "r16" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.", "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions", "negatedTerseLabel": "Undistributed earnings in unconsolidated affiliates" } } }, "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r928", "r931" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]", "terseLabel": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r311", "r615", "r620", "r621", "r622", "r628", "r632", "r637", "r638", "r784" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r247", "r257", "r328", "r329", "r363", "r618", "r629", "r757" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax (provision) benefit" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r15" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Trade payables\u00a0- third party and affiliates" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r15" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r15" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r15" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Liabilities", "terseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInReceivables": { "auth_ref": [ "r15" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Receivables", "negatedLabel": "Trade receivables\u00a0- third party and affiliates, net" } } }, "localname": "IncreaseDecreaseInReceivables", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r336", "r337", "r338", "r343", "r583" ], "calculation": { "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "terseLabel": "Incremental shares attributable to equity awards(1)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r411", "r414" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails", "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Indefinite-Lived Intangible Assets [Line Items]", "terseLabel": "Indefinite-lived Intangible Assets [Line Items]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r213" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "periodEndLabel": "As of June 30, 2023", "periodStartLabel": "As of December 31, 2022" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.", "label": "Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)", "terseLabel": "Exchange rate changes" } } }, "localname": "IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r73", "r213" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails", "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r70", "r74" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetIncludingGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.", "label": "Intangible Assets, Net (Including Goodwill)", "terseLabel": "Goodwill and intangible assets, net" } } }, "localname": "IntangibleAssetsNetIncludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r146", "r246", "r299", "r359", "r702", "r843", "r951", "r1132" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 7.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r44" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 9.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Interest (Note 7)" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r902", "r948", "r949" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest Rate Swap [Member]" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofInterestRateSwapNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "domainItemType" }, "us-gaap_IntersegmentEliminationMember": { "auth_ref": [ "r357", "r368", "r369", "r370", "r371", "r372", "r374", "r378" ], "lang": { "en-us": { "role": { "documentation": "Eliminating entries used in operating segment consolidation.", "label": "Intersegment Eliminations [Member]", "terseLabel": "Intersegment Eliminations", "verboseLabel": "Eliminations" } } }, "localname": "IntersegmentEliminationMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]", "terseLabel": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r209", "r905" ], "calculation": { "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r280", "r904", "r939" ], "calculation": { "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories", "totalLabel": "Total" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": { "auth_ref": [ "r209", "r1051" ], "calculation": { "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.", "label": "Inventory, Raw Materials and Supplies, Net of Reserves", "terseLabel": "Raw materials and supplies" } } }, "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r209", "r906" ], "calculation": { "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work-in-process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeDividend": { "auth_ref": [ "r196" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of dividend income on nonoperating securities.", "label": "Investment Income, Dividend", "terseLabel": "Dividend income - equity investments" } } }, "localname": "InvestmentIncomeDividend", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r197", "r358" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "auth_ref": [ "r1048" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.", "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures", "terseLabel": "Investments in affiliates" } } }, "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r179", "r240", "r743", "r939", "r1064", "r1074", "r1111" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r45", "r268", "r310", "r392", "r438", "r439", "r441", "r442", "r443", "r445", "r447", "r449", "r450", "r645", "r649", "r650", "r683", "r939", "r1099", "r1114", "r1115" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r141" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Liabilities, Fair Value Disclosure", "negatedLabel": "Total liabilities" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r3", "r152", "r165", "r215", "r265", "r266" ], "calculation": { "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Liabilities", "totalLabel": "Disposal Group, Including Discontinued Operation, Liabilities" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r3", "r152", "r165", "r214", "r215", "r265", "r266" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current", "terseLabel": "Disposal Group, Including Discontinued Operation, Liabilities, Current" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": { "auth_ref": [ "r48" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.", "label": "Liability for Uncertainty in Income Taxes, Noncurrent", "terseLabel": "Uncertain tax positions" } } }, "localname": "LiabilityForUncertainTaxPositionsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LicensingAgreementsMember": { "auth_ref": [ "r108", "r614", "r1106" ], "lang": { "en-us": { "role": { "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).", "label": "Licensing Agreements [Member]", "terseLabel": "Licenses" } } }, "localname": "LicensingAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [ "r1063" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r42" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing base" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r42" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Available for borrowing" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r42", "r1063" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LinesOfCreditCurrent": { "auth_ref": [ "r170", "r235" ], "calculation": { "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails": { "order": 2.0, "parentTag": "us-gaap_DebtCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Line of Credit, Current", "terseLabel": "Revolving credit facilities(2)" } } }, "localname": "LinesOfCreditCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Borrowing supported by a written promise to pay an obligation.", "label": "Loans Payable [Member]", "terseLabel": "Loans Payable" } } }, "localname": "LoansPayableMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r36", "r238", "r464", "r478", "r918", "r919", "r1126" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "terseLabel": "Long-term debt, including current installments of long-term debt, carrying amount" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "auth_ref": [ "r36", "r736" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.", "label": "Long-Term Debt and Lease Obligation", "terseLabel": "Total" } } }, "localname": "LongTermDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": { "auth_ref": [ "r44" ], "calculation": { "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails": { "order": 1.0, "parentTag": "us-gaap_DebtCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as current.", "label": "Long-Term Debt and Lease Obligation, Current", "negatedTerseLabel": "Long-Term Debt and Lease Obligation, Current", "terseLabel": "Current installments of long-term debt" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.", "label": "Long-Term Debt and Lease Obligation, Including Current Maturities", "terseLabel": "Subtotal" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-Term Debt, Fair Value", "verboseLabel": "Long-term debt, including current installments of long-term debt, fair value" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r275" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt, net of unamortized deferred financing costs" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r47", "r82" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.", "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Long-term debt, weighted average interest rate, at point in time" } } }, "localname": "LongtermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r430", "r431", "r432", "r436", "r1095", "r1096" ], "lang": { "en-us": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingency Nature [Axis]", "terseLabel": "Loss Contingencies by Nature of Contingency [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [ "r430", "r431", "r432", "r436", "r1095", "r1096" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r430", "r431", "r432", "r436", "r1095", "r1096" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyAccrualCarryingValueCurrent": { "auth_ref": [ "r430" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 10.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.", "label": "Loss Contingency, Accrual, Current", "terseLabel": "Legal (Note 14)" } } }, "localname": "LossContingencyAccrualCarryingValueCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualPayments": { "auth_ref": [ "r1094" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow reducing loss contingency liability.", "label": "Loss Contingency Accrual, Payments", "terseLabel": "Loss contingency accrual, carrying value, payments" } } }, "localname": "LossContingencyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r430", "r431", "r432", "r436", "r1095", "r1096" ], "lang": { "en-us": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]", "terseLabel": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r52", "r239", "r310", "r392", "r438", "r441", "r442", "r443", "r449", "r450", "r683", "r742", "r820" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.", "label": "Equity, Attributable to Noncontrolling Interest", "periodEndLabel": "Balance as of the end of the period, noncontrolling interest", "periodStartLabel": "Balance as of the beginning of the period, noncontrolling interest", "terseLabel": "Noncontrolling interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "auth_ref": [ "r222" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "negatedTerseLabel": "Distributions/dividends to noncontrolling interests" } } }, "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Subsidiary, Ownership Percentage, Parent", "terseLabel": "Noncontrolling interest, ownership percentage by parent" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r306" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r306" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r202", "r203", "r204" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r191", "r204", "r245", "r266", "r291", "r294", "r298", "r310", "r318", "r322", "r323", "r324", "r325", "r328", "r329", "r340", "r355", "r369", "r375", "r378", "r392", "r438", "r439", "r441", "r442", "r443", "r445", "r447", "r449", "r450", "r670", "r683", "r751", "r839", "r857", "r858", "r911", "r951", "r1099" ], "calculation": { "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss)", "terseLabel": "Net earnings (loss) attributable to Celanese Corporation", "totalLabel": "Net earnings (loss)", "verboseLabel": "Net earnings (loss) attributable to Celanese Corporation" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r119", "r229", "r291", "r294", "r328", "r329", "r750", "r1054" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedLabel": "Net (earnings) loss attributable to noncontrolling interests", "terseLabel": "Net earnings (loss) attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r126" ], "lang": { "en-us": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net Investment Hedging [Member]" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r255", "r256", "r258", "r263", "r316", "r317", "r320", "r321", "r330", "r331", "r394", "r395", "r625", "r626", "r627", "r663", "r667", "r671", "r672", "r673", "r684", "r685", "r686", "r704", "r705", "r710", "r722", "r723", "r724", "r773", "r774", "r775", "r776", "r777" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.", "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/RecentAccountingPronouncements" ], "xbrltype": "textBlockItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "New Accounting Pronouncements, Policy" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/RecentAccountingPronouncementsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r109", "r495", "r1067", "r1068", "r1069", "r1133" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interests" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Not Designated as Hedging Instrument" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofForeignCurrencyForwardsDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NontradeReceivablesCurrent": { "auth_ref": [ "r1050" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.", "label": "Nontrade Receivables, Current", "terseLabel": "Non-trade receivables, net" } } }, "localname": "NontradeReceivablesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotionalAmountOfNonderivativeInstruments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payments on a nonderivative instrument.", "label": "Notional Amount of Nonderivative Instruments", "terseLabel": "Notional Amount of Nonderivative Instruments" } } }, "localname": "NotionalAmountOfNonderivativeInstruments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsDerivativeFinancialInstrumentsScheduleofNetInvestmentHedgesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OffsettingAssetsTableTextBlock": { "auth_ref": [ "r183", "r285" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements.", "label": "Offsetting Assets [Table Text Block]", "terseLabel": "Offsetting Assets" } } }, "localname": "OffsettingAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OffsettingLiabilitiesTableTextBlock": { "auth_ref": [ "r183", "r285" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements.", "label": "Offsetting Liabilities [Table Text Block]", "terseLabel": "Offsetting Liabilities" } } }, "localname": "OffsettingLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r355", "r369", "r375", "r378", "r911" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Operating profit (loss)", "totalLabel": "Operating profit (loss)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r707" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating leases" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r707" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r706" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating Lease, Right-of-Use Asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r368", "r369", "r370", "r371", "r372", "r378" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r281", "r939" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r272" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "verboseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "auth_ref": [ "r54", "r297", "r693", "r696", "r700", "r752", "r1052" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "terseLabel": "Other comprehensive income (loss) before reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeTax": { "auth_ref": [ "r300", "r693", "r694", "r700", "r727", "r752", "r1052", "r1053" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Tax", "totalLabel": "Total other comprehensive income (loss), before tax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r287", "r288" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "terseLabel": "Gain (loss) on cash flow hedges", "verboseLabel": "Gain (loss) on cash flow hedges, net amount" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax": { "auth_ref": [ "r287", "r288" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax", "terseLabel": "Gain (loss) on cash flow hedges, gross amount" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": { "auth_ref": [ "r289" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax", "negatedTerseLabel": "Gain (loss) on cash flow hedges, income tax (provision) benefit" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r287", "r288", "r652", "r653", "r657" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Gain (Loss) Recognized in Other Comprehensive Income (Loss)" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": { "auth_ref": [ "r5", "r186" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax", "terseLabel": "Foreign currency translation gain (loss), gross amount" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r5" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Foreign currency translation gain (loss)" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "auth_ref": [ "r5", "r10", "r690", "r699" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax", "negatedTerseLabel": "Foreign currency translation gain (loss), income tax (provision) benefit" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r654" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax" } } }, "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r22", "r33", "r292", "r295", "r300", "r693", "r694", "r700", "r727", "r752", "r1052", "r1053" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Total other comprehensive income (loss), net of tax", "totalLabel": "Total other comprehensive income (loss), net of tax", "verboseLabel": "Other comprehensive income (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": { "auth_ref": [ "r8", "r186", "r926", "r1104" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax", "negatedTerseLabel": "Pension and postretirement benefits gain (loss), gross amount" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r8", "r186" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedTerseLabel": "Pension and postretirement benefits" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": { "auth_ref": [ "r8", "r10", "r228" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax", "terseLabel": "Pension and postretirement benefits gain (loss), income tax (provision) benefit" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTax": { "auth_ref": [ "r10", "r296", "r300", "r618", "r633", "r635", "r693", "r697", "r700", "r727", "r752" ], "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Tax", "negatedTerseLabel": "Income tax (provision) benefit", "totalLabel": "Total other comprehensive income (loss), tax" } } }, "localname": "OtherComprehensiveIncomeLossTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r128", "r139" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Current Other assets", "verboseLabel": "Current Other assets" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current liabilities.", "label": "Other Current Liabilities [Member]", "terseLabel": "Current Other liabilities" } } }, "localname": "OtherCurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other current liabilities.", "label": "Other Current Liabilities [Table Text Block]", "terseLabel": "Schedule of Current Other Liabilities" } } }, "localname": "OtherCurrentLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]", "terseLabel": "Covenants Not to Compete and Other" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r44", "r939" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Other liabilities", "totalLabel": "Total" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities, Current [Abstract]", "terseLabel": "Other Liabilities, Current [Abstract]" } } }, "localname": "OtherLiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r48" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermDebt": { "auth_ref": [ "r36", "r238", "r1126" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt classified as other.", "label": "Other Long-Term Debt", "terseLabel": "Other long-term debt" } } }, "localname": "OtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent assets.", "label": "Other Noncurrent Assets [Member]", "terseLabel": "Noncurrent Other assets" } } }, "localname": "OtherNoncurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other Noncurrent Liabilities [Member]" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r198" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income (expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonrecurringIncomeExpense": { "auth_ref": [ "r199" ], "calculation": { "http://www.celanese.com/role/OtherChargesGainsNetScheduleofOtherChargesGainsNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other expense (income) that is infrequent in occurrence or unusual in nature.", "label": "Other Nonrecurring (Income) Expense", "negatedLabel": "Other (charges) gains, net (Note 14)", "negatedTerseLabel": "Other (charges) gains, net", "negatedTotalLabel": "Total" } } }, "localname": "OtherNonrecurringIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofOtherChargesGainsNetDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).", "label": "Other Operating Activities, Cash Flow Statement", "terseLabel": "Other, net" } } }, "localname": "OtherOperatingActivitiesCashFlowStatement", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPensionPlansDefinedBenefitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide retirement benefits, classified as other. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Other Pension Plan [Member]", "terseLabel": "Benefit payments to nonqualified pension plans" } } }, "localname": "OtherPensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r508", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r535", "r536", "r537", "r538", "r539", "r540", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r558", "r561", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r577", "r578", "r579", "r926", "r927", "r928", "r929", "r930" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefits Plan [Member]", "terseLabel": "Post-retirement Benefits", "verboseLabel": "Benefit payments to other postretirement benefit plans" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherShortTermBorrowings": { "auth_ref": [ "r39", "r816" ], "calculation": { "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails": { "order": 3.0, "parentTag": "us-gaap_DebtCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer.", "label": "Other Short-Term Borrowings", "terseLabel": "Short-term borrowings, including amounts due to affiliates(1)" } } }, "localname": "OtherShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSundryLiabilitiesCurrent": { "auth_ref": [ "r44", "r81" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.", "label": "Other Sundry Liabilities, Current", "terseLabel": "Other Sundry Liabilities, Current" } } }, "localname": "OtherSundryLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r1042", "r1055" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedLabel": "Other, net" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r59" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Purchases of treasury stock, including related fees" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r419", "r1059" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "negatedTerseLabel": "Cash payments" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r59" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Common Stock", "negatedLabel": "Common stock dividends" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfFinancingCosts": { "auth_ref": [ "r58" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for loan and debt issuance costs.", "label": "Payments of Financing Costs", "negatedTerseLabel": "Issuance cost of bridge facility" } } }, "localname": "PaymentsOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r56", "r642" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payments to acquire businesses, gross" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r56" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedTerseLabel": "Acquisitions, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r201" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Capital expenditures on property, plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent": { "auth_ref": [ "r94", "r95", "r171", "r223" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 11.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as current.", "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Current", "terseLabel": "Benefit obligations (Note 8)" } } }, "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r94", "r95", "r172", "r223" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as noncurrent.", "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent", "terseLabel": "Benefit obligations" } } }, "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitContributions": { "auth_ref": [ "r14" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for pension and other postretirement benefits. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree.", "label": "Payment for Pension and Other Postretirement Benefits", "negatedLabel": "Pension and postretirement contributions" } } }, "localname": "PensionAndOtherPostretirementBenefitContributions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitExpense": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost (reversal of cost) for pension and other postretirement benefits.", "label": "Pension and Other Postretirement Benefits Cost (Reversal of Cost)", "terseLabel": "Pension and postretirement net periodic benefit cost" } } }, "localname": "PensionAndOtherPostretirementBenefitExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r507", "r532", "r534", "r540", "r557", "r559", "r560", "r561", "r562", "r563", "r575", "r576", "r577", "r926" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "Retirement Benefits [Text Block]", "terseLabel": "Benefit Obligations" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligations" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": { "auth_ref": [ "r171", "r508", "r509", "r531", "r926" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.", "label": "Liability, Defined Benefit Plan, Current", "negatedTerseLabel": "Current Other liabilities" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r237", "r509", "r531", "r1125" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans.", "label": "Liability, Defined Benefit Plan", "negatedTerseLabel": "Benefit obligations" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r508", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r558", "r561", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r577", "r578", "r581", "r926", "r927", "r931", "r932", "r933" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Pension Benefits", "verboseLabel": "Cash contributions to defined benefit pension plans" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PositionAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by position taken for a security.", "label": "Position [Axis]", "terseLabel": "Position [Axis]" } } }, "localname": "PositionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_PositionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicates position taken for a security.", "label": "Position [Domain]", "terseLabel": "Position [Domain]" } } }, "localname": "PositionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "domainItemType" }, "us-gaap_PostemploymentBenefitsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Postemployment Benefits [Abstract]" } } }, "localname": "PostemploymentBenefitsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r173", "r480" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r173", "r818" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r173", "r480" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r173", "r818", "r837", "r1133", "r1134" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r173", "r738", "r939" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.01\u00a0par value, 100,000,000\u00a0shares authorized (2023 and 2022: 0 issued and outstanding)" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r1043", "r1056" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other, net" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsToMinorityShareholders": { "auth_ref": [], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.", "label": "Proceeds from (Payments to) Noncontrolling Interests", "terseLabel": "Distributions to noncontrolling interests" } } }, "localname": "ProceedsFromPaymentsToMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": { "auth_ref": [ "r1057", "r1058", "r1061" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.", "label": "Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less", "terseLabel": "Net change in short-term borrowings with maturities of 3 months or less" } } }, "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "auth_ref": [ "r200" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Proceeds from Sale of Productive Assets", "terseLabel": "Proceeds from sale of businesses and assets, net" } } }, "localname": "ProceedsFromSaleOfProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromShortTermDebt": { "auth_ref": [ "r57" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Proceeds from Short-Term Debt", "terseLabel": "Proceeds from short-term borrowings" } } }, "localname": "ProceedsFromShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r266", "r291", "r294", "r305", "r310", "r318", "r328", "r329", "r355", "r369", "r375", "r378", "r392", "r438", "r439", "r441", "r442", "r443", "r445", "r447", "r449", "r450", "r643", "r646", "r647", "r670", "r683", "r732", "r749", "r786", "r839", "r857", "r858", "r911", "r935", "r936", "r952", "r1054", "r1099" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 }, "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net earnings (loss)", "totalLabel": "Net earnings (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAdditions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Additions", "terseLabel": "Capital expenditures" } } }, "localname": "PropertyPlantAndEquipmentAdditions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r18", "r733", "r745", "r939" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant and equipment (net of accumulated depreciation\u00a0- 2023: $3,830; 2022: $3,687)" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r54", "r297", "r693", "r698", "r700", "r752", "r1052" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "terseLabel": "Amounts reclassified from accumulated other comprehensive income (loss)" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r60", "r782" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-Term Debt", "negatedLabel": "Repayments of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfShortTermDebt": { "auth_ref": [ "r60" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Repayments of Short-Term Debt", "negatedTerseLabel": "Repayments of short-term borrowings" } } }, "localname": "RepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r150", "r613", "r1122" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "negatedLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units (RSUs)" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]", "terseLabel": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r16", "r422", "r424", "r1090" ], "calculation": { "http://www.celanese.com/role/OtherChargesGainsNetScheduleofOtherChargesGainsNetDetails": { "order": 1.0, "parentTag": "us-gaap_OtherNonrecurringIncomeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "negatedLabel": "Restructuring(1)", "negatedTerseLabel": "Restructuring Charges", "terseLabel": "Additions" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetNarrativeDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofOtherChargesGainsNetDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [ "r418", "r419", "r424", "r425" ], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [ "r418", "r419", "r420", "r421", "r424", "r425", "r426" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails", "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r419", "r423" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r1049", "r1091", "r1092" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Current", "terseLabel": "Restructuring (Note 18)" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]", "terseLabel": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r176", "r222", "r741", "r773", "r777", "r783", "r819", "r939" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r261", "r313", "r314", "r315", "r319", "r327", "r329", "r393", "r396", "r610", "r611", "r612", "r623", "r624", "r658", "r660", "r661", "r664", "r668", "r770", "r772", "r787", "r1133" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r508", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r558", "r561", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r577", "r578", "r579", "r581", "r926", "r927", "r928", "r929", "r930", "r931", "r932", "r933" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r508", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r558", "r561", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r577", "r578", "r579", "r581", "r926", "r927", "r928", "r929", "r930", "r931", "r932", "r933" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r356", "r357", "r368", "r373", "r374", "r380", "r382", "r384", "r504", "r505", "r720" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Net sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r259", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r506" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/RevenueRecognition" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionAndDeferredRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue Recognition and Deferred Revenue [Abstract]", "terseLabel": "Revenue Recognition and Deferred Revenue [Abstract]" } } }, "localname": "RevenueRecognitionAndDeferredRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r252" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue, remaining performance obligation, amount" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r253" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r253" ], "lang": { "en-us": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "auth_ref": [ "r40" ], "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Sales and Excise Tax Payable, Current", "terseLabel": "Sales and use tax/foreign withholding tax payable" } } }, "localname": "SalesAndExciseTaxPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r54", "r1112", "r1113" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r62" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r185" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.", "label": "Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Components of Other Comprehensive Income (Loss), Net" } } }, "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r47", "r86", "r89", "r144", "r145", "r147", "r149", "r220", "r221", "r918", "r920", "r1066" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Long-term Debt" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r20", "r96", "r97", "r98", "r99" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": { "auth_ref": [ "r20", "r96", "r97", "r98", "r99" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.", "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r129", "r134", "r655" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Schedule of Changes in Fair Value of Derivatives" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "auth_ref": [ "r19", "r24", "r37", "r152", "r158", "r159", "r160", "r161", "r162", "r166", "r168", "r169", "r216" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "terseLabel": "Disposal Groups, Including Discontinued Operations" } } }, "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r1071" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings (Loss) Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of Effective Tax Rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": { "auth_ref": [ "r207" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.", "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]", "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]" } } }, "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r675", "r676" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r72", "r75", "r721" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r72", "r75" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r913" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r913", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r26", "r213" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r26", "r213" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r38", "r180", "r181", "r182" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Schedule of Line of Credit Facilities [Table Text Block]", "terseLabel": "Schedule of Balances Available for Borrowing" } } }, "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of Net Benefit Costs [Table Text Block]", "terseLabel": "Schedule of Net Periodic Benefit Costs Recognized" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/BenefitObligationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "terseLabel": "Schedule of Notional Amounts of Derivative and Nonderivative Instruments" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r418", "r419", "r420", "r421", "r424", "r425", "r426" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresDisposalGroupsIncludingDiscontinuedOperationsDetails", "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "auth_ref": [ "r79", "r80" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Schedule of Restructuring Reserve by Type of Cost" } } }, "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r66", "r67", "r68", "r69" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r66", "r67", "r68", "r69" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Business Segments" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]", "terseLabel": "Schedule of Short-term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShortTermDebtTextBlock": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table Text Block]", "terseLabel": "Schedule of Short-term Debt" } } }, "localname": "ScheduleOfShortTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r83", "r84", "r85", "r86", "r87", "r88", "r89", "r220", "r221", "r222", "r276", "r277", "r278", "r349", "r480", "r481", "r482", "r484", "r487", "r492", "r494", "r779", "r780", "r781", "r782", "r922", "r1030", "r1062" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": { "auth_ref": [ "r90", "r91", "r92", "r93" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table Text Block]", "terseLabel": "Schedule of Treasury Stock" } } }, "localname": "ScheduleOfTreasuryStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfVariableInterestEntitiesTable": { "auth_ref": [ "r113", "r114", "r115", "r116", "r117", "r644", "r645", "r649", "r650", "r716", "r717", "r718" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.", "label": "Schedule of Variable Interest Entities [Table]", "terseLabel": "Schedule of Variable Interest Entities [Table]" } } }, "localname": "ScheduleOfVariableInterestEntitiesTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.", "label": "Secured Debt [Member]", "terseLabel": "Secured Debt" } } }, "localname": "SecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r352", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r378", "r384", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r421", "r426", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r913", "r1046", "r1128" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails", "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails", "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r351", "r352", "r353", "r354", "r355", "r367", "r372", "r376", "r377", "r378", "r379", "r380", "r381", "r384" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r195" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "negatedLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Notes [Abstract]", "terseLabel": "Senior Notes [Abstract]" } } }, "localname": "SeniorLongtermNotesCurrentAndNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r15" ], "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "All Award Types" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "periodEndLabel": "Balance as of the end of the period (in shares)", "periodStartLabel": "Balance as of the beginning of the period (in shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]", "terseLabel": "Short-term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt arrangement having an initial term within one year or the normal operating cycle, if longer.", "label": "Short-Term Debt [Member]", "terseLabel": "Loans Payable" } } }, "localname": "ShortTermDebtMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]", "terseLabel": "Short-term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r40" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-Term Debt, Type [Domain]", "terseLabel": "Short-term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermDebtWeightedAverageInterestRate": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of short-term debt outstanding calculated at point in time.", "label": "Short-Term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Weighted average interest rate, short-term borrowings" } } }, "localname": "ShortTermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SiteContingencyLineItems": { "auth_ref": [ "r434", "r914", "r915", "r1034", "r1035", "r1036", "r1088", "r1098" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Site Contingency [Line Items]", "terseLabel": "Site Contingency [Line Items]" } } }, "localname": "SiteContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SiteContingencyTable": { "auth_ref": [ "r434", "r914", "r915", "r1034", "r1035", "r1036", "r1088", "r1098" ], "lang": { "en-us": { "role": { "documentation": "Information and financial data about the reasonably possible loss or the recognized and additional reasonably possible loss from an environmental remediation obligation.", "label": "Site Contingency [Table]", "terseLabel": "Site Contingency [Table]" } } }, "localname": "SiteContingencyTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r264", "r352", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r378", "r384", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r416", "r421", "r426", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r913", "r1046", "r1128" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails", "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails", "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r260", "r276", "r277", "r278", "r310", "r335", "r339", "r341", "r343", "r349", "r350", "r392", "r438", "r441", "r442", "r443", "r449", "r450", "r480", "r481", "r484", "r487", "r494", "r683", "r779", "r780", "r781", "r782", "r787", "r788", "r789", "r790", "r791", "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r818", "r840", "r859", "r882", "r883", "r884", "r885", "r886", "r1030", "r1062", "r1070" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r22", "r51", "r261", "r296", "r297", "r298", "r313", "r314", "r315", "r319", "r327", "r329", "r348", "r393", "r396", "r495", "r610", "r611", "r612", "r623", "r624", "r658", "r659", "r660", "r661", "r662", "r664", "r668", "r693", "r695", "r696", "r697", "r698", "r700", "r709", "r770", "r771", "r772", "r787", "r859" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r313", "r314", "r315", "r348", "r720", "r778", "r798", "r810", "r811", "r812", "r813", "r814", "r815", "r818", "r821", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r829", "r832", "r833", "r834", "r835", "r836", "r838", "r841", "r842", "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r859", "r944" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r313", "r314", "r315", "r348", "r720", "r778", "r798", "r810", "r811", "r812", "r813", "r814", "r815", "r818", "r821", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r829", "r832", "r833", "r834", "r835", "r836", "r838", "r841", "r842", "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r859", "r944" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_StockAppreciationRightsSARSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.", "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)" } } }, "localname": "StockAppreciationRightsSARSMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r22", "r173", "r174", "r222" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Stock awards (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r22", "r173", "r174", "r222" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Issuance of treasury stock under stock plans (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r22", "r222" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Stock awards" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r100", "r173", "r174", "r222" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Issuance of treasury stock under stock plans" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r174", "r177", "r178", "r208", "r820", "r837", "r860", "r861", "r939", "r953", "r1064", "r1074", "r1111", "r1133" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "terseLabel": "Celanese Corporation stockholders' equity", "totalLabel": "Total Celanese Corporation shareholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r109", "r110", "r118", "r261", "r262", "r297", "r313", "r314", "r315", "r319", "r327", "r393", "r396", "r495", "r610", "r611", "r612", "r623", "r624", "r658", "r659", "r660", "r661", "r662", "r664", "r668", "r693", "r695", "r700", "r709", "r771", "r772", "r785", "r820", "r837", "r860", "r861", "r887", "r952", "r1064", "r1074", "r1111", "r1133" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance as of the end of the period", "periodStartLabel": "Balance as of the beginning of the period", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Shareholders' Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]", "terseLabel": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r219", "r309", "r479", "r481", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r493", "r495", "r666", "r862", "r863", "r888" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Equity [Text Block]", "terseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r701", "r711" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r701", "r711" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r701", "r711" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TrademarksAndTradeNamesMember": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trademarks and Trade Names [Member]", "terseLabel": "Trademarks and Trade Names" } } }, "localname": "TrademarksAndTradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails", "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized": { "auth_ref": [ "r30" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.", "label": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized", "terseLabel": "Transfer of financial assets accounted for as sales, amount derecognized" } } }, "localname": "TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivableSecuritizationFacilityNarrativeDetails", "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockAcquiredAverageCostPerShare": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.", "label": "Shares Acquired, Average Cost Per Share", "terseLabel": "Average purchase price (in dollar per share)" } } }, "localname": "TreasuryStockAcquiredAverageCostPerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofTreasuryStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_TreasuryStockCommonMember": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common [Member]", "terseLabel": "Treasury Stock, Common" } } }, "localname": "TreasuryStockCommonMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Shares", "terseLabel": "Treasury Stock, Common, Shares" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r22", "r174", "r222" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "negatedTerseLabel": "Purchases of treasury stock (in shares)", "verboseLabel": "Shares repurchased (in shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofTreasuryStockDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r50", "r90", "r93" ], "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, at cost (2023: 61,611,401 shares; 2022: 61,661,493 shares)" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r22", "r90", "r222" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedLabel": "Purchases of treasury stock, including related fees", "terseLabel": "Shares repurchased (in $ millions)" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofTreasuryStockDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [ "r418", "r419", "r424", "r425" ], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary": { "auth_ref": [ "r428" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year One", "terseLabel": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year One" } } }, "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary": { "auth_ref": [ "r428" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Four", "terseLabel": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Four" } } }, "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary": { "auth_ref": [ "r428" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two", "terseLabel": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two" } } }, "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary": { "auth_ref": [ "r428" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three", "terseLabel": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three" } } }, "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount": { "auth_ref": [ "r428" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).", "label": "Unrecorded Unconditional Purchase Obligation", "terseLabel": "Unrecorded unconditional purchase obligations" } } }, "localname": "UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecordedUnconditionalPurchaseObligationDueInRemainderOfFiscalYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in remainder of current fiscal year.", "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year", "terseLabel": "Unrecorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year" } } }, "localname": "UnrecordedUnconditionalPurchaseObligationDueInRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnsecuredDebt": { "auth_ref": [ "r36", "r238", "r1126" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Unsecured Debt", "terseLabel": "Senior unsecured debt" } } }, "localname": "UnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r63", "r64", "r65", "r248", "r249", "r250", "r251" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Estimates and Assumptions" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/RecentAccountingPronouncementsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableInterestEntityLineItems": { "auth_ref": [ "r644", "r645", "r649", "r650", "r716", "r717", "r718" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Variable Interest Entity [Line Items]", "terseLabel": "Variable Interest Entity [Line Items]" } } }, "localname": "VariableInterestEntityLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r334", "r343" ], "calculation": { "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average shares\u00a0- diluted (in shares)", "totalLabel": "Weighted average shares\u00a0- diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r333", "r343" ], "calculation": { "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average shares\u00a0- basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 10 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1000": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "ii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1001": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "iii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1002": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "iv", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1003": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "6", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1004": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "6", "Publisher": "SEC", "Section": "402", "Subparagraph": "i", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1005": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1006": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1007": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "A", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1008": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "B", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1009": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "C", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1010": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "D", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1011": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "E", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1012": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subparagraph": "ii", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1013": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subparagraph": "iii", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1014": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1015": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1016": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1017": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "A", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1018": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "C", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1019": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "D", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1020": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "E", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1021": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "F", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1022": { "Name": "Regulation S-K", "Number": "229", "Publisher": "SEC", "Section": "408", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1023": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "408", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1024": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "A", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1025": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "B", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1026": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "C", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1027": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "D", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1028": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "408", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1029": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1030": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r1031": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r1032": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r1033": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r1034": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)(1)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r1035": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)(2)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r1036": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)(3)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r1037": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)(4)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r1038": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)(5)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r1039": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-11", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1040": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-14", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r1041": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-17", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r1042": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1043": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1044": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1045": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1046": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1047": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1048": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1049": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1050": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1051": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1052": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1053": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1054": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1055": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1056": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1057": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1058": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1059": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1060": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1061": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1062": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1063": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1064": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1065": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1066": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1067": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1068": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1069": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1070": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1071": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1072": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1073": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1074": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1075": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1076": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1077": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1078": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1079": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-31", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1080": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1081": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1082": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1083": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1084": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1085": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1086": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1087": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1088": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1089": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1090": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482047/420-10-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1091": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1092": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1093": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1094": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1095": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1096": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1097": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1098": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1099": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1100": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1101": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1102": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1103": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1105": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1107": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1108": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1109": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1111": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1112": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1114": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1115": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1116": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1117": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1118": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1119": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1120": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1121": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1128": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1129": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1130": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(3)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1132": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1133": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1134": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1136": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1137": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1138": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org//205/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "3B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480463/815-10-45-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(13))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(14))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483613/220-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r205": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r206": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org//350/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r217": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r218": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org//470/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r219": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.E)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147479836/810-10-S99-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r231": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org//815/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(20))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(1)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(2)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org//250/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org//606/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(21))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org//260/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org//280/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(7))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org//330/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "410", "URI": "https://asc.fasb.org//410-30/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q1)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "https://asc.fasb.org//715/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org//740/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482551/740-270-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "4CCC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4CCC", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480627/815-20-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)(ii)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(1)", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(2)", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(3)", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(16))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(17))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column A))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column B))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column C))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column D))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column E))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column F))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column G))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column H))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column I))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column J))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column K))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(4)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(7)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r872": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13A(Column E))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r876": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r877": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column F))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r878": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r879": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r880": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r881": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r882": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r883": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r884": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r885": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r886": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r887": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r888": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r889": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r890": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r891": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r892": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r893": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r894": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r895": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r896": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r897": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r898": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r899": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r900": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r901": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r902": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r903": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r904": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r905": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r906": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r907": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-20", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r908": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r909": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r910": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r911": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r912": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r913": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r914": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481899/410-30-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r915": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481899/410-30-55-16", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r916": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481899/410-30-55-17", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r917": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r918": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r919": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r920": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r921": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r922": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r923": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r924": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r925": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r926": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r927": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r928": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r929": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r930": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r931": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r932": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r933": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r934": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r935": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r936": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r937": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r938": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r939": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r940": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r941": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r942": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r943": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r944": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r945": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r946": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r947": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r948": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r949": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r950": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r951": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r952": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r953": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r954": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r955": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r956": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r957": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r958": { "Name": "Form 20-F", "Paragraph": "a", "Publisher": "SEC", "Section": "16", "Subsection": "J", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r959": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r960": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r961": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "A", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r962": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "B", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r963": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "C", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r964": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "D", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r965": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "E", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r966": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "ii", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r967": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "iii", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r968": { "Name": "Form 20-F", "Paragraph": "2", "Publisher": "SEC", "Section": "6", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r969": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "ii", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r970": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r971": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r972": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "i", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r973": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "ii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r974": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "iii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r975": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "iv", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r976": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "v", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r977": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Subparagraph": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r978": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Subparagraph": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r979": { "Name": "Form 40-F", "Paragraph": "b", "Publisher": "SEC", "Section": "19", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r980": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r981": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r982": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "i", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r983": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "ii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r984": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "iii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r985": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "iv", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r986": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "v", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r987": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Subparagraph": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r988": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Subparagraph": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r989": { "Name": "Form N-CSR", "Paragraph": "b", "Publisher": "SEC", "Section": "18", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r990": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r991": { "Name": "Regulation S-K", "Number": "229", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r992": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r993": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "ii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r994": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "iii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r995": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "iv", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r996": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "vi", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r997": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "3", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r998": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "4", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r999": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "i", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 109 0001306830-23-000129-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001306830-23-000129-xbrl.zip M4$L#!!0 ( "J#"%=XLJ?&9*@! "--&P / 8V4M,C R,S V,S N:'1M M[+UM=Z/*L3;\_?P*'B7GSLQ:DLV;A/#,UKTTMF9OY/.MY%@BR*"NKNZ*+WE77T+2^,=4[$NP^=515>>H *,.. MW'T2C:FJRUVEUWZ^,J#>GXJFU)F:W7Y'-32I PRH=4S0-:>RJIM//;%M7DVG MBMQ7-1FJAJ)VI[K>5^6^J2E0TW3E25'Q:V*:X+X51TDT:>GR?[]_FQ@S. <=R_$# MX!COT_==59:T(P2+[EB_!ETT=X8?W=N[#"]ND+:#9K;U[-5,CU%7ZG;$?D>1 M-E]I'1OAYIRN$(F>?VE!I_-CTD(8A\ 7@O_[KOSX'5F##@8&$,"+VY\OPH\^7X8.?7/-M M\-FT7@0_>+,1MTS+7]C@[;[U>X1NA%_YJF29TR*_H^BU2'YYEA&]_ M#1[@])>6T4&S=L [M&HW- _;8,>'K_\"WEF A49AV5*4U$!%W MT<#Z>&1;3\WPDNNEYZ$W?+5\ ]C_A, ;.>8-TF@M(63*+RW$R"L3?=*9HZ?, MD*IY'X/:&DCRI2*=_OJ5'GU__U?TB;]^0[\BTK4:G:[JK<$Q7?^G M:]='S__5=4U_Z)@3Z+U8!O0GKFUFG)!\G@EUQ7--2#G3A+H)$QJC87G0#T:O M"_28K#A3SS2+7J&SZ)UG%CWI7.#JGFE"\IDFI)QI0GTE84)?70]:STZXV!EO MC]CH 9^QFH87R!:[^ C>!6./N@.F?C>K>NX"S(&YWDUO!/PJYP)OWVUDM31 MST,=/0D[M(1!%<\TH21V4YO0F:P5/X?UH]D;XE6S3/:+/?)-?18'+,/]'?V\<[ MW2F\DR;/+#(HJ:*43GY>:-EU#]TI4.&%EDJ=%,:+M5+(SX_$T,$!W9!I+HJX MY^H_P!?H+.$#G".+ AD&]] C 7?'@'=/MO4,PK$OH!% \]&:HUONIA/TJ3\- M+9$PE"UMQ>GQALN5N?1(I'X]1T5"^J^7<<#:60?\!H&W,5[D\&7;4U#$?HGC ME<6X\5YN[_EX< JQ-0G]F(TJO"]YY9--.C0C@6R07@5O"S0?WYHO;+R[13Z; M>63"[WM2%Z^^B1YPN?V$\.WOKXQ&X+M+C_Q%-M6N(AJ2>>!=C=7GD&P\K?ZR M3/SWU(*>0)X/8[?TKL?_L[TAM?OEP>JC[:YWWMZZNK/Y>O>1R:][Q9)"+)D,T&_B,%5;XIXE>]KJP+<,* MOL/Y$WJ%:O*;$>135XHU20-P:\&OUXF$#'14 MMY:245D-.]6O)J7X-.:77DE,Z ^Y)F&L81#/K=T1U M_:#H2KJ9+1TKG)8_ \@K6\]L#H&/F#F("$LNKAZQNK;Z&S_C@",G,D"J7<2H MYT#,FJY+XA1O$RY*9;WZ,;DY@:;,><=R>IK*]*10*MP]/H$.:;51+CIL8NL> M>A,LG&M:F-8+FL/FK;=AK-'U3H3AWO?QAS?0<>>6$_?8M"ICZQ&7VZ-/EH+" M'?#,2GB3H=F4\,[4"O=8LTT-'S#H*!*5J;'OXHW^L\31?'>^]ML<*@DJR[PIVL*C.H&,-#+MQ; MJPG-98HT+]R;*YCFCQXQ[=\(U4,&5,4RDMG?8&6+]A0M))G]#50&:,^ I22S MOW_*&J/*L9CDJOO6):PDU%;QJOO8):PDU&A?=5][:)HD/138]\ RQ\XU6%@! ML"MC157=E2Z#_C0MJ:I[RF>C/P/6E%)U%[L<9I5C42E5]\U+6EEHK>Q*U?WS MDE86:O2ONH_^ -@.= < 0^?N_"K8E(I5?>YSTIXBK:44G4?NGC"LV!$5=W; M/C.72K*>JNZ7GWOUH+9L5]TA/_?J08WPE??$#6,Y7]KH7I.<-8ZI9U(5$TJM MO*-=,B\H6E5JY?WH,GC!@*&E5MX!+YUQY=A>:M4]][*U'T5S3*VZ,U\V+RA: M:&KA_GUY4ZNZ4XR+\Z 9>:YMD^IT807*RMB;5?=V2R _31.SZC[ONY%%Z58TAVJ^Y&E[.JT%K4NU7WG,M95:B1O^K^[_D.1% [(MJMNNMZ+II+ M%&E>=1>U[M7FNE7?ES[K<<6S%&'885#5O>_S)X#3TUY5=[W/37N:*T?5_>Y2 MCG&5L8)4W>DNY1A7"2M)K^H>=SE)K]0T6J_J+G<9]*>XHO2J[G.7=IREC#JP M57?62SO.4L;*4G4O_\QY@?146M6]][,2GN9:4G6O_/SI_&4L(E7WW\^?SE_& MZE%U3[_\-"9Z>JWJSGS9O*"XQFB5]]=+SY$MJ3-"Y1W]TAE7SDJD53U"4$I2 M!#V%5W6?OP3RTUQOJN[%EY7I6,824W7'OZQ,QS)6E<)C!>6I#.8<;-\+KNY^ M.M#S9]9BW4KHVG5\U[9,;-'\'3UHB<#&;J;FN@N'L\1C.= Y9X%^73T@?8\7 MC5EG^\O2MQSH^T,#*8ZPK?&:?]_=L!7R=\1 SP)VX0':33612T"8]:=+)O>. M7I;2Z^6M6T]L;S,%!IG@GFBAR:^NI9&M]0,7:!!.$/>X\$JFA\'YPG;?8$S/ M+/2\]<7LLM]G-J# %AC+. [19S9FP!AO2C#@^LR%!0Y8.= &B%/PVO46KD=Z MOR?P(]6+)FAJYM*&=]/0I/\.@YEKCIT79+"_&_J;GT)X"^9P/:[;9>!9COL" M_NI:3A#97\6;7[),8P7O,Q>4B&?^=ROPE]:U^RTP.=-S,YVY4 AG^I$ S";; M$P,P[[?F6A.8#<#<6/["]8']J^\=0-T M"4_7-"T<@V+7Y]]!%W/I)534P_^X'@0CYQG9 MDX@8SO,]0F=@&3XU!4;#)LH;.]CR'G*!@,G@6A5!0);))PM]]BOPKQ'%D#ZT M<60:.&^500-S@;O2T7!>3U\].>RTPTCF0H)59"0M(5L'W8#C+(%-OFS;\P/! MO/"F\?M-V>)ZR_U8_JI3]NC'0_: GLYL0._=N(NB1Y/P$>^6V0HJT#Q;4)_6 MKI?.;*PNF>Q# P9O]O4,6)4YA:LS%WYC#.4,Y"/HS$7)&!$)%GC#7#"+,?DI MQH?7F8T0L;-*T"0WT[^+?K MD2C==G#NFV7@YSC/PVW, 7:+L+:#Y"8^:XMOO\]F ]SRHD&\PY_[GX04X'[-Y>%5Y((K/N,[M+ M!@/VK"0RZW^SO, PP3EF77G6ER,FN,>LD\_RXL4$YY@- ;"[TA7CIDHBLV$! MEA>OHIA1KZ!!.>X158;4*W9P?O^(*C.8#1Z,'1-.3V'(HP=,. ?>[_[0,!.[0BXKL_$#]EG"@B$F,1MR8)]_!6DYB=EH CLG(JG2F]D8 #OTIKED2,QZ M[=I4LW MJ3Z9N5[P"+TYOJDZ"&?6=V:#UE1QS:Q;?(S6E=?AS/J_K%&=*M:9=7'CJ(YS MU'X\3*!CN=X/!PUBB:A^ZP;0OUE"C,?*H%UFUC5EC^XT\2XSZW\>H/MAHJO5 M 3NS3BAC1*>*=&8]T0-$_S&YJ078F?5%V:,[5;Q7RAM-6E&[U<%[I3S3^5\E*3]$R%\%XI/[5]4\U1VBXS#8-QZ54'[U5S5DND.U6\5\U?/6I'5@CO5?-72Z0[5;S7RE_5JH/W6OFKQ=*= M*MYKY:]6".^U\E]7\U1+I3A7O MM?)7]>K@O5;^:K%TIXKWJOFK1^W("N&]:OYJB72GBO&]NLHJ ISQ,EU>U#96>>@/>;J -WJ!YXX&?JP'0Y[*_TQ%'V>#SL:HH.[?F MJHK293:@T$A(; G^%I?S"3ZSX8MOKO,GW#?$X0>IU6!;0>!@-B6^AU6MY4KU+AG7R%,U*_FKVZ2_2T M?*]JP:/KF>6 AC$\+'FIGL;P=1-+PWD[V,3R^O:?JZ^G;V(I]2H5YEJ!YQ^N M]SOF'UA8 ;!3JF@*?N?I+Z>!GAX==5&I:%NC.!Y3)'?-\X0BN9NWYC,1F8T0 M_AUX%@ZV/J"YK?FS^G",)N$] >=W\@OT WQ7P;8B!^99@ U@LVQR8X\Q&QZP_2E^@)[Y8'DV$I9*$@*6AVUJH7Y&LQWFBD[6M4B=$WC.Q.+0M6">HT&B9P> M)#N:)!](F WM'3HJN?3XT2@TOT '_7(&;T@M0ZJ8#94D<8KTK+YWD=BM;XPXU1SF M,1OO8%;,Y/2LZ$(9L4L MDWE/D5/,1BVJ)&9E,8_9F =+8E90O$]G-HB13G(:9D_HE8UCG)U=10D,CT^P MQ0\>Z^!O ?L!#<"T2)+(Q-HX$'0/?!]8QH/U M KU;^/.OT/-A 2GP3"SDS 8&6.64U$M=;&7WUGR<8C8*P"JG9"E]A0R)8H4, MG=DH +.<(HN/E.H\X,ZM^3C%K,O/+*<4K-)D->4ZM7EK'D[)(K/Q 98X58QO M@Q8R5HD_63[Y\#]+]*71"_JQ;U_OW%"\<&A(JZ04CLU;\PE'X;& C(00^QU1 M/K\U*XO,.N$3G**.OS/ZSQ*-Z]J=+UP'_>EOPW5H&,OYTL;I[(\>\O]LHDJ& MYK^7?C O!+_%>("RR*Q'GIT3OP++^>;Z_BT,KH$_^VJ[/W^#YC.\!UZE6,*L M4YZ=)=MQ$1(JJ:*0,.M\,ZNN&(B9R"*SGCC[NHT)_C'KGS.O")E@'[-..[-: MLR"_4&+6*6=?$1;%$G9===9U6U$<87:C_@9-XP7IGA?X?DC'7\G!ES<,?\MY M?H"A?O)GUF*;54A4QLX+#/D1W5W/)4=B-JYPX(C55]>#UK-SO?20]C+>;J#C MSBTG%*K$H^DU!U OY98050 Q&P[A ,H&H!W__TP'!V6)V>!-' \?+/_W;4ZM M@#3Y"1;TT).]6;!6<'"(6GT]66(V.%1$T]KRX,80QYF-*]&IJ%CO9:&,:H^R MQ&PH*R+[#?21&1$&.+9YY#IF= V:-?4:F U4I5.BD0TX>C5FN(OR-9J=!PQJ MQE_)""G(W9>9C8EQIA>VD208JH@>8CAN>DX,554%,!O#K!;[RI(^AJ.F>VD9?&V2 U#8(VB ;H%*QR*9M MNS,AY96*-#8:(67I$&;CB"PQIRSQ939*R!)SRI(V@;_F@2>LC1/;6-_#!IBP54*G )+OL*TOZF(T:\O25:L@_LY%-#J!J:*#:1E\;E<%2 MDOKIUC;ZVBCTE*1[NK6-OC9G_>A6*@C:Z,R(LM:(2D4Z&XV0LG0(LW%,SARY MRP.$V03Z*["\OP-[";^\K7_]#4T4>,;L[1M\@?:.?EG=-'86R\ G=U"K>+@Q MF.\0^,NP2^Q7C[2U,MX.C&3C5O\!EV/T*-(G2:9NU@(U]*-[W_E+:Q!?@ T< M TYF$ ;?7"-F&*2Y;FB#!T/?AT&A%0I+R< HJ(I9E\>DN<9HJL9 %H'!E<8) M2H/AG1"N-+C28,;,8$ADF=U[XK+!7'BS\7)+>Z4_5Y%ZJAJ#VLUNG#94%AJ#![+YH0Z%1D)K\9H$GR[8"J]+=3ZIEV=78NNHQNQ7/ MU0:76K:DEK9&?P_[IE?J#&D.9E,TN.9@W."HJ7/&;$8*%XC2]'7398(G O$= M.KY#5_,]?9J=[7H\$8AKC*9JC"8E E%5&LPF G'IY%&LNML:YXI[4]48/ ^) M:XQZ:HP*Q;W/D+Q(56GP5*2**@V>BD1;%C2>BL26+# $#693D7@(AR7$UM*L MJFP,1>.90!45C]+W\[E+UMQ BL;3@"JJ-KC4UB>0NYCM#K/'?3.R'1X]F!HJ?SF0F/F%QLS MHZFA^LQN@C#/D?=2E)*NZQVIC"JS?68W*C*R[\;"?KB%;WAG776DB-G(\R1 MV,+?^;+T+0?Z_B1\A+^F_,A!C@B$'G(ST*V>!>S<3H[O!5>(R;YK6R:1QC$: M@[_C7R$" PR#U8"*%-#R>C#WF0TN)B-C:,#@S;Z> Q!]ZZ3L0?6J&0!"#NC6#HF"0X4U-X,!="20,/TKTT>N3(MDAO(W1G35G$ M;'2%K_;OI>#3(H-FU?@^L_&>QJ_V92&"N<@37^U9@@=S 3%V5_N26*0S&R'C MJWVY+9YT9H-OC5_MRT($0$OBLG,1>OXFEPPQYF+PC&US!9%=>8B77SE9*.7JLY5MJV(S,6MFKR %\5DYB)??$TNF./,A;^8 M6F:+HGI)\:C@;;$Z21J']@?X ITE?(!SI"F1_KJ'WM3UYOB4[-V3;3T3(H]> M%] (H/F(R?Y\-YV@3_TI,/"UR"HICE<[/'4YG@B>*AS]*\A37+_X5^@^>V QLPP0 MG?/%EV]=+Y@-Y^A]!JAE!KTB,1?_XY@H.<]2D9@+^G%,E)R-HT@\RL@N)DJ* M/$L5#D:>'Q.KL8V^CX8UM268BUMR/)1J1S 7U>1X*-6&8"[_C^.A5/N!N>Q MEO& +P]]"]P# ]=6JJD)P5,7F85$658$CUHR"XF2# F9!RV9A41)MH3,8Y89 M(3%QES7?VY!YS))=3)1D3<@\9LDN)LHR)WC\%'C#LX OT<.<5 M^C IJ&]8CT?8FL9Q9F-G"1P_M34B9_X&\YD-J#6!^,Q&N?@JRY#AW6,V2-;X M)9D)># ;6^/K-V-(838RQSFUPREFXVK<,MBW"6GV,>TQ&V5K_&)?%,>K&FMK MU/I=$/,U9L-M]2*^]7KE09ML /@S:R$ S_!<>YNH^"L7KO=\*8NBFKALX;@!;PM1SYP]PZO_2FG9Z74G /^668%O.[P_''TB>AN]K"8$;/<+I M=%N"ZYG0^Z6%PW"7.^,L:N ],O!>GH'WRAFX0@:NYABX5L; -5D6\$\IQ\#[ MY0R\3P:NY1BX7L; )4G!))>D7"B7Q'+&WNV3L??[><8NE3)V65')V/4\0BK) MY8R]V\5CEV4QS]B54L:N2%@WHG_D\!\I_"?73-1R9J+H9.QJ.!,UG(F::R:E MK+.2T@UGTLVC/J52EMIN5Q/PSS[YV:#WR.^903R06G9A'1DI16SU)SS'D)/T4?N*[2\^ ?OCG M# *3N"&F]3+XC'X05\R:3A6YKVHR5 U%[4YUO:_*?5-3H*;IRI.B_HN\8/T= M/WC#PYU;3F<&K>=9<*7*%UIW$7SZ:9G![$H2Q?]N;=\*O&=T=^ NKB1I$:"+ M_@(XJZN&:[O>U9^0*R=.IY^FR&WI3,'G:N#(C/32%R!.2YT1>>",HZB#(V6/CP:O7+)]/R%S9X0WXHF1_Y MTJ?H\4]N$+CS*PP*Y!D'N'Y&]!+ROO#R.UXNQ! S 0)G8*[>'%V^()(-__X&7Q0CIX[=ACI?Z%HJK\L5J_F^JQEX1OWNJ&".D*D73T/808#,E? M6DC+;H,J@@G"H4 .] E$\I#$1-\4-2WOJ&DM1DVW!C]NQX^C&V'R.'P<3;85:_S@>PP- M?C*Z_O$P?AR/)L+P]D88_>_U;\/;7T?"]=WW[^/)9'QWR\Z,=E?-^!G] R#3 MQGD.7*?]?_XD]<1/-Q?7%X(L=E7]X%0*'WL_Q8+?&OSKM/^QPZ%>*@Y]=;UY MR!IL,CNN<[LD=;*$*!K]@(T; [M%#L!Q?1-:5S>NL<3A\,>W!;)_L$6*W,;6 M0!([?R-6Z_M3!FG(T67"J.E*"C)JPA4PWJC94L';5HUV(7RZR9CL1X*;D?^L505Z\"CM&IPVG>^0,*9D>PD.\ MTR[\<"S#-:'P?7( PWJ2I(9&:&;@_FT)/(0Q^^T!+EPO0$X>D@(0(,\*S=*' M!IJ/:S\!VW:#)_=U!7&Y-?@_?](UM?OI(,H/K\\%$S2=3MBEYYY*(/3\VX_A MP^/HX=L_A8?1_=W#HW#_XV'R8WC[*#S>"6B->D0+D2 IPMV#('4_F!^%NZ_" MXV\C86/Y6B]=P^M'?%G2%76+2 >PJA[!:@9CZ BQ0^VRIP[<13FT1NI7"&90 M^,\*D4*X*2A Y&":0AJ:R4VC679YOR>AM%HXQ95J; MU&AM4FN^-CT^#&\G8[("%;PXI?%\SV+()Q*&V/'7[GQN^3@K1OAJ(;,9L?\) M>E=">@2.2$X+_G+XW16TNCAI1\+-V27Q%/->9L*\SQ&SU/L7NGCXN![9[K,;?K S#G7Q M>A+M-/3%UN4Z0ITL(\5[MVHJJ$J_1M^'M:()C M,0]([0P?23 FFS!$)#^OTB /O+("]#(C1=3CP^@5&(& 9X^W*=[I(0!?F"P@ M[GZ![%++$:S %ZYGQ&K]F"F64R&WOJND][XS/KF;/F*0PU=*;2B6N:9G%=*Q M8T1)O&BU(VF_U\A,#+RW:V2Q[=M+/KYCX;DO^#GO9KW6&MQ &_P$'J1K,E6? MP(_@=1PEY1J$R-L&0;\UT/L=495%3>Z=X@U5";GI]2"1P%Y]22Y7/CK MTK-\TS(P%;%"W<(NN\(VT(1;]^)C M"EL\G,W@\Y-W>7C99<0RSRI]0]/TH.]'_WQ#SY-6DJ>W!K(L"_^X$+ZAY?C: M12]#_WZQ7\R+MC!96@AYR%)-;YA4FT+7Z-<[[]']N=;IDM@:C+T7)!^[)&AG M=H2BEQ!YOO/NT?IA.<;[=H>$?-'_W7W+J2^Y=]$B9?__UB)3-X.);2&L(R!@$"<#;#O\4#9_X M";V7_1(\,C5\@%58+#U_B5VUP!70'60]E>0/3Q^QQ.%-AJ$17*6?UWG]-%V_ M4*7N*>$95;SH]0K(ID(>FDP_4PV-MB^E>VQD/5?%$CSB@AQ+Y7RT@C E<@2, MF7!M ]^OH!E\ZN0]0/3.Y&W^Y-H?_"IZ "=./5RK5H$FPOS1JS$#SC/ZP!'^ M,;/0)P]K[1;G5U9_F^SH4BUO+M61RG^3Y"NENAO&_A')2*G'MK GO " M["44_DQ"WA+>4A;\V9D"'16@921UH="M"4FBO)Q"6VA;2608#=^-K$%T=3NH M)N$<=V1IX/'^T_5^#S&Y%NPTP:*:DUE))=3]UD"ZD.3N?R-#SK%<3[AU S0^ M$PEU8@I"<\@7+\:B5$V4 M95F.9)E3*:%D^OAG6'/+%RW(WDN7>D),IGS#W MN# ?)W,OE3 C7T4^;&1KS45I+UF8^Y$P3P>>3(GB]\0 ]% MS!3\I3$3_)F+T]%71RB#&0AVI_(3;(\7#S;\8X,V_R)J9$Z:'72\]#STX/ F& MA3T P=)?0Q3Y@?^$_BX4HU=%@#SSJ3>"KO4IZ4Q#H(GOD ;1%K/+"$743VF2 M;[K5T E8+I!(S*T@0)($;20:GNO@M<%^$W!QY3=AC)<,8)#DOAL0@/!@VHZV M>'_&9OK2PQ+=J8K=Z S*,BR3)DPZC\('S$WMDR K\D5T1S"S?#1DL,!G40ZI M#8&2Q@@'O-8!T/]XD3GM6Z)+E&D@0$&PT;"L PD%SC M6ODF0;J'E\;83P4$TT[,!7^.U %ZA[=:P)!HS!$%WMK8&$ /0^LF)M"S\.RY M/X/9ZO(%L@T@&9D)IY9#CD.3O.'6H9&UA%;LAX='T"+K?.O "%KXB!O60I'U M(C]UY)7=LFFL7##-^E,._WK7B(+/KO<68R63FPAMC>BF#8.YWQI\B^=.O"8[ M27K_@5B%%;J?4VSEKDK[U5JJ5PLE:L_A+F-R,*)(-=H8AMS&J4W.E'*9,CFT M9&PQ)J-F)0]==:9)6=-#T1.+>C2&*:/X93H/2U:/_)4\\7JU[JC5ZK>"@J;E8WEXLGRA!!S@&5F1(->*#W?AFW#C'!)[I"_@DMV4> M.NZB? ?8^TTYO0IF_C([BOX,VC;*P@)'Q PB,T>%HE(84%_C%B#/-X352L> M0$;QE0Z*+Y,>9I=MU. X>7B6#C/8709$6HG8XE,'_HKMWN8QO.U#"]%1A9#> MZQ,,;5QU!'UYN'Q>^D%X40VKL)&X3 25KR26@AZV1*XB 4KXWM8.>/06PJ9A MH:78_Z4UOOT:$W E@R)CFI!'W+U/9KMN')IOQW3)X1;\P);@&P"37%QC3,85 M4?OM?E=NR^^I8:NQ#E)YCB6=Q.OVI!.+NVN:7D1=VXJ%_)"SS8-R0:H?C^%?"$1K,, M#G\EOM5(W#'^W?X8Z5JAX.;$X7=F:Y%8@&?8>?(@^+T#I@'TKH#]$[SYN,09 M[Y?2A'XI5(VDE+7PXTK(D3K_DQ]?)N.;\?!AG*YE 5.S>J\?'Y9_K][PB6FZ MK@@NA+6"A1'Q87'AWW!V[]5_*S;#Q^&7;R-A_]TA*_C MV^'M]7CX34#._MW#]ZAJZYX%D6AX9S6L3TKD3<)0T4B)*]A7%E(RCB4#4I36 M8!S N2!=9 ("YUOY?/NZWA@@1?GF!_R!-VJ8 KS,J^W!D^KVLV555QZ1N, M9^QX< 8='Y\/PGT1YE#X\,WU_8_-L1;T2EL+^MI:J#8+^();CP47L5+E"V[Y M0&%=YG%902-:<-_7K*VUZ@NP@6- 83*#$*U781IB994(A)756'CT%=YT MQ%!;@^G'U3EX7'\W<,EBDK 8\23-.B-"SZ/9T6:DH8I3V+O.T]_+' MDI%QWX$#GHDF_8LOW%B^L?1]7.T"6X]#!]AOOD4L_W?5BS2R&5;>P?<\0']I M[V9DWHNTLL*UJY=WCQ0W*[8HQBF'_WFMB>+Q65BM M"5GL;A6;6%>;N'O\;?1P$K, +7X]JT'MH4LY5K MTZK*I,;.MB]G7$;&_7#"?@D0-YZ< !MN'OG8Z)V+@V _?%(E.3)FN>ZMB>[5 MN.ZMK C+"CN;NYQQ&1EW Z> Y,S\6. >-="Q7&]#YW+]6@O]BCG-]6M5Q;3' MS@XN9UQ&QGU'WT$V[10B4W8C5X;KU7KHU1[7J]45SU5F3)?KU?+'DI%Q=Z1- MY]@).Q6B1W&-6@^-JG.-6EG!5.1(H_:X1BU_+!D9-WJ=64\6/\-8$T6*6:IF M.N?K<-1:+]3;&E'#6DOA-44"QH( M>>*5%2 ]8*086GQMC!.9T#O"A*A?80E*JNC6QPQ-ZL?M\,?-^'%T(XQO'T[=_2B<=JIIZ@>F>>;NN_I%MR>=TGU7 MU2\TD7Z?7$F\Z*FG/?;XM:ZB\L%6:K#=PYE>NCV?BJZ?A@[PI\% M]%P;ERUK"_#5@'A&,^"%=7<6T(O^,D$ /N;C@6% F*,X^9DC@(1 MQ!1 Q\/ M.*@(Y&P3%H68:9.0-U/S_FR]7CFN\]4#!BEUMW2LX %'S9:^V4*3=_#HR0=& M1Q);@@D-:PYL_Y=6I]<2'#"'^-;.,P"+JP?X ITE_.JYYG MV%;[/8ZS.N.L;)AUQ=:@V^[AK70.L_K"3"X=9Q+&F2BK#.$LKV%?!:/RVO4# MO*5XNF$9,^F*2,@'FI8E)N3=]%?7-?VA8TZ@]V(9T)^XMIE5$F2\L$NBOB<) M'U,+03P0"U6VJ9U:#J4DXY$>E)360&IK?8E#J:Y0.A>2U-9 ;2L*1U)MD91@ M M*#$F[NV>YJ^Y9>*5"B%#DD[];"O#B6[;U?/=?WA87G3JT@3QPQ==RY(K)" MTQ0D-+XG)(Z!?Z\UZ%&+VF0)_U?%UVXTM!(6]./0TEH#3:05>.;0JAFT,B K MVX+>QUZ&(FD<>!QX)UB6.9"G8^2I^%1)-9#7A(CB!-KHP^>V\ P=Z &;[-T# MW3Q9-Q(2-GJ^XL\QTU-<%,0;.36H-OEFQFUA4V"=7@K'"UU14N"1989+EIK(#.R M%C4A@/8 ?0@\8T8"9R9\@;:[P"4D>-2,R@&0D+C($;EY)^UA+P3W&-L/+W/G MM29H2996#A6FP)!ZIR(86*:R>QP): MFA -"PML?S!FP'N&_D?A&5CX4+(#JMZWBXPXZ'*#%V#'=^ M. BLR:V!E ?UW%-E.3%D;T'UT?C1;[EA@\\],'20C$/GW+989L2HK8'"0V(5 M0@M-6RP)+9M):5/K%9J=/Z#GQJ"HVT):IB]+\B>&M$\38F9?70_]Z>"B,3/@ M/$-BKPD?;-?W/YYNM5775:%IM$6TO4:B 1WC[=%#XPH?^RLB\C=$XB\020@D MA[[W1**'EN+<*>GU9>(6H()WT86!!!34A!O?KNPTG(/[CW_QD$L4R62/MZ<:(M2[O+%YT)@$^*'H_\L MK>!-L!P<%!0@\!PT?"0YM]A,'/-L?," M_8!T/XV1&+PKD]LDX+X[R\A)6-E/18[>&O1HE7SBR&$2.84 1Q>1I\L;6=0: M. F6WJG(P1L3$DNM=F@&#@D?=@TY\K?EF(@@5QU]OXUTN:W07*?COL<2H>-C M8.!M8)>'!VOK#=-PB%)^A $G:,CM)^1,8A!D3#L@-SGNG8 M2:TPX!7BQYH=$3<0,P@OMEFQXD3$B(@-(1-BQ$YF)M^"Y^R6V6-C):2=+!*%BC,<+"R#A1Y69%X2H>Y@231= MTZ-%B=L#XV' (EE]8[U8)G3,R-X2.@) M81'FR A;Y^SQ>GYTBC"[VZ>>#H;1)1$WP6#(!>'^:GDE_+*#1T<^%NS82PS&5XWR-XA?[H-? (JGE .]M',"Y MC^0.O]5S20?G(S%J"9_3H'8\BIGJ"Q0=[49C-=-ISL*QJN!^]+G=&8[5>F*5 M*:B2RERY/JB#2/KYY^('I; I%D1>[JEY"T<0+2XQ'6ZH&&\FF8U&#!M<9B MRF3SX%A-D$(-*/&-3SA.:H*35 9@*J#@OB9RGI-4/&Q:?-B4QTK+BI6B.^PE M)M&]Z^$/AD'@64_+ #S9\-%-[<_+>$]+KHP3Q/WYBH5):<%40LZ(2JL-"X=I MS6#*"DIEG!G.]YPX2HL)CM*"*6XXHU8&IDT(?,9:W&LS&]<%-RT_LL"AF=< MCPC4:&%,,,!O-LB]%L!M"8V]Y6:)>[7?SX /[Y;!/9J(:^[L::1O62C)*K6> MA5EY7J&@2MUP7$R6;*&(WD=NMS7(4R:)P[6F<&43K3TJ">$N)M.H1'<36.OQ^FJ M/H4J1/Q$,\N0RF73G0(IG4+Y&0XIEB%U9D0I(E=2-4=4+DO^%$A);"FIAG5U MCPVH\QAZB4DLL8+CWT(D4_%>KB+3JU_)(S/L0Z^8L'=>$"JMP?Y.*7NA%HX_ M-N/8>>&G4BDYP>%7-_BE-6?SXJ];#?5',T%;TAFW;6_W.\?S/.QB3-A[SYU: M 1:?..'HX=QI6G$#9G0T3_<[2^[T<6CA-E/4RL9R:-4,6GF0A3M42;S6"$?6 M*3G*QZ&EX[SBRIPE:D)>,385/ZQLQ8\"MA4%L)$U+@2NX&SEC0M6E#B>*RQ: M03&AVF@4T?W=\SHQ35^-W93B)Z5K@J"$19P*@F+WH#B":H*@,P!(YH62:PR@ M!&./"H*4N"I"E2_B4,48X9[A=PUMX$ ?"M>NMW##8# /)!832-R2I3@Y47D= M!HXN*L9B'+JZ.)S(@SX<77D-R3APX<-3$M\&X>#*;63&H4MK#?3J[(0T(:@X MG*,)!/N!Q$SV9 J:;#!+0>PPW25^T0%NL2TQ\6BEZM!R@G*"1K* M,I)UMY]R5XJ,,ZI(%5Z=H>,I_,03>[4;XX"CXSJ,M,)4'#A, J< W'1%'"-@ MJ51^@+P5N< M#%$\2,FW\MG.0'&%L(JR(0XV9(4;GQ"-/ M6.*'&EFU-9.V7+L]GHO$T554+E)7X[E('%T%Y2)U^SP7B8.KJ%RDKLYSD1@S M&W?#D\C^1W.=SQ$2_!GP8,B:CO $?,O@R4@\U8,3E!.4$[1YR4CO^XT\[RC. M5KJ'W@0OF,>#"7+V35WTX"]X\8V>'AE5XMJHZN$.M!-K2.:S MXQNRB6*BM@8B!7N0[_6SM->?VB"DL.6?B+ N01@CN_P<7,6!JP1L]0BV>))2 M[;&U:RZ> UP:2XJKZ>E)Z;:6^)8L#0-SM:8<1]OI89=(T>:[3 M>ZZ3:=G+ )H\VXGGDG""4^51!9+>4])& L3"+IL)!!P>%4L\RD)7?T#&HRCJV;H*B;W*0E> M.L]^8B_[*6FSB6_;%I'_%(E*C)3TZ1ZGY&D"-<5;MJ24(WB36@/E0J=U1H[C MK:9XHP6W\$CFO@?#X<;A=G(6U!&\D4.;7:TJ>&M"'M0_R!_0% :%7B&8?:3 MGS\?/W,F1-4E*"3<<5MT?/MU5WQ6#!B&]+]=SI^@=SRU%847W*L[ MW$ZT.JC!30_A)LE*6U%YL]FZPZU%_C6ME\%G]&/UZCGPGBTG#$#O8,* B,!>Q/[!YR?O M_ZF/H88B/0E$,@;1!$(AF$$!&(8[1Z]_PP>@'#= +PA<M$%@ MO+)2^JLE0-12U.]7UOBKW34V!FJ8K3XKZ+TEOK;XT\U8S6""Q[3QY$/S> 5,T MP2M@_P1O?NMRFRZ(*#M\2$G"PP2;3@LC6,@WI%?<,/_I"BD!Z.&[T' ,V,1 M9A[6LW]*9AWRV1^QKA'O1M>#N:C(3K MNX?[NX?AX_CN5AC>W@B3'U\FXYOQ\&$\FJ32B@Q-ZL?M\,?-^'%T(XQO'T3NV_CFR'^DW>%UY^UU478JBOHCA2].;H\@6YM&-%A-=4_4*7E8.7Q0OIX+5CCY7$ MBZ[>/>FQQZ]UE<,OY8-E<+ ]44[UV(0H:*);H^_=&N.WA/)Y'L=EU^3<4T!$ M8!_12@F%[^B^F2^,T )J$LOYKTL'"HK8%E*4=:@K:2;6:UK"Y 7/AE^=(<.& M;?+)HJRD0$^J":?*BX%SG?B:PU/A(ZBA\'2+YYJZ8C#YP.Z>3IE MLN?Y5L5,_?7=$A40< S@SX2I[?X49M!\AKPV[.E["L?$YQJ1^2NB\F^8R)@% M^,,ASFU]@(8-?-^:(I*LQ D+S692^M1ZA6;G#^BY^\(DBR)N>]&7)?D3+R!; M9_@E1*3IPF\?9A)RA')O>7"$L8RP<@$FMP:YMTPXOEC&5\*62=$ P[NV+!59 M;UB ]![S%$$$.*:P)^J@D.C$0N0B)"[[K>X\"5D MPKV-9I3&C9-%7*^+H3U,'CM@R>;,A;7TWD^7FO?#D<@R$ID'8H\#L1% I!%- MI;P.:\@U9PAT-".JS#=(>'0#8 LNE=2B;'7JMA/ZJRAWY\\-."9%?;S3OY^3 ME[G'2#H652@LT6#,T=BL/88Y4BB+0E.NYF"N$; K%G42+IC5WX^UTD,=!UY% M@4?#N#V&O+!V5@601S,V*W?9#\Z&9FR1!FP#>Y1DS2"($:B5,*&_["6FS;WK MD5V.(/"LIR6I._/HWKH.?I/GVFB SV-\=A?Z09P XJ.-O$,8A^C5)^;XK!D^2X$L]=^^Z@$=V_D)DUHKRL6-D519QZ@9=MY<"WZH7M^%@I6R,QX%5 M0B:.3*LI&D$.W\P@N M(;E*HZ$;7C%X0S?>T.V,:&YD0[>M1FY?AFBNUR-A\MMH])AN4H=F==[V9[I^ MT>\JIW0_TY0+6=/HM[V2+I!P%-*C*UTSKDH]NO1M^E8>W:U;0%^&I /"/G(ASR,I_1A!KZ80'(0!CZ/CQ2KR7?K-F+:<1' M$*AN 3> 9 TK>(1K5I%J1Z3()OS/TGH!=NA4G7Y^INX!024A((A(B?\;O5/S M ?J!9QD!-/&%H6-N?[!QYW8Y#VAZ]>+V]FS;"%)H>/6!"P4..$&+KDPW]D!<=(9A9GBDL@!>\ M$44/IE/+MD# ZRCG4/%#PT!$P4*VHO*91]Y8=%S M:W"JB-((HK3<"1P4$=4PN_K6=3K!KDHFY].Y87VRUKW%6;&(IN\RXJ\E9%\( M^JU!3]ZO6\/-XAH!)D&I9@.,C@"CL028AK7]&#LOB#.N9W'3-(>27%'Q#=D/ M60T'!2^F-PA9+J+EKXA&BW6Y"?0I?ISE+*%YMX!A[MAA M*TXAU:-XR?]: RHIEI(#4*F+J2L*B\74&^8RD!J/ CB^T<\MOB0-3,@82LT1 MS:KB[FHL&7;<-3BW9DT'E"X"2FV[6%6DVK\1)4'ET(V\7EI*T_7$;1JEUQKT MVG),DV%&BZ'Q8GU,*>-\X-,P^'K4/"7VBHA4,',51]["5CJ^8#F44C4:+4(I M@N41PEI^R'JEP ,8SE?VN1,N@D7'L080KQ>Y1#BDVA7PI\I9]"M7GFS\4;TNPVC M%LG#.:XT_ ?Y?#4/W'$N0-=&JSEDQ;4JM@9*NQ]3(?L3GJ:<=9K):5WE3!-7 M\&GW^ON%)CYN'[WEX>7,T#W(I!/V2U6Y->BVN_FC)7S#@F5$)6@)JHA2"*)B M>F=5?E>":=\MVDIRG@4; A\*A"P==]I9HC_X#D7>'8H5=;]AXC[@M]Q-?_B0 MQ$#BI$!M#51QOTPOWZRH$6:2-BNR8J:+,".QA)ES^S1EH:5Z'!Q:;+VW,9#OH>[L;#4F)L;G^=6D]D HR' U/'D M)],ZDJ>YT$YSP37V#R8PJ'WD0LDL&0+<>"PQT^4X5G2$%35W/5=N-&;B]*^N M:_ZT;)O;B2R&5G[/'<[3/F*.=&7;X!$VO+6N5.1I00!26P>+0W\;#+^-OX\?Q:$+:-(S^ M]F/\^,\\)7DLQ1 M;;J &N=5)=FY-Z\.)2U+7::REBG[D-BGR@PY?"BK M?-NNUEA*664Z)Y;(V<"N5,,TL*KHWPV7DT(=NH98) F*=H.FE(K1]40D*"Q5 M8>=F[KDU;FY0I2Y(UY.H%:3C=G&^3%T[14"0&RNITG4WY.=$:Z4G8VM%4GF' MK%J#*4T^+P4P*<2-$EDZKUW_O34 MUH"'F6N-EN2(1WJTX / +!W[:7#=4DHF=*-SD]+'.TZUAGJXRI N5R9-B6?' M,:6<*2!0(XGQ^+WS*P^ U E76 M8C\Y026%644U/,[-M*[]X1AH-,!RL)85%JYO8:+SVD#Y@R%O7UUO35TD'_\%GIO7H%^C J14([A,:"SA= MAS;$N$@JC X=/ZQI3W;;$? ##P:6!_$Q'?0I_@#.%[;[AC^(:(]K7ON;5LA1 M*2%E?7DF1ZU1EE0LO7B4D4+ %4KQJ(5-NUM />\.8$.LDDR%T]>X#8L3SEF).7X.-S[R$S060I]<6.T[+3BXX#1 MD7Z,:PZDO8C;N8*FT&D%YJ*'2H(9TD!I-L (F,^#!F6N;T//_ M(N &8L$;+T9$;REL ,EX,:)82MU[J\0&/W"-W]O'&X3>0X^(XG'+X3= MU@#!MBV&_Z7E0#AV :S?*WS /7^)O11VQ3T'8^Z6@1^@5R)-$#>UWGF(GS * M[3RC&/O^$K-_?P#][ ,XA1F'!X"\F!3 2OY L,@K",C<=Z+G:5# S]^4.!>*ZER-HFXF+O:O72>??9NTR(7OR&I*ZJ<: MMTE+WHG#"2U;\2RV;0:*YC4;]1,,VPP4SCT\O"%/S:JE;\SN375E/&6<)BZ, MJHEMM=MO]Y7]+)=-@ZGP*6R9P1GG@>MSBF@.JM96E?VLR$UK[].)_D5FX3B1 M)?V0)9+2;:MRS%1RL"3S%/*P1 ]9HFI*6X]I^$O+ &_(KE"" ;[!N8QVDR+2 ML[[YQB++$$JPOO- B)[IS:L4E1\.[Q%7H:RB'!X$_M)[6_D&("#GM(LRI%:O M([B/1"!Z4J;U3A&1W]"3VCU):JLQQKH0CJ\HXX/>-)1P&N@_5=\_[1I-HYD1 MLP\T5^PMCL4HW,2C<(J(7"AD(^K[WLE''B^K!X82EFP*&.J&&-I76*5@J&&U M6X=HU)C8P!86P#([EB,88&$%@+<9SU&M;TW4>T33L7,=4C0._#CKO,_[$]0: M+4G5^M*C!>>:4^N/R% N956TY0/$YUNA*4#@.;@_%S^D<[*27-%R%)%R:!C+ M^=+&.Q(W<&H95M;"#(J(XY;(:5!8*F?);=)SZ],"@*438,E:#8_Y5$7U;G!1 M<,GI'\.=+SPXPR=C7^"J -,'V_7]CZ3\7L,,V)RA 1]- /T64TIX179R[.-Z MD^AA09UOB.*W,+B;/H+7&.&1Q-9 $_>-EO3>';=NF8;2GCHN#DI2:Q#7@:L4 M*-$T?2M2I_H:VL"!/A2N76_AACU[PG#L^A &/'X(@Y>2S&4SDRA;1.OPN$M6 M4T:2<;2M)].R9'@QTYHA,,&XIH! A2!0H55J@=2YMHV+D5@( M$AX\M31U=0T?FKKZN^6X'I*/<43+.%' E9WRUX[@]C'+,$E0J&E@@C-!J57[ MY[;O2;8O-VS/:]BN.X7>X_8)KC,, L]Z6@:XD=BCN[U>OJ,UL#)\%M1I&K232JKQ;%0.:O%ONLA^J#A>,C>)4)%,^QP*RW:JN=O"4.=NA8Q_#FDZG<3H M0%I'D.ZU96H9)N5#FBP]EV3Y764*;Z208T"\.M,&B9Z$$9F4 M-8)0"&90 ;>X@3.&P[).&Z 7A"XY,K2 C_F)H M$?+Q"4]20^IB.U]Z@PK1NU4Y7%E7C16N/&B#P'J!GWY:9C!;X7?CBQ%?Q?>O M@"RR3=^XM%C ;&F4T7NJYH,54-1NU-=[ZMRW]04 MJ&FZ\J2H_Y*[K=679M[[L89GV'GR(/B] Z9H@E? _@G>_-;E-ET047;XD)*$ MAPDVG19&L)!O2)-$FT!72/:AA^]"PP',C$68>5B3_BF9=/HX?Q=S2[V\G=M_'-$'\X>43_?!_= M/DZ$NZ_"Z&\_QH__3#7%0W,DB\:[JB,+%9JK#18^O%K]\FEUB,IRR(C)ESY% MCX_T(Q;FG46*O"^\_"[G^(@]EO7(4XK>'%V^()=V%M[PFJI?*$K_X&7Q0CIX M[=AC)?%"4^63'GO\6E-<#)5=&4D=B6(%)Y0+1Q?>\\YJ-CJ0]KAW%TZAY-P\P"O =3C MP#PG,.E;+DS3J9^*3A_&CO!G 3W7QBWBV@)\-2">$4:F8(( ?,Q"0_9J753E M3DY83MAJWD4J)#E42(JHM14U=Z=FCB56L!2GD'I% M*B2%187$G4;NC5?KSH958"$Z1P _@6?RH!]XEA%$36B&F."D*,97UYM"*UB>4%-75EN#GMCNZ2PUXN6'3:F;#5H* MLV$?=Z1N:W;8'30*T+=]9E3=Z2L*E)W_&Q];; 7I^[Z[*@[C45U MUZAS^OM!=8B;;-(*IS?F)-H!):\7&=KJ'V^>Q>C!YA+B7HU!89RZUXL,BNFT M@V(HH>3(63\8ZP3:2BK2-Y*,] 7GJ ]M0RE10?AM( M1PK*YZ]XHRA,]9[C8"I"+\E%ZB65Z"5-Z;7E?NY*8!Q*3.LE^7QZ*>J)F:=K M"D_-8O_.AF4081U+3&UL5F\UV19(T:;H=T0FIVD91HIC+/ M"JI65E"MY.J )B_R^*TJAA%?W-!9I'78+1VW*A1SJ17\LD5C]H[L%A:-4:4P M&B/FC\9P +(,P*SZK\C3OFJXXZ6):EM4>US_-0!^V?3?W@GAXO2?0BT:72P MFY +-$1#Q;0'MG /++,S=H1KL+ "8!>3%U2!1!8^Q.*&R'.!,N8"T5CX^(8M MET:3D,#%EE55E" M").VX," +"+@E?FZEGS?0$XX;#8T_[WT ]):[=%]-\JQ33YV M(HN<^/]/N_L'#[@3J&\%< *]%\N X8;# S3<9X<\A>P]Q(EVKS606&H#SB)R M.?IIH%]).&54!OHUQM#/L^)8R8IKZOYDA4SW6@5J,VG2O=,,IQCU.$VE3^O< M2[5V 5AY!@?Y$9#OI<:? G(=@5S-7;&)[S10 L ## #ZT!1&P,,!T%3=J%BW M_:MQ:)>59_##PWS#H#GQ5R5-DGNNG?0N+O$BU?RH("O/X(!6TN0^YP.TA&L6 MM26Q0AL.[ 4\JG)GPW9R;F$@P,CV%3[8KN]_%$ 0>-;3,@#8$ IIH&1YN-ZT7RX3.D18:W'YF)LDZ:9FX63$S9#&Q MI^,D4&T-M'T+N18UAEAY!D=KXD*1%JU=A-;]Y8+%RC.95JG&;@4S9JXUN7JO M/=?, M7V[IW2MK-_X)D]O-/TEN0N^^[2 MHQL .S;S4R"%(B/._D6 A+=U<)C2!60K)-B9^DX7?BZDI^(*BSVY@,./">SB M3A>7A4QK7$)&' 59Z*)UK]WOYTZN/ILL-.$P\*WK8"!XKFWC+:8QPH0'_8"? M":[43/F9X.KOS3*V&M9]O4O(J?UN.:Z'5KF50HQ;T'IH0>OQ$[\ :T)^ M:1JX:K@,2X7.\]8MM2?-L5-GVQRS*F..U3-O(I.()N2];AWG&V[P_='=-L*/ MR7"_WIT467D&1[.:4":7"IKUUF!_WX?9XZOLU6VHRIU4"W_VXE=Z\K?EF- ) MKCIXEYPER;NQ_%!"$,#]R_518>HK/C?*S[LQF+#D[UKE-]# W='A5\^=;T'B MD-+\+0RXQNA.#;=19"._A45P_;;V#'L)2;)O>OAQZ<+^V7+$M)4Y->V MQ7[NAD#T,<#]8RZ!)>?+2K$ 9L8BS#RLMO^4S#H-F=(DH<.="M=8XSMX.P<,XF!Q@!>E MH%F+1?/UZ-OP=C09"==W#_=W#\/'\=VM,+R]$28_ODS&-^/APW@T2:45&9K4 MC]OACYOQX^A&&-\^CA[&W]'L;B=WW\8W0_SAY!']\WUT^S@1[KX*H[_]&#_^ M,Y?B#Q-\UJJ.+'AHKC98^/!J]3O"^\_"[G M%V(HZY'[&KTYNGQ!+NTLX.$U5;]0E/[!R^*%=/#:L<=*XH6FRB<]]OBUKG+X MI7RP3 ZVE^JQ"<&79.]$:NW(6R1!B6IE^J8*=NDDT5921/72C/AIA%.IHJNC,2N M!)%(6^Q4:3NY\+7WG(-JK3ZD'<[=I9.F7"BG'@=FR<"D;[!&/#$Z_;W4MJV*I./;KWN;\>1K8]]? M0C/=EKKXOJ6.>_>(_;:J*6U=R7WDC>&S&PW#4ER.Y%YIVVR%E*;6*S0[?T#/ MCF[-*=QSJ3O%!;U'=4J3G6NUI"MUOSQU(ZJ"UJ\EI?T H-;?34, M;O55K:U2"VXQTUV(_O',^J,P[OAS0FFC$\)B&Q#LT@Z+"'(6Q2E!.J%F43PE2WZQDK^-9!9.B'G&%OJ7WEC\MJAK]5?@H M>8\8GHY5-EVRA@%[1=I&_=:@)[5[Z#]5S[V)P9,?S@RE3!5LNWM]?C+T;LU6 M.*>OX\(YJK[?H*$699GK"::L>DDK4"_I(M%+FM)KR_TZ]Y6J)Y2RZ:6]ADZ% MZ25="O52GA;K/#F+_3L;ED.$=2PQM;%9O?)I?9)81(HV1;\C,CE-RS$ZK(D. MK&K]O57MF#8ZM/M.?GX!/C2OW?D".CXIH95Y%921NA+;8BY]Q7?:6;&CXM:^ MA+8IQW;:#V%L?]53ZMTJK9XPRJRY]C>22]1<*LX4:LMJGKXE''(L:ZXTF\89 M-5?JK""=WJ8RSPKB64'L!5?DQ-S//,&57ACTE:2V*N8V#/A^>&5 F"DL(^\E M@187EM'"L,Q^5G'FL R'(?LPS*H+B]P T\,-,$U4VR*UCO B=DT^XNA6@4^'AUG6M$L?(,#MA>0C_/=(#%C;H5EM+H&K813KC4><*1 M9<'8""VW!0<&9!$!K\Q7O^1["[V$PG%#\]]+/R#MUQ[==P,=V^=C)[+.25#@ M:7>/X0&W=/6M $Z@]V(9,-R4>("&^^R0IY#]B3C1EEL#JA M?D*YY7VH=Q'45;4J4&_"#L0## #ZT!1&P,/!T%3]JUCW ZH1M&?E&7SS@&\> M-"@6FZ;<9IY-=E7$)6&DMJS16NBXV<8!?030:>HIY@.TUAKH[9ZF,81G'J-A M)493[4V=6Q@(,#)]A0^VZ_L?!1 $GO6T# "V@P)7N(9H^8<^%*Y=;^%Z)-K) MO)G,0]V]O;RZ;<6(6#]V#'<.OR&NQZF]/O)6F0I,LX@SCE4J6-TK4Y 1JSI: MHI7<*<:,GE>JP#H2M< ,S\*;UHME0N=(SPUN/C.3?IVT3-RLF!FRF)C3,1(H MB%+**0I@9-/E' Z6-B6^W1\G[8VU>.7VJ97N6& MAK&<+VT00%.X0RN;)^!<00_.H.-;+U (O5GA _9G/[;16P/F?:44SRAPXYFQ MF99$K89%IXO=>&9LF:S@2IC-<]M;"C.<\]Y?]M36H"OUZUD!BY5G<-1V>GNE MN'*A%F< ROLUETM!;<-"U*$99FR9859DAMFA&9;S(!L/!9Y5-+6]<] '1)-P M?LO^?M],(NTS'\%KG+#B1*;^?A83#VES'%/%\=XQ"LHXUG"$(,^BPV/=/-;= MH !?)NE5]TZ4YC(0^ZV!)E(H2!]+X$\%][UUD!5*+CQ58E:DW?+ M7?;=I4 M7, !R 1V<:>+RT*F-:[P,R6RA-:]=K^_7Y6955EHPFG@6]?!0/!- =/G6USS*J,.5;/O(E,(II09F+K0-]P M@^^/[K81?DR&<>4PAH[\L8A$CF8J:$Z(!U!!88*7"1+7]Q!O+ M#^4!P=F_7!\-IKZ^BHCR.=M$QU MGJ?%@5X(T!-JLZ MGC5V#'N)27+O>OCQZ>)2V=)8%+$UZ+7%/JV-%(H8X"X=E\"2D\+.(H$23JJ4 MY=S+-#L22!;R2T(E]*]IO0P^HQ^KD<^!]VPYH1VQ@R\#8B)&4!I\?O(N!^OI MG_H8:HC4DP IDR:+$!)O$QCXH"IPWG!@U'$#2 *F^,K2 0A3N*X(B9=:4)#Q,L.FT,(*%?$,**3H-<(5T"/3P76@X@)FQ"#,/J^T_);-. M0Z8TR3API\(UUO@.WH$ @SA8'.!%*6C68M%\/?HVO!U-1L+UW35)I188F]>-V^.-F_#BZ$<:WCZ.'\7:)IV\+)X(1V\=NRQDGC1U;LG/?;XM:YR^*6Y!MM/]=B$,$&B':WOW1IC MZ88H.H^INVM8[(E0V+W9>A6^H[MFOC!"2M(DUM%?EPX4%+$M;%F)>2FTX:UD MB/FP33Y9E)4T098T$TY/N$B#[#^J5H25J:)/KQ3Z^JF(]&'L"'\6T'-MO*'X M,0N]:G$NYVX!L8&'7*$A\FU?D,,!V4\"/?49#J8E9 H#'X]! MW7ONU H.-,E09-S0I]>&5(_K:03>P$ M5QU]WUDKMXZP^>^E'Y H'@X >A"QV["08^K$G)_ *97H8P/X,V'AN3C3TA2> MWH0/2Y^$"S\*[GHA!8U?2.N=&5PAM9%4D.J<]UL$_Q*2>/2Z0'?!.%&)/;](Z3C[ZR"BI:2UOCJ#D MN!<-".D(0OMF+8OGLBH7VZC<@.OE,]S *?0\$B0D#3$"\ I]T@^C89Y!OF7K M@&6WHFY8(^(1O$9F7*1W8E2-*L:5-JE%;Z-ZXH9NY"4S7' W8UH'M;@'D%5G M_ KPW@K>@Q$0Z_%B$B5%XY32IZ6/ON'[Z'TDKHU^"W*HUJ;8<\=%!%,<;V+> M.1,D"G?3>P_O; 5O]S9P GSX8H'MNCA)D>.J[' OH":H2="LI\-&:0WR-"G@ ML>S3N$_.5'6> -Z_Q@=BT#((3MX4;(AUD7!*#?=N^(()>KU!SSC(XSW _8 B MCTW7""H)ZC(]5G!;2XDAK#3*_OSAF*MZ0TA-KI."+,S\K;.!8#JU; O]RH/1 MIRO0]T*/N-)3>-#W.PQF+O+77F"4JT6Z\=VL:MW=>5L%H>($J!?KP'&[M":0 M2E"TQ6"*M'UD U.-,EK)#@,/GE(*GA)JK@^ O)__N ;^[*OM_IRLCKG'B4 _ MG[?/K=<*6Z^Y@*.W!CR>6OIIKR.9[,CDQ7"PG"7Z($IKYUD65#0N%I#[B.A? MWG[X>" M\!9N;ZY#3'R+,W>>[E+MC"K=0\5FJ:J'<]K8PSJ=N. M.6$4?[*N\E%2N_DX#HVT$2S!X M&XV\!&LX'_3PL;T83XI1Z%&RF9E6ZF%".X52[FEMI3*?T;2T(+"P2$]27*_ MM(*E!\F)^$5TS+8M+/!!6Q)F@JO3MCS*='I=+/!&3H8\ND,#D=.#6^>9AXYY M[$AS#Y_O%//DS_$H$]/82:J(E0L\>$.TQTB(LF$-,PB[POHB89(=KC)"_"00 M,M)L6/2I2(WZ95V]A1R_PZ9H=,7<[M0ZM5ZAV?D#>FZ8:T'*6WWGVY1RM8,2ZJ?@#UG[P M9ZX77 7,FRMPI./EO!3)GK0>C1UJ.9K*O,X=$S^-M3;.;+S((*.'9: M\/W&%D(BOIL^X*9\ASWYP";!%]H&Y_'6^3[S&/M"NW#G?6:%_9^'Y!+>IX: MM*"=B06M*D3U"VOTU-:^=F[FJB6O11&]OC [UJ$<%>DS4G00!J@BR8[*9PV7 M,AZ*+%ZVCB08#NL827!A4G#"'%&XK8ZJGJX84J5W8*7H470<-""K0RFQGA!4 MJJ2H:Z"R/44=5491I1_X8@3K+ NP7>>1

B]P"!PW;(/X$CB3$$QH_Y64HC>FP^DNH5M.*T]+'*2K\LG9>DSP3N M?;$Z M8S"8JT\U 2:>93XR9:H;6-_NY<(DZH,(U'%LZPVLL5_&G*+5T6\O9>TCRMK+ M6,IC9M08#VKBX;@P(5NV<#ZT%/W)]6B1XU.P-L-CU&Z,U7V.@I2E:PVD?63I MDDC"Q,\*4H7J%HQ\!HF?TSAQ:,_$3[%,EYUYMU_BW9:'26V,^U4T$:Q-XF>% MDNYEPV_/Q,\M\8>)G_T*0COJE_A9S&9J3=X__A2I@9X>, 5&SXR ZK_RXH2. MR?_ RJ]/L)&.-%%70< _TCK?3:/5_P:+?^?@F<+__S%9[&\,'0=&P$RJ,N>8 MV2]25Q:=-&R;69-ZGU( /QZY?B6T]<]32#\!RP?*Z)9HF:*\,473%*S*4C$9 MEU+2]C1^K_-U#Q-QS7P;'!%\F3[)_'07'<@!DO\*(D2DH%]_"%=I[CX^/G [GAX*"0RZ-JU!CWNR=4L;>4?M!M MM]13)]D,?MJ/6&=Y+9_L^RXLD>F&$YO%_/:BY:YN?4A]OXVIF$UUM/>QK'SG M3T^+D' O@GNO_ZILIM_N-,9#+1]P<*IX)B;U+L#NX?!?TWH:_PW^B08^UST0 ML_GKEV!C, PG%P@9_VWBO1O'L]_U,94!;;0)9RKB[($Q)9@Q13<,=PZO?T%U MPG$#1M'S^$OHZ*!0!N2&AF%:W:GI/.:[6$_OEV3*#670&4C<*>+236_0)#"(,5M_RZBN^^6C3DFO9U4G_ MBZ/'0V9-IUU5ZPU5UC.ZO?YT--)ZJF8.NVPX''4GW=Z_NKU&=-/,BV:PT!_9 MU<1C^H\K?0H3?*_;S_J+WWB771=8E*5]V'()5R_8='JP!>/[!O3-Q9ZFL/% M0IB'5\%P]-J,19EY2(W_M'GKAHWQ=Z0U* C>("$G([$^+H)%:B]>'[[#0OC> M?/Q\_?7CPT?EYN[;_=VWZ^^W=U^5ZZ\?E(???WVX_7![_>WVX\-* E"767R] M^_[Q0?E^IWS_[X_*[U^O?_]P^_WC!^7VZ_>/WVZ_P-R^/MQ]OOUPC5]^NOUZ M_?7F]OJS\O =OOCR\>OW@@EN>6Z'C()\5+*+^ M7!^8;WC6 D\$B!*_ZK[E8X,9YL,.TSGY#@_YU:9TN4B&4+D48SDA,Z]1F#9! MZ^P9ZL#HLTZO-]"U@3H8#-N3=F]@:"-SU%#@+?H",>2%7]/5T7"JLG:OW=,UL]^= M#J8Z;+YN=@U]1P*[[\;3$]]C UK+V (*JQ=W6P'G2,SU!@0)@"0.UUL(*DUX ML$ ']\.);YF6[F'EY3;3="0@VQHS-47BD MY_@+AM).\()5G&&,(',K0G1J*=]3(%Q0@R5XT0R&AQH_J8V8@L(<6"C&/)"> M%J[] E $86NF!XKN@;C% _[@[4\X3G@/K#\^X@H$\A $M<4"ME 7#2YU7WEF MMHW_U0VXV!:OQ3YKSS/+F-$S27";,YAYP.+9P!4P(L5ANF?#D8&'S/4_X O+ M,4/4!9B?G0_S^"+0%A4KF#- M,NN2*IZBAR VNKC)S=0^@LZ 7\$2H"P+](04&/X)20-'C%@(NF'&_.2&^!)< M4WA@$T;!O$>JW>*!# 8K:]D!!Q^NLFO2U1.<.OV\T"VR":&AR*5.[3Y^N1"/ M78"NI,-"/S8SN$D/"*Y"RFS9;(VT75_J EH#[]%Z_+&O)2>W#IQ,H 7_&^H> MG"$X*-\88A(#MS[!OG"5M].^^E_E36/YHL9;3E:H]EDCHDP-!01%.O*N4D2M MX% K'^#[9SRY1N9[V'10S7*DC!^A[%N4WUL/K?2K@LPIBV\'RI?<\J#\MVN; M5*?^\^>;S$!L:TXZH&WI$TJ8BXC>FF$=?V]+XG*%S'#L6:Q%Z/?=5'2B_01. M+%3..9OU,^I$ $05[OM[Z# .\&Z[R?]0VVJ7+H8_5))\@))QAE5\3IZ!S0$U M9PO=$WS- $R;1,^H%P)^#AWJ:+3P@&Y;"R!IRB,25.!)+_@[6P31*P"D#DWT M 6=">W5-HIP.YP\AK_QV?7T/_!NGASR-6]I]' +N*#,%:4?^D%@^0E&J,'5( MFH1G8HF(=O<9IYD1(%R@YH+)IH5/]I-YAH55O43A 7PC1-.AO^C#&Q05']MPT;G-I6>'>R;DVBU!X#_*$(@WOJSIGRQG9]'Q@4.:JF MMOO,7X8N*X![=$#P".GF'R!VT).Y^&/Q!F2N8Y.8YR!<;!BF$7H>%=F *G',)' L)F/Y/D[M3>/AXTWC+9UG?[<3#0/T*' M>Q%HE%E)8 LB05/@R\YYQ@OH#()'?(!=GD^8)_A$)^$3*DG!N&8@*K&)!Y3C M1?S82W.3>$PP=WP7[$RP1(MAF-<.:.7VDO2E@.#U/W6G"W?\)%(A1S^T]V2] MP$U1UHH.ET5P-TGQ>6+1LD4O EH+0& _@2+3[HKW(I_Q^"[6??$BHNJ!5(JD M!%@UZGZIYN+-+//%@X(,%*9.[%*7E@YHM^&G M2V_JV&V>^QO@>RRCX<:?_G#A+

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�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ħ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�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